Sentence,class,file
Am J Clin Der-matol 2012; 13(1):1-17; PMID:22175301; http://dx.doi.org/10.2165/11593220-000000000-00000DERMATO-ENDOCRINOLOGY e1267080-17,Non-OADS,/arxiv_data1/oa_pdf/da/75/kder-09-01-1267080.PMC5386101.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/83/53/main.PMC5386102.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/83/53/main.PMC5386102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/83/53/main.PMC5386102.pdf
http://dx.doi.org/10.1016/j.jgr.2016.02.004J Ginseng Res 41 (2017) 151 e158,OADS,/arxiv_data1/oa_pdf/83/53/main.PMC5386102.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/f9/main.PMC5386103.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/72/f9/main.PMC5386103.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/f9/main.PMC5386103.pdf
http://dx.doi.org/10.1016/j.jgr.2016.02.005J Ginseng Res 41 (2017) 144 e150,OADS,/arxiv_data1/oa_pdf/72/f9/main.PMC5386103.pdf
Evid Based Complement Alternat Med 2013. http://dx.doi.org/10.1155/2013/871648 .,OADS,/arxiv_data1/oa_pdf/72/f9/main.PMC5386103.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/bd/main.PMC5386119.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/54/bd/main.PMC5386119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/bd/main.PMC5386119.pdf
http://dx.doi.org/10.1016/j.jgr.2016.03.005J Ginseng Res 41 (2017) 201 e208,Non-OADS,/arxiv_data1/oa_pdf/54/bd/main.PMC5386119.pdf
Korean Red Ginseng extract (KRGE) used was high-value commercial concentrated pure extract prepared from 6-yr-old premium Korean Red Ginseng roots (see http://www.kgcus.com/Concentrated-Extract-50g.html ).,Non-OADS,/arxiv_data1/oa_pdf/54/bd/main.PMC5386119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/1b/main.PMC5386120.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/b1/1b/main.PMC5386120.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/1b/main.PMC5386120.pdf
http://dx.doi.org/10.1016/j.jgr.2016.03.004J Ginseng Res 41 (2017) 195 e200,OADS,/arxiv_data1/oa_pdf/b1/1b/main.PMC5386120.pdf
J Sci Food Agric 2015. http://dx.doi.org/10.1002/jsfa.7363 .,Non-OADS,/arxiv_data1/oa_pdf/b1/1b/main.PMC5386120.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/b6/main.PMC5386121.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org http://dx.doi.org/10.1016/j.jgr.2016.08.005 p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/05/b6/main.PMC5386121.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).J Ginseng Res 41 (2017) 215 e221,Non-OADS,/arxiv_data1/oa_pdf/05/b6/main.PMC5386121.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC5386122.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC5386122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/55/10/main.PMC5386122.pdf
http://dx.doi.org/10.1016/j.jgr.2016.02.007J Ginseng Res 41 (2017) 169 e179,OADS,/arxiv_data1/oa_pdf/55/10/main.PMC5386122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/fa/main.PMC5386123.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/88/fa/main.PMC5386123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/fa/main.PMC5386123.pdf
http://dx.doi.org/10.1016/j.jgr.2016.02.006J Ginseng Res 41 (2017) 159 e168,OADS,/arxiv_data1/oa_pdf/88/fa/main.PMC5386123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/72/main.PMC5386124.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/58/72/main.PMC5386124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/72/main.PMC5386124.pdf
http://dx.doi.org/10.1016/j.jgr.2016.01.004J Ginseng Res 41 (2017) 120 e126,OADS,/arxiv_data1/oa_pdf/58/72/main.PMC5386124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/78/main.PMC5386125.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org http://dx.doi.org/10.1016/j.jgr.2016.12.006 p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/59/78/main.PMC5386125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).J Ginseng Res 41 (2017) 222 e226,Non-OADS,/arxiv_data1/oa_pdf/59/78/main.PMC5386125.pdf
The authors would like to thank Enago (http://www.enago.co.kr ) for the English language review.,Non-OADS,/arxiv_data1/oa_pdf/59/78/main.PMC5386125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/b1/main.PMC5386126.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/54/b1/main.PMC5386126.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/b1/main.PMC5386126.pdf
http://dx.doi.org/10.1016/j.jgr.2016.03.006J Ginseng Res 41 (2017) 209 e214,OADS,/arxiv_data1/oa_pdf/54/b1/main.PMC5386126.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/dc/main.PMC5386127.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/1e/dc/main.PMC5386127.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/dc/main.PMC5386127.pdf
http://dx.doi.org/10.1016/j.jgr.2016.02.003J Ginseng Res 41 (2017) 134 e143,OADS,/arxiv_data1/oa_pdf/1e/dc/main.PMC5386127.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/50/main.PMC5386128.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org http://dx.doi.org/10.1016/j.jgr.2017.01.011 p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/4c/50/main.PMC5386128.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).J Ginseng Res 41 (2017) 227 e231,Non-OADS,/arxiv_data1/oa_pdf/4c/50/main.PMC5386128.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/aa/main.PMC5386129.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/ac/aa/main.PMC5386129.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/aa/main.PMC5386129.pdf
http://dx.doi.org/10.1016/j.jgr.2016.02.001J Ginseng Res 41 (2017) 127 e133,OADS,/arxiv_data1/oa_pdf/ac/aa/main.PMC5386129.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/e9/main.PMC5386130.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/95/e9/main.PMC5386130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/e9/main.PMC5386130.pdf
http://dx.doi.org/10.1016/j.jgr.2016.03.001J Ginseng Res 41 (2017) 188 e194,OADS,/arxiv_data1/oa_pdf/95/e9/main.PMC5386130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/2a/main.PMC5386131.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/78/2a/main.PMC5386131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/2a/main.PMC5386131.pdf
http://dx.doi.org/10.1016/j.jgr.2016.03.003J Ginseng Res 41 (2017) 113 e119,OADS,/arxiv_data1/oa_pdf/78/2a/main.PMC5386131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/52/main.PMC5386132.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter /C2112017 The Korean Society of Ginseng, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/45/52/main.PMC5386132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/52/main.PMC5386132.pdf
http://dx.doi.org/10.1016/j.jgr.2016.03.002J Ginseng Res 41 (2017) 180 e187,OADS,/arxiv_data1/oa_pdf/45/52/main.PMC5386132.pdf
FEMS Microbiol Lett 2015;362:1 e7.http://dx.doi.org/10.1093/femsle/fnv172 .,OADS,/arxiv_data1/oa_pdf/45/52/main.PMC5386132.pdf
Front Microbiol 2016. http://dx.doi.org/10.3389/fmicb.2014.00183 .,OADS,/arxiv_data1/oa_pdf/45/52/main.PMC5386132.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/95/euw369.PMC5386137.pdf
"LV myocardium and cavity, left atrium (LA) and aortic cavities is done at the DHZB using the ZIB Amira software (https://amira.zib.de/).",Non-OADS,/arxiv_data1/oa_pdf/dc/95/euw369.PMC5386137.pdf
The purpose of this clipped aorta is to provide physiologicalboundary conditions for the mechanical problem which still allow a hori-zontal movement of the left ventricular base as it is observed in vivo .T h e resulting high resolution multi-label segmentation is meshed using CGAL(http://www.cgal.org/) with a target size of 1.25 mm in the LV myocar-dium and 1 mm in the aorta wall.,Non-OADS,/arxiv_data1/oa_pdf/dc/95/euw369.PMC5386137.pdf
The pro - portion of the world’s population aged 65 and over was 8% in  2010 and is projected to rise to 16% by 2050 (http://www.who.int/aging/publications/global_health.pdf).,Non-OADS,/arxiv_data1/oa_pdf/b3/98/nmccrj-3-075.PMC5386171.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ © The Author(s) 2017",Non-OADS,/arxiv_data1/oa_pdf/71/65/aps2016136a.PMC5386307.pdf
We found combination  scaffolds of salmon fibrin with interpenetrating networks (IPNs) of hyaluronic acid (HA) with and  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/39/nihms854854.PMC5386322.pdf
RPKM (reads per kilobase pair per  million mapped reads) were calculated as described [ 67] for hg19 RefSeq genes using the  SeqMonk program ( http://www.bioinformatics.babraham.ac.uk/projects/seqmonk/ ).,OADS,/arxiv_data1/oa_pdf/5f/39/nihms854854.PMC5386322.pdf
2008. http://dx.doi.org/10.3824/stembook.1.1.1 14.,Non-OADS,/arxiv_data1/oa_pdf/5f/39/nihms854854.PMC5386322.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/40/main.PMC5386405.pdf
"Also, GSSG methyl ester is not suitable for in vivo study since it will be quickly hydrolyzed in plasma before it canreach the targeted site.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.06.017 2405-5808/ &2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/1a/40/main.PMC5386405.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: GSSG, glutathione disul ﬁde; GSH, glutathione; DDAB, di- methyldioctadecylammonium bromide; PBS, phosphate buffered saline; FBS, fetal bovine serum; BBB, blood-brain barrier nCorrespondence to: South Dakota State University, College of Pharmacy, Box 2202C, Brookings, SD 57007, United States.",Non-OADS,/arxiv_data1/oa_pdf/1a/40/main.PMC5386405.pdf
Appendix A. Transparency document Transparency document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2016.06.017 .,Non-OADS,/arxiv_data1/oa_pdf/1a/40/main.PMC5386405.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/prbm-10-085.PMC5386595.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3e/0a/prbm-10-085.PMC5386595.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2017:10 85–95Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 85 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S113093 Compulsive exercise: links, risks and  challenges faced Mia Beck Lichtenstein1 Cecilie Juul Hinze2 Bolette Emborg3 Freja Thomsen2 Simone Daugaard  Hemmingsen4 1Department of Psychology, Faculty  of Health Sciences, University of  Southern Denmark, 2Research Unit  for T elepsychiatry and E-mental Health, Mental Health Services in the Region of Southern Denmark,  Odense,  3Department of Public  Health, Aarhus University, Aarhus,   4Research Unit, Child and Adolescent  Psychiatry, Mental Health Services in the Region of Southern Denmark,  Odense, DenmarkAbstract: Compulsive exercise is a condition described since 1970s.",Non-OADS,/arxiv_data1/oa_pdf/3e/0a/prbm-10-085.PMC5386595.pdf
"B. Winsløws Vej 20, 220B, DK-5000 Odense C, DenmarkTel +45 2 621 8846Email mia@mialic.dkJournal name: Psychology Research and Behavior Management Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Lichtenstein et alRunning head recto: Compulsive exerciseDOI: http://dx.doi.org/10.2147/PRBM.S113093",Non-OADS,/arxiv_data1/oa_pdf/3e/0a/prbm-10-085.PMC5386595.pdf
Available  from: http://www.mensjournal.com/magazine/eminem-the-home-body-20150731.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/prbm-10-085.PMC5386595.pdf
"Available from: http://schol-aryrepository.miami.edu/oa_dissertations/12, University of Miami; 2014.",Non-OADS,/arxiv_data1/oa_pdf/3e/0a/prbm-10-085.PMC5386595.pdf
"Psychology Research and Behavior Management 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/3e/0a/prbm-10-085.PMC5386595.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2017:9 31–45Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  31 REviEw open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S70568New insights into therapeutic activity and  anticancer properties of curcumin Abir Kumar Panda Dwaipayan Chakraborty irene Sarkar Tila KhanGaurisankar Sa Division of Molecular Medicine, Bose  institute, Kolkata, west Bengal, indiaAbstract:  Natural compounds obtained from plants are capable of garnering considerable  attention from the scientific community, primarily due to their ability to check and prevent the  onset and progress of cancer.",Non-OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
"The term “ chemotherapeutic Correspondence: Gaurisankar Sa Division of Molecular Medicine, Bose institute, P-1/12, CiT Scheme vii M, Kolkata 700054, west Bengal, indiaTel +91 33 2569 3258Fax +91 33 2355 3886Email gauri@jcbose.ac.inJournal name: Journal of Experimental Pharmacology Article Designation: ReviewY ear: 2017V olume: 9Running head verso: Panda et alRunning head recto: New insights into therapeutic activity of curcuminDOI: http://dx.doi.org/10.2147/JEP .S70568",Non-OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
Available from: https://www.cancer.gov/about-cancer/understanding/statistics.,Non-OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
"Avail-able from: http://seer.cancer.gov/csr/1975_2013/, based on November  2015 SEER data submission.",OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
Available from http://www.who.int/health-info/global_burden_disease/en/.,Non-OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
"Journal of Experimental Pharmacology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/4e/jep-9-031.PMC5386596.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/59/oajsm-8-061.PMC5386597.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/59/oajsm-8-061.PMC5386597.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2017:8 61–70Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 61 OriginAl reSeArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S127854What is the effect of a shoulder-strengthening  program to prevent shoulder pain among junior  female team handball players?",Non-OADS,/arxiv_data1/oa_pdf/e3/59/oajsm-8-061.PMC5386597.pdf
"5 In addition to the  throwing movements, handball players are also tackled,6 which increase the potential  for shoulder injuries.3correspondence: håvard Østerås norwegian University of Science and Technology, Department of neuromedicine and Movement Science, Trondheim, norwayTel +47 7355 9305 email havard.osteras@ntnu.no Journal name: Open Access Journal of Sports Medicine Article Designation: Original ResearchY ear: 2017V olume: 8Running head verso: Sommervold and ØsteråsRunning head recto: The effect of a shoulder-strengthening program to prevent shoulder painDOI: http://dx.doi.org/10.2147/OAJSM.S127854",Non-OADS,/arxiv_data1/oa_pdf/e3/59/oajsm-8-061.PMC5386597.pdf
Available from: https://www.handball.no/ regioner/nhf-sentralt/om-oss/organisasjon/nokkeltall/.,Non-OADS,/arxiv_data1/oa_pdf/e3/59/oajsm-8-061.PMC5386597.pdf
"Open Access Journal of Sports Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/e3/59/oajsm-8-061.PMC5386597.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/59/oajsm-8-061.PMC5386597.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/11/62/cmar-9-097.PMC5386598.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/11/62/cmar-9-097.PMC5386598.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 97–102Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  97 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S125259Symptomatic central nervous system involvement  in adult patients with acute myeloid leukemia  Nael Alakel1,* Friedrich Stölzel1,* Brigitte Mohr1 Michael Kramer1 Uta Oelschlägel1 Christoph Röllig1 Martin Bornhäuser1 Gerhard Ehninger1 Markus Schaich2 1Department of Internal Medicine I,   University Hospital Carl Gustav  Carus at the T echnische Universitaet Dresden, Dresden,  2Hematology,   Oncology and Palliative Medicine,  Rems-Murr-Klinikum, Winnenden,  Germany *These authors contributed equally to  this workIntroduction: Acute myeloid leukemia (AML) rarely involves the central nervous system  (CNS).",Non-OADS,/arxiv_data1/oa_pdf/11/62/cmar-9-097.PMC5386598.pdf
"74, 01307 Dresden, GermanyTel +49 351 458 2321Fax +49 351 458 5344Email nael.alakel@uniklinikum-dresden.deJournal name: Cancer Management and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Alakel et alRunning head recto: Central nervous system involvement in adult patients with AMLDOI: http://dx.doi.org/10.2147/CMAR.S125259",Non-OADS,/arxiv_data1/oa_pdf/11/62/cmar-9-097.PMC5386598.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/11/62/cmar-9-097.PMC5386598.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 102 Alakel et al 21.,Non-OADS,/arxiv_data1/oa_pdf/11/62/cmar-9-097.PMC5386598.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/91/ijwh-9-163.PMC5386599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 163–169International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  163OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S12949 3 effect of menopause on hormonal receptors  in ampullae of the fallopian tube with a special  reference to the p53 signature rie Urabe1 T oru Hachisuga1 Taeko Ueda1 T oshinori Kawagoe1 T omoko Kurita1 seiji Kagami1 Masanori Hisaoka2 Y oshihisa Fujino3 1Department of Obstetrics  and gynecology, 2Department  of Pathology and Oncology,   3Department of Preventive Medicine  and community Health, school of  Medicine, University of Occupational  and environmental Health, Iseigaoka,   Yahatanishi-ku, Kitakyushu, JapanObjectives:  Age-related changes in the expression of hormonal receptors have not been well  examined in the fallopian tube (FT).",Non-OADS,/arxiv_data1/oa_pdf/c3/91/ijwh-9-163.PMC5386599.pdf
"Recent morphologic and molecular genetic studies of women with a hereditary  mutation in BRCA1  and BRCA2  have reported new findings regarding the carcinogenesis  and histogenesis of pelvic serous carcinoma.5 It appears that a significant subset of  pelvic serous carcinomas originates from the distal FT rather than the ovarian sur - face epithelium and/or ovarian cortical inclusion cyst (CIC).6 In addition, the p53 correspondence: Toru Hachisuga Department of Obstetrics and  gynecology, school of Medicine,  University of Occupational  and environmental Health,  1–1, Iseigaoka, Yahatanishi-ku,  Kitakyushu 807-8555, Japan Tel +81 93 691 7449 Fax +81 93 691 9337 email thachisu@med.uoeh-u.ac.j p Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2017 Volume: 9 Running head verso: Urabe et al Running head recto: Hormonal receptors in the fallopian tube DOI: http://dx.doi.org/10.2147/IJWH.S129493",Non-OADS,/arxiv_data1/oa_pdf/c3/91/ijwh-9-163.PMC5386599.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c3/91/ijwh-9-163.PMC5386599.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/91/ijwh-9-163.PMC5386599.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/20/jpr-10-783.PMC5386600.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/48/20/jpr-10-783.PMC5386600.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 783–786Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  783 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S133369Retrospective analyses versus RCTs: comparing  like with like?",Non-OADS,/arxiv_data1/oa_pdf/48/20/jpr-10-783.PMC5386600.pdf
"6, 52078 Aachen, GermanyEmail Christian.Elling@grunenthal.comJournal name: Journal of Pain Research  Article Designation: LETTERY ear: 2017V olume: 10Running head verso: Baron et alRunning head recto: Retrospective analyses versus RCTs: comparing like with like?DOI: http://dx.doi.org/10.2147/JPR.S133369",Non-OADS,/arxiv_data1/oa_pdf/48/20/jpr-10-783.PMC5386600.pdf
Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/20/jpr-10-783.PMC5386600.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/48/20/jpr-10-783.PMC5386600.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 786 Baron et al and can, therefore, be rapidly uptitrated without relevant side  effects.",Non-OADS,/arxiv_data1/oa_pdf/48/20/jpr-10-783.PMC5386600.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2017:9 67–79Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 67 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S131668 Recommendations for optimizing methotrexate  treatment for patients with rheumatoid arthritis Alfonso E Bello1  Elizabeth L Perkins2  Randy Jay3  Petros Efthimiou4 1Illinois Bone & Joint Institute,   Glenview, IL, 2Rheumatology  Care Center, Birmingham, AL,   3Arizona Arthritis & Rheumatology  Associates, Phoenix, AZ, 4Division of  Rheumatology, New Y ork Methodist  Hospital, Brooklyn, NY, USAAbstract: Methotrexate (MTX) remains the cornerstone therapy for patients with rheumatoid  arthritis (RA), with well-established safety and efficacy profiles and support in international  guidelines.",Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
"Regardless of how methotrexate is  Correspondence: Alfonso E. Bello  Illinois Bone & Joint Institute, 2401 Ravine Way, Glenview, IL 60025, USAEmail abello@ibji.comJournal name: Open Access Rheumatology: Research and Reviews Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Bello et alRunning head recto: Optimizing methotrexate in RADOI: http://dx.doi.org/10.2147/OARRR.S131668",Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
Available from: http://acrabstracts.org/abstract/secular-trends-in-use-of-disease-modifying-anti-rheumatic-drugs-for-the-treatment-of-rheumatoid-arthritis-in-the-united-states.,Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
Available from: http://acrabstracts.org/abstract/efficacy-and-safety-of-tofacitinib-monotherapy-versus-combination-therapy-in-a-latin-american-subpopulation-of-patients-with-rheuma - toid-arthritis-a-pooled-phase-3-analysis.,Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
"Open Access Rheumatology: Research and Reviews 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 79 Optimizing methotrexate in RA  97.,Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
Available from: http://acrabstracts.org/abstract/oral-to-subcutaneous-metho-trexate-dose-conversion-strategies-in-the-treatment-of-rheumatoid-arthritis.,Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
Available from: http://acrabstracts.org/abstract/early-use-of-subcutaneous-mtx-monotherapy-vs-mtx-oral-or-com-bination-therapy-significantly-delays-time-to-initiating-biologics-in-early-ra/.,Non-OADS,/arxiv_data1/oa_pdf/99/a5/oarrr-9-067.PMC5386601.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2017:10 93–99Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  93 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S129665Comparison of CYP2C9, CYP2C19, CYP2D6,  ABCB1 , and SLCO1B1  gene-polymorphism  frequency in Russian and Nanai populations Dmitrij Alekseevitch  Sychev1 Grigorij Nikolaevich Shuev1 Salavat Shejhovich Suleymanov 2 Kristina Anatol’evna Ryzhikova 3 Karin Badavievich Mirzaev3 Elena Anatol’evna Grishina3 Natalia Evgenievna Snalina3 Zhannet Alimovna Sozaeva3 Anton Mikhailovich Grabuzdov 4 Irina Andreevna Matsneva4 1Department of Internal Medicine  and Clinical Pharmacology, Russian  Medical Academy of Continuing Professional Education, Ministry of Healthcare, Moscow,  2Saiko Russian– Japanese Medical Center, Khabarovsk,   3Research Centre, Russian Medical  Academy of Continuous Professional Education, Ministry of Healthcare,   4Department of General Medicine,   Sechenov First Moscow State Medical University, Moscow, Russian FederationBackground: The efficiency and safety of drug therapy depends on the peculiarities of function- ing of the P450 cytochrome group and transporting proteins.",Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
"1 The most clinically significant are genes encoding  cytochrome P450 enzymes – CYP2C9, CYP2D6, CYP2B6, CYP3A4, CYP3A5, and  CYP2C19 – which are responsible for the metabolism of almost half of all drug classes Correspondence: Grigorij Nikolaevich  ShuevEmail shuevgrigorii@gmail.comJournal name: Pharmacogenomics and Personalized Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Sychev et alRunning head recto: Gene-polymorphism frequency in Russians and NanaisDOI: http://dx.doi.org/10.2147/PGPM.S129665",Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
Available from: https://www.pharmgkb.,Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
Available from: https://www.pharmgkb.,Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
Available from: https://www.pharmgkb.,Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
"Pharmacogenomics and Personalized Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 99 Gene-polymorphism frequency in Russians and Nanais  25.,Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
Available from: https://www.pharmgkb.,Non-OADS,/arxiv_data1/oa_pdf/58/7e/pgpm-10-093.PMC5386602.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a1/84/lra-10-025.PMC5386604.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a1/84/lra-10-025.PMC5386604.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2017:10 25–29Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  25 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S123157Spinal anesthesia after intraoperative cardiac  arrest during general anesthesia in an infant Emmett E Whitaker1,2 Veronica Miler1,2 Jason Bryant1,2 Stephanie Proicou1 Rama Jayanthi3,4 Joseph D T obias1,2 1Department of Anesthesiology &  Pain Medicine, Nationwide  Children’s Hospital, 2Department  of Anesthesiology & Pain Medicine,  The Ohio State University College of Medicine,  3Division of Pediatric  Urology, Nationwide Children’s Hospital,  4Department of Urology,   The Ohio State University College of Medicine, Columbus, OH, USAAbstract: Although generally safe and effective, severe perioperative complications, including  cardiac arrest, may occur during general anesthesia in infants.",Non-OADS,/arxiv_data1/oa_pdf/a1/84/lra-10-025.PMC5386604.pdf
"19–21 Despite reassuring results from recent, prospec- tive clinical trials in Sun et al,22 there has been a renewed interest in the use of spinal Correspondence: Emmett E Whitaker Department of Anesthesiology & Pain Medicine, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, OH 43205, USATel +1 614 722 4200Fax +1 614 722 4203Email: Emmett.whitaker@nationwidechildrens.orgJournal name: Local and Regional Anesthesia Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Whitaker et alRunning head recto: Spinal anesthesiaDOI: http://dx.doi.org/10.2147/LRA.S123157",Non-OADS,/arxiv_data1/oa_pdf/a1/84/lra-10-025.PMC5386604.pdf
"Local and Regional Anesthesia 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/a1/84/lra-10-025.PMC5386604.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 29 Spinal anesthesia  21.,Non-OADS,/arxiv_data1/oa_pdf/a1/84/lra-10-025.PMC5386604.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d3/71/jpr-10-775.PMC5386605.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d3/71/jpr-10-775.PMC5386605.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 775–781Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  775 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S118047Factors affecting patients’ comfort during  fiberoptic bronchoscopy and endobronchial  ultrasound Fatma Yıldırım1  Şevket Özkaya2  Ahmet Selim Yurdakul1 1Department of Pulmonary Medicine,   Faculty of Medicine, Gazi University,   Ankara, T urkey; 2Department of  Pulmonary Medicine, Faculty of Medicine, Bahcesehir University,  Istanbul, T urkeyObjective: This study investigated the factors that can affect the comfort of patients who  underwent diagnostic fiberoptic bronchoscopy (FOB) and diagnostic endobronchial ultraso- nography (EBUS) for the first time and the effect of the patients’ anxiety level on their comfort  during the procedure.",Non-OADS,/arxiv_data1/oa_pdf/d3/71/jpr-10-775.PMC5386605.pdf
"4,5 Previous  studies have shown that the anxiety levels of the patients before the procedure and the experience of the operator carrying out the process affect the patients’ comfort Correspondence: Fatma Yıldırım  Department of Pulmonary Medicine, Faculty of Medicine, Gazi University 06500, Beşevler/Çankaya, Ankara, TurkeyTel +90 535 952 82 30Fax +90 312 202 19 90Email fatma_bodur2000@yahoo.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Yıldırım et alRunning head recto: Patient comfort during FOB and EBUSDOI: http://dx.doi.org/10.2147/JPR.S118047",Non-OADS,/arxiv_data1/oa_pdf/d3/71/jpr-10-775.PMC5386605.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/d3/71/jpr-10-775.PMC5386605.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 781 Patient comfort during FOB and EBUS willingness for the repetition of procedure.13 In our study, we  found that nasal route in the FOB group was an independent  risk factor increasing the patient’ s discomfort level.",Non-OADS,/arxiv_data1/oa_pdf/d3/71/jpr-10-775.PMC5386605.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/28/0c/imcrj-10-113.PMC5386606.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/28/0c/imcrj-10-113.PMC5386606.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 113–116International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 113 EDITORIAL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S135900The first 8 years: International Medical Case Reports  Journal  – summary of publications from 2008 to  July 2016 RJ Prineas1 SG Fraser2 CE Stevens3 1Division of Public Health Sciences,   Wake Forest University School of  Medicine, Winston-Salem, NC, USA;   2Sunderland Eye Infirmary, Sunderland,   UK; 3Department of Epidemiology,   New Y ork Blood Center, New Y ork,  NY, USAThe case report has a secure place in medical reporting and medical history stretching  back to hand-written manuscripts, early medical texts, and earliest medical scientific publications.",Non-OADS,/arxiv_data1/oa_pdf/28/0c/imcrj-10-113.PMC5386606.pdf
The most common categories were related to Correspondence: RJ Prineas c/o Dove PressJournal name: International Medical Case Reports Journal Article Designation: EDITORIALY ear: 2017V olume: 10Running head verso: Prineas et alRunning head recto: Prineas et alDOI: http://dx.doi.org/10.2147/IMCRJ.S135900,Non-OADS,/arxiv_data1/oa_pdf/28/0c/imcrj-10-113.PMC5386606.pdf
A list of the editors serving on the Editorial Board appear on https://www.dovepress.com/editors_in_chief.php.,Non-OADS,/arxiv_data1/oa_pdf/28/0c/imcrj-10-113.PMC5386606.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/28/0c/imcrj-10-113.PMC5386606.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 116 Prineas et alDove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/28/0c/imcrj-10-113.PMC5386606.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2017:10 101–106Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  101 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S131390Association of the PPP3CA c.249G>A variant  with clinical outcomes of tacrolimus-based  therapy in kidney transplant recipients Patricia C Salgado1 Fabiana DV Genvigir1 Claudia R Felipe2 Helio T edesco-Silva Jr2 Jose O Medina-Pestana2 Sonia Q Doi3 Mario H Hirata1 Rosario DC Hirata1 1Department of Clinical and  T oxicological Analysis, School of  Pharmaceutical Sciences, University of Sao Paulo,  2Division of Nephrology,   Hospital do Rim, Federal University of Sao Paulo, Sao Paulo, Brazil;  3School  of Medicine, Uniformed Services University of the Health Sciences,  Bethesda, MD, USABackground: The effects of genetic variants related to the pharmacodynamic mechanisms of  immunosuppressive drugs on their therapeutic efficacy and safety have been poorly explored.",Non-OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
"2,3 Consequently, both cytokine synthesis  and T cell activation decrease.3 Calcineurin is a Ca2+/calmodulin-dependent serine/threonine phosphatase that is com- posed of catalytic A (CnA) and regulatory B subunits.4 For CnA, three isoforms encoded  by PPP3CA (CnAα ), PPP3CB (CnAβ ), and PPP3CC (CnAγ ) have been  identified.5 Both Correspondence: Fabiana DV Genvigir Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo, Avenida Professor Lineu Prestes, 580, Bloco 17, 05508-900 Sao Paulo, SP, BrazilTel +55 11 3091 3660Fax +55 11 3813 2197Email fdallavecchia@yahoo.com.brJournal name: Pharmacogenomics and Personalized Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Salgado et alRunning head recto: PPP3CA c.249G>A variant and kidney transplantationDOI: http://dx.doi.org/10.2147/PGPM.S131390",Non-OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
Available from: http://www.meddra.org.,Non-OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
Available from: http://www.ncbi.nlm.nih.gov/SNP/.,OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
"Pharmacogenomics and Personalized Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 106 Salgado et al,Non-OADS,/arxiv_data1/oa_pdf/1a/10/pgpm-10-101.PMC5386607.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10 111–122Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 111 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S116810 Comparative effectiveness of glycemic control in  patients with type 2 diabetes treated with GLP-1  receptor agonists: a network meta-analysis of  placebo-controlled and active-comparator trials Michelle E Orme1 Hiep Nguyen2 Jackie Y Lu3 Susan A Thomas3 1ICERA Consulting Ltd, Swindon, UK;   2AstraZeneca, Wilmington, DE,    3AstraZeneca, Fort Washington,   PA, USABackground: Clinical studies of patients with type 2 diabetes show that GLP-1 receptor agonists  (GLP-1 RAs) improve glycemic control and promote weight loss.",Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
"Both the Ameri-can Association of Clinical Endocrinologists guidelines and the American Diabetes Correspondence: Hiep Nguyen AstraZeneca, 1800 Concord Pike –   B2B-112, Wilmington, DE 19850, USATel +1 215 542 3351Email hiep.nguyen@astrazeneca.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Orme et alRunning head recto: Glycemic control in T2D patients taking GLP-1 RAsDOI: http://dx.doi.org/10.2147/DMSO.S116810",Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
Available from http://www.idf.org/guideline-type-2-diabete.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
Available from http://www.nice.org.uk/guidance/indevel-opment/gid-cgwave0612/documents.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
Available  from: http://www.mrc-bsu.cam.ac.uk/bugs/winbugs/dicpage.shtml#q15.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT00849017.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 122 Orme et al  62.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
Available from: https://clinicaltrials.gov/ct2/show/results/NCT00838903.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/dmso-10-111.PMC5386609.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 709–736Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  709 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128655Evidence and consensus recommendations for the  pharmacological management of pain in India Gur Prasad Dureja1  Rajagopalan N Iyer2  Gautam Das3  Jaishid Ahdal4  Prashant Narang4 On behalf of the Pain  Working Group 1Delhi Pain Management Centre,   New Delhi, Delhi, 2Department of  Orthopaedics, Raja Rajeswari Medical  College and Hospital, Bengaluru,  Karnataka,  3Daradia Pain Clinic,   Kolkata, West Bengal, 4Department  of Medical Affairs, Janssen India,  Johnson & Johnson Pvt Ltd, Mumbai,  Maharashtra, IndiaAbstract:  Despite enormous progress in the field of pain management over the recent years,  pain continues to be a highly prevalent medical condition worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
"9 Globally, approximately 20% of adults suffer from pain, of Correspondence:  Prashant Narang Department of Medical Affairs, Janssen  India, Johnson & Johnson Pvt Ltd, 501 Arena Space, Off Jogeshwari Vikhroli Link Road, Jogeshwari East, Mumbai, Maharashtra, India   Tel +91 98 1164 6909   Email pnarang1@ITS.JNJ.comJournal name: Journal of Pain Research  Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Dureja et alRunning head recto: Evidence and consensus recommendations on pain managementDOI: http://dx.doi.org/10.2147/JPR.S128655",Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.iasp-pain.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.painmed.org/files/facts-and-figures-on-pain.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.healthdata.org/sites/default/files/files/country_profiles/GBD/ihme_gbd_coun-try_report_india.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: https://www.hrw.org/sites/default/files/reports/hhr0511W .pdf.,OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from:  http://fhs.mcmaster.ca/paininstitute/documents/pathophysiology_of_chronic_pain.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://iasp.files.cms-plus.com/Content/ContentFolders/Publications2/PainClinicalUpdates/Archives/PCU06-1_1390263807201_21.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.iasp-pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Classification-of-Chronic-Pain.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://apps.who.int/iris/bitstream/10665/44540/1/9789241548120_Guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://apps.who.int/medicinedocs/pdf/whozip39e/whozip39e.pdf.,OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://healthbrk.com/health-problems/drug/10503-acetaminophen-new-world-encyclopedia.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.nature.com/sub-jects/combination-drug-therapy?WT.ac= search_subjects_combina- tion_drug_therapy.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Avail-able from: http://apps.who.int/medicinedocs/documents/s19979en/s19979en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://indianexpress.com/article/india/india-news-india/do-you-take-one-of-these-300-banned-drugs/.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregu - latoryinformation/guidances/ucm384691.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.cdsco.nic.in/writereaddata/FDC%20Guidelines%20_%20Revised1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://cdsco.nic.in/writereaddata/SND-Approval-Drugs-may-List1-2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: https://theacpa.org/uploads/documents/ chronicle_fall06_82806.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://apps.who.int/iris/bitstream/10665/44540/1/9789241548120_Guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: https://usa1990fa.files.wordpress.com/2014/10/analgesia-in-patients-with-impaired-renal-function.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.ulm.edu/~biglane/4058%20Pain%20-pharmacists-guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://sosmanuals.com/manuals/cae48184b - 7bae3b1d85105ea85375b60.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://sosmanuals.com/manuals/cae48184b-7bae3b1d85105ea85375b60.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Available from: http://www.smly.fi/@Bin/172109/lumbo-pelvic_workshoplevi07handouts.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 736 Dureja et al,Non-OADS,/arxiv_data1/oa_pdf/0d/d6/jpr-10-709.PMC5386610.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d7/4e/imcrj-10-109.PMC5386611.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d7/4e/imcrj-10-109.PMC5386611.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 109–112International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 109 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S119353Aortic valve papillary fibroelastoma causing  embolic strokes: a case report and review Avraham Miller1 Audrik Perez1 Swathi Pabba2 Vijay Shetty3 1Internal Medicine, Maimonides  Medical Center, Brooklyn, NY, USA;   2Chalmeda Anand Rao Institute  of Medical Sciences, T elangana,   India; 3Department of Cardiology,   Maimonides Medical Center, Brooklyn,  NY, USA Abstract:  Papillary fibroelastomas (PFEs) are the second most common benign neoplasms  of the cardiac valves and are being recognized more frequently because of higher resolution  imaging technology.",Non-OADS,/arxiv_data1/oa_pdf/d7/4e/imcrj-10-109.PMC5386611.pdf
"Correspondence: Avraham Miller Internal Medicine, Maimonides Medical Center, 4802 10th Ave, Brooklyn, NY 11219, USATel +1 728 283 6000Email avmiller@maimonidesmed.org Journal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Miller et alRunning head recto: Aortic valve papillary fibroelastomaDOI: http://dx.doi.org/10.2147/IMCRJ.S119353",Non-OADS,/arxiv_data1/oa_pdf/d7/4e/imcrj-10-109.PMC5386611.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/d7/4e/imcrj-10-109.PMC5386611.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 112 Miller et al the paucity of existing data, which consists of single-case  reports employing a variety of methods.",Non-OADS,/arxiv_data1/oa_pdf/d7/4e/imcrj-10-109.PMC5386611.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2b/e7/oajsm-8-071.PMC5386612.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2b/e7/oajsm-8-071.PMC5386612.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2017:8 71–83Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 71 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S106699Anterior cruciate ligament injury/reinjury in  alpine ski racing: a narrative review Matthew J Jordan1 Per Aagaard2 walter Herzog1 1Human Performance Laboratory,    The University of Calgary, Calgary,    AB, Canada; 2Department of Sports  Science and Clinical Biomechanics,   SDU Muscle Research Cluster (SMRC), University of Southern Denmark, Odense M, DenmarkAbstract:  The purpose of the present review was to: 1) provide an overview of the current  understanding on the epidemiology, etiology, risk factors, and prevention methods for anterior  cruciate ligament (ACL) injury in alpine ski racing; and 2) provide an overview of what is known  pertaining to ACL reinjury and return to sport after ACL injury in alpine ski racing.",Non-OADS,/arxiv_data1/oa_pdf/2b/e7/oajsm-8-071.PMC5386612.pdf
"Correspondence: Matthew J Jordan Canadian Sport institute Calgary,   2500 University Drive Nw, Calgary,   AB T2N 1N4, CanadaTel +1 403 714 4655email mjordan@ucalgary.caJournal name: Open Access Journal of Sports Medicine Article Designation: ReviewY ear: 2017V olume: 8Running head verso: Jordan et alRunning head recto: ACL injury/reinjury in alpine ski racingDOI: http://dx.doi.org/10.2147/OAJSM.S106699",Non-OADS,/arxiv_data1/oa_pdf/2b/e7/oajsm-8-071.PMC5386612.pdf
"Open Access Journal of Sports Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/2b/e7/oajsm-8-071.PMC5386612.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/e7/oajsm-8-071.PMC5386612.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/40/27/ijnrd-10-077.PMC5386613.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/40/27/ijnrd-10-077.PMC5386613.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2017:10 77–84International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 77 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S103785 Pediatric acute kidney injury: prevalence, impact  and management challenges Eileen Ciccia   Prasad Devarajan Division of Nephrology and  Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati,  OH, USAAbstract:  The incidence of pediatric acute kidney injury (AKI) is increasing globally, as are  the associated morbidities and mortality.",Non-OADS,/arxiv_data1/oa_pdf/40/27/ijnrd-10-077.PMC5386613.pdf
"5 Where no previous serum creatinine measures are Correspondence: Prasad Devarajan Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, MLC 7022, Cincinnati, OH 45229-3039, USA Tel +1 513 636 4531   Email prasad.devarajan@cchmc.orgJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Ciccia and DevarajanRunning head recto: Pediatric AKIDOI: http://dx.doi.org/10.2147/IJNRD.S103785",Non-OADS,/arxiv_data1/oa_pdf/40/27/ijnrd-10-077.PMC5386613.pdf
"International Journal of Nephrology and Renovascular Disease 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/40/27/ijnrd-10-077.PMC5386613.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 84 Ciccia and Devarajan 31.,Non-OADS,/arxiv_data1/oa_pdf/40/27/ijnrd-10-077.PMC5386613.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):827.   https://doi.org/ 10.18549/PharmPract.201 7.01.827    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Background : Antimicrobial resistance is becoming a major public health challenge worldwide, caused primarily by the misuse of  antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):827.   https://doi.org/ 10.18549/PharmPract.201 7.01.827    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 the European Antimicrobial Resistance Surveillance  Network (EARS -Net).There are curr ently no approved  treatment guidelines for various infectious diseases at all  levels of health care in Kosovo.,Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):827.   https://doi.org/ 10.18549/PharmPract.201 7.01.827    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 To determine the sources of antibiotics used by Kosovar  citizens, the survey asked how respondents obtained their  last course of antibiotics.",OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):827.   https://doi.org/ 10.18549/PharmPract.201 7.01.827    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 Respondents were asked if they remembered r eceiving any  information about the unnecessary use of antibiotics in the  last 12 months.,Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):827.   https://doi.org/ 10.18549/PharmPract.201 7.01.827    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 for a cold19, compared to 27 % in US (20), 17% in Hong  Kong21 and 3 % in Australia .22   Only 25.9% of Kosovar respondents gave the correct  answer that antibiotics are not effective against cold and  flu, compared to 52% in the EU.",Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):827.   https://doi.org/ 10.18549/PharmPract.201 7.01.827    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 Coates A, Bergst rom R, Wright GD, Brown ED, Cars O.",Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
"Available from:  http://ec.europa.eu/public_opinion/archives/ebs/ebs_407_en.pdf  (accessed Aug 6, 2016).",Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):827.   https://doi.org/ 10.18549/PharmPract.201 7.01.827    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 29.,Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
Available from: http://www.euro.who.int/en/health -topics/disease -prevention/antimicrobial - resistance/publications/2016/central -asian-and-eastern -european -surveillance -of-antimicrobial -resistance.,Non-OADS,/arxiv_data1/oa_pdf/6d/6a/pharmpract-15-827.PMC5386617.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):839.   https://doi.org/ 10.18549/PharmPract.201 7.01.839    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 188 5-642X ) 1   Abstract   Objective : To determine which drug references Utah pharmacists use most frequently.,Non-OADS,/arxiv_data1/oa_pdf/08/16/pharmpract-15-839.PMC5386618.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):839.   https://doi.org/ 10.18549/PharmPract.201 7.01.839    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 188 5-642X ) 2 people live within 5 miles of a pharmacy, where they have  access to the expertise of the community pharmacist.",Non-OADS,/arxiv_data1/oa_pdf/08/16/pharmpract-15-839.PMC5386618.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):839.   https://doi.org/ 10.18549/PharmPract.201 7.01.839    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 188 5-642X ) 3 located in an urban cluster (6%) or rural area (11%).,Non-OADS,/arxiv_data1/oa_pdf/08/16/pharmpract-15-839.PMC5386618.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):839.   https://doi.org/ 10.18549/PharmPract.201 7.01.839    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 188 5-642X ) 4 never us e references to answer questions.,Non-OADS,/arxiv_data1/oa_pdf/08/16/pharmpract-15-839.PMC5386618.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):839.   https://doi.org/ 10.18549/PharmPract.201 7.01.839    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 188 5-642X ) 5     References     1.,Non-OADS,/arxiv_data1/oa_pdf/08/16/pharmpract-15-839.PMC5386618.pdf
"http://kff.org/other/state - indicator/total -retail -rx-drugs/   (accessed July 13, 2016).",Non-OADS,/arxiv_data1/oa_pdf/08/16/pharmpract-15-839.PMC5386618.pdf
"https://www.census.gov/geo/reference/urban -rural.html    (accessed May 31, 2016).",Non-OADS,/arxiv_data1/oa_pdf/08/16/pharmpract-15-839.PMC5386618.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):846.   https://doi.org/ 10.18549/PharmPract.201 7.01.846    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Background : Value added services (VAS) are an innovative dispensing system created to provide an alternative means of collecting  partial drug supply from our hospital.,Non-OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):846.   https://doi.org/ 10.18549/PharmPract.201 7.01.846    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 automated dispen sing system, manpower scheduling plan,  electronically delivered prescription and  redesign of  pharmacy workflow.4-8 In Malaysia, one of the methods  adopted was implementation of Value Added Services  (VAS).",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):846.   https://doi.org/ 10.18549/PharmPract.201 7.01.846    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 will reduce patient waiting time in the Ambulatory  Pharmacy.,Non-OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):846.   https://doi.org/ 10.18549/PharmPract.201 7.01.846    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 (b=0 .0008, 95%CI : 0.0004  : 0.0011, p< 0.001), and number  of refill prescriptions (b=0.0004, 95%CI : 0.0002  : 0.0007,  p<0.001).",OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):846.   https://doi.org/ 10.18549/PharmPract.201 7.01.846    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 consistently been a factor in determining quality of  pharmaceutical care servic es provided.,Non-OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):846.   https://doi.org/ 10.18549/PharmPract.201 7.01.846    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 Strength and limitation   Large sample size and long period of follow up were the  major strengths of this study.,Non-OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
Available from:  http://www.mps.org.my/newsmaster.cfm?&menuid=36&action=view&retrieveid=3465  (accesed  2011 21 July ).,Non-OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):846.   https://doi.org/ 10.18549/PharmPract.201 7.01.846    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 9.,Non-OADS,/arxiv_data1/oa_pdf/6c/ea/pharmpract-15-846.PMC5386619.pdf
"Pharmacy Practice  2017  Jan-Mar;15(1):853.   https://doi.org/ 10.18549/PharmPract.201 7.01.853    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Objective : To evaluate the current community pharmacists’ interventions and job satisfaction, secondary to the alteration in the  financial rewards.",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Pharmacy Practice  2017  Jan-Mar;15(1):853.   https://doi.org/ 10.18549/PharmPract.201 7.01.853    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 individual is satisfied with the job overall), or at t he facet  level (whether or not the individual is satisfied with  different aspects of the job) .8 Spector lists 14 common  facets: appreciation, communication, coworkers, fringe  benefits, job conditions, nature of the work, organization,  personal growth, poli cies and procedures, promotion  opportunities, recogni tion, security, and supervision .8  In Lebanon, all pharmacists must be registered in the  Lebanese Order of Pharmacists (LOP) in order to practice.",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Pharmacy Practice  2017  Jan-Mar;15(1):853.   https://doi.org/ 10.18549/PharmPract.201 7.01.853    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 age for the pharmacists was 42.52 (SD= 11.47 ) years;  45.9%  were males; 45.3% lived in Mount Lebanon, 17.1% in the  South and 14.3% in Bekaa.",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
Pharmacy Practice  2017  Jan-Mar;15(1):853.   https://doi.org/ 10.18549/PharmPract.201 7.01.853    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 DISCUSSION   This is a cross sectional pilot study carried out on  community pharmacists in all Lebanon’s districts to assess  the socioeconomic status and the financial situation of  these pharmacists nowadays as compared to the  last  decade.,Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Pharmacy Practice  2017  Jan-Mar;15(1):853.   https://doi.org/ 10.18549/PharmPract.201 7.01.853    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 pharmacists even worse and resulted in even more serious  losses, clearly shown by the results of this study.",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
Pharmacy Practice  2017  Jan-Mar;15(1):853.   https://doi.org/ 10.18549/PharmPract.201 7.01.853    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 oppo site to the study done by Dossa et al .,Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Available at: http://apps.who.int/medicinedocs/en/d/Jh2995e/   (accessed January 10, 2017).",OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Available at:  http://www.fip.org/community_pharmacy  (accessed January 10, 2017).",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Available at:  http://www.bls.gov/ooh/healthcare/pharmacists.htm#tab -2 (accessed January 10, 2017).",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Available at :  http://www.moph.gov.lb/Drugs/Documents/K arar796 -2014.pdf  (accessed January 10, 2017).",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
"Availa bel at:   https://business.tcnj.edu/files/2015/08/ECO -495-2015_Patrick -ODonnell.pdf  (accessed January 10, 2017).",Non-OADS,/arxiv_data1/oa_pdf/92/fd/pharmpract-15-853.PMC5386620.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Background : Medication reconciliation is a major component of safe patient care.,Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 reconciliation at admission to a hospital is common in Saudi  Arabia .,Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 variances between what was recorded as  prescribed in  admission orders and what medications were taken by a  patient were considered to be unintentional medication  discrepancies and were recorded as a reconciliation error.,OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 admitted to the surgery department.,Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 intervention, affecting about 8.6% of patients (95% C I 4.9 to  12.3) patients.",Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 identify the strategies for standardization, we need to  clearly define and classify medication discrepancies as these  are the only quantitative measures related to the  medication reconciliation process”.",Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 history verification we re more important rather than  patient characteristics .29   Study limitations: This study has important limitations.,Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Available at:  http://www.who.int/patientsafety/implementation/solutions/high5s/ps_medication_reconciliation_fs_2010_en.pdf  (accessed  Oct 4, 2016 ).",Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Available from:  http://www.ihi.org/topics/adesmedicationreconciliation/Pages/default.aspx  (accessed Dec 24, 2016) .",OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Available from:  http://www.nccmerp.org/sites/default/files/indexCo lor2001 -06-12.pdf  (accessed Oct 4, 2016).",OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Available from: https://www.ismp.org/tools/institutionalhighAlert.asp  (accessed Oct  4, 2016).",OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Available at:  http://www.ismp.org/Tools/highAlertMedicationLists.asp  (accessed Oct 4, 2016).",OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):864.   https://doi.org/ 10.18549/PharmPract.201 7.01.864    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 8 17. WHO Collab orating Centre for Drug Statistics Methodology .,Non-OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Available at:  https://www.whocc.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system/  (accessed Oct 4, 2016).",OADS,/arxiv_data1/oa_pdf/f6/6d/pharmpract-15-864.PMC5386621.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):873.   https://doi.org/ 10.18549/PharmPract.201 7.01.873    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Objective : This work aimed to describe attitudes and practices of both community pharmacies and patent and proprietary medicine  vendor (PPMV) outlets towards over -the-counter (OTC) analgesic use for musculoskeletal pain states within Zaria, Nig eria.",Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):873.   https://doi.org/ 10.18549/PharmPract.201 7.01.873    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 factors, however the prognosis of patients with this  condition in third world settings like Nigeria is remarkably  worse .18 Other side effects of NSAID misuse can include  gastrointestinal (GI) side effects and bleeding.",Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):873.   https://doi.org/ 10.18549/PharmPract.201 7.01.873    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 as inappropriate.,Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):873.   https://doi.org/ 10.18549/PharmPract.201 7.01.873    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 pharmacies provided the simulated patient with  information on duration of therapy, and asked the patient  questions about their past medical and medication history.",Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):873.   https://doi.org/ 10.18549/PharmPract.201 7.01.873    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 warned him not to take other analgesics (especially  paracetamol) simultaneously.,Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
at:  https://www.niams.nih.gov/Health_ Info/Back_Pain/default.asp#2  (accessed 20 January 2017) .,Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):873.   https://doi.org/ 10.18549/PharmPract.201 7.01.873    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 5.,Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
Available at;  http://www.fda.gov/Drugs/DrugSafety/ucm451800.htm  (accessed on 10 October 2016).,Non-OADS,/arxiv_data1/oa_pdf/be/4c/pharmpract-15-873.PMC5386622.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Background : Chemotherapy induced nausea and vomiting (CINV) remains the most distressing event in patients receiving highly  emetogenic chemotherapy (HEC) or moderately emetogenic chemotherapy (MEC).,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 2 receiving moderately and highly emetogenic  chemotherapy.15-19  Many randomized controlled  trials (RCTs) have been then  conducted to confirm the effect of addition of olanzapine  to the standard antiemetic regimen.20-32 A previous  meta - analysis conducted by Wang et al.33 revealed that the rate  of patie nts achieving total control of nausea and vomiting  was significantly higher in the olanzapine group.,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 3 RESULTS   Literature searches and selection   The details of our search strategy were depicted in Figure  1.,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 4 studies, combined together, the overall complete response   was higher in olanzapine group compared with non - olanzapine gro up (OR 2.48; 95%CI 1.59 to 3.86, p<0.0001,  Figure  2C).",Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 5 to 32.90, p= 0.31, Figure 3B).",Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 6 No nausea   The percentages of no nausea were 82.7%, 64.3%, 61.6% in  olanzapine group versus 71.3%, 41.8%, and 40.6% in non - olanzapine group in acute, delayed and overall phases,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 7 to NK-1 recepto r antagonist (OR  1.27; 95%CI 0.80 to 2.03,  p=0.30, Figure 6 A).",Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 8 aprepitant achieved complete responses  of 75% in acute  and 57% in delayed phases.41 This indicates that there still  gaps to reach the ideal goal of 100% complete response .,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 9 containing regimen is statistically superior to non - olanzapine regimen in preventing CINV in 13 of the 2 4  analyzed efficacy parameters ( Table 1).,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 10 The subgroup analysis based on whether olanzapine used  as alternative to NK -1 antagon ists or in combination was  conducted.,OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 11 The strength of our study includes a rigorous  search of  several databases and other sources to identify eligible  RCTs.,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 12 RCT or cohort study that identifies the use of olanzapine in  steady or in combination of NK -1 antagonists with  economical evaluation .,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 13 17.,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):877.   https://doi.org/ 10.18549/PharmPract.201 7.01.877    www.pharmacypractice.org  (eISSN : 1886 -3655  ISSN: 1885 -642X ) 14 39.,Non-OADS,/arxiv_data1/oa_pdf/d8/5f/pharmpract-15-877.PMC5386623.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Objectives : To evaluate perception, extent of involvement and barriers to pharmacy practice -based research among community and  hospital pharmacists in Ibadan, Oyo state, southwestern Nigeria.",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 well as guarantee evidence -based practice12 which will not  only improve the quality of pharmaceutical care delivered  by the pharmacist but will als o broaden the scope of  pharmacy practice.13,14 Traditionally, pharmacy has been  slower than medicine and nursing in participating in  practice -based research.15 However, this trend has steadily  improved over the last few decades with more pharmacists  especially in developed countries getting involved in  PPBR.15-19 Notwithstanding the increasing involvement of  pharmacists in PPBR, a number of barriers limiting greater  pharmacists’ participation in practice -based research have  been identified.",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 Data collection and recruitment procedure   All elig ible pharmacists were visited in their respective  practice sites.,OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 There was a significant difference among HP participants  with different years of experience in practice and their  opinion on feasibility of conducting PPBR on routine  patient’s care activities [Kruskal -Wall is (K-W)=9.10, p= 0.03].",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 experience in practice and other opin ion on relevance,  scope and barriers to PPBR  (Tables 3 and 4 ).",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 DISCUSSION   This study showed that pharmacists in their specific areas  of practice are interested in pharmacy practice -based  research (PPBR) and agreed that conduct of  PPBR may help  in identifying gaps on which to focus for improved practice.,Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 such as prescription screening for errors, review of  patients’ previous medications to identify and resolve drug  therapy problems as well as self -medication issues.",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 8 of pharmacist’s professional duties , as well as constituting a  barrier to proactive engagement of hospital pharmacists in  PPBR.",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 9 countries, pharmacists do not have direct access to  physician generated data and this may serve as hindrance  to PPBR in PC, MTM and PV.",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Available at http://www.fip.org  (accessed 30 October,  2016 ).",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):881.   https://doi.org/ 10.18549/PharmPract.201 7.01.881    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 10 16.,Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Available at http://www.rpharms.com/about - pharmacy -pdfs/census08.pdf  (accessed 29 October,  2016 ).",Non-OADS,/arxiv_data1/oa_pdf/1c/4c/pharmpract-15-881.PMC5386624.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Background : Investigating beliefs about medicines has been of interest over the past years, with studies aiming to better understand  theoretical reasons behind development of such beliefs.",Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 METHODS   Instrument   The BMQ  consists of an 18 -item questionnaire which  assesses medication beliefs in general and in specific  conditions allowing for the investigation of the overall  perceptions of medication in general (BMQ –General) , as  well as perceptions o f medication in more definite  situations such as chronic illnesses (BMQ –Specific).21   The BMQ -General comprises 8 items which are subdivided  into two sub -scales.",Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 handled by the principal investigator and would not be  accessible to the hospital staff.,Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 Principal Component Analysis (PCA) using Varimax rotation  with Kaiser normalisation was carried out to analyse  component loading of the items on the respective sub - scales.,OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 healthcare professionals highly proficient in both the  Maltese and English language.,Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 By convention, acceptable internal consistency is proven by  obtaining values of alpha  that are over 0.7025,26 thus, the  higher the value of alpha , the higher the degree or internal  consistency27 and the more reliable a scale is in measuring  what it is designed to measure.",Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 consistency with alpha  values in the range of 0.79 -0.85 for  patients with diabetes and 0.064 -0.72 for HIV patients.16  Therefore, internal consistency for the present study can be  taken to be acceptable within the scope of the  psychometric properties of the scale.",Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 8 remedies were part of folklore which people in Malta  moved away from upon introduction of what is today  considered to be conventional medicine.31 In addition,  Maltese healthcare professionals might be mistrusting of  natural remedies, resulting in less promotion of such  remedies, as is the case with other medical professionals  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Available at:  http://www.who.int/medicines/areas/rational_use/Manual1_HowtoInvestigate.pdf  (accessed 2014 Jun 28).,Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Available at: http://www.ft.dk/samling/20081/a lmdel/suu/bilag/704/738838.pdf  (accessed 2016 Oct 24) .,Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Available at: http://www.psyktestbarn.no/cms/ptb_mm.nsf/lupgraphics/ITC%20guidelines.pdf/$file/ITC%20guidelines.pdf   (accessed 2016 Oct 24) .,Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):886.   https://doi.org/ 10.18549/PharmPract.201 7.01.886    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 9 18.,Non-OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Available at:  https://scholarworks.iupui.edu/bitstream/handle/1805/344/gliem+&+gliem.pdf?sequence= 1  (accessed 2016 Oct 24) .,OADS,/arxiv_data1/oa_pdf/15/fa/pharmpract-15-886.PMC5386625.pdf
Pharmacy Practice  2017  Jan-Mar;15(1):890.   https://doi.org/ 10.18549/PharmPract.201 7.01.890    www.pharma cypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Background : Community pharmacists play a crucial role in reducing medication related health problems and improving the patient’s  overall wellbeing.,Non-OADS,/arxiv_data1/oa_pdf/ec/22/pharmpract-15-890.PMC5386626.pdf
"Pharmacy Practice  2017 Jan- Mar;15(1):890.   https://doi.org/ 10.18549/PharmPract.201 7.01.890    www.pharma cypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 services.8-10 In Ethiopia, there are more than 6 50  community pharmacists, which are divided into pharmacy,  drug store and rural drug vendors based on the type of  medications they are supposed to dispense and the  qualification of dispensers.11 Pharmacies are run only by a  pharmacist (with qualification o f a university degree or  above), drug shop run by druggist (with qualification of  diploma in pharmacy) and rural drug vendor run by health  assistant.",Non-OADS,/arxiv_data1/oa_pdf/ec/22/pharmpract-15-890.PMC5386626.pdf
"Pharmacy Practice  2017 Jan- Mar;15(1):890.   https://doi.org/ 10.18549/PharmPract.201 7.01.890    www.pharma cypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 absorbed wel l from gastro intestinal tract , whereas,  omeprazole decreases the acidic content of the gastro  intestinal tract .",Non-OADS,/arxiv_data1/oa_pdf/ec/22/pharmpract-15-890.PMC5386626.pdf
"Pharmacy Practice  2017 Jan- Mar;15(1):890.   https://doi.org/ 10.18549/PharmPract.201 7.01.890    www.pharma cypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 RESULTS   The cross -sectional survey of community pharmacists   Out of 84 community pharmacists invited to parti cipate, 78  of them consented and returned a filled -out questionnaire,  giving a response rate of 92.8%.",Non-OADS,/arxiv_data1/oa_pdf/ec/22/pharmpract-15-890.PMC5386626.pdf
"Pharmacy Practice  2017 Jan- Mar;15(1):890.   https://doi.org/ 10.18549/PharmPract.201 7.01.890    www.pharma cypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 (69.05%) were the most common type s of information  provided while what to do when d ose is missed (100%),  contraindication (95.2%) and the importance of compliance  or adherence (92.9%) were the most commonly ignored  type s of information.",OADS,/arxiv_data1/oa_pdf/ec/22/pharmpract-15-890.PMC5386626.pdf
Pharmacy Practice  2017 Jan- Mar;15(1):890.   https://doi.org/ 10.18549/PharmPract.201 7.01.890    www.pharma cypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 lack of interest and updated information as well as limited  knowledge could be the real factors behind their poor  counseling practice.,Non-OADS,/arxiv_data1/oa_pdf/ec/22/pharmpract-15-890.PMC5386626.pdf
Pharmacy Practice  2017  Jan-Mar;15(1):890.   https://doi.org/ 10.18549/PharmPract.201 7.01.890    www.pharma cypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 14.,Non-OADS,/arxiv_data1/oa_pdf/ec/22/pharmpract-15-890.PMC5386626.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Background : The availability of over -the-counter drugs (OTCs) has increased in Sweden since a re -regulation of the pharmacy market  in 2009, through which non -pharmacy retailers became permitted to provide certain OTCs.",Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 OTC pharmacy customers  is uncertainty about the aim of  the drug, resulting in an  incorrect choice of product.9,11,12  Other common OTC drug -related problems are therapy  failure and adverse reactions, overdoses and drug  duplications, contraindications and pra ctical administration   issues.9,11 Studies have also noted a lack of knowledge  among the public about OTCs to treat pai n and colds.5,12,13  Because of the increased availability of OTCs and our  limited knowledge about the public’s use and safety  perception of OTCs, the Swedish M edical Products Agency  (MPA) decided to conduct a study to increase our  knowledge.",Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 Ethical approval   The study was approved by the Regional Ethical Review  Board in Uppsala Sweden on September 19 2012 with the  reference number 2012/331.,Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 40% in respondents born in Africa and 42% in Asia -born,  compared to 62% in study participants born in Sweden.",Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 Both men and women 60 years or older marked all the  possible response options to a lesser extent than younger  and middle -aged respondents (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 in about  half of the countries in Europe, such as in Finland,  Germany, Belgium, France, Spain and Italy.",Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 Like in questionnaire studies in general, there is also a risk  of a selection bias through which the most interested  respond.",Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
Basle; 2008.  http://fip.org/abstracts?page=abstracts&action=item&item=2194  (accessed 29 April 2015).,Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
http://www.scb.se/sv_/Vara -tjanster/SCBs -data-for- forskning/SCBs -datalager/Registret -over-totalbefolkningen -RTB/  (accessed 29 April 2015).,OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
http://www.scb.se/lisa/  (accessed 29 April 2015).,Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
http://www.scb.se/sv_/Dokumentation/Publikationer - om-statistiska -metoder/  (accessed 29 April 2015).,Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):894.   https://doi.org/ 10.18549/PharmPract.201 7.01.894    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 8 18.,Non-OADS,/arxiv_data1/oa_pdf/04/50/pharmpract-15-894.PMC5386627.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Objective : To analyze the link between the rank at the national pharmacy residency examination and the choice of pharmacy specialty  for hospital residency -admitted French pharmacy students.,Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 Pharmacists, w hich places applicants into pharmacy  residency training positions.11 By this way, ranking by  programs, generally based on applicants’  scores calculated  using screening tools and onsite interviews12, is confronted  to program preferences established by candi dates.",Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 RESULTS   Numbers of residency -admitted pharmacy students  categorized by specialty and by year of examination are  summarized in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 least selective (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 Biology”, these ranks ranged from 42.8 (SD= 21.5 ) (for  Nantes university hospital) to 167 (SD= 13.3 ) (for Reims  univer sity hospital) and were significantly different  between university hospitals (p<0.0001).",Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 as in other countries currently  displays mark ed and deep  changes.22,23 Indeed, French medical biology laboratories  are presently subject to laboratory consolidation,  restructuration and accreditation24, with potential  implication of commercial companies, which may result in a  reduction of the number of positions for clinical laboratory  directors in the future.22 With respect to the “Hospital  Pharmacy” specialty, the rate of annual formation of new  hospital pharmacists (about 4.2%) is approximately twice  than that for new medical biologis ts.",Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 students can have the choice between clinical biology and   hospital pharmacy for specializing.,Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
"https://www.natmatch.com/ashprmp/   (accessed July 20, 2016).",Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
"http://www.cng.sante.fr/Concours -donnant -acces -au-3eme.html   (accessed November 20, 2016).",Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
"Ordre National des Pharmaciens, les ph armaciens: panorama au 1er Janvier 2016.  http://www.ordre.pharmacien.fr/content/download/272315/1437425/version/13/file/Demogra phie-2015_Brochure - VDEF.pdf  (accessed August, 6, 2016).",Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):912.   https://doi.org/ 10.18549/PharmPract.201 7.01.912    www.ph armacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 8 22.,Non-OADS,/arxiv_data1/oa_pdf/d6/b5/pharmpract-15-912.PMC5386628.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 1   Abstract   Systematic reviews and pairwise meta -analyses of randomized controlled trials, at the intersection of clinical medicine, epidemiology  and statistics, are positioned at the top of evidence -based practice hierarchy.",Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 2 technologies are available in the  market for certain  conditions .16-19 Nonetheless, there is often a lack of, or  limited, evidence in the literature from head -to-head  clinical trials, which hampers conclusions  being drawn  from comparisons of drug efficacy and safety profiles.",Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 3 method allows investigators to incorporate results from  trials in which the common comparator was C, as well as  trials in which the common comparator was D. Thus, more  than one common treatment can be used to conduct an  indirect comparison between two treatments.",Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 4 (graphical methods) are usually employed, and facilitate  the interpretation of the results.26,29   Networks of any kind (ITC, NMA or MTC) may take on  different shapes and are usuall y visually represented by  figures, called network plots or graphs (Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 5 accompanied by a network graph or diagram for better  understanding and interpretation of results .30,31 For  instance, closed loop refers to a part in the network where  all the interventions are directly connected forming a  closed geometry (e.g.",Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 6 to statistics differ in their definitions of probability.,Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 7 Another advantage of MTC analys es usually related to  Bayesian method is the ability to provide treatment ranking  probabilities (rank order or rankograms).,Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
"Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 8 Since NMAs are usually based on Bayesian statistics, robust  softwares with well -designed program codes are required.",Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 9 Epilogue   NMA in all its formats and statistical approaches can  provide findings of fundamental importance for the  development of guidelines and for evidence -based  decisions in health care.,Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 10 23.,Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
Pharmacy Practice  2017 Jan-Mar;15(1):943.   https://doi.org/ 10.18549/PharmPract.201 7.01.943    www.pharmacypractice.org  (eISSN: 1886 -3655  ISSN: 1885 -642X ) 11 53.,Non-OADS,/arxiv_data1/oa_pdf/fb/cf/pharmpract-15-943.PMC5386629.pdf
"Other specific details are available on the company websites (Cell Systems, http://www.cell- systems.com/cert/22/137/Products/Products/ACBRI-Site-Sand ScienCell, https://www.sciencellonline.com/human-brain-microvascular-endothelial-cells.html).",Non-OADS,/arxiv_data1/oa_pdf/8b/57/EPI-58-576.PMC5386820.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)EAF2 regulates DNA repair in the prostate JA i et al 2065 Oncogene (2017) 2054 –2065",Non-OADS,/arxiv_data1/oa_pdf/95/21/onc2016373a.PMC5386836.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Dual lysine residues critical for secreted Hsp90 αfunction M Zou et al 2171 Oncogene (2017) 2160 –2171",Non-OADS,/arxiv_data1/oa_pdf/02/21/onc2016375a.PMC5386837.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/4c/cd/acb-50-1.PMC5386920.pdf
"Original Article https://doi.org/10.5115/acb.2017.50.1.1 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Sunita AthavaleDepartment of Anatomy, All India Institute of Medical Sciences, C-166 Emerald Park City, Bhopal, MP , IndiaTel: +91-8878895453, Fax: +91-7552970166, E-mail: sunita.anatomy@aiimsbhopal.edu.inIs tricuspid valve really tricuspid?",Non-OADS,/arxiv_data1/oa_pdf/4c/cd/acb-50-1.PMC5386920.pdf
"Anat Cell Biol 2017;50:1-6 Sunita Athavale, et al 2 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.1that “endless variations were found in number, size, shape,  fusion, and location of papillary muscles.",OADS,/arxiv_data1/oa_pdf/4c/cd/acb-50-1.PMC5386920.pdf
Tricuspid valve https://doi.org/10.5115/acb.2017.50.1.1Anat Cell Biol 2017;50:1-6 3 www.acbjournal.orgin between.,Non-OADS,/arxiv_data1/oa_pdf/4c/cd/acb-50-1.PMC5386920.pdf
"Anat Cell Biol 2017;50:1-6 Sunita Athavale, et al 4 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.12Major commisures 2Leaflets (A+1/2I, 1/2I+S)6cases 3Major commisures 3Leaflets (A,I,S)4cases1Major commisure 1Leaflet (A+I+S)6cases3Major commisures 3Leaflets (A+1/2I, 1/2I, S)6cases2Major commisures 2Leaflets (SVL, A+I+S)4cases 2Major commisures 2Leaflets (A+I, S)5cases2Major commisures 2Leaflets (A+2/3I, 1/3I+S)1case2Major commisures 2Leaflets (A,I+S)6cases2Major commisures 2Leaflets (A+1/3I, 2/3I+S)4cases Fig.",Non-OADS,/arxiv_data1/oa_pdf/4c/cd/acb-50-1.PMC5386920.pdf
"Tricuspid valve https://doi.org/10.5115/acb.2017.50.1.1Anat Cell Biol 2017;50:1-6 5 www.acbjournal.orgCharacterization of leaflets Depending on the number and position of the major and  minor commissures, the pattern of leaflets and their charac- terization is depicted in Table 1 and Fig.",Non-OADS,/arxiv_data1/oa_pdf/4c/cd/acb-50-1.PMC5386920.pdf
"Anat Cell Biol 2017;50:1-6 Sunita Athavale, et al 6 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.1not consider the presence of scallops in single leaflet.",OADS,/arxiv_data1/oa_pdf/4c/cd/acb-50-1.PMC5386920.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/17/f2/acb-50-12.PMC5386921.pdf
"Human anatomical dissection is also important in the medical syllabus because it is here that students learn the es-sential language of medicine and how to develop understand-ing through experimentation and acquire expertise in solv -Original Article https://doi.org/10.5115/acb.2017.50.1.12 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Rafael Romero-ReverónDepartment of Human Anatomy, José María Vargas Medical School, Faculty of Medicine, Universidad Central de Venezuela, Orthopedic Trauma Surgery Service at Centro Médico Docente La Trinidad, Caracas 1080, VenezuelaTel: +58-4166389552, Fax: +58-2129459068, E-mail: rafa1636@yahoo.esVenezuelan surgeons view concerning teaching human anatomical dissection Rafael Romero-Reverón1,2 1Department of Human Anatomy, José María Vargas Medical School, Faculty of Medicine, Universidad Central de Venezuela, Caracas, 2Orthopedic Trauma  Surgery Service at Centro Médico Docente La Trinidad, Caracas, Venezuela Abstract:  Currently, the importance of human anatomical dissection have come under debate in many countries but there  are not references in Venezuela on this concern.",Non-OADS,/arxiv_data1/oa_pdf/17/f2/acb-50-12.PMC5386921.pdf
Anatomical dissection in medical syllabus https://doi.org/10.5115/acb.2017.50.1.12Anat Cell Biol 2017;50:12-16 13 www.acbjournal.orgtrenched as the best way to picture topographical landmarks  and anatomical variation allowing medical students to ap-preciate relationships between different organs and structures and the three-dimensionality of the structures of the human body.,Non-OADS,/arxiv_data1/oa_pdf/17/f2/acb-50-12.PMC5386921.pdf
"Anat Cell Biol 2017;50:12-16 Rafael Romero-Reverón 14 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.12to select what form of imaging as a complementary tool in  anatomical education should be further explored in anatomi-cal education, 41 of respondents’ (63.07%) selected three-dimensional computerized tomography imaging compared to other imaging modalities (P <0.001) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/17/f2/acb-50-12.PMC5386921.pdf
Anatomical dissection in medical syllabus https://doi.org/10.5115/acb.2017.50.1.12Anat Cell Biol 2017;50:12-16 15 www.acbjournal.orgman anatomical dissection for learning human anatomy were  not evaluated.,Non-OADS,/arxiv_data1/oa_pdf/17/f2/acb-50-12.PMC5386921.pdf
Anat Cell Biol 2017;50:12-16 Rafael Romero-Reverón 16 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.12school: beyond learning about anatomy: a qualitative study.,Non-OADS,/arxiv_data1/oa_pdf/17/f2/acb-50-12.PMC5386921.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
"Odors are detected in the majority of mammals by means of two systems, the main olfactory system and the vomerosensory Original Article https://doi.org/10.5115/acb.2017.50.1.17 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Sanaa A. M. ElgayarDepartment of Histology, Faculty of Medicine, Assiut University, Assiut  71515, EgyptTel: +20-1273636763, Fax: +20-882343703, E-mail: selgar1@hotmail.comMorphology of cat vomeronasal organ non-sensory epithelium during postnatal development Sanaa A. M. Elgayar, Heba M. Saad-Eldin, Ola A. Haussein Department of Histology, Faculty of Medicine, Assiut University, Assiut, Egypt Abstract:  The vomeronasal organ has an important role in mammal’s social and sexual behaviours.",Non-OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
"Anat Cell Biol 2017;50:17-25 Sanaa A. M. Elgayar, et al 18 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.17The study of Salazar et al.",OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
Developing cat vomeronasal organ https://doi.org/10.5115/acb.2017.50.1.17Anat Cell Biol 2017;50:17-25 19 www.acbjournal.orgthe specimen.,Non-OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
"Anat Cell Biol 2017;50:17-25 Sanaa A. M. Elgayar, et al 20 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.17middle and caudal (Fig.",OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
"Developing cat vomeronasal organ https://doi.org/10.5115/acb.2017.50.1.17Anat Cell Biol 2017;50:17-25 21 www.acbjournal.orgness measures 27.91±7.18 mm at birth (Table 1, Fig.",Non-OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
"Anat Cell Biol 2017;50:17-25 Sanaa A. M. Elgayar, et al 22 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.17the epithelial surface (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
Developing cat vomeronasal organ https://doi.org/10.5115/acb.2017.50.1.17Anat Cell Biol 2017;50:17-25 23 www.acbjournal.orgdarkened nucleus and cytoplasm.,Non-OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
"Anat Cell Biol 2017;50:17-25 Sanaa A. M. Elgayar, et al 24 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.17Discussion The rotation of the VND, which we have detected in the  cat, occurs in its RS for 90° and results in a transverse orienta- tion of its lumen, there the VND opens into the nasopalatine duct.",OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
Developing cat vomeronasal organ https://doi.org/10.5115/acb.2017.50.1.17Anat Cell Biol 2017;50:17-25 25 www.acbjournal.orgaggregation.,Non-OADS,/arxiv_data1/oa_pdf/e4/69/acb-50-17.PMC5386922.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
"In addition, in in-vitro fertiliza-Original Article https://doi.org/10.5115/acb.2017.50.1.26 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Reza NejatbakhshDepartment of Anatomical Sciences, Faculty of Medicine, Zanjan University of Medical Sciences, Mahdavi Blvd, Zanjan, IranTel: +98-24-33440301, Fax: +98-24-33449553, E-mail: reza_nejat@yahoo.comRelationship between meiotic spindles visualization and intracytoplasmic sperm injection outcomes in human oocytes Elham Asa1, Reza Tabatabaee1, Ahmad Farrokhi2, Reza Nejatbakhsh2 1ACECR Center for Infertility Treatment, Qom Branch, Qom, 2Department of Anatomical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran Abstract:  In assisted reproductive techniques, the operator attempts to select morphologically best embryos to predict embryo  viability.",Non-OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
Meiotic spindles and ICSI outcomes https://doi.org/10.5115/acb.2017.50.1.26Anat Cell Biol 2017;50:26-32 27 www.acbjournal.orgis a key determinant of oocyte developmental potential.,OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
"Anat Cell Biol 2017;50:26-32 Elham Asa, et al 28 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.26discontinuous density-gradient centrifugation.",OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
"Meiotic spindles and ICSI outcomes https://doi.org/10.5115/acb.2017.50.1.26Anat Cell Biol 2017;50:26-32 29 www.acbjournal.organ average age of 30.5±7.5 years (range, 23–38 years), and a  duration of infertility between 1 to 10 years.",Non-OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
"Anat Cell Biol 2017;50:26-32 Elham Asa, et al 30 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.26Embryo morphology scoring After 72 hours, morphology of embryos was checked and  scored according to their quality.",OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
Meiotic spindles and ICSI outcomes https://doi.org/10.5115/acb.2017.50.1.26Anat Cell Biol 2017;50:26-32 31 www.acbjournal.orghas become feasible.,Non-OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
"Anat Cell Biol 2017;50:26-32 Elham Asa, et al 32 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.264.",OADS,/arxiv_data1/oa_pdf/60/ad/acb-50-26.PMC5386923.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"We found that the corpuscles in late-stage fetuses can be classified into two types: (1) thin, small, im-mature corpuscles with tightly packed lamellae, of thickness 30–70 µm and length 0.3–0.7 mm; and (2) thick, long, mature  corpuscles with loosely packed lamellae, of thickness 80–150  µm and length 0.5–2.0 mm and morphology similar to that in Introduction Three stages in the development of digital Pacinian cor - puscles in the human fetus have been described: (1) a pri- mordial stage, consisting of one type of cell distributed along “stag-horn-like” nerve twigs and observed in fetuses of crown-rump length (CRL) 70–90 mm; (2) an avascular Original Article https://doi.org/10.5115/acb.2017.50.1.33 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Ji Hyun KimDepartment of Anatomy, Seonam University College of Medicine, 439 Chunhyang-ro, Namwon 55724, KoreaTel: +82-63-620-0313, Fax: +82-63-620-0301, E-mail: 407kk@hanmail.netPacinian corpuscle-like structure in the digital tendon sheath and nail bed: a study using late-stage human fetuses Ji Hyun Kim1, Koichiro Sakanaka2, Naomitsu Tomita2, Gen Murakami2,3, Hiroshi Abe4, Shinichi Abe2 1Department of Anatomy, Seonam University College of Medicine, Namwon, Korea, 2Department of Anatomy, Tokyo Dental College, Tokyo, 3Division of  Internal Medicine, Iwamizawa Asuka Hospital, Iwamizawa, 4Department of Anatomy, Akita University School of Medicine, Akita, Japan Abstract:  Pacinian corpuscle-like structures were identified in the digital tendon sheaths and nail beds of hands obtained from  eight of 12 human fetuses of gestational age 20–34 weeks (crown-rump length, 150–290 mm).",Non-OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"Anat Cell Biol 2017;50:33-40 Ji Hyun Kim, et al 34 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.33 AA BB CC DDFig.",OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
Aberrant Pacinian corpuscles https://doi.org/10.5115/acb.2017.50.1.33Anat Cell Biol 2017;50:33-40 35 www.acbjournal.orgadults [2].,Non-OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"Anat Cell Biol 2017;50:33-40 Ji Hyun Kim, et al 36 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.33extended.",OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"Aberrant Pacinian corpuscles https://doi.org/10.5115/acb.2017.50.1.33Anat Cell Biol 2017;50:33-40 37 www.acbjournal.orgthin and small corpuscles with tightly packed lamellae, of  thickness 30–70 µm and length 0.3–0.7 mm (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"Anat Cell Biol 2017;50:33-40 Ji Hyun Kim, et al 38 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.33interphalangeal joint.",OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"Aberrant Pacinian corpuscles https://doi.org/10.5115/acb.2017.50.1.33Anat Cell Biol 2017;50:33-40 39 www.acbjournal.orgthe middle phalangeal segment near the proximal interpha- langeal joint showed thinning of the tendon sheath at the base attached to the phalangeal bone, with the sheath interrupted by loose tissue (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"Anat Cell Biol 2017;50:33-40 Ji Hyun Kim, et al 40 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.33process similar to that of typical Pacinian corpuscles.",Non-OADS,/arxiv_data1/oa_pdf/4e/17/acb-50-33.PMC5386924.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
"For exam-ple, East Asians generally have relatively protruding eyeballs in the orbit, while Caucasians generally have relatively deeply Original Article https://doi.org/10.5115/acb.2017.50.1.41 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Wu-Chul SongDepartment of Anatomy, Konkuk University School of Medicine, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, KoreaTel: +82-2-2030-7819, Fax: +82-2-2030-7845, E-mail: anatomy@kku.ac.krThree-dimensional and topographic relationships between the orbital margins with reference to assessment of eyeball protrusion Kang-Jae Shin, Shin-Hyo Lee, Ki-Seok Koh, Wu-Chul Song Department of Anatomy, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea Abstract:  This study investigated the topographic relationships among the eyeball and four orbital margins with the aim of  identifying the correlation between orbital geometry and eyeball protrusion in Koreans.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
"Anat Cell Biol 2017;50:41-47 Kang-Jae Shin, et al 42 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.41the soft tissue over the lateral orbital margin is very thin.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
Orbital geometry and eyeball protrusion https://doi.org/10.5115/acb.2017.50.1.41Anat Cell Biol 2017;50:41-47 43 www.acbjournal.orgThe normality of the variables was confirmed by Kol- mogorov-Smirnov test.,OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
"Anat Cell Biol 2017;50:41-47 Kang-Jae Shin, et al 44 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.411/282).",OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
Orbital geometry and eyeball protrusion https://doi.org/10.5115/acb.2017.50.1.41Anat Cell Biol 2017;50:41-47 45 www.acbjournal.orgasymmetry.,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
"Anat Cell Biol 2017;50:41-47 Kang-Jae Shin, et al 46 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.41analyze differences between racial groups by comparing with  the previous studies, due to methodological differences (e.g., research device, positions of landmarks, and ages of subjects), to the best of my knowledge the present study is the first to investigate the geometric characteristics of the orbital margins regarding eyeball protrusion in Asians.",Non-OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
Orbital geometry and eyeball protrusion https://doi.org/10.5115/acb.2017.50.1.41Anat Cell Biol 2017;50:41-47 47 www.acbjournal.orgPathol 2008;4:181-6.,Non-OADS,/arxiv_data1/oa_pdf/9d/0a/acb-50-41.PMC5386925.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"There is general Original Article https://doi.org/10.5115/acb.2017.50.1.48 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Taekyun ShinDepartment of Veterinary Anatomy, College of Veterinary Medicine, Jeju National University, 102 Jejudaehak-ro, Jeju 63241, KoreaTel: +82-64-754-3363, Fax: +82-64-756-3354, E-mail: shint@jejunu.ac.kr *These two authors contributed equally to this work.Potential involvement of glycogen synthase  kinase (GSK)-3 β in a rat model of multiple  sclerosis: evidenced by lithium treatment Meejung Ahn1,*, Jeongtae Kim2,*, Changnam Park1, Jinhee Cho1, Y oungheun Jee1, Kyungsook Jung3,  Changjong Moon4, Taekyun Shin1 1Department of Veterinary Anatomy, College of Veterinary Medicine, Jeju National University, Jeju, Korea, 2Department of Molecular Anatomy, School of  Medicine, University of the Ryukyus, Nishihara, Japan, 3Eco-friendly Material Research Center, Korea Research Institute of Bioscience and Biotechnology,  Jeongeup, 4Department of Veterinary Anatomy, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea Abstract:  Glycogen synthase kinase (GSK)-3 β has been known as a pro-inflammatory molecule in neuroinflammation.",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
GSK-3β in rat EAE https://doi.org/10.5115/acb.2017.50.1.48Anat Cell Biol 2017;50:48-59 49 www.acbjournal.orgthe blockage of GSK-3 signaling may be a therapeutic strategy  for neuroprotection in CNS disease [14].,Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"Anat Cell Biol 2017;50:48-59 Meejung Ahn, et al 50 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.48Cell Signaling Technology.",OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"GSK-3β in rat EAE https://doi.org/10.5115/acb.2017.50.1.48Anat Cell Biol 2017;50:48-59 51 www.acbjournal.orgHarris’ hematoxylin for 5 seconds, washed under running  tap water for 20 minutes, dehydrated using a graded ethanol series, cleared with xylene, and mounted using Canada bal-sam (Junsei Chemical Co., Tokyo, Japan).",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"Anat Cell Biol 2017;50:48-59 Meejung Ahn, et al 52 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.48An inhibitor of GSK-3 β, lithium, ameliorates rat EAE  paralysis  To assess the role of GSK-3 β in rat EAE, myelin basic pro- tein (MBP)–immunized Lewis rats were treated with lithium.",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
GSK-3β in rat EAE https://doi.org/10.5115/acb.2017.50.1.48Anat Cell Biol 2017;50:48-59 53 www.acbjournal.org BC D11 13 155 4 3 2 1 0 13 57 9Clinicalscore 17 19 21**EAE+vehicle EAE+lithium Days PI**A Fig.,Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"Anat Cell Biol 2017;50:48-59 Meejung Ahn, et al 54 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.48given vehicle (30.79±3.67%, P <0.01).",OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"GSK-3β in rat EAE https://doi.org/10.5115/acb.2017.50.1.48Anat Cell Biol 2017;50:48-59 55 www.acbjournal.organd anti-inflammatory cytokines, such as IL-10 in the serum  levels (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"Anat Cell Biol 2017;50:48-59 Meejung Ahn, et al 56 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.48decrease in the VCAM-1 immunoreactivity in lithium-treated  (13.1±0.5%, P<0.05) compared with vehicle-treated rats (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"GSK-3β in rat EAE https://doi.org/10.5115/acb.2017.50.1.48Anat Cell Biol 2017;50:48-59 57 www.acbjournal.orgflammation [35-37] and is regulated by the PI3K/Akt and/or  Wnt signaling pathway [14, 38, 39].",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"Anat Cell Biol 2017;50:48-59 Meejung Ahn, et al 58 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.48Kim MD, Shin T. Increased phosphorylation of cyclic AMP re- sponse element-binding protein in the spinal cord of Lewis rats  with experimental autoimmune encephalomyelitis.",OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"GSK-3β in rat EAE https://doi.org/10.5115/acb.2017.50.1.48Anat Cell Biol 2017;50:48-59 59 www.acbjournal.org(GSK3): inflammation, diseases, and therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/f4/ec/acb-50-48.PMC5386926.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
"Increased pul monary vascular resistance and over-proliferation of Original Article https://doi.org/10.5115/acb.2017.50.1.60 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Jae Chul LeeDepartment of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, KoreaTel: +82-31-738-0270, Fax: +82-31-738-0271, E-mail: beas100@snu.ac.krTherapeutic effect of prostaglandin E1 in monocrotaline-induced pulmonary arterial hypertension rats Jae Chul Lee1,2 1Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seongnam, 2Department of Anatomy, Seoul National  University College of Medicine, Seoul, Korea Abstract:  Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular disease characterized by sustained increase  in pulmonary arterial pressure and excessive thickening and remodeling of distal small pulmonary arteries.",Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
Therapeutic efficacy of PGE1 in PAH https://doi.org/10.5115/acb.2017.50.1.60Anat Cell Biol 2017;50:60-68 61 www.acbjournal.orgutility of PGE1 has been limited due to its chemical instability  and extremely hydrophobic nature which results in low drug absorption and poor bioavailability.,Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
Anat Cell Biol 2017;50:60-68 Jae Chul Lee 62 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.60Histologic findings of pulmonary arteries Heart and lung tissues were fixed with 10% buffered for - malin and then embedded in paraffin.,Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
Therapeutic efficacy of PGE1 in PAH https://doi.org/10.5115/acb.2017.50.1.60Anat Cell Biol 2017;50:60-68 63 www.acbjournal.orgperature.,Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
"Anat Cell Biol 2017;50:60-68 Jae Chul Lee 64 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.60ment of cardiac fibrosis, lung fibrosis, and remodeling, lung  and RV samples were collected at 28 days after administration of MCT to determine histology patterns in the lung and RV .",OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
Therapeutic efficacy of PGE1 in PAH https://doi.org/10.5115/acb.2017.50.1.60Anat Cell Biol 2017;50:60-68 65 www.acbjournal.orgitive TUNEL staining (the presence of dark brown nuclei was  observed) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
Anat Cell Biol 2017;50:60-68 Jae Chul Lee 66 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.60proteins in the lung.,Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
"Therapeutic efficacy of PGE1 in PAH https://doi.org/10.5115/acb.2017.50.1.60Anat Cell Biol 2017;50:60-68 67 www.acbjournal.orgPGE1, a naturally occurring eicosanoid, is synthesized  from 20-carbon polyunsaturated fatty acid dihomo-gamma- linolenic acid (DGLA) via cyclooxygenase-1 and -2 pathways [31, 32].",Non-OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
Anat Cell Biol 2017;50:60-68 Jae Chul Lee 68 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.6012.,OADS,/arxiv_data1/oa_pdf/49/f9/acb-50-60.PMC5386927.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/d6/05/acb-50-69.PMC5386928.pdf
"Ge-netic, hormonal, and environmental factors are known to be Original Article https://doi.org/10.5115/acb.2017.50.1.69 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Mohammad Hassan HeidariDepartment of Anatomical Sciences and Biology, Proteomics Laboratory, School of Medicine, Shahid Beheshti University of Medical Sciences, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran 19839-63113, IranTel: +98-2122439976, Fax: +98-2122439976, E-mail: heidari34@gmail.comEvaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker Mohammad Hassan Heidari1,2, Abolfazl Movafagh3, Mohammad-Amin Abdollahifar1, Shabnam Abdi4,  Mohamadreza Mashhoudi Barez2, Hadi Azimi5, Afshin Moradi6, Amin Bagheri7, Matineh Heidari8,   Jafar Hessam Mohseni9, Maryam Tadayon10, Hoda Mirsafian11, Mahdi Ghatrehsamani12 1Department of Anatomy and Biology, Faculty of Medicine, Shahid Beheshti University, Tehran, 2Department of Anatomical Sciences and Biology,  Proteomics Laboratory, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 3Department of Medical Genetics, Cancer Research  Center, School of Medicine, Shahid Beheshti University of Medical Science, Tehran, 4Department of Anatomical Sciences and Biology, School of  Medicine, Azad University of Medical Sciences, Tehran, 5Department of English Language Teaching, School of Medicine, Shahid Beheshti University of  Medical Sciences, Tehran, 6Department of Pathology, Shohada Hospital, Shahid Beheshti University of Medical Science, Tehran, 7Cardiac Surgery and  Transplantation Research Center, Tehran University of Medical Sciences, Tehran, 8School of Medicine, Tehran University of Medical Sciences, Tehran,  9Mohseni Clinical Diagnostic Laboratory, Noshahr, 10Department of Education Region 1 Tehran (Shemiranat), Tehran, Iran, 11Institute of Biological  Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia, 12Cellular and Molecular Biology Research Centre, Shahrekord University of  Medical Sciences, Shahrekord, Iran Abstract:  Prostate cancer is the most common cancer type in men and is the second cause of death, due to cancer, in patients  over 50, after lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/d6/05/acb-50-69.PMC5386928.pdf
"Anat Cell Biol 2017;50:69-72 Mohammad Hassan Heidari, et al 70 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.69involved in the incidence of this cancer.",Non-OADS,/arxiv_data1/oa_pdf/d6/05/acb-50-69.PMC5386928.pdf
sHLA-G levels in patients with prostate cancer https://doi.org/10.5115/acb.2017.50.1.69Anat Cell Biol 2017;50:69-72 71 www.acbjournal.orgwas observed between the three groups (P <0.05) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d6/05/acb-50-69.PMC5386928.pdf
"Anat Cell Biol 2017;50:69-72 Mohammad Hassan Heidari, et al 72 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.69py.",OADS,/arxiv_data1/oa_pdf/d6/05/acb-50-69.PMC5386928.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/41/7e/acb-50-7.PMC5386929.pdf
"[1] in Swiss Original Article https://doi.org/10.5115/acb.2017.50.1.7 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Raveendranath VeeramaniDepartment of Anatomy, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Pondicherry 605006, IndiaTel: +91-9043997352, Fax: +91-0413-2272067, E-mail: dr_raveendra@rediffmail.comMorphometric study of tensor of vastus intermedius in South Indian population Raveendranath Veeramani, Dhivyalakshmi Gnanasekaran  Department of Anatomy, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Abstract:  Tensor of vastus intermedius is a newly discovered muscle located between vastus lateralis and vastus intermedius.",Non-OADS,/arxiv_data1/oa_pdf/41/7e/acb-50-7.PMC5386929.pdf
Anat Cell Biol 2017;50:7-11 Raveendranath Veeramani and Dhivyalakshmi Gnanasekaran 8 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.7lowerlimbs (8 paired and 11 unpaired) and nine female lower - limbs (3 paired and 3 unpaired).,Non-OADS,/arxiv_data1/oa_pdf/41/7e/acb-50-7.PMC5386929.pdf
Tensor of vastus intermedius in South Indian population https://doi.org/10.5115/acb.2017.50.1.7Anat Cell Biol 2017;50:7-11 9 www.acbjournal.orgnation of two or all the three aponeurosis (Fig.,Non-OADS,/arxiv_data1/oa_pdf/41/7e/acb-50-7.PMC5386929.pdf
Anat Cell Biol 2017;50:7-11 Raveendranath Veeramani and Dhivyalakshmi Gnanasekaran 10 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.7value was 170.84 mm and minimum value was 23.19 mm).,OADS,/arxiv_data1/oa_pdf/41/7e/acb-50-7.PMC5386929.pdf
"Tensor of vastus intermedius in South Indian population https://doi.org/10.5115/acb.2017.50.1.7Anat Cell Biol 2017;50:7-11 11 www.acbjournal.orgdistal course of the TVI inserted into the upper medial aspect  of patella fusing with either the VL, VI , RF, or a combination of two or all the three aponeurosis.",Non-OADS,/arxiv_data1/oa_pdf/41/7e/acb-50-7.PMC5386929.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2017.",Non-OADS,/arxiv_data1/oa_pdf/b4/4f/acb-50-73.PMC5386930.pdf
"Here, we present a unique case of intrathoracic rib in a  3-year-old boy with an unusual appearance of an intrathorac-ic rib, which is originating from an inferior-lateral portion of a second rib, without articulation with the vertebrae through Case Report https://doi.org/10.5115/acb.2017.50.1.73 pISSN 2093-3665   eISSN 2093-3673 Corresponding author: Shabnam AbdiDepartment of Anatomical Sciences, School of Medicine, Azad University of Medical Sciences, Tehran Medical Branch, Islamic Azad University, Khaghani St., Shariati Ave., Tehran, P .O.",Non-OADS,/arxiv_data1/oa_pdf/b4/4f/acb-50-73.PMC5386930.pdf
"Anat Cell Biol 2017;50:73-75 Mohammad-Amin Abdollahifar, et al 74 www.acbjournal.org https://doi.org/10.5115/acb.2017.50.1.73appears to be an accessory second rib coursing into the chest  cavity and migrates inferior-interior toward seventh rib.",Non-OADS,/arxiv_data1/oa_pdf/b4/4f/acb-50-73.PMC5386930.pdf
A rare intrathoracic rib https://doi.org/10.5115/acb.2017.50.1.73Anat Cell Biol 2017;50:73-75 75 www.acbjournal.orgDiscussion  Intrathoracic ribs are uncommon congenital variation  where an incomplete supra- or normonumerary rib follows  an abnormal course in the intrathoracic cavity and may origi-nate from a vertebra or a rib [3].,Non-OADS,/arxiv_data1/oa_pdf/b4/4f/acb-50-73.PMC5386930.pdf
China  *Correspondence: cychung@tju.edu.cn http://dx.doi.org/10.14348/molcells.2017.0011  www.molcells.org       Microglia are the primary resident immune cells of the central  nervous system (CNS).,Non-OADS,/arxiv_data1/oa_pdf/97/5f/molce-40-3-163.PMC5386953.pdf
"Cells 2017; 40(3): 169-177  169              Minireview       Functional Enhancers As Master Regulators of  Tissue-Specific Gene Regulation and Cancer  Development    Je Yeong Ko1, Sumin Oh2, and Kyung Hyun Yoo3,*      1Molecular Medicine Laboratory, Department of Biological Science s, 2Research Institute of Women’s Health, 3Laboratory of  Biomedical Genomics, Department of Biological Sciences, Sookmyu ng Women’s University, Seoul 04310, Korea  *Correspondence: khryu@sookmyung.ac.kr  http://dx.doi.org/10.14348/molcells.2017.0033  www.molcells.org       Tissue-specific transcription is  critical for normal developmen t,  and abnormalities causing undesi rable gene expression may  lead to diseases such as cancer.",Non-OADS,/arxiv_data1/oa_pdf/44/12/molce-40-3-169.PMC5386954.pdf
"Cells 2017; 40(3): 178-185              Minireview       Transcription Factor OsDOF18  Controls  Ammonium Uptake by Inducing Ammonium  Transporters in Rice Roots    Yunfei Wu, Wenzhu Yang, Jinhuan Wei,  Hyeryung Yoon, and Gynheung An*      Crop Biotech Institute and Gradu ate School of Biotechnology, Ky ung Hee University, Yongin 17104, Korea  *Correspondence: genean@khu.ac.kr http://dx.doi.org/10.14348/molcells.2017.2261  www.molcells.org       Nitrogen is one of the most important mineral elements for  plant growth.",Non-OADS,/arxiv_data1/oa_pdf/3a/ea/molce-40-3-178.PMC5386955.pdf
"RT-PCR analyses   Total RNA was isolated from seedling roots at 4 DAG using RNAiso Plus (TaKaRa, Shiga, Japan; http://www.takarabio.",OADS,/arxiv_data1/oa_pdf/3a/ea/molce-40-3-178.PMC5386955.pdf
"Cells 2017; 40(3): 186-194              Minireview       A Role of Central NELL2 in the Regulation of  Feeding Behavior in Rats    Jin Kwon Jeong1,*, Jae Geun Kim2, Han Rae Kim3, Tae Hwan Lee3, Jeong Woo Park3, and  Byung Ju Lee3,*      1Department of Pharmacology and Physiology, School of Medicine &  Health Sciences, The George Washington University, USA,  2Division of Life Sciences, College of Life Sciences and Bioengi neering, Incheon National University, Incheon 22012, Korea,  3Department of Biological Sciences, University of Ulsan, Ulsan 4 4610, Korea  *Correspondence: jinkwon0911@gwu.edu (JKJ); bjlee@ulsan.ac.kr ( BJL)  http://dx.doi.org/10.14348/molcells.2017.2278  www.molcells.org       A brain-enriched secreting si gnal peptide, NELL2, has been  suggested to play multiple roles in the development, survival,  and activity of neurons in mammal.",Non-OADS,/arxiv_data1/oa_pdf/ea/68/molce-40-3-186.PMC5386956.pdf
"Cells 2017; 40(3): 195-201  195              Minireview       MiR-186 Inhibited Migration of NSCLC via  Targeting cdc42 and Effecting EMT Process    Ying Dong1, Xintian Jin2, Zhiqiang Sun3, Yueming Zhao4, and Xianjing Song5,*      1Department of Radiotherapy, The Tumor Hospital of Jilin Provinc e, Changchun 130021, China, 2Department of Thoracic, The  Tumor Hospital of Jilin Province, Changchun 130021, China, 3Department of Invasive Technology, The Tumor Hospital of Jilin  Province, Changchun 130021, China, 4Department of Oncology, The Tumor Hospital of Jilin Province, C hangchun 130021,  China, 5Department of Cardiology, The Second Hospital of Jilin Universi ty, Changchun 130041, China  *Correspondence: xianjingsong@yeah.net  http://dx.doi.org/10.14348/molcells.2017.2291  www.molcells.org       In this study, qRT-PCR was employed to identify that miR-186  expression level in NSCLC tissues are highly associated with lymph node metastasis.",Non-OADS,/arxiv_data1/oa_pdf/8b/5b/molce-40-3-195.PMC5386957.pdf
"Cells 2017; 40(3): 202-210              Minireview       Hepatitis C Virus Nonstructural 5A Protein  (HCV-NS5A) Inhibits Hepatocyte Apoptosis  through the NF- b/miR-503/bcl-2 Pathway    Zhengyuan Xie*, Zhihua Xiao, and Fenfen Wang      Department of Gastroenterology, T he Second Affiliated Hospital,  Nanchang University, Nanchang 330006, China  *Correspondence: xzyxzy1230@163.com http://dx.doi.org/10.14348/molcells.2017.2299  www.molcells.org       The nonstructural protein 5A (NS5A) encoded by the human  hepatitis C virus (HCV) RNA genome is a multifunctional  phosphoprotein.",Non-OADS,/arxiv_data1/oa_pdf/cf/36/molce-40-3-202.PMC5386958.pdf
*Correspondence: zeng_hyz@sohu.com  http://dx.doi.org/10.14348/molcells.2017.2303  www.molcells.org       Transforming growth factor 1 (TGF1)/Smad4 signaling  plays a pivotal role in maintenance of the dynamic balance between bone formation and resorption.,Non-OADS,/arxiv_data1/oa_pdf/11/7f/molce-40-3-211.PMC5386959.pdf
"Cells 2017; 40(3): 222-229              Minireview       Adipose-Derived Stem Cells Suppress  Inflammation Induced by IL-1  through  Down-Regulation of P2X7R Mediated by  miR-373 in Chondrocytes of Osteoarthritis    Rilong Jin*, Miaoda Shen, Liedao Yu, Xuanwei Wang, and Xiangjin Lin      Department of Orthopedics Surgery, The First Affiliated Hospita l, College of Medical Zhejiang University, Hangzhou, 310003  China  *Correspondence: rilongjin@163.com http://dx.doi.org/10.14348/molcells.2017.2314  www.molcells.org       Adipose-derived stem cells (ADSCs) were previously consid- ered to have an anti-inflammatory effect, and Interleukin-1   (IL-1) was found to be a pro-inflammatory factor in chon- drocytes, but the mechanism  underlying ADSCs and IL-1  i s   unclear.",Non-OADS,/arxiv_data1/oa_pdf/93/60/molce-40-3-222.PMC5386960.pdf
"*Correspondence: sooykim@chonnam.ac.kr  http://dx.doi.org/10.14348/molcells.2017.0002 www.molcells.org       In the Arabidopsis genome, approximately 80 MAP3Ks (mi- togen-activated protein kinase  kinase kinases) have been  identified.",OADS,/arxiv_data1/oa_pdf/7b/cb/molce-40-3-230.PMC5386961.pdf
"3Expression values are from e-FP Browser (http://bar.utoronto.ca /efp/cgi-bin/efpWeb.cgi)        RESULTS    Expression patterns of Arabidopsis MAP3K14-18   T o  e x a m i n e  t h e  s t r e s s - i n d u c t i o n  p a t t e r n  o f  MAP3K16  e x - pression, we conducted real-time RT-PCR using RNA isolated  from seedlings.",OADS,/arxiv_data1/oa_pdf/7b/cb/molce-40-3-230.PMC5386961.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Tamara Alempijevic, MD, PhD, Pro - fessor,  University of Belgrade, School of Medicine, 2 Dr Koste  Todorovica Street, 11000 Belgrade,  Serbia.",Non-OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
Various global  registries have been established and the first guidelines  for diagnosis and management have come to define the  Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i10.491World J Hepatol   2017  April 8; 9(10): 491-502 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
World J Hepatol  2017; 9(10): 491-502   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/v9/ i10/491.,Non-OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i10.,OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
Available from: URL: https://www.fda.gov/Drugs/ ScienceResearch/ResearchAreas/ucm071471.htm 6 Zimmerman HJ .,Non-OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
"Ava ilable  from: URL: https://www.fda.gov/downloads/Drugs/Science  Research/ResearchAreas/ucm076777.pdf 27 Chen M , Borlak J, Tong W. High lipophilicity and high daily  dose of oral medications are associated with significant risk for  drug-induced liver injury.",Non-OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
"Available from: URL:  https://www.fda.gov/downloads/safety/MedWatch/Safetyin - formation/safetyalertsforhumanmedicalproducts/ucm168409.pdf  148 Bañares R , Catalina MV, Vaquero J. Molecular adsorbent re - circulating system and bioartificial devices for liver failure.",Non-OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1b/a5/WJH-9-491.PMC5387361.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Azita Hekmatdoost, MD, PhD, RD,  Department of Clinical Nutrition and Dietetics, Faculty of Nutri­ tion Sciences and Food Technology, National Nutrition and Food  Technology Research Institute, Shahid Beheshti University of  Medical Sciences, West Arghavan St., Farahzadi Blvd., P .O.",Non-OADS,/arxiv_data1/oa_pdf/6a/34/WJH-9-503.PMC5387362.pdf
Adjustment for known risk factors of NAFLD strengthened Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i10.503World J Hepatol   2017  April 8; 9(10): 503-509 © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/6a/34/WJH-9-503.PMC5387362.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/34/WJH-9-503.PMC5387362.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/6a/34/WJH-9-503.PMC5387362.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Helen Vidot,  BSc,  Department Nutrition  and Dietetics, Royal Prince Alfred Hospital, Building 12,  Missenden Road, Camperdown NSW 2050,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/50/cd/WJH-9-510.PMC5387363.pdf
"Patients who  presented with acute, fulminant or subacute disease,  with a primary diagnosis of liver cancer, were assessed  for re-transplantation or who did not have a 25-OHD Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i10.510World J Hepatol   2017  April 8; 9(10): 510-518 © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/50/cd/WJH-9-510.PMC5387363.pdf
World J Hepatol  2017; 9(10): 510-518   Available from: URL:  http://www.wjgnet.co m/1948-5182 /full/v9/ i10/510.,Non-OADS,/arxiv_data1/oa_pdf/50/cd/WJH-9-510.PMC5387363.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i10.510 INTRODUCTION Hepatic encephalopathy (HE) describes a complex  collection of neuropsychiatric symptoms ranging from  sub-clinical neuropsychiatric changes to coma[1] and has  been identified in up to 55% of patients with chronic  liver disease[2].,Non-OADS,/arxiv_data1/oa_pdf/50/cd/WJH-9-510.PMC5387363.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/50/cd/WJH-9-510.PMC5387363.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Henning Pflugrad,  Department of  Neurology, Hannover Medical School,  Carl-Neuberg-Str.",Non-OADS,/arxiv_data1/oa_pdf/a8/85/WJH-9-519.PMC5387364.pdf
"pflugrad.henning@mh-hannover.de Telephone:  +49-511-5323121  Fax:  +49-511-5323123 Received:  October 19, 2016 Peer-review started:  October 21, 2016 First decision:  January 5, 2017 Revised:  January 23, 2017 Accepted:  March 12, 2017 Article in press:  March 13, 2017 Published online:  April 8, 2017 Abstract AIM To investigate the impact of hepatic encephalopathy Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i10.519World J Hepatol   2017  April 8; 9(10): 519-532 © 2017 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/a8/85/WJH-9-519.PMC5387364.pdf
World J Hepatol  2017; 9(10): 519-532  Available from: URL:   http://www.wjgnet.co m/1948-5182 /full/v9/i10/519.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/WJH-9-519.PMC5387364.pdf
htm  DOI:  http://dx.doi.org/10.4254/wjh.v9.i10.519 INTRODUCTION During the last 35 years specialized transplantation centres  with outpatient clinics for follow-up and improvement of  immunosuppressive therapy have significantly increased  survival rates after orthotopic liver transplantation (OLT)[1].,Non-OADS,/arxiv_data1/oa_pdf/a8/85/WJH-9-519.PMC5387364.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a8/85/WJH-9-519.PMC5387364.pdf
A nega - tive attentional set leads to the inhibition of stimuli with distractor-like  this is an open access article under the cc B y-nc-nd license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/fb/acp-13-052.PMC5387411.pdf
"retrieved from:  http://www.crsltd.com/  chua, F. (2015 ).",Non-OADS,/arxiv_data1/oa_pdf/c1/fb/acp-13-052.PMC5387411.pdf
Url: http://www.uv.es/revispsi/ articulos2.02/5.,Non-OADS,/arxiv_data1/oa_pdf/c1/fb/acp-13-052.PMC5387411.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Bariatric Surgery Reduces Risk of Colorectal Adenomas Kedrin et al.",Non-OADS,/arxiv_data1/oa_pdf/6d/6f/ctg20171a.PMC5387748.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Clinical and Tr anslational Gastroenterology websit e (http://www.nature.com/ctg)EoE Gene Score for Diagnosis and Monitoring Treatment Dellon et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/b1/ctg20172a.PMC5387749.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Triamcinolone Injection Prevents Stricture After ESD Nagami et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/0b/ctg20175a.PMC5387750.pdf
CF was diagnosed by sweat confidence interval (Cl) 460 mmol/l or the presence of two CF-causing mutations (http://www.cftr2.org).,Non-OADS,/arxiv_data1/oa_pdf/b0/49/ctg201710a.PMC5387753.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Improvement in the Intestinal pH With CFTR Modulation Gelfond et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/49/ctg201710a.PMC5387753.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/4.0/Translational Medicine: Bench to Bedside 3 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/2f/9f/ctg20177a.PMC5387756.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Clinical and Trans lational Gastroenterology website ( http://www.nat ure.com/ctg)HBD2 Expression in PSC Chang et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/69/ctg20178a.PMC5387757.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-CommercialLicense (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/3b/fww045.PMC5387889.pdf
"53 HFEA, available at: <http://www.hfea.gov.uk/fertility-clinics-treatment-abroad.html >accessed 22 November 2016.",Non-OADS,/arxiv_data1/oa_pdf/ec/3b/fww045.PMC5387889.pdf
(2015) cl 8.7.1 <http://consultations.nhmrc.gov.au/ﬁles/consultations/drafts/artdraftethicalguide lines150722.pdf >accessed 22 November 2016.,Non-OADS,/arxiv_data1/oa_pdf/ec/3b/fww045.PMC5387889.pdf
This  is  an  open access article under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/63/main.PMC5387892.pdf
Erythrocyte  sedimen- http://dx.doi.org/10.1016/j.ijscr.2017.02.041 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/0e/63/main.PMC5387892.pdf
E-mail: lily.xiao@flinders.edu.au ORCID ID: http://orcid.org/0000-0002-4631-2443 www.smj.org.sa     Saudi Med J 2017; Vol.,Non-OADS,/arxiv_data1/oa_pdf/81/ff/SaudiMedJ-38-229.PMC5387897.pdf
Available from: http://apps.who.int/iris/bitstream /10665/186463/1/9789240694811_eng.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/81/ff/SaudiMedJ-38-229.PMC5387897.pdf
Available from http://media.wix.com/ugd/dded87_40b9f f0bf53840478331915a8ed8b2fb.pdf.,Non-OADS,/arxiv_data1/oa_pdf/81/ff/SaudiMedJ-38-229.PMC5387897.pdf
Available from URL: http://www.britishgerontology.org/DB/gr-editions- 2/generations-review/student-nurses-attitudes-and-knowledge-towards-the.html 26.,Non-OADS,/arxiv_data1/oa_pdf/81/ff/SaudiMedJ-38-229.PMC5387897.pdf
Available from: http://www.who.int/ ageing/about/who_activities/en/.,OADS,/arxiv_data1/oa_pdf/81/ff/SaudiMedJ-38-229.PMC5387897.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/05/22/SaudiMedJ-38-251.PMC5387900.pdf
Available  from URL: http://seer.cancer.gov/archive/csr/1975_2006/.,Non-OADS,/arxiv_data1/oa_pdf/68/ac/SaudiMedJ-38-262.PMC5387902.pdf
"Available from URL:  http://www.accessdata.fda.gov/ drugsatfda_docs/label/2010/020938s020,021530s008MedGu ide.pdf 20.",Non-OADS,/arxiv_data1/oa_pdf/96/6a/SaudiMedJ-38-284.PMC5387905.pdf
Available from URL: http://www.sut.ac.th/im/data/read6.pdf 21.,OADS,/arxiv_data1/oa_pdf/d5/11/SaudiMedJ-38-292.PMC5387906.pdf
Available from: http://www.moh.gov.sa/en/ministry/ mediacenter/news/pages/news-2014-03-23-001.aspx 24.,Non-OADS,/arxiv_data1/oa_pdf/d5/11/SaudiMedJ-38-292.PMC5387906.pdf
Available from: http://www.acgme.org/What-We-Do/ Accreditation/Clinical-Experience-and-Education-formerly- Duty-Hours/GraduateMedicalEducation/DutyHours 25.,Non-OADS,/arxiv_data1/oa_pdf/d5/11/SaudiMedJ-38-292.PMC5387906.pdf
Available from: http://www.unisdr.org/2009/campaign/ pdf/wdrc-2008-2009-information-kit.pdf   7.,Non-OADS,/arxiv_data1/oa_pdf/a9/49/SaudiMedJ-38-302.PMC5387908.pdf
Available  from: http://ec.europa.eu/chafea/documents/health/leaflet/ who-toolkit.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/49/SaudiMedJ-38-302.PMC5387908.pdf
Sample references are available from:   http://www.nlm.nih.gov/bsd/uniform_requirements.html,Non-OADS,/arxiv_data1/oa_pdf/a5/85/SaudiMedJ-38-322.PMC5387913.pdf
Available from: http://www.who.int/mediacentre/news/releases/2017/early-cancer-costs/en/,Non-OADS,/arxiv_data1/oa_pdf/cd/1f/SaudiMedJ-38-328.PMC5387916.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/71/main.PMC5387917.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).Photoacoustics  6  (2017)  16–25 Contents  lists  available  at  ScienceDirect Photoacoustics journal  homepage:  www.else  vie  r.com/locate  /pacs,Non-OADS,/arxiv_data1/oa_pdf/d9/71/main.PMC5387917.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be `found,  in  the  online  version,  at  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/d9/71/main.PMC5387917.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014707).,Non-OADS,/arxiv_data1/oa_pdf/68/ea/bmjopen-2016-014707.PMC5387930.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/49/6d/bmjqir.u222156.w8291.PMC5387931.pdf
Available from:http://www.jointcommission.org.,Non-OADS,/arxiv_data1/oa_pdf/49/6d/bmjqir.u222156.w8291.PMC5387931.pdf
Available from: https://psnet.ahrq.gov/primers/primer/9/handoffs-and-signouts.,Non-OADS,/arxiv_data1/oa_pdf/49/6d/bmjqir.u222156.w8291.PMC5387931.pdf
Availablefrom: https://www.mededportal.org/publication/9311.,Non-OADS,/arxiv_data1/oa_pdf/49/6d/bmjqir.u222156.w8291.PMC5387931.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012805).,Non-OADS,/arxiv_data1/oa_pdf/3d/20/bmjopen-2016-012805.PMC5387932.pdf
Funding The study was funded by a competitive grant from the Richmond Group of Charities (http://www.richmondgroupofcharities.org.uk).,Non-OADS,/arxiv_data1/oa_pdf/3d/20/bmjopen-2016-012805.PMC5387932.pdf
http://www.mortality.org 41.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/bmjopen-2016-012805.PMC5387932.pdf
http://www.humanfertility.org 42.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/bmjopen-2016-012805.PMC5387932.pdf
http://www.who.int/healthinfo/statistics/mortality_rawdata/en/ 45.,Non-OADS,/arxiv_data1/oa_pdf/3d/20/bmjopen-2016-012805.PMC5387932.pdf
http://apps.who.int/nha/database/Country_Profile/Index/en 50.,OADS,/arxiv_data1/oa_pdf/3d/20/bmjopen-2016-012805.PMC5387932.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013034).,Non-OADS,/arxiv_data1/oa_pdf/0e/54/bmjopen-2016-013034.PMC5387933.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014478).,Non-OADS,/arxiv_data1/oa_pdf/67/4c/bmjopen-2016-014478.PMC5387934.pdf
2013. http://www.ohri.ca/programs/ clinical_epidemiology/oxford.asp 14.,Non-OADS,/arxiv_data1/oa_pdf/67/4c/bmjopen-2016-014478.PMC5387934.pdf
"Folate and caloric intakeswill be calculated using the USDA Nutrient Database (http://ndb.nal.usda.gov/), adapted to the Italian food consumption.",Non-OADS,/arxiv_data1/oa_pdf/11/f4/bmjopen-2016-014756.PMC5387935.pdf
"The different types of PM will be treated with a ‘Gamble Solution modi ﬁed’that mimics the chemical and physical composition of the interstitial ﬂuid deep regions of the lung (http://www.ivhhn.org) and tested as follows: (1) separate exposure of macrophages and A549 cells in culture at varying levels of PM for timesvarying from 4 to 48 hours; (2) after exposure to PM, the culture medium conditioned by macrophages will be used to grow non-exposed A549 cells in order to studythe in ﬂuence of the mediators released by macrophages; (3) the cellular toxicity of the PM in the cells treated in (1) will be measured by the lactate dehydrogenase(LDH) level released from cells A549; (4) non- radioactive quanti ﬁcation of cell proliferation and cell viability of A549 cells exposed to PM, by means of WST-1colorimetric assay and direct microscopic counts; (5) evaluation of the expression of biomarkers of oxidative stress as heme-oxygenase-1 (HO-1) and pro- ﬁbrotic marker as transforming growth factor β(TGF-B) on the same cells by quantitative real-time PCR; (6) evaluation by ELISA of the release of a biomarker of in ﬂammation as interleukin 8 (IL-8) in the culture medium 4 Barchitta M, et al.BMJ Open 2017; 7:e014756.",Non-OADS,/arxiv_data1/oa_pdf/11/f4/bmjopen-2016-014756.PMC5387935.pdf
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0387 16.,Non-OADS,/arxiv_data1/oa_pdf/11/f4/bmjopen-2016-014756.PMC5387935.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 014968).,Non-OADS,/arxiv_data1/oa_pdf/a3/b4/bmjopen-2016-014968.PMC5387936.pdf
"University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany).http://www.mortality.org 27.",Non-OADS,/arxiv_data1/oa_pdf/a3/b4/bmjopen-2016-014968.PMC5387936.pdf
2014. http://joannabriggs.org/ assets/docs/sumari/ReviewersManual-Methodology-JBI_UmbrellaReviews-2014.pdf (accessed15 Aug 2016).,OADS,/arxiv_data1/oa_pdf/9f/fe/bmjopen-2016-015421.PMC5387937.pdf
http://www.cadth.ca/sites/default/files/is/cadth_ Handout_greymatters_light_e.pdf (accessed 15 Aug 2016).,OADS,/arxiv_data1/oa_pdf/9f/fe/bmjopen-2016-015421.PMC5387937.pdf
2014. http://n2canada.ca/isct_downloads/ISCT_version.pdf 56.,OADS,/arxiv_data1/oa_pdf/72/78/bmjopen-2016-015420.PMC5387939.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014947).,Non-OADS,/arxiv_data1/oa_pdf/16/6d/bmjopen-2016-014947.PMC5387940.pdf
2016. http://www.who.int/mediacentre/ factsheets/fs204/en/# (accessed 10 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/16/6d/bmjopen-2016-014947.PMC5387940.pdf
2015. http://www.worldhepatitisalliance.org/sites/default/files/resources/documents/Hep%20B%20Guidelines.pdf (accessed 10 Oct2016).,Non-OADS,/arxiv_data1/oa_pdf/16/6d/bmjopen-2016-014947.PMC5387940.pdf
2016. http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_32-en.pdf?ua=1 (accessed 10 Oct 2016).,OADS,/arxiv_data1/oa_pdf/16/6d/bmjopen-2016-014947.PMC5387940.pdf
2016. http://apps.who.int/immunization_monitoring/globalsummary/wucoveragecountrylist.html(accessed 10 Oct 2016).,OADS,/arxiv_data1/oa_pdf/16/6d/bmjopen-2016-014947.PMC5387940.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014643).,Non-OADS,/arxiv_data1/oa_pdf/73/5f/bmjopen-2016-014643.PMC5387941.pdf
Global status report on alcohol and health 2011. http://www.who.int/substance_abuse/publications/global_alcohol_report/msbgsruprofiles.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/73/5f/bmjopen-2016-014643.PMC5387941.pdf
2005. https://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/guide.pdf 42.,Non-OADS,/arxiv_data1/oa_pdf/73/5f/bmjopen-2016-014643.PMC5387941.pdf
https://www.nice.org.uk/guidance/CG108 (accessed 27 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/97/8a/bmjresp-2016-000164.PMC5387942.pdf
"2nd edn, 2006. http://www.brit-thoracic.org.uk/delivery-of-respiratory-care/ burden-of-lung-disease-reports (accessed 26 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/97/8a/bmjresp-2016-000164.PMC5387942.pdf
"See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode Figure 4 Need for continuous education Figure 3 Necessity for cardiac monitoring during IV fluid replacement 4 Thirumal V, Love G. BMJ Quality Improvement Reports 2017; 6:u213676.w7336.",Non-OADS,/arxiv_data1/oa_pdf/0d/1f/bmjqir.u213676.w7336.PMC5387944.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012565).,Non-OADS,/arxiv_data1/oa_pdf/3c/65/bmjopen-2016-012565.PMC5387945.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010711).,Non-OADS,/arxiv_data1/oa_pdf/7b/6c/bmjopen-2015-010711.PMC5387946.pdf
http://dx.doi.org/10.1016/B978-012369462- 1/50003-X 8.,OADS,/arxiv_data1/oa_pdf/7b/6c/bmjopen-2015-010711.PMC5387946.pdf
"London: The Health Foundation, 2011. http://www.health.org.uk/media_manager/public/75/publications_pdfs/Helping%20people%20help%20themselves.pdf (accessed 15 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/01/5f/bmjopen-2016-014109.PMC5387947.pdf
https://www.stroke.org.uk/sites/ default/files/stroke_statistics_2015.pdf (accessed 28 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/01/5f/bmjopen-2016-014109.PMC5387947.pdf
An Implementation Guide and Toolkit for Making Every Contact Count: Using every opportunity to achieve health and wellbeing.https://www.england.nhs.uk/wp-content/uploads/2014/06/mecc-guid-booklet.pdf (accessed 28 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/01/5f/bmjopen-2016-014109.PMC5387947.pdf
"London: MRC Population Health Science Research Network, 2014. http://www.populationhealthsciences.org/MRC-PHSRN-Process-evaluation-guidance-final-2-.pdf (accessed28 Aug 2016).",Non-OADS,/arxiv_data1/oa_pdf/01/5f/bmjopen-2016-014109.PMC5387947.pdf
https://www.stroke.org.uk/sites/default/files/struggling_to_recover_report_lowres.pdf (accessed 28 Aug2016).,Non-OADS,/arxiv_data1/oa_pdf/01/5f/bmjopen-2016-014109.PMC5387947.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012997).,Non-OADS,/arxiv_data1/oa_pdf/8d/96/bmjopen-2016-012997.PMC5387948.pdf
2013. http://www.goldcopd.org/uploads/users/ files/GOLD_Report_2013_Feb20.pdf (accessed 5 Jul 2014).,OADS,/arxiv_data1/oa_pdf/8d/96/bmjopen-2016-012997.PMC5387948.pdf
2008. http://www.gacguidelines.ca/ site/GAC_Guidelines/assets/pdf/AMI07-ACS_-_Unstable_angina_Non-ST-Elevation_Mar_5_08_Final.pdf (accessed 5 Jul 2014).,OADS,/arxiv_data1/oa_pdf/8d/96/bmjopen-2016-012997.PMC5387948.pdf
http://www.drugepi.org/dope-downloads/ (accessed 28 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/96/bmjopen-2016-012997.PMC5387948.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012837).,Non-OADS,/arxiv_data1/oa_pdf/df/40/bmjopen-2016-012837.PMC5387949.pdf
"Norwegian Tobacco Statistics, 2016. https://helsedirektoratet.no/ folkehelse/tobakk-royk-og-snus/statistikk-om-royking-bruk-av-snus-og-e-sigaretter (accessed 16 March 2017).",OADS,/arxiv_data1/oa_pdf/df/40/bmjopen-2016-012837.PMC5387949.pdf
"Brussels, Belgium: European Commission, Health & ConsumerProtection Directorate-General, 2008. http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf (accessed 25Oct 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/40/bmjopen-2016-012837.PMC5387949.pdf
"Norwegian Department of Health, 2015. https://www.regjeringen.no/contentassets/7066e0ea25d9478ba3e354f50b6a2317/horingsnotat_standardiserte_tobakkspakninger_fctc_art53_170315.pdf (a ccessed 16 March 2017).",Non-OADS,/arxiv_data1/oa_pdf/df/40/bmjopen-2016-012837.PMC5387949.pdf
Free T concentration was calcu-lated using sex hormone binding globulin and albumin concentrations (http://www.issam.ch/freetesto.htm).,Non-OADS,/arxiv_data1/oa_pdf/b2/1c/bmjopen-2016-014125.PMC5387951.pdf
"Befolkningens utbildning 2014, 2015. http://www.sverigeisiffror.scb.se/hitta-statistik/sverige-i-siffror/utbildning-jobb-och-pengar/ befolkningens-utbildning/ (accessed 18 Aug 2016).",OADS,/arxiv_data1/oa_pdf/77/3f/bmjopen-2016-014264.PMC5387952.pdf
http://www.socialstyrelsen.se/register/dodsorsaksregistret (accessed13 Apr 2016).,OADS,/arxiv_data1/oa_pdf/77/3f/bmjopen-2016-014264.PMC5387952.pdf
"To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjgast-2017- 000136) Received 24 January 2017 Revised 1 March 2017 Accepted 3 March 2017 1Division of Endocrinology, Department of Medicine, Leiden University MedicalCentre, Leiden, The Netherlands 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus,Denmark Correspondence to LHA Broersen; l.h.a.broersen@lumc.nlABSTRACT Background: Corticosteroids are a potential risk factor for mortality in patients with perforated diverticulardisease, due to blinding of disease severity, hamperedwound healing or adrenal insufficiency.",Non-OADS,/arxiv_data1/oa_pdf/7d/83/bmjgast-2017-000136.PMC5387955.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcodeREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjqir.u221836.w8226.PMC5387956.pdf
Joint Royal College of Physicians Training Board Quality Criteria for Core Medical Training (CMT) 2015. https://www.jrcptb.org.uk/sites/default/file/0711_JRCPTB_CMT_A4_4pp_WEB.pdf (accessed 17/11/16) 2.,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjqir.u221836.w8226.PMC5387956.pdf
Core medical training and acute care common stem (medicine) https://www.jrcptb.org.uk/specialties/core-medical-training-and-acute-care-common-stem-medicine (accessed 20/11/16) 3.,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjqir.u221836.w8226.PMC5387956.pdf
Core Medical Training Decision Aid –Revised September 2015 https://www.jrcptb.org.uk/sites/default/files/CMT%20ARCP%20Decision%20Aid%20%28September%202015%29.pdf(accessed 20/11/2016) 4.,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjqir.u221836.w8226.PMC5387956.pdf
Specialty Training Curriculum for Core Medical Training August 2009 (Amendments 2013) https://www.jrcptb.org.uk/sites/default/files/2009%20CMT%20Curriculum%20%28amendments%202013%29%20100516.pdf (accessed 20/11/16) 5.,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjqir.u221836.w8226.PMC5387956.pdf
2015. http://www.who.int/hepatitis/strategy2016-2021/Draft_global_health_sector_ strategy_viral_hepatitis_13nov.pdf (accessed 5 Dec 2016).,Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
http://edoc.rki.de/series/infektionsepidemiologische-jahrbuecher/2015/PDF/infektionsepidemiologischesjahrbuch-meldepflicht.pdf (accessed 5 Dec 2016).,Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
Ten years of responsibility of PEI for blood and blood products 2006 http://www.pei.de/EN/institute/who-collaborating-centres/who-collaborating-centre-blood-ivd/blood-products/who-ten-years-responsibility-pei-chronological-overview.html 18.,Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
"Wiesbaden, 2012. https://www.destatis.de/EN/Publications/Specialized/Population/StatYearbook_Chapter2_5011001129004.pdf?__blob=publicationFile (accessed 5 Dec 2016).",Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
"Population depending on sex and age (age classes of relevance to infrastructure) 2011. https://ergebnisse.zensus2011.de/?locale=en#StaticContent:00,BEG_1_1_2,m,table 26.",Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
2015. https://www.ihs.com/country-industry-forecasting.,Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
"The Eco-Hep Report: A macroeconomic overview of viral hepatitis C in Germany, 2016.https://www.leberhilfe-projekt.de/files/Projekte/Hepatitis-C-Belastung-in-Deutschland/downloads/Eco-Hep-Report-GERMAN.pdf (accessed5 Dec 2016).",Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
"Gilead Sciences I. Gilead Announces Data for Investigational, All-Oral, Pan-Genotypic Three-Drug Regimen of Sofosbuvir,GS-5816 and GS-9857 for Chronic Hepatitis C. 2015. http://www.gilead.com/news/press-releases/2015/4/gilead-announces-data-for-investigational-alloral-pang enotypic-threedrug-regimen-of- sofosbuvir-gs5816-and-gs9857-for-chronic-hepatitis-c (accessed5 Dec 2016).",Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
"Janssen Enters into a Worldwide Collaboration with Achillion Pharmaceuticals, Inc. to CombatHepatitis C Virus ,2015. http://www.investor.jnj.com/releasedetail.",Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
"General Methods: Version 4.2, 2015 http://www.iqwig.de/download/IQWiG_General_Methods_Version_%204-2.pdf 35.",Non-OADS,/arxiv_data1/oa_pdf/9e/49/bmjgast-2016-000130.PMC5387957.pdf
http://www.fda.gov/Drugs/ NewsEvents/ucm471446.htm.,Non-OADS,/arxiv_data1/oa_pdf/23/a5/bmjopen-2016-012586.PMC5387958.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014106).,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
http://www.nhs.uk/ conditions/vaccinations/pages/vaccination-schedule-age-checklist.aspx3.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
https://www.gov.uk/government/publications/cover-of-vaccination-evaluated-rapidly-cover-programme-annual-data 4.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ VaccineCoverageAndCOVER/ 12.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk –england-and-wales –scotland-and- northern-ireland/mid-2011-and-mid-2012/stb —mid-2011 —mid-2012- uk-population-estimates.html 13.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/192979/28_CHIS_service_specification_VARIATION_130422.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
http://apps.who.int/iris/bitstream/10665/44038/1/9789241597555_eng.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
http://webarchive.nationalarchives.gov.uk/20160129193951/http://www.ons.gov.uk/ons/ guide-method/geography/beginner-s-guide/census/super-output- areas –soas-/index.html 20.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
http://www.euro.who.int/__data/assets/pdf_file/0003/119802/E68405.pdf 21.,OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
http://www.cdc.gov/measles/vaccination.html 22.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
2009 (cited 3 August 2016).https://www.nice.org.uk/guidance/ph21/resources/immunisations- reducing-differences-in-uptake-in-under-19s-1996231968709 24.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/493181/SFR052016_Text.pdf 25.,Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
"https://www.gov.uk/government/news/measles-vaccination-advice-for-young-adults 26. le Polain de Waroux O, Saliba V, Cottrell S, et al.",Non-OADS,/arxiv_data1/oa_pdf/74/8c/bmjopen-2016-014106.PMC5387959.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013817).,Non-OADS,/arxiv_data1/oa_pdf/b8/64/bmjopen-2016-013817.PMC5387960.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/bmjopen-2016-013817.PMC5387960.pdf
Updated June 2016. http://www.who.int/mediacentre/factsheets/fs339/en.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/bmjopen-2016-013817.PMC5387960.pdf
2014. http://www.who.int/tobacco/mpower/en/ 22.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/bmjopen-2016-013817.PMC5387960.pdf
"Tobacco Free Initiative, 2014. http://www.who.int/tobacco/ control/legislation/implementantion/en/ 23.",Non-OADS,/arxiv_data1/oa_pdf/b8/64/bmjopen-2016-013817.PMC5387960.pdf
http://dx.doi.org/13/suppl_2/ii51 [pii] 10.1136/tc.2004.008359 24.,Non-OADS,/arxiv_data1/oa_pdf/b8/64/bmjopen-2016-013817.PMC5387960.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/27/31/bmjdrc-2016-000342.PMC5387961.pdf
Available from: http://epi.vgregion.se/upload/L%C3%A4kemedel/L%C3%A4kemedelskommitt%C3%A9n/ Substans/RMR%20Blodglukos_2013.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/27/31/bmjdrc-2016-000342.PMC5387961.pdf
https://clinicaltrials.gov/ct2/show/record/NCT02232698.,Non-OADS,/arxiv_data1/oa_pdf/27/31/bmjdrc-2016-000342.PMC5387961.pdf
Available from: https://www.ndr.nu/pdfs/Arsrapport_NDR_2014.pdf 29.,Non-OADS,/arxiv_data1/oa_pdf/27/31/bmjdrc-2016-000342.PMC5387961.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2017- 015861).,Non-OADS,/arxiv_data1/oa_pdf/bf/9e/bmjopen-2017-015861.PMC5387963.pdf
BMC Infect Dis 2016;16:182. http://www.biomedcentral.com/1471-2334/ 16/182.,Non-OADS,/arxiv_data1/oa_pdf/bf/9e/bmjopen-2017-015861.PMC5387963.pdf
2015; http://www.pwatoronto.org/ (accessed 5 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/bf/9e/bmjopen-2017-015861.PMC5387963.pdf
© QSR International Pty Ltd. http://www.qsrinternational.com/ 30.,Non-OADS,/arxiv_data1/oa_pdf/bf/9e/bmjopen-2017-015861.PMC5387963.pdf
http://www.moph.gov.lb/userfiles/files/HealthCareSystem/Pharmaceuticals/%D9%8FEthics/DrugsEthicalStandards/CodeofEthics2016-Final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f5/2f/bmjopen-2016-013041.PMC5387964.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013868).,Non-OADS,/arxiv_data1/oa_pdf/44/07/bmjopen-2016-013868.PMC5387966.pdf
Data access for the KNHANES V is available from http://knhanes.cdc.go.kr.,OADS,/arxiv_data1/oa_pdf/44/07/bmjopen-2016-013868.PMC5387966.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/44/07/bmjopen-2016-013868.PMC5387966.pdf
http://knhanes.cdc.go.kr(accessed 28 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/44/07/bmjopen-2016-013868.PMC5387966.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/lupus-2016- 000193).,Non-OADS,/arxiv_data1/oa_pdf/11/a1/lupus-2016-000193.PMC5387967.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014240).,Non-OADS,/arxiv_data1/oa_pdf/43/5d/bmjopen-2016-014240.PMC5387968.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/5d/bmjopen-2016-014240.PMC5387968.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013877).,Non-OADS,/arxiv_data1/oa_pdf/b7/9d/bmjopen-2016-013877.PMC5387969.pdf
Authors are referred to appropriate methodological guidance on reporting these aspectsof their study (available from http://www.equator-network.org).,Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
"Table 1 Terminology, definitions and resources Term used in this paperDefinition Sources of informationAlternative terminology and similar concepts Implementation strategyMethods or techniques used to enhance the adoption, implementation and sustainability of a clinical programme or practice14–16Implementation approach Implementation programmesImplementation processImplementation intervention Exemplar resources: Consolidated Framework For Implementation Research (CFIR) http://www.cfirguide.org/imp.html Dissemination and implementation models http://www.dissemination-implementation.org/index.aspx Implementation outcomeProcess or quality measures to assess the impact of the implementation strategy, such as adherence to a new practice, acceptability, feasibility, adaptability, fidelity, costs and returns 14 58End point Intervention The evidence-based practice, programme, policy, process, or guideline recommendation that is being implemented (or deimplemented).12In the context of healthcare, this might be a preventive, diagnostic or therapeutic clinical practice, delivery system change, or public health activity being implemented to improve patient ’s outcomes, system quality and efficiency, or population health.Treatment Evidence-based intervention Health outcome Patient-level health outcomes for a clinical intervention, such as symptoms or mortality; or population-level health status or indices of system function for a system/organisational-level intervention.14Health statusClient outcome Logic pathway The manner in which the implementation strategy is hypothesised to operate Logic model Causal pathway/modelMechanisms of action/impactTheory of changeDriver diagramsCause-and-effect diagram (Ishikawa, fishbonediagrams) Donabedian model Exemplar resource: Logic models: https:/www.wkkf.org/resource-directory/resource/2006/02/wk-kellogg-foundation-logic-model-developm ent-guide Process evaluation A study that aims to understand the functioning of an intervention, by examining its implementation, mechanisms of impact and contextual factors.",Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
"Available from https://www.ioe.ac.uk/MRC_PHSRN_Process_evaluation_guidan ce_ final(2).pdf ‘Barriers and facilitators ’Aspects related to the individual (ie, healthcare practitioner or healthcare recipient) or to the organisation that ‘determine its degree of readiness to implement, barriers that may impede implementation, and strengths that can be used in the implementation effort ’50Drivers Mediators, ModeratorsContextual factorsEnablersOrganisational conditions for change Pinnock H, et al.BMJ Open 2017; 7:e013318.",Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
"37A rich description of the context is critical to enable readers to assess the external validity of the study,38and decide how the study context compares to their situation and if/how the implementation strategy might be transposed, or need adapting.39Similarly, the social, political and economic context influences the ‘entrenched practices and other biases ’that hinder evidence-based deimplementation of unproven practices.40 41 The Consolidated Framework for Implementation Research (CIFR) defines 39 constructs that may guide reporting of thesecontextual dimensions (http://www.cfirguide.org/imp.html).",Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
CONCLUSIONS The StaRI standards are registered with the EQUATOR Network (http://www.equator-network.org) and the checklist is available from this journal and BMJ.com.,Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
"Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare:research grants from Chief Scientist Office (HP), Asthma UK (AS, HP, SJCT), Farr Institute (AS), NIHR HS&DR (HP, SJCT), NIHR CLAHRC (SJCT) for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; CRC is theItem 27.",Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
https://catalyst.harvard.edu/pathfinder (accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
http://www.nihcm.org/pdf/CER_International_Experience_09.pdf(accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
http://www.equator-network.org/wp-content/uploads/2013/09/Proposal-for-reporting-guidelines-of-Implementation-Research-StaRI.pdf (accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
"London: MRC, 2008. http://www.mrc.ac.uk/complexinterventionsguidance (accessed Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
http://cfirguide.org/index.html (accessed Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
2002. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf(accessed Jun 2016).,OADS,/arxiv_data1/oa_pdf/0f/c3/bmjopen-2016-013318.PMC5387970.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012252).,Non-OADS,/arxiv_data1/oa_pdf/c6/6f/bmjopen-2016-012252.PMC5387971.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-014456).,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
Social Research (NatCen) (http://www.natcen.ac.uk/).,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
2015. https://http://www.england.nhs.uk/ ourwork/qual-clin-lead/diabetes-prevention/ (accessed 30 Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
2011. http://www.who.int/diabetes/publications/report-hba1c_2011.pdf?ua=1 (accessed 30 Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
2012. https://www.nice.org.uk/guidance/ph38 (accessed 30 Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
"Leeds, UK: The Health and Social Care Information Centre, 2008. http://content.digital.nhs.uk/ catalogue/PUB00430/heal-surv-phys-acti-fitn-eng-2008-rep-v2.pdf(accessed 30 Jan 2017).",Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
"Leeds, UK: The Health and Social Care Information Centre, 2008. http://content.digital.nhs.uk/catalogue/PUB00430/heal-surv-phys-acti-fitn-eng-2008-rep-v3.pdf(accessed 30 Jan 2017).14.",Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
2010. http://apps.who.int/iris/bitstream/10665/44399/1/9789241599979_eng.pdf (accessed 30 Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
2011. https://http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216370/dh_128210.pdf (accessed 30Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/c6/22/bmjopen-2016-014456.PMC5387972.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011742).,Non-OADS,/arxiv_data1/oa_pdf/cf/a0/bmjopen-2016-011742.PMC5387973.pdf
http://www.dnvk.dk/ English/newregulationsonmedicinaldevices.aspx (accessed 23 Jun 2016).,Non-OADS,/arxiv_data1/oa_pdf/cf/a0/bmjopen-2016-011742.PMC5387973.pdf
https://help.fitbit.com/articles/en_US/Help_ article/1988 (accessed 19 Aug 2016).,OADS,/arxiv_data1/oa_pdf/cf/a0/bmjopen-2016-011742.PMC5387973.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/26/bmjqir.u204420.w6531.PMC5387975.pdf
2008http://www.ncepod.org.uk/2008report3/Downloads/SACT_summary.pdf 3.,OADS,/arxiv_data1/oa_pdf/56/26/bmjqir.u204420.w6531.PMC5387975.pdf
2009 http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_ consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_104501.pdf 4.,OADS,/arxiv_data1/oa_pdf/56/26/bmjqir.u204420.w6531.PMC5387975.pdf
2012 https://www.nice.org.uk/Guidance/CG151 5.,Non-OADS,/arxiv_data1/oa_pdf/56/26/bmjqir.u204420.w6531.PMC5387975.pdf
2012 https://rqia.org.uk/RQIA/files/8e/8e2b97e3-58dc-4d77-b1cd-08312cec5742.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/56/26/bmjqir.u204420.w6531.PMC5387975.pdf
See:http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/bmjqir.u209593.w7966.PMC5387977.pdf
Institute for Healthcare Improvement IHI Program to Prevent CAUTI 2011 http://www.ihi.org/ 2.,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/bmjqir.u209593.w7966.PMC5387977.pdf
HICPAC Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009 http://www.cdc.gov/hicpac/cauti 3.,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/bmjqir.u209593.w7966.PMC5387977.pdf
APIC CAUTI Elimination Guide 2008 http://www.apic.org/4.,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/bmjqir.u209593.w7966.PMC5387977.pdf
National Healthcare Safety Network (NHSN) 2015 https://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/a9/c4/bmjqir.u209593.w7966.PMC5387977.pdf
doi:10.1136/bmjopen-2016- 015365 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-015365).,Non-OADS,/arxiv_data1/oa_pdf/fb/34/bmjopen-2016-015365.PMC5387979.pdf
"Antimicrobial resistance: global report on surveillance, 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/ (accessed 23 Jun 2016).",OADS,/arxiv_data1/oa_pdf/fb/34/bmjopen-2016-015365.PMC5387979.pdf
"This is an Open Access article d istributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/9d/evw183.PMC5387980.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000399).,Non-OADS,/arxiv_data1/oa_pdf/b0/74/rmdopen-2016-000399.PMC5387982.pdf
"We adopted standardised de ﬁnitions of struc- tural lesions of the SIJ on MRI for fat metaplasia, erosion and ankylosis, which were developed by the Canada – Denmark MRI Working Group, 18and which were extended in a subsequent report to include back ﬁll.7 Calibration of readers was undertaken using a validated calibration tool available at http://www.carearthritis.",Non-OADS,/arxiv_data1/oa_pdf/b0/74/rmdopen-2016-000399.PMC5387982.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/42/bmjqir.u216501.w7906.PMC5387984.pdf
2009. http://ncat.nhs.uk/sites/default/files/NCAG%20Report.pd 2.,Non-OADS,/arxiv_data1/oa_pdf/3e/42/bmjqir.u216501.w7906.PMC5387984.pdf
http://www.ncepod.org.uk/2008report3/Downloads/SACT_ report.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/3e/42/bmjqir.u216501.w7906.PMC5387984.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/51/tow285.PMC5387985.pdf
"(https://www.whitehouse.gov/sites/default/ﬁles/microsites/ostp/Pollinator %20Health%20Strategy%202015.pdf, accessed 25 November 2016).",Non-OADS,/arxiv_data1/oa_pdf/b9/51/tow285.PMC5387985.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcodeREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/19/99/bmjqir.u214416.w5476.PMC5387986.pdf
http://www.ismp.org/Tools/BestPractices/TMSBP-for-Hospitals.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/19/99/bmjqir.u214416.w5476.PMC5387986.pdf
Irving (TX): AmericanCollege of Emergency Physicians; 2000 Dec [cited 2014 Apr].Available from: https://www.acep.org/Clinical---Practice-Management/ Guidelines-for-Care-of-Children-in-the-Emergency-Department/ 5.,Non-OADS,/arxiv_data1/oa_pdf/19/99/bmjqir.u214416.w5476.PMC5387986.pdf
"Available from: https://psnet.ahrq.gov/webmm/case/293 Greenwalt M, et al.BMJ Quality Improvement Reports 2017; 6:u214416.w5476.",OADS,/arxiv_data1/oa_pdf/19/99/bmjqir.u214416.w5476.PMC5387986.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011502).,Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
"RStudio: Integrated Development for R. 2015.http://www.rstudio.com/ (accessed 18 Jan 2016)) for the R software, V .3.1.0 (2014-04-10) —‘Spring Dance ’ (R Core T eam.",Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
"R: A language and environment for statis-tical computing 2015. http://www.R-project.org/ (accessed 18 Jan 2016)), was used to perform statistical analysis.",OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
http://www.who.int/entity/healthinfo/global_burden_disease/GHE2015_Deaths_Global_2000_2015.xls?ua=1 (accessed 22 Mar 2017).,OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
https://www.iarc.fr/en/publications/books/sp161/AirPollutionandCancer161.pdf (accessed 18 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
In: Monographs on the evaluation of carcinogenic risk to humans.International Agency for Research on Cancer (IARC).http://monographs.iarc.fr/ENG/Classification/ (accessed 22 Mar 2017).,Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
"Washington: The National Academy Press, 2014. http://www.nap.edu/catalog/18660/health-literacy-and-numeracy-workshop-summary(accessed 18 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
http://www.cdc.gov/mmwr/ preview/mmwrhtml/rr5013a1.htm (accessed 18 Jan 2016).,OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
Anno 2011. http://www.unipa.it/dipartimenti/dipartimentodiscienzeperlapromozi onedellasaluteematernoinfantileg.,Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
http://www.cro.it/opencms/export/sites/cro/it/azienda_informa/_docs/ registro-tumori-1995-2005.pdf (accessed 18 Jan 2016).,OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
http://pti.regione.sicilia.it/portal/page/portal/PIR_PORTALE/PIR_LaStrutturaRegionale/PIR_AssessoratoSalute/PIR_AreeTematiche/PIR_Atlanteoncologico (accessed 18 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
Associazione Italiana Registri Tumori (AIRTUM) 2015. http://www.registri-tumori.it/cms/it/copertura (accessed 18 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
2015. http://www.demo.istat.it (accessed 18Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
"University of Iowa, 2008. http://ir.uiowa.edu/etd/208 (accessed 18 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/74/33/bmjopen-2016-011502.PMC5387987.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-014158).,Non-OADS,/arxiv_data1/oa_pdf/16/d1/bmjopen-2016-014158.PMC5387988.pdf
J Pediatr Psychol 2016;41:1 –13 http://dx.doi.org/10.1093/jpepsy/jsw1031 11.,Non-OADS,/arxiv_data1/oa_pdf/16/d1/bmjopen-2016-014158.PMC5387988.pdf
2016. http://www.nap.edu.au/ (accessed 12August 2016).,Non-OADS,/arxiv_data1/oa_pdf/16/d1/bmjopen-2016-014158.PMC5387988.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000394).,Non-OADS,/arxiv_data1/oa_pdf/d8/85/rmdopen-2016-000394.PMC5387989.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/24/d2/bmjopen-2016-013442.PMC5387991.pdf
http://www.socialinclusion.ie/documents/ NAPinclusionReportPDF.pdf (accessed 7 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/d2/bmjopen-2016-013442.PMC5387991.pdf
http://www.publichealthagency.org/sites/default/files/181114%20Active%20Travel%20Action%20Plan.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/24/d2/bmjopen-2016-013442.PMC5387991.pdf
"HSE Framework for Action on Obesity 2008 –2012 , 2010.. http://www.thehealthwell.info/node/52589 (accessed 7 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/24/d2/bmjopen-2016-013442.PMC5387991.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/45/evx049.PMC5387992.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/e7/tox027.PMC5387993.pdf
(http://www.natesc.,Non-OADS,/arxiv_data1/oa_pdf/1f/e7/tox027.PMC5387993.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/a8/evx048.PMC5387994.pdf
"Treeswere visualized with Figtree ( http://tree.bio.ed.ac.uk/software/ ﬁgtree/ ; last accessed March 16, 2017).",OADS,/arxiv_data1/oa_pdf/ac/a8/evx048.PMC5387994.pdf
"All the above software was retrieved from “Molecular evolution and phylo- genetics and epidemiology” website ( http://tree.bio.ed.ac.uk ; last accessed March 16, 2017).Table 1 Organellar Genomes Used in This Study Spp.",OADS,/arxiv_data1/oa_pdf/ac/a8/evx048.PMC5387994.pdf
"OrganellarGenomeDRAW— A Suite of Tools for Generating Physical Maps of Plastid and Mitochondrial Genomes and Visualizing Expression Data Sets, p. 1–7.Available from: http://doi.org/10.1093/nar/gkt289 .",OADS,/arxiv_data1/oa_pdf/ac/a8/evx048.PMC5387994.pdf
"6 Third-party tools, ANTs7(http://stnava.github.io/ANTs/) and FSL8(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) framework,were used to register all modalities to the patient ’s native T1 space.",OADS,/arxiv_data1/oa_pdf/51/cb/EPI4-1-152.PMC5387998.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/63/main.PMC5388013.pdf
E-mail address: drsaritachoudhary@yahoo.com.Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.002 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/d0/63/main.PMC5388013.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/63/main.PMC5388013.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/8e/main.PMC5388014.pdf
E-mail address: kumarpre@hotmail.com (R.K. Premchand).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.10.004 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/19/8e/main.PMC5388014.pdf
http://www.acc.org/latest-in-cardiology/articles/2015/06/11/10/57/ how-should-we-treat-vsds-and-acute-mr-post-mi?w_nav=TI .,Non-OADS,/arxiv_data1/oa_pdf/19/8e/main.PMC5388014.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC5388015.pdf
Voevoda).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.016 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC5388015.pdf
"Available at http://data.euro.who.int/dmdb/ [accessed 25.05.13] 2.Bressler J, Folsom AR, Couper DJ, Volcik KA, Boerwinkle E. Genetic variants identiﬁed in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study.",OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC5388015.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/c6/bmjqir.u206586.w4692.PMC5388016.pdf
"To incorporate the delayed presentation and lack of STEMI networks, the non-PCI-Capable hospital pathway utilizes two critical time parameters that differentiate treatment strategies: 1) Symptom onset to ﬁrst medical contact (FMC), with a cut off of less than 3 h, the time during which http://dx.doi.org/10.1016/j.ihj.2016.12.020 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/dc/24/main.PMC5388017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/main.PMC5388018.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.012 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/5c/5a/main.PMC5388018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/26/main.PMC5388019.pdf
"E-mail addresses: rajesh.bajari@gmail.com (R. Bajari), drstak@yahoo.com (S. Tak).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2017.01.020 0019-4832/ /C2232017 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/06/26/main.PMC5388019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/26/main.PMC5388019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/8e/main.PMC5388020.pdf
http://dx.doi.org/10.1016/j.ihj.2016.12.003 0019-4832/© 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ae/8e/main.PMC5388020.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
E-mail address: amishapa@gmail.com (A. Patel).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.06.012 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
"Because 29 of the 44 websites investigated offered limited or no search function- ality, we also browsed the websites and used Google site search for all the websites (e.g., ‘‘acute coronary’’ OR ‘‘heart attack’’ OR infarction site: http://www.accindia.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
"We registered our protocol, including our search strategy, though PROSPERO (http://www.crd.york.ac.uk/PROSPERO/ ; registration no.",Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
2010. http://dx.doi.org/10.1016/ s0140-6736(12)61728-0 .,OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
http://www.who.int/mediacentre/news/notes/2012/ncd_20121109/en/ .,Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
http://www.wpro.who.int/ health_services/health_systems_framework/en/ .,OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
"16.The Motor Vehicles Act, 1988 .http://www.tn.gov.in/sta/Mvact1988.pdf .",Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
2013;10(6):e1001465.20.Management of ST Elevation Myocardial Infarction .http://www.stemiindia.com ; Accessed 26.06.15.,Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
29.European Social Charter of 1961 (Revised) .http://conventions.coe.int/treaty/en/ Treaties/Html/163.htm .,Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
2008. http://www.who.int/iris/handle/10665/ 107916#sthash.DqzYnCX8.dpuf 33.42 U.S.C.,OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
1395DD – Examination and Treatment for Emergency Medical Conditions and Women in Labor .http://www.gpo.gov/fdsys/granule/USCODE-2010-title42/ USCODE-2010-title42-chap7-subchapXVIII-partE-sec1395dd .,Non-OADS,/arxiv_data1/oa_pdf/81/a7/main.PMC5388021.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000389).,Non-OADS,/arxiv_data1/oa_pdf/ed/e6/rmdopen-2016-000389.PMC5388024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/aa/jiw423.PMC5388029.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/aa/jiw423.PMC5388029.pdf
"Therefore, we believe that this was the actual cause of the auto-mode switch.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.08.002 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/9e/25/main.PMC5388032.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/9e/25/main.PMC5388032.pdf
http://dx.doi.org/10.1016/j.ihj.2017.03.005 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ed/1b/main.PMC5388033.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/cb/main.PMC5388034.pdf
"These drugs are superior,Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.06.006 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/48/cb/main.PMC5388034.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/48/cb/main.PMC5388034.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.joa.2016.06.006 .,OADS,/arxiv_data1/oa_pdf/48/cb/main.PMC5388034.pdf
Available at: 〈http://www.j-circ.or.,Non-OADS,/arxiv_data1/oa_pdf/48/cb/main.PMC5388034.pdf
Available at: 〈http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/48/cb/main.PMC5388034.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/c5/main.PMC5388035.pdf
The patient has not suffered from inappropriate ICD therapies due to TWOS for a period of 4 years despite participating in some dance parties.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.06.003 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/56/c5/main.PMC5388035.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/56/c5/main.PMC5388035.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/41/main.PMC5388036.pdf
"No prospective, rando- mized clinical CB2 trials have been conducted to investigate the need for an additional (bonus) freezing cycle after PVI is achieved.We therefore conducted an investigation of the optimal freezing cycles in AF patients treated with CB2 ablation.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.06.005 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/7e/41/main.PMC5388036.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/7e/41/main.PMC5388036.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/6e/main.PMC5388037.pdf
"Localization of infarct [8_TD$DIFF]/C15Septal: V1 and V2 /C15Anterior: V3 and V4 /C15Lateral: V5 and V6 /C15Antero-septal: V1 –V4 /C15Antero-lateral: V3 –V6 /C15Extensive anterior: V1 –V6 /C15Inferior: II, III, aVF /C15High Lateral: I, aVL /C15Posterior: tall R wave and ST depression in V1 –V2 2.A new LBBB in a patient with symptoms consistent with MI should be treated like a STEMI http://dx.doi.org/10.1016/j.ihj.2017.03.003 0019-4832/© 2017 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/3f/6e/main.PMC5388037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) S6 –S7 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/3f/6e/main.PMC5388037.pdf
4.https://www.heart.org/idc/groups/heart-public/@wcm/@mwa/documents/ downloadable/ucm_467056.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3f/6e/main.PMC5388037.pdf
5.http://www.mayoclinic.org/ ﬁrst-aid/ ﬁrst-aid-heart-attack/basics/art- 20056679 .,Non-OADS,/arxiv_data1/oa_pdf/3f/6e/main.PMC5388037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/8f/main.PMC5388039.pdf
All patients gave their written informed consent and the study protocol was approved by the hospital's institutional review board.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.08.004 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/bf/8f/main.PMC5388039.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/bf/8f/main.PMC5388039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/26/main.PMC5388040.pdf
"However, initial clinical studies comparing BiV pacing with LV only pacing indicated that BiV and LV pacing may provide aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.014 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/72/26/main.PMC5388040.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorrespondence to: Department of Cardiology, School of Medicine, Hamadan University of Medical Sciences, P.O.",Non-OADS,/arxiv_data1/oa_pdf/72/26/main.PMC5388040.pdf
Available from: 〈http://www.heart.org/HEARTORG/Conditions/HeartFailure/Cardiac-Resyn chronization-Therapy_UCM_452920_Article.jsp 〉; 2014 [updated 02.01.13; cited 31.01.14].,Non-OADS,/arxiv_data1/oa_pdf/72/26/main.PMC5388040.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5388042.pdf
Heart rate (HR)Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.010 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5388042.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorrespondence to: Department of Cardiology, University of Ioannina, 1 Stavrou Niarxou Avenue, 45500 Ioannina, Greece.",Non-OADS,/arxiv_data1/oa_pdf/4e/20/main.PMC5388042.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/e1/main.PMC5388043.pdf
"Among them, 164 patients who had received a ﬁrst catheter ablation of AF wereContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.013 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/d1/e1/main.PMC5388043.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author at: Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.",Non-OADS,/arxiv_data1/oa_pdf/d1/e1/main.PMC5388043.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/fa/main.PMC5388044.pdf
"Previous studies suggest that the RVEF may have a prognostic value in post- myocardial infarction patients [10–12], and a poor right ventricularContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.005 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/9b/fa/main.PMC5388044.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: CMR, cardiovascular magnetic resonance; ICD, implantable cardi- overter de ﬁbrillator; LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction nCorresponding author at: Sunnybrook Health Sciences Centre, Medical Imaging, 2075 Bayview Avenue, Room AG56-c, Toronto, ON, Canada M4N 3M5.Fax:þ416 480 5855.",Non-OADS,/arxiv_data1/oa_pdf/9b/fa/main.PMC5388044.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.04.001 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5388045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 145 e151,Non-OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5388045.pdf
2014;4:4932. http://dx.doi.org/ 10.1038/srep04932 .,Non-OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5388045.pdf
http://dx.doi.org/10.3791/3769 .,Non-OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5388045.pdf
2014:186864. http://dx.doi.org/10.1155/2014/186864 .,OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5388045.pdf
2015;61:8. http://dx.doi.org/10.1016/ j.psyneuen.2015.07.408 .,OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5388045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC5388046.pdf
"2 D), which was then selected as the optimalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.006 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC5388046.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ac/dd/main.PMC5388046.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.02.004 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/7a/d0/main.PMC5388047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 141 e144,Non-OADS,/arxiv_data1/oa_pdf/7a/d0/main.PMC5388047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
http://dx.doi.org/10.1016/j.ihj.2017.02.014 0019-4832/© 2017 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Indian Heart Journal 69 (2017) S51 –S56 Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2008;371(9622)1435 –1442 Available from: http://www.sciencedirect.com/science/article/pii/S0140673608606236 .,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2013;34(2)121 –129 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2009;2(10)901 –908 Available from: http://www.ncbi.nlm.nih.gov/ pubmed/19850247 [cited 01.09.14].,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
Available from: http://www.gadm.org/home [cited 16.11.16].,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
Available from: http://censusindia.gov.in/pca/ cdb_pca_census/Houselisting-housing-Kerl.html .,OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
Available from: http://www.censusindia.gov.in/2011-prov- results/data_ ﬁles/india/FinalPPT2011chapter7.pdf%5Cnhttp://www.censusindia.gov.in/2011-prov-results/data_ ﬁles/india/Final PPT 2011_chapter3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2007;6:47 Available from: http://www.pubmedcentral.nih.gov/articlerender.,OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2013;369(10) 901 –909 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24004117 [cited 28.07.14].,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2013;127(4)e362 –e425 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23247304 [cited 10.07.14].,OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2011;4(6)599 –604 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21700244 [cited 01.09.14].,OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
2012;64(6)582 –587 Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC791/3860 .,Non-OADS,/arxiv_data1/oa_pdf/9a/19/main.PMC5388050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/a2/main.PMC5388051.pdf
"Among these strategies, the effects of rate-control strategies and rhythm-control strategies on survival remain controversialContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.008 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/48/a2/main.PMC5388051.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorrespondence to: Tomoaki Ishigami, MD., PhD., Associate Professor, Yoko- hama City University Graduate School of Medicine, Department of Medical Scienceand Cardio-renal Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama-city, Kanagawa236-0004, Japan.",Non-OADS,/arxiv_data1/oa_pdf/48/a2/main.PMC5388051.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.joa.2016.07.008 .,OADS,/arxiv_data1/oa_pdf/48/a2/main.PMC5388051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/50/14/main.PMC5388052.pdf
Many of the follow-up tasks of the pacemaker andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.06.002 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/50/14/main.PMC5388052.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ICD, implantable cardioverter de ﬁbrillator; AV, atrial –ventricular; PM, pacemaker; CRT, cardiac resynchronization therapy; SD, standard deviation;SJM, St. Jude Medical nCorrespondence to: Maria Vittoria Hospital, Via Cibrario 72, Turin, Italy.",Non-OADS,/arxiv_data1/oa_pdf/50/14/main.PMC5388052.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/b5/main.PMC5388054.pdf
http://dx.doi.org/10.1016/j.ihj.2017.02.019 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/b4/b5/main.PMC5388054.pdf
"[Internet], Available from: http://linkinghub.elsevier.com/retrieve/pii/ S0104184313500282 .",Non-OADS,/arxiv_data1/oa_pdf/b4/b5/main.PMC5388054.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821808/ ?tool=pmcentrez .,OADS,/arxiv_data1/oa_pdf/b4/b5/main.PMC5388054.pdf
"[Internet], Available from: http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/b4/b5/main.PMC5388054.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/ba/main.PMC5388055.pdf
"For patients receiving warfarin, the frequency of prothrombin time-international nor malized ratio (PT-INR) testing and follow-up ranged from once perweek (if a control value needed to beContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.007 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/82/ba/main.PMC5388055.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author at: Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.",Non-OADS,/arxiv_data1/oa_pdf/82/ba/main.PMC5388055.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/8b/main.PMC5388056.pdf
"Therefore, the purpose of the study is to reveal the trends in physiological inhibitors such as AT III, PC or PS, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.011 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/e0/8b/main.PMC5388056.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/e0/8b/main.PMC5388056.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/bd/main.PMC5388057.pdf
These ﬁndings strongly indicate that the slow pathway could be located close to the fast pathway inContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.009 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/90/bd/main.PMC5388057.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/90/bd/main.PMC5388057.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/dd/main.PMC5388058.pdf
"In the present case, the barrier to the laser extraction was an ossi ﬁedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.06.007 1880-4276/ &2016 Japanese Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/d3/dd/main.PMC5388058.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorrespondence to: Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA.",Non-OADS,/arxiv_data1/oa_pdf/d3/dd/main.PMC5388058.pdf
http://dx.doi.org/10.1093/europace/euv-245 .,Non-OADS,/arxiv_data1/oa_pdf/d3/dd/main.PMC5388058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/0e/main.PMC5388059.pdf
Study population A total of 32 patients who had undergone biatrial anastomosis heart transplantation and were operated between January 2005Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.07.015 1880-4276/ &2016 Japanese Heart Rhythm Society.,Non-OADS,/arxiv_data1/oa_pdf/6f/0e/main.PMC5388059.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorrespondence to: Department of Cardiology, Kartal Kosuyolu High Speciality Training and Research Hospital, 34846, Kartal, Istanbul, Turkey.Fax:þ90 216 4596321.",Non-OADS,/arxiv_data1/oa_pdf/6f/0e/main.PMC5388059.pdf
"http://dx.doi.org/10.15171/jcvtr.2014.019 , Epub 2014 Dec 30.",Non-OADS,/arxiv_data1/oa_pdf/6f/0e/main.PMC5388059.pdf
"Biomed Res Int 2014 .http://dx.doi.org/10.1155/2014/451520 , Epub 2014 May 4.",Non-OADS,/arxiv_data1/oa_pdf/6f/0e/main.PMC5388059.pdf
"MohananJ, Praveen ChandraK, (Col.) R. GirishL, O. Rabindra NathM, Rakesh GuptaN, C. RaghuO, Sameer DaniP, Sandeep BansalQ, Sanjay TyagiR, Satyanarayan RoutrayS, Satyendra Tewarig, Sarat ChandraT, Shishu Shankar MishraU, Sibananda DattaV, S.S. ChaterjeeW, Soumitra Kumarc, Soura Mookerjeea, Suma M. Victorj, Sundeep Mishrad, Thomas AlexanderX, Umesh Chandra SamalY, Vijay TrehanT aMedical College, Kolkata, West Bengal, India bKing George ’s Medical University, Lucknow, Uttar Pradesh, India cVivekananda Institute of Medical Sciences, Kolkata, West Bengal, India dAll India Institute of Medical Sciences (AIIMS), New Delhi, India eBillroth Institute of Cardiology, Chennai, Tamil Nadu, India fSeth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India gSanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India hLokmanya Tilak Municipal Medical College & General Hospital, Mumbai, Maharashtra, India iParas HMRI Hospital, Patna, Bihar, India jMadras Medical Mission, Chennai, Tamil Nadu, India kInstitute of Post Graduate Medical Education & Research and Memorial Hospital, Kolkata, West Bengal, India lIndira Gandhi Institute of Medical Sciences, Patna, Bihar, India mJawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry, India nHoly family Hospital, Mumbai, Maharashtra, India oSri Jaydeva Institute of Cardiovascular Sciences & Research, Bangaluru, Karnataka, India pRuby Hall Clinic, Pune, Maharashtra, India qNH-RTIICS, Kolkata, West Bengal, India rBM Birla Heart Research Center, Kolkata, West Bengal, India sMother Heart Care Hospital, Thrissur, Kerala, India tHero DMC Heart Institute, Ludhiana, Punjab, India uAssam Medical College, Dibrugarh, Assam, India vMoolchand Medcity, New Delhi, India wLisie Hospital, Kochi, Kerala, India xSree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India yMadras Medical College, Chennai, Tamil Nadu, India zPushpagiri Institute of Medical Sciences, Tiruvalla, Kerala, India ABelle Vue Clinic, Kolkata, West Bengal, India BNRS Medical College, Kolkata, West Bengal, India CApollo Hospital, Chennai, Tamil Nadu, India DIPGMER & SSKM Hospital, Kolkata, West Bengal, India EBraj Birla Heart Research Center, Kolkata, West Bengal, India FApollo Hospital, New Delhi, India GLaxmi Hospital, Palakkad, Kerala, India HThe Fatima Hospital, Calicut, Kerala, India IESI Hospital, Manicktala, Kolkata, West Bengal, India JWestfort Hi-Tech Hospital, Thrissur, Kerala, India http://dx.doi.org/10.1016/j.ihj.2017.03.006 0019-4832/© 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/aa/e9/main.PMC5388060.pdf
Available at http://health.gov/dietaryguidelines/2015/ guidelines/ .,Non-OADS,/arxiv_data1/oa_pdf/aa/e9/main.PMC5388060.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/f7/main.PMC5388062.pdf
"The LVETs were used to determine AoVTI, and PEPs were measured from the onset of the QRS to the initial upstroke of theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/joaJournal of Arrhythmia http://dx.doi.org/10.1016/j.joa.2016.08.003 1880-4276/ &2016 Japanese Heart Rhythm Society.",OADS,/arxiv_data1/oa_pdf/42/f7/main.PMC5388062.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/main.PMC5388062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/1f/nihms854405.PMC5388063.pdf
"OcAlphaMed Press 1066-5099/2016/$30.00/0 http://dx.doi.org/ 10.1002/sctm.16-0337 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non- commercial and no modifications or adaptations are made.",Non-OADS,/arxiv_data1/oa_pdf/05/d9/SCT3-6-1096.PMC5388064.pdf
"Addi-tionally, the ﬁnal product does not need to be placed on the mar-ket in the Member States as long as the cells are not being commercialized or sold to outside parties (http://www.ema.europa.eu/ema).",Non-OADS,/arxiv_data1/oa_pdf/05/d9/SCT3-6-1096.PMC5388064.pdf
"Thus,SVF is exempt from regulation in Australia based on the criteria discussed previously (https://www.tga.gov.au).",Non-OADS,/arxiv_data1/oa_pdf/05/d9/SCT3-6-1096.PMC5388064.pdf
List of clinical trials utilizing SVF currently listed at http://clinicaltrials.gov Disease/ conditionStudy status (Number of enrolled patients)Therapeutic injection composition/ combination Outcome/adverse effectsReferencea (Country andregulation) Alopecia Recruiting (8) SVF injection into a 2 32 cm areaOngoing NCT02626780 (United States: FDA) Osteoarthritis Complete (6) phase 1SVF injected directly into the intra-articular spacewith a mean of 12 3106 viable nucleated SVF cells per kneeImprovement in WOMAC and VAS scores.,Non-OADS,/arxiv_data1/oa_pdf/05/d9/SCT3-6-1096.PMC5388064.pdf
"CURRENT CLINICAL STUDIES A search on http://clinicaltrials.gov was performed (Search terms:Stromal vascular fraction, Adipose derived stromal cells, Adipose derived regenerative cells, Adipose derived stromal vascular frac- tion and Adipose derived stem cells).",OADS,/arxiv_data1/oa_pdf/05/d9/SCT3-6-1096.PMC5388064.pdf
"Such treatment potential explains why MSCs are the subject of over 600 clinical trials at the time of this review according to http://clinicaltrials.gov, targeting a wide array of diseases.",Non-OADS,/arxiv_data1/oa_pdf/05/d9/SCT3-6-1096.PMC5388064.pdf
"Hence, numerous clinical trials have been conducted in patients with heart disease, diabetes, periph- eral arterial disease, pulmonary disease, and cancer in which puta- tive EPCs have been examined as a biomarker or used as celltherapy (http://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/05/d9/SCT3-6-1096.PMC5388064.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.04.002 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/4d/ba/main.PMC5388066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 152 e157,Non-OADS,/arxiv_data1/oa_pdf/4d/ba/main.PMC5388066.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.06.005 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 264 e268,Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
"A model such as that advanced by the Health Record Bank Alliance ( http://www.healthbanking.org/ ) where health bank organizations compete to store patient data and offer associated services, are particularly applicable for low resource economies.",Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
http://dx.doi.org/10.1016/ j.ijmedinf.2007.11.005 .,OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
2010: 63e75.http://dx.doi.org/10.4038/sljbmi.v1i1.1487 .,Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
http://dx.doi.org/10.1136/ amiajnl-2013-002068 .,Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
2005;12:3 e7.http://dx.doi.org/10.1197/jamia.M1664 .,Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
http://dx.doi.org/10.1016/ j.ijmedinf.2014.01.007 .,OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
1935;25:24 e35.http://dx.doi.org/10.1364/JOSA.25.000024 .,Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
http://dx.doi.org/10.1002/asi.22635 .,Non-OADS,/arxiv_data1/oa_pdf/7d/ca/main.PMC5388077.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.06.009 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 269 e271,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
2014;15: 124. http://dx.doi.org/10.1186/1471-2369-15-124 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
2015;14:6. http://dx.doi.org/10.1186/1476-069X-14-6 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
2013;14:180. http://dx.doi.org/10.1186/1471-2369-14-180 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
http://dx.doi.org/10.1038/ki.2011.428 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
Available from: http://www.indigenousmedimini.gov.lk/Statistics.html 9.,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
http://dx.doi.org/ 10.1016/j.socscimed.2004.11.077 .,OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
2011:14. http://dx.doi.org/ 10.4038/jccpsl.v14i1.2947 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
2014;8:73. http://dx.doi.org/10.4103/0973- 7847.134229 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
http://dx.doi.org/10.1002/ffj.1875 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
http://dx.doi.org/ 10.1038/ki.2008.129 .,Non-OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
http://dx.doi.org/10.1016/ j.jep.2013.06.028 .,OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
http://dx.doi.org/10.1056/NEJM200006083422301 .,OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
http://dx.doi.org/10.1016/ j.jep.2012.10.056 .,OADS,/arxiv_data1/oa_pdf/84/b6/main.PMC5388078.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.05.007 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/63/dc/main.PMC5388079.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 245 e250,Non-OADS,/arxiv_data1/oa_pdf/63/dc/main.PMC5388079.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.06.001 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/0c/4d/main.PMC5388080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 165 e171,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/main.PMC5388080.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.07.001 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 188 e194,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2002;64: 1e25.http://dx.doi.org/10.1093/bmb/64.1.1 .C.-T. Wu et al.,OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1007/s00384-012- 1521-8 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/ 10.1002/cncr.24591 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1111/j.1365- 2354.2006.00667.x .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2002;162:281. http://dx.doi.org/10.1001/archinte.162.3.281 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1056/NEJM199906033402206 .,OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1016/S0738-3991(99)00063-4 .,OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1056/ NEJM199301283280406 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2007;7:4. http://dx.doi.org/10.1186/1472-6874-7-4 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1001/jama.280.18.1569 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2004;343: 1e19.http://dx.doi.org/10.1016/j.sigm.2004.07.003 .,OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.3892/ijo.2013.1931 .15.,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2012;12:160. http://dx.doi.org/ 10.1186/1472-6882-12-160 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1016/j.clcc.2011.03.003 .,OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2010;10:225. http://dx.doi.org/10.1186/1472-6963-10-225 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://nhird.nhri.,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://www.cdc.gov/ nchs/icd/icd9cm.htm .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://www.mohw.,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2013:2013. http://dx.doi.org/10.1155/2013/201329 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
2012;2012:891893. http://dx.doi.org/10.1155/2012/891893 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.3109/13697130903060081 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.1007/s00520-006-0198-3 .,Non-OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
http://dx.doi.org/10.2165/11597910-000000000-00000 .C.-T. Wu et al.,OADS,/arxiv_data1/oa_pdf/90/1e/main.PMC5388081.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.06.007 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/f3/22/main.PMC5388082.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 172 e177,Non-OADS,/arxiv_data1/oa_pdf/f3/22/main.PMC5388082.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.05.006 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 234 e244,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
"AYUSH research portal ( http://ayushportal.nic.in/ ) included infor- mation regarding 4175 clinical trial, 8514 pre-clinical research, 6002 drug research and 2926 fundamental research information related to ISM or plants used in these systems as on January 2016.70 Safety evolution and to ﬁnd the mode of administration or use also a critical criteria of these study.",OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: https://www.ncbs.res.in/HistoryScienceSociety/content/ overview-indian-healing-traditions .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
2013;2013:1 e12.http://dx.doi.org/10.1155/2013/376327 .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Available from: http://www.niscair.res.in/ conclave/downloadables/Plenary%20Session%203/pdf/Ansari.pdf Accessed on 8 January 2015.,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
2014;2014:1 e20.http://dx.doi.org/ 10.1155/2014/525340 .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
2013;2013:1 e25.http://dx.doi.org/10.1155/ 2013/627375 .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.nistads.res.in/ indiasnt2008/t4industry/t4ind19.htm .36.Mangathayaru K. Pharmacognosy: An Indian Perspective .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://herbalnet.healthrepository.org/bitstream/123456789/ 2075/6/3.%20Ayur53-65.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.pib.nic.in/newsite/ erelcontent.aspx?relid ¼14876 .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.plimism.nic.in/index.html .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.ccrum.net/research/upc/ .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://indianmedicine.nic.in/writereaddata/linkimages/ 0913923524-Summary.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.indianmedicine.nic.in .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.pharmabiz.com/NewsDetails.aspx?,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://planningcommission.gov.in/aboutus/committee/strgrp12/st_ ayush0903.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.crism.net/about_us.htm .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://iaf-ngo.org/pdf/GLOBAL%20RESURGENCE%20 &%20INTL.,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://iaf-ngo.org/pdf/Globalisation%20of%20Ayurveda%20-%20a%20 global%20vision%20for%20next%20decade%20(No.1).pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: https://www.karnataka.gov.in/ ayush/Siddha%20system.pdf .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://ayushportal.nic.in/default.,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
Accessed from: http://www.icmr.nic.in/About_Us/ICMR_ Achievements.html#TraditionalMedicine Research__ .,Non-OADS,/arxiv_data1/oa_pdf/03/f5/main.PMC5388083.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.08.007 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 178 e187,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://www.jtcm.org/jtcm_n/portal_e6_page.php?button_ num¼e6&cnt_id ¼23.,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.carbpol.2011.06.036 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.bbapap.2006.11.018 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.jep.,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.jep.2013.02.019 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.jep.2010.12.025 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/ 10.1016/j.drudis.2009.03.012 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/ j.jep.2013.12.029 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.3390/molecules200712376 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.foodchem.2012.03.095 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
2003;424(6952):1013. http://dx.doi.org/ 10.1038/4241013a .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/ j.foodhyd.2011.04.014 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/ 10.1016/j.ijpharm.2010.11.025 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/10451555 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.bbapap.2009.12.003 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.bpc.2003.09.004 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/ 10.1007/s00726-003-0017-9 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.foodres.2012.07.034 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.jcis.2006.07.081 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/ 10.1016/j.carbpol.2008.09.002 .J.,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/j.carbpol.2013.05.049 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
2009;6(1):14. http://dx.doi.org/10.1186/1743-8977-6-14 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1016/ j.tifs.2011.06.004 .,OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1104/pp.002436 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1021/nl072455t .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1289/ehp.7339 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/ 10.2147/IJN.S36111 .40.,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
http://dx.doi.org/10.1021/ jp712087m .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
2010;7(1):25. http://dx.doi.org/10.1186/1743-8977-7-25 .,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/main.PMC5388084.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.05.001 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/74/64/main.PMC5388085.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 158 e164,Non-OADS,/arxiv_data1/oa_pdf/74/64/main.PMC5388085.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.05.002 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 195 e204,Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
available at: http://www.who.int/en/ .,Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
"Sydney, Australian Bureau of Statistics, 2008 (Report No.4102.0) http://www.abs.gov.au/ AUSSTATS/abs .",Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
"Compiled in collaboration between WHO and Ministry of Health, Lao PDR, 2012 http://www.wpro.who.int/health_services/ service_delivery_pro ﬁle_laopdr.pdf .18.AlBedah AMN, Khalil MKM, Elolemy AT, et al.",Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
134: Traditional Medicine ; 2003. available at: http://www.who.int/mediacentre/factsheets/2003/fs134/ en/.,Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
2007. http://dx.doi.org/ 10.1093/ecam/nem157 .,Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
2008:1 e6.http://dx.doi.org/10.1093/ ecam/nen039 .,Non-OADS,/arxiv_data1/oa_pdf/c1/dd/main.PMC5388086.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.05.005 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/43/c9/main.PMC5388087.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 205 e233,Non-OADS,/arxiv_data1/oa_pdf/43/c9/main.PMC5388087.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2016.06.004 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/af/47/main.PMC5388088.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 7 (2017) 251 e263,Non-OADS,/arxiv_data1/oa_pdf/af/47/main.PMC5388088.pdf
Available form: http://consensus.nih.gov/1997/ 1997Acupuncture107html.htm .,OADS,/arxiv_data1/oa_pdf/af/47/main.PMC5388088.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ea/8b/ott-10-1983.PMC5388194.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1983–1992OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1983Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10929 5 The activity, safety, and evolving role of brigatinib  in patients with ALK-rearranged non-small cell  lung cancers Joshua K Sabari1 Fernando C Santini1,2 Alison M Schram2 isabella Bergagnini1 Ruqin Chen1 Chebli Mrad1 w victoria Lai1 Kathryn C Arbour1 Alexander Drilon2,3 1Thoracic Oncology Service, Division  of Solid Tumor Oncology, Department  of Medicine, Memorial Sloan Kettering  Cancer Center, 2Developmetal  Therapeutics, Division of Solid T umor  Oncology, Department of Medicine,   Memorial Sloan Kettering Cancer  Center, 3Thoracic Oncology Service,   Division of Solid T umor Oncology,   Department of Medicine, Memorial  Sloan Kettering Cancer Center, weill  Cornell Medical College, New Y ork,   NY, USAAbstract:  Brigatinib (AP26113) is a dimethylphosphine oxide group-containing tyrosine  kinase inhibitor (TKI) constructed around a bisanilinopyrimidine scaffold with potent activity  against the anaplastic lymphoma kinase (ALK) and several other targets.",Non-OADS,/arxiv_data1/oa_pdf/ea/8b/ott-10-1983.PMC5388194.pdf
"The ALK mutations most commonly found  after TKI exposure include: L1196M for crizotinib, G1202R and compound ALK  mutations after ceritinib, and G1202R after alectinib.4,5 Beyond ALK-dependent  mechanisms of acquired resistance, the activation of alternative pathway-mediated Correspondence: Alexander Drilon Developmental Therapeutics, Division  of Solid Tumor Oncology, Department  of Medicine, Memorial Sloan Kettering  Cancer Center, 300 east 66th Street,  New York, NY 10065, USA Tel +1 646 888 4206 Fax +1 646 227 7276 email drilona@mskcc.or g Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Sabari et al Running head recto: Brigatinib and ALK-rearranged non-small cell lung cancers DOI: http://dx.doi.org/10.2147/OTT.S109295",Non-OADS,/arxiv_data1/oa_pdf/ea/8b/ott-10-1983.PMC5388194.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ea/8b/ott-10-1983.PMC5388194.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/8b/ott-10-1983.PMC5388194.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/da/opth-11-613.PMC5388196.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 613–618Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  613Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13320 0 Incidence of interface fluid syndrome after laser  in situ keratomileusis in egyptian patients amr a gab-alla Ophthalmology Department, Faculty  of Medicine, suez Canal University,   ismailia, egyptPurpose:  To determine the incidence of interface fluid syndrome (IFS) secondary to  steroid-induced elevation of intraocular pressure (IOP) following laser in situ keratomileusis  (LASIK) in myopic Egyptian patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/da/opth-11-613.PMC5388196.pdf
"This collection is termed interface fluid syndrome  (IFS).6–8 Among interface complications, diffuse lamellar keratitis (DLK) is a well-defined  condition in the literature (most common and the most common etiology mistaken Correspondence: amr a gab-alla Ophthalmology Department, Faculty  of Medicine, suez Canal University,  ring road, ismailia 41522, egypt Tel +20 122 283 6261 email amrophth@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Gab-Alla Running head recto: Incidence of interface fluid syndrome after LASIK DOI: http://dx.doi.org/10.2147/OPTH.S133200",Non-OADS,/arxiv_data1/oa_pdf/5c/da/opth-11-613.PMC5388196.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5c/da/opth-11-613.PMC5388196.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/da/opth-11-613.PMC5388196.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/00/44/ijn-12-2689.PMC5388197.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2689–2702International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2689RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S13197 3 Polyphenol nanoformulations for cancer therapy:  experimental evidence and clinical perspective Yasamin Davatgaran- Taghipour1,2 Salar Masoomzadeh3 Mohammad Hosein  Farzaei4,5 Roodabeh Bahramsoltani6 Zahra Karimi-Soureh7 Roja Rahimi6,8 Mohammad Abdollahi9,10 1Department of Medical Nanotechnology,   School of Advanced Technologies in  Medicine, T ehran University of Medical  Sciences, T ehran, Iran; 2PhytoPharmacology  Interest Group (PPIG), Universal Scientific  education and Research Network (USeRN),   T ehran, Iran; 3Zanjan Pharmaceutical  Nanotechnology Research Center, School  of Pharmacy, Zanjan University of Medical  Sciences, Zanjan, Iran; 4Pharmaceutical  Sciences Research Center, Kermanshah  University of Medical Sciences, Kermanshah,   Iran; 5Medical Biology Research Center,   Kermanshah University of Medical  Sciences, Kermanshah, Iran; 6Department  of Traditional Pharmacy, School of  Traditional Medicine, T ehran University of  Medical Sciences, T ehran, Iran; 7School of  Pharmacy, Shahid Beheshti University of  Medical Sciences, T ehran, Iran; 8evidence- Based Medicine Group, Pharmaceutical  Sciences Research Center, Tehran  University of Medical Sciences, T ehran,   Iran; 9T oxicology and Diseases Group,   Pharmaceutical Sciences Research Center,   T ehran University of Medical Sciences,   T ehran, Iran; 10Department of Toxicology  and Pharmacology, Faculty of Pharmacy  and Pharmaceutical Sciences Research  Center, Tehran University of Medical  Sciences, T ehran, IranAbstract:  Cancer is defined as the abnormal cell growth that can cause life-threatening  malignancies with high financial costs for patients as well as the health care system.",Non-OADS,/arxiv_data1/oa_pdf/00/44/ijn-12-2689.PMC5388197.pdf
"In addition, cells  of malignant tumors have a tendency to become metastatic and attack tissues other than  the place in which the primary tumor was formed.1 Common modalities in the treat - ment of cancer consist of nonpharmacological treatments, such as radiation therapy,  surgical operation, stem cell therapy and hyperthermia, as well as pharmacological  intervention, including immunotherapy, chemotherapy, and hormone therapy,  as well as a combination of these methods.1 Nevertheless, all of these methods, Correspondence: Mohammad Abdollahi Division of Toxicology, Department of  Toxicology and Pharmacology, Faculty of  Pharmacy and Pharmaceutical Sciences  Research Center, Tehran University of Medical  Sciences, Keshavarz Bulvard, ebn-e-Sina Street,  Tehran 1417614411, Iran email mohammad@tums.ac.i r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Davatgaran-Taghipour et al Running head recto: Polyphenol nanoformulations for cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S131973",Non-OADS,/arxiv_data1/oa_pdf/00/44/ijn-12-2689.PMC5388197.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/00/44/ijn-12-2689.PMC5388197.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/44/ijn-12-2689.PMC5388197.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0d/ae/amep-8-269.PMC5388198.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0d/ae/amep-8-269.PMC5388198.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 269–275Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 269 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S131638 Mastery learning: how is it helpful?",Non-OADS,/arxiv_data1/oa_pdf/0d/ae/amep-8-269.PMC5388198.pdf
"Other features, which determine the Correspondence: Manjunath  Siddaiah-SubramanyaDepartment of General Surgery, Logan Hospital, Armstrong Road & Loganlea Road, Meadowbrook, Brisbane QLD 4131, AustraliaTel +61 44 771 9975Email manjunathbss9@yahoo.comJournal name: Advances in Medical Education and Practice Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: Siddaiah-Subramanya et alRunning head recto: Mastery learningDOI: http://dx.doi.org/10.2147/AMEP .S131638",Non-OADS,/arxiv_data1/oa_pdf/0d/ae/amep-8-269.PMC5388198.pdf
Available from: http://home.absurgery.org/default.jsp?news_newreqs.,Non-OADS,/arxiv_data1/oa_pdf/0d/ae/amep-8-269.PMC5388198.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/0d/ae/amep-8-269.PMC5388198.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 275 Mastery learning,Non-OADS,/arxiv_data1/oa_pdf/0d/ae/amep-8-269.PMC5388198.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/12/ijn-12-2553.PMC5388199.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2553–2567International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2553OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13075 3 cuprous oxide nanoparticle-inhibited melanoma  progress by targeting melanoma stem cells Bin Yu,1,2,* Ye Wang,3,* Xinlu  Yu,1,* hongxia Zhang,1  Ji Zhu,4 chen Wang,1 Fei  chen,1 changcheng liu,1  Jingqiang Wang,2 haiying  Zhu1 1Department of cell Biology, second  Military Medical University, 2state Key  laboratory of genetic engineering  and collaborative Innovation center  of genetics and Development,   Ministry of education Key laboratory  of contemporary anthropology,   Department of genetics and  Development, school of life sciences,   Fudan University, 3Department of  Urinary surgery, 4Department of  Plastic surgery, changhai hospital,   second Military Medical University,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  Recent studies have shown that metal and metal oxide have a potential function in anti - tumor therapy.",Non-OADS,/arxiv_data1/oa_pdf/93/12/ijn-12-2553.PMC5388199.pdf
"Therefore, isolation and identification of CSCs is crucial for facilitating correspondence: Jingqiang Wang state Key laboratory of genetic  engineering and collaborative Innovation  center of genetics and Development,  Ministry of education Key laboratory  of contemporary anthropology,  Department of genetics and  Development, school of life sciences,  room e201-7, life sciences Building,  2005 songhu road, Jiangwan campus  of Fudan University, shanghai 200438,  People’s republic of china Tel +86 21 5163 0733 email jingqiangwang@fudan.edu.c n  haiying Zhu Department of cell Biology, second  Military Medical University, 800,  Xiangyin rd, shanghai 200433,  People’s republic of china Tel +86 21 8187 0944 email hyzhu@smmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Yu et al Running head recto: CONPs inhibited melanoma progress  DOI: http://dx.doi.org/10.2147/IJN.S130753",Non-OADS,/arxiv_data1/oa_pdf/93/12/ijn-12-2553.PMC5388199.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/93/12/ijn-12-2553.PMC5388199.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/12/ijn-12-2553.PMC5388199.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/ec/ijn-12-2813.PMC5388200.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2813–2828International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2813OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13278 4 Development of gold nanoparticles coated  with silica containing the antibiofilm drug  cinnamaldehyde and their effects on pathogenic  bacteria Mohankandhasamy  ramasamy Jin-hyung lee Jintae lee school of chemical engineering,   Yeungnam University, gyeongsan,   republic of KoreaAbstract:  Emerging resistance to antibiotics is a mounting worldwide health concern and  increases the need for nonantibiotic strategies to combat infectious diseases caused by bacterial  pathogens.",Non-OADS,/arxiv_data1/oa_pdf/19/ec/ijn-12-2813.PMC5388200.pdf
"In the present study, nanotechnology was used to develop a new  means of effectively combating biofilm infections.correspondence: Jintae lee 320, school of chemical engineering,  Yeungnam University, Daedong,  gyeongsan, gyeongsangbukdo 38541,  republic of Korea Tel +82 53 810 2533 Fax +82 53 810 4631 email jtlee@ynu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ramasamy et al Running head recto: Development of gold nanoparticles with antibiofilm drug cinnamaldehyde DOI: http://dx.doi.org/10.2147/IJN.S132784",Non-OADS,/arxiv_data1/oa_pdf/19/ec/ijn-12-2813.PMC5388200.pdf
Available  from: http://www.who.int/drugresistance/documents/surveillancereport/ en/.,OADS,/arxiv_data1/oa_pdf/19/ec/ijn-12-2813.PMC5388200.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/19/ec/ijn-12-2813.PMC5388200.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/ec/ijn-12-2813.PMC5388200.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/60/tcrm-13-427.PMC5388201.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 427–437Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  427Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/TCRM.S8114 1 Role of pirfenidone in the management  of pulmonary fibrosis Keith C Meyer1,2 Catherine A Decker3,4 1University of wisconsin Lung  Transplant and Advanced Lung Disease  Program, 2Department of Medicine,   Section of Allergy, Pulmonary and  Critical Care Medicine, Clinical  Sciences Center, University of  wisconsin School of Medicine  and Public Health, 3Department of  Pharmacy, 4Department of Pulmonary  Medicine, University of wisconsin  Hospital and Clinics, Madison,    wi, USAAbstract:  Pulmonary fibrosis is associated with a number of specific forms of interstitial lung  disease (ILD) and can lead to progressive decline in lung function, poor quality of life, and,  ultimately, early death.",Non-OADS,/arxiv_data1/oa_pdf/89/60/tcrm-13-427.PMC5388201.pdf
"Although IPF is characterized by a usual interstitial pneumonia  (UIP) pattern on lung histopathologic specimens,2,4 a UIP or UIP-like pattern can be  seen with other forms of ILD such as lung disease associated with connective tissue  disease (CTD-ILD) or chronic fibrosing hypersensitivity pneumonitis (HP).5–7 There - fore, alternative causes of UIP must be ruled out before a confident diagnosis of IPF is  established.4 Non-IPF forms of fibrotic ILD (Table 1) can also progress to end-stage  disease,5,7 and some of these entities may be difficult to discern from IPF, despite a  comprehensive clinical evaluation, high-resolution computed tomographic (HRCT)  imaging of the thorax, invasive surgical procedures to obtain diagnostic lung tissue,  and a multidisciplinary team evaluation.8 IPF accounts for approximately one-fifth of all cases of ILD and has a median  survival that is estimated to range from 3 to 5  years with an annual death rate  of .30,000 per year in the United States.9 Historically, IPF was considered a disease Correspondence: Keith C Meyer Department of Medicine, Section of  Allergy, Pulmonary and Critical Care  Medicine, K4/910 Clinical Sciences  Center, University of wisconsin  School of Medicine and Public Health,  600 Highland Avenue, Madison,  wi 53792, USA Tel +1 608 263 6363 Fax +1 608 263 3104 email kcm@medicine.wisc.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Meyer and Decker Running head recto: Pirfenidone for IPF DOI: http://dx.doi.org/10.2147/TCRM.S81141",Non-OADS,/arxiv_data1/oa_pdf/89/60/tcrm-13-427.PMC5388201.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics­and­clinical­risk­management­journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/89/60/tcrm-13-427.PMC5388201.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/60/tcrm-13-427.PMC5388201.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/57/30/ijn-12-2645.PMC5388202.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2645–2656International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2645OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13267 0 Detection of influenza viruses by coupling  multiplex reverse-transcription loop-mediated  isothermal amplification with cascade invasive  reaction using nanoparticles as a sensor Yiyue Ge1 Qiang Zhou2 Kangchen Zhao1 Ying Chi1 Bin liu3 Xiaoyan Min4 Zhiyang Shi1 Bingjie Zou2 Lunbiao Cui1 1Institute of Pathogenic Microbiology,   Key Laboratories of Enteric  Pathogenic Microbiology (Ministry  of Health), Jiangsu Provincial Center  for Disease Control and Prevention,   2Department of Pharmacology,   Jinling Hospital, Medical School of  Nanjing University, 3Department  of Biomedical Engineering, Nanjing  Medical University, 4Department of  Geriatrics, The First Affiliated Hospital  of Nanjing Medical University, Nanjing,   Jiangsu, People’s Republic of ChinaAbstract:  Influenza virus infections represent a worldwide public health and economic  problem due to the significant morbidity and mortality caused by seasonal epidemics and  pandemics.",Non-OADS,/arxiv_data1/oa_pdf/57/30/ijn-12-2645.PMC5388202.pdf
"At present, real-time reverse transcription polymerase  chain reaction (RT-PCR) is a powerful molecular diagnostic method for influenza Correspondence: Lunbiao Cui Institute of Pathogenic Microbiology,  Jiangsu Provincial Center for Disease  Control and Prevention, No 172 Jiangsu  Road, Nanjing, Jiangsu 210009,  People’s Republic of China Tel +86 25 8375 9424 email lbcui@jscdc.c n  Bingjie Zou Department of Pharmacology, Jinling  Hospital, Medical School of Nanjing  University, No 305 Zhongshan East  Road, Nanjing, Jiangsu 210002,  People’s Republic of China Tel +86 25 8086 0196 email zbj523@163.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ge et al Running head recto: Detection of influenza viruses by mRT-LAMP-CIRN DOI: http://dx.doi.org/10.2147/IJN.S132670",Non-OADS,/arxiv_data1/oa_pdf/57/30/ijn-12-2645.PMC5388202.pdf
"Available from: http://www.who.int/csr/resources/ publications/swineflu/ CDCRealtimeRTPCR_SwineH1Assay - 2009_20090430.pd f. Accessed January 6, 2017.",OADS,/arxiv_data1/oa_pdf/57/30/ijn-12-2645.PMC5388202.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/57/30/ijn-12-2645.PMC5388202.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/30/ijn-12-2645.PMC5388202.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/f6/ott-10-1993.PMC5388203.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1993–2002OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1993Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12464 5 long noncoding rna nB aT -1 suppresses  tumorigenesis and predicts favorable prognosis  in ovarian cancer changsheng Yan1 Yi Jiang1 Yicong Wan1 lin Zhang2 Jinhui liu1 shulin Zhou1 Wenjun cheng1 1Department of gynecology, The First  affiliated hospital of nanjing Medical  University, 2Department of Obstetrics  and gynecology, Zhongda hospital  affiliated to southeast University,   Medical school, southeast University,   nanjing, Jiangsu, People’s republic  of chinaAbstract:  Long noncoding RNA (lncRNA) has been proven to be involved in many biological  processes in ovarian cancer (OC).",Non-OADS,/arxiv_data1/oa_pdf/d3/f6/ott-10-1993.PMC5388203.pdf
"Among these, there is a kind of  noncoding RNA called long noncoding RNA (lncRNA, .200 bp in length), which  has been proven to regulate many biological processes from nuclear organization to  epigenetic modification of posttranscriptional regulation and RNA splicing,6,7 espe - cially in cancers.correspondence: Wenjun cheng Department of gynecology, The  First Affiliated Hospital of Nanjing  Medical University, 300 guangzhou  road, nanjing 210029, Jiangsu,  People’s republic of china email wenjunchengdoc@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Y an et al Running head recto: Long noncoding RNA NBAT-1 in ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S124645",Non-OADS,/arxiv_data1/oa_pdf/d3/f6/ott-10-1993.PMC5388203.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d3/f6/ott-10-1993.PMC5388203.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/f6/ott-10-1993.PMC5388203.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b0/16/clep-9-205.PMC5388204.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b0/16/clep-9-205.PMC5388204.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 205–215Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 205 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S128627 The association between thyroid disorders and  incident gout: population-based case–control study Saskia G Bruderer1,2  Christoph R Meier1–3  Susan S Jick3  Michael Bodmer1,4 1Basel Pharmacoepidemiology  Unit, Division of Clinical Pharmacy  and Epidemiology, Department of Pharmaceutical Sciences, University of Basel,  2Hospital Pharmacy,   University Hospital Basel, Basel,  Switzerland;  3Boston Collaborative  Drug Surveillance Program, Boston University School of Public Health,  Lexington, MA, USA;  4Division  of General Internal Medicine,  Zug Community Hospital, Baar,  SwitzerlandContext:  Thyroid hormones influence kidney function and thereby might alter serum urate  levels, a major risk factor for gouty arthritis.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/clep-9-205.PMC5388204.pdf
"5,6  Several case series provided evidence of a possible association between hypothy- roidism and gout.7–9 One study reported a material association between hypo- and  hyperthyroidism and the risk of gout,10 and two other studies reported a correlation Correspondence: Christoph R Meier Basel Pharmacoepidemiology Unit, University Hospital Basel, Spitalstrasse 26, CH-4031 Basel, Switzerland Tel +41 61 556 53 69   Fax +41 61 265 88 75   Email christoph.meier@usb.chJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Bruderer et alRunning head recto: Thyroid disorders and goutDOI: http://dx.doi.org/10.2147/CLEP .S128627",Non-OADS,/arxiv_data1/oa_pdf/b0/16/clep-9-205.PMC5388204.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/b0/16/clep-9-205.PMC5388204.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/a6/cia-12-635.PMC5388205.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 635–643Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  635OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12960 1 Age-based model for metacarpophalangeal joint  proprioception in elderly Mike D rinderknecht1 Olivier lambercy1 Vanessa raible2 Joachim liepert2 roger gassert1 1rehabilitation engineering  laboratory, Department of health  sciences and Technology, Institute  of robotics and Intelligent systems,   eTh Zurich, Zurich, switzerland;   2Department of n eurorehabilitation,   Kliniken schmieder, Allensbach,   germanyAbstract:  Neurological injuries such as stroke can lead to proprioceptive impairment.",Non-OADS,/arxiv_data1/oa_pdf/34/a6/cia-12-635.PMC5388205.pdf
"There is some literature showing that Correspondence: Mike D rinderknecht rehabilitation engineering laboratory,  Department of health sciences and  Technology, Institute of robotics  and Intelligent systems, eTh Zurich,  lengghalde 5, Ch-8092 Zurich,  switzerland Tel +41 44 510 7238 email mike.rinderknecht@hest.ethz.c h Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Rinderknecht et al Running head recto: Age-based model for MCP proprioception DOI: http://dx.doi.org/10.2147/CIA.S129601",Non-OADS,/arxiv_data1/oa_pdf/34/a6/cia-12-635.PMC5388205.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/34/a6/cia-12-635.PMC5388205.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/34/a6/cia-12-635.PMC5388205.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9c/55/ijgm-10-095.PMC5388206.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9c/55/ijgm-10-095.PMC5388206.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 95–99International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 95 PersPectIves open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S128953recognition and management of  platelet‑refractory bleeding in patients with  Glanzmann’s thrombasthenia and other severe  platelet function disorders Meera chitlur1 Madhvi rajpurkar1 Michael recht2 Michael D tarantino3 Donald L Yee4 David L cooper5 sriya Gunawardena5 1carman and Ann Adams Department  of Pediatrics, Wayne state University  and children’s Hospital of Michigan,   Detroit, MI, UsA; 2Oregon Health and  science University, Portland, Or, UsA;   3Bleeding and clotting Disorders  Institute, Peoria, IL, UsA; 4Department  of Pediatrics, Baylor college of  Medicine, Houston, tX, UsA; 5clinical  Development, Medical and regulatory  Affairs, Novo Nordisk Inc., Plainsboro,   NJ, UsAAbstract:  Patients with rare qualitative platelet disorders or platelet function disorders (PFDs)  may present to the hospital physician with severe bleeding episodes or excessive surgical bleed- ing.",Non-OADS,/arxiv_data1/oa_pdf/9c/55/ijgm-10-095.PMC5388206.pdf
"Glanzmann’ s thrombasthenia (GT) is one of the well-known rare PFDs, occurring  in an estimated 1 per 1 million individuals and is associated with abnormalities in correspondence: Meera chitlur carman and Ann Adams Department of Pediatrics, Wayne state University and children’s Hospital of Michigan, 3901 Beaubien Blvd., Detroit, MI 48201, UsAtel +1 313 745 5515Fax +1 313 745 5237email mchitlur@med.wayne.eduJournal name: International Journal of General Medicine Article Designation: PerspectivesY ear: 2017V olume: 10Running head verso: Chitlur et alRunning head recto: Platelet refractoriness in GTDOI: http://dx.doi.org/10.2147/IJGM.S128953",Non-OADS,/arxiv_data1/oa_pdf/9c/55/ijgm-10-095.PMC5388206.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international‑journal‑of‑general‑medicine‑journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/9c/55/ijgm-10-095.PMC5388206.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 99 Platelet refractoriness in Gt References  1.,Non-OADS,/arxiv_data1/oa_pdf/9c/55/ijgm-10-095.PMC5388206.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/28/ijn-12-2673.PMC5388207.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2673–2687International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2673OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S13125 1 comparative study of porous hydroxyapatite/ chitosan and whitlockite/chitosan scaffolds for  bone regeneration in calvarial defects Ding Zhou1,* chao Qi2,* Yi-Xuan chen1 Ying-Jie Zhu2 T uan-Wei sun2 Feng chen2 chang-Qing Zhang1 1Department of Orthopedic surgery,   shanghai Jiao Tong University  affiliated sixth People’s hospital,   shanghai Jiaotong University,   2state Key laboratory of high  Performance ceramics and superfine  Microstructure, shanghai Institute  of ceramics, chinese academy  of sciences, shanghai, People’s  republic of china *These authors contributed equally  to this workAbstract:  Hydroxyapatite (HAP; Ca10(PO4)6(OH)2) and whitlockite (WH; Ca18Mg2(HPO4)2(PO4)12)  are widely utilized in bone repair because they are the main components of hard tissues such  as bones and teeth.",Non-OADS,/arxiv_data1/oa_pdf/7f/28/ijn-12-2673.PMC5388207.pdf
"Whitlockite (WH: Ca18Mg2(HPO4)2(PO4)12), a second most abundant mineral  in living bone (about 20% based on the amount of Mg2+), is formed by the partial correspondence: chang-Qing Zhang Department of Orthopedic surgery,  Shanghai Jiao Tong University Affiliated  sixth People’s hospital, 600 Yishan road,  shanghai 200233, People’s republic of  china email zhangcq@sjtu.edu.c n  Ying-Jie Zhu state Key laboratory of high  Performance Ceramics and Superfine  Microstructure, shanghai Institute of  ceramics, chinese academy of sciences,  1295 Dingxi road, shanghai 200050,  People’s republic of china email y.j.zhu@mail.sic.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhou et al Running head recto: Comparison of WH/chitosan and HAP/chitosan in bone regeneration DOI: http://dx.doi.org/10.2147/IJN.S131251",Non-OADS,/arxiv_data1/oa_pdf/7f/28/ijn-12-2673.PMC5388207.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7f/28/ijn-12-2673.PMC5388207.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/28/ijn-12-2673.PMC5388207.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/88/eb/dddt-11-1107.PMC5388208.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1107–1113Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1107CliniC al Trial repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13186 6 effects of intrathecal dexmedetomidine on  shivering after spinal anesthesia for cesarean  section: a double-blind randomized clinical trial Karim nasseri1,2 negin Ghadami1 Bijan nouri2 1Department of anesthesiology,   Faculty of Medicine, Kurdistan  University of Medical Sciences,   Sanandaj, iran; 2Social Determinants  of Health research Center, Kurdistan  University of Medical Sciences,   Sanandaj, iranBackground:  Shivering is among the common troublesome complications of spinal anesthesia  (SA), and causes discomfort and discontentment in parturients undergoing cesarean sections  (CSs).",Non-OADS,/arxiv_data1/oa_pdf/88/eb/dddt-11-1107.PMC5388208.pdf
"In previous studies, different pharmacological and nonpharmacological techniques  have been attempted to prevent shivering, but a gold-standard method has not yet been  determined.6 Dexmedetomidine has highly specific α2-adrenergic receptor-agonist  properties, with strong impacts on the central nervous system without respiratory  depression.3,7 It is postulated that intravenous dexmedetomidine could reduce shivering  thresholds via its centrally mediated actions without any major adverse effects.8,9Correspondence: Karim nasseri Department of anesthesiology, Kurdistan  University of Medical Sciences, pasdaran  Street, 6617713446, Sanandaj, iran Tel +98 87 3366 0733 Fax +98 871 3323 3600 email nasseri_k@muk.a c Journal name: Drug Design, Development and Therapy Article Designation: Clinical Trial Report Y ear: 2017 Volume: 11 Running head verso: Nasseri et al Running head recto: Intrathecal dexmedetomidine effect on shivering DOI: http://dx.doi.org/10.2147/DDDT.S131866",Non-OADS,/arxiv_data1/oa_pdf/88/eb/dddt-11-1107.PMC5388208.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/88/eb/dddt-11-1107.PMC5388208.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/eb/dddt-11-1107.PMC5388208.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/f1/opth-11-605.PMC5388209.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 605–611Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  605Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13490 9 increase in average foveal thickness after internal  limiting membrane peeling Kazuyuki Kumagai1 Mariko Furukawa1 T etsuyuki suetsugu1 nobuchika Ogino2 1Department of Ophthalmology,   Kami-iida Daiichi general hospital,   2Department of Ophthalmology,   nishigaki eye Clinic, aichi, JapanPurpose:  To report the findings in three cases in which the average foveal thickness was  increased after a thin epiretinal membrane (ERM) was removed by vitrectomy with internal  limiting membrane (ILM) peeling.",Non-OADS,/arxiv_data1/oa_pdf/18/f1/opth-11-605.PMC5388209.pdf
"This study Correspondence: Kazuyuki Kumagai Department of Ophthalmology, Kami-iida  Daiichi general hospital, 2-70 Kamiiida  Kita-machi, aichi 462-0802, Japan Tel +81 52 991 3111 Fax +81 52 991 3220 email ganka@kamiiida-hp.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kumagai et al Running head recto: Increase in average foveal thickness after ILM peeling DOI: http://dx.doi.org/10.2147/OPTH.S134909",Non-OADS,/arxiv_data1/oa_pdf/18/f1/opth-11-605.PMC5388209.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/18/f1/opth-11-605.PMC5388209.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/f1/opth-11-605.PMC5388209.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/ott-10-1955.PMC5388210.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1955–1967OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1955Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12607 5 exploratory cohort study and meta-analysis of  BIM deletion polymorphism in patients with  epidermal growth factor receptor-mutant non- small-cell lung cancer treated with epidermal  growth factor receptor tyrosine kinase inhibitors si sun1,2 hui Yu1,2 huijie Wang1,2 Xinmin Zhao1,2 Xintai Zhao3 Xianghua Wu1,2 Jie Qiao1,2 Jianhua chang1,2 Jialei Wang1,2 1Department of Medical Oncology,   Fudan University shanghai cancer  center, 2Department of Oncology,   shanghai Medical college, Fudan  University, 3shanghai shines  Biomedical co. ltd., shanghai,   People’s republic of chinaBackground:  Non-small-cell lung cancer (NSCLC) patients with epidermal growth factor  receptor ( EGFR ) mutations might develop primary and secondary resistance to tyrosine kinase  inhibitors (TKIs).",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/ott-10-1955.PMC5388210.pdf
"Using targeted therapies could specifically attack correspondence: Jialei Wang Department of Medical Oncology, Fudan  University shanghai cancer center,  270 Dong an road, 200032 shanghai,  People’s republic of china Tel +86 21 6417 5590 (ext 5006) Fax +86 21 6443 0160 email luwangjialei123@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Sun et al Running head recto: BIM deletion polymorphism in NSCLC patients treated with EGFR-TKIs DOI: http://dx.doi.org/10.2147/OTT.S126075",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/ott-10-1955.PMC5388210.pdf
"Available from: http://www.ohri.ca/programs/clinical_epidemiology/ oxford.ht m. Accessed January 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/ott-10-1955.PMC5388210.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4a/2f/ott-10-1955.PMC5388210.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/2f/ott-10-1955.PMC5388210.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"4, 642 –653 http://dx.doi.org/10.1080/15548627.2016.1274850",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Lancet 2005; 366(9497):1640-9; PMID:16271645; http://dx.doi.org/10.1016/S0140-6736(05)67663-5 [3] Gnaci /C19nska M, Ma »gorzewicz S, Stojek M, ºysiak-Szyd »owska W, Sworczak K. Role of adipokines in complications related to obesity: a review.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nat Rev Immunol 2011; 11(2):85-97; PMID:21252989; http://dx.doi.org/10.1038/nri2921 [5] Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS. Adipocyte death de ﬁnes mac- rophage localization and function in adipose tissue of obese mice and humans.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"J Lipid Res 2005; 46(11):2347-5; PMID:16150820;http://dx.doi.org/10.1194/jlr.M500294-JLR200 [6] Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nat Med 2011; 17(2):179-88; PMID:21217695; http://dx.doi.org/10.1038/nm.2279 [7] Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, et al.Inﬂammasome is a central player in the induction of obesity and insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nature 2012; 481(7381):278-86; PMID:22258606; http://dx.doi.org/10.1038/nature10759 [9] Yahagi N, Shimano H, Matsuzaka T, Najima Y, Sekiya M, Nakagawa Y, Ide T, Tomita S, Okazaki H, Tamura Y, et al.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"J Biol Chem 2003; 278(28):25395-400; PMID:12734185; http://dx.doi.org/10.1074/jbc.M302364200 [10] Inoue N, Shimano H, Nakakuki M, Matsuzaka T, Nakagawa Y, Y a m a m o t oT ,S a t oR ,T a k a h a s h iA ,S o n eH ,Y a h a g iN ,e ta l .Lipid synthetic transcription factor SREBP-1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Mol Cell Biol 2005; 25(20):8938-47; PMID:16199872; http://dx.doi.org/10.1128/MCB.25.20.8938-8947.2005 [11] Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, Nojima A, Nabetani A, Oike Y, Matsubara H, et al.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nat Med2009; 15(9):1082-7; PMID:19718037; http://dx.doi.org/10.1038/ nm.2014 [12] Levine B, Kroemer G. Autophagy in the Pathogenesis of Disease.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Cell 2008; 132:27-42; PMID:18191218; http://dx.doi.org/10.1016/j.cell.2007.12.018 [13] Mizushima N, Levine B, Cuervo AM, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nature 2008; 451(7182):1069-75; PMID:18305538; http://dx.doi.org/10.1038/nature06639[14] Mizushima N, Komatsu M. Autophagy: Renovation of cells and tis- sues.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Cell 2011; 147:728-41; PMID:22078875; http://dx.doi.org/10.1016/j.cell.2011.10.026 [15] Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ, Czaja MJ.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"J Clin Invest 2009; 119:3329-39;PMID:19855132; http://dx.doi.org/10.1172/JCI35541 [16] Zhang Y, Goldman S, Baerga R, Zhao Y, Komatsu M, Jin S. Adipose- speciﬁc deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Mol Med 2010; 16:235-46; PMID:20386866; http://dx.doi.org/10.2119/molmed.2010.00023 [19] Yoshizaki T, Kusunoki C, Kondo M, Yasuda M, Kume S, Morino K, Sekine O, Ugi S, Uzu T, Nishio Y, et al.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochem Biophys Res Commun 2012; 417:352- 7; PMID:22155234; http://dx.doi.org/10.1016/j.bbrc.2011.11.114 [20] Mikami K, Okita N, Tokunaga Y, Ichikawa T, Okazaki T, Takemoto K, Nagai W, Matsushima S, Higami Y. Autophagosomes accumulatein differentiated and hypertrophic adipocytes in a p53-independent manner.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochem Biophys Res Commun 2012; 427:758-63; PMID:23041188; http://dx.doi.org/10.1016/j.bbrc.2012.09.134 [21] Gornicka A, Fettig J, Eguchi A, Berk MP, Thapaliya S, Dixon LJ, Feldstein AE.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Signals from the lyso- some: a control centre for cellular clearance and energy metabolism.Nat Rev Mol Cell Biol 2013; 14(5):283-96; PMID:23609508; http://dx.doi.org/10.1038/nrm3565 [23] Kaminskyy V, Zhivotovsky B. Proteases in autophagy.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochim Bio- phys Acta 2012; 1824(1):44-50; PMID:21640203; http://dx.doi.org/10.1016/j.bbapap.2011.05.013 [24] Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Autophagy 2005; 1(2):84-91; PMID:16874052; http://dx.doi.org/10.4161/auto.1.2.1697 [25] Komatsu M, Ichimura Y. Physiological signi ﬁcance of selective deg- radation of p62 by autophagy.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"FEBS Lett 2010; 584(7):1374-8;PMID:20153326; http://dx.doi.org/10.1016/j.febslet.2010.02.017 [26] Mizushima N, Yoshimori T, Levine B.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"J Clin Endocrinol Metab 2011; 96:E268-77; PMID:21047928; http://dx.doi.org/10.1210/jc.2010-1681 [28] Jansen HJ, van Essen P, Koenen T, Joosten LA, Netea MG, Tack CJ, Stienstra R. Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proin ﬂammatory cytokine expres- sion.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"J Clin Invest 2010; 120(10):3421-31;PMID:20921628; http://dx.doi.org/10.1172/JCI42918 [30] Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, et al.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Science 2011; 332(6036):1429-33;PMID:21617040; http://dx.doi.org/10.1126/science.1204592 [31] Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, Huynh T, Carissimo A, Palmer D, Klisch TJ, et al.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nat Cell Biol 2013; 15(6):647-58; PMID:23604321; http://dx.doi.org/10.1038/ncb2718 [32] Zheng X, Chu F, Mirkin BL, Sudha T, Mousa SA, Rebbaa A.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochim Biophys Acta 2008; 1783(12):2294-300;PMID:18775751; http://dx.doi.org/10.1016/j.bbamcr.2008.07.027 [33] Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitz- gerald KA, Latz E. Silica crystals and aluminum salts activate the NALP3 inﬂammasome through phagosomal des tabilization.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nat Immunol 2008; 9(8):857-65; PMID:18604209; http://dx.doi.org/10.1038/ni.1636 [35] Yang L, Li P, Fu S, Calay ES, Hotamisligil GS.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Defective hepatic auto- phagy in obesity promotes ER stress and causes insulin resistance.Cell Metab 2010; 11(6):467-78; PMID:20519119; http://dx.doi.org/ 10.1016/j.cmet.2010.04.005 [36] Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, Azuma K, Hirose T, Tanaka K, Kominami E, et al.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Cell Metab 2008; 8(4):325-32;PMID:18840363; http://dx.doi.org/10.1016/j.cmet.2008.08.009 [37] Moscat J, Diaz-Meco MT.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"J Biol Chem 2013; 288(50):35769-80;PMID:24174532; http://dx.doi.org/10.1074/jbc.M113.511212 [39] Mangieri LR, Mader BJ, Thomas CE, Taylor CA, Luker AM, Tse TE, Hui- singh C, Shacka JJ.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
PLoS One 2014; 9(4):e93257; PMID:24695574; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Proc Natl Acad Sci USA 1998; 95(8):4516-21; PMID:9539769; http://dx.doi.org/10.1073/ pnas.95.8.4516 [41] Potts W, Bowyer J, Jones H, Tucker D, Freemont AJ, Millest A, Mar- tin C, Vernon W, Neerunjun D, Slynn G, et al.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Int J Exp Pathol2004; 85(2):85-96; PMID:15154914; http://dx.doi.org/10.1111/ j.0959-9673.2004.00373.x [42] Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, Bronson RT, Olsen BR.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochem J 1992; 282(Pt 2):577-82; PMID:1312333; http://dx.doi.org/10.1042/bj2820577[44] Turk B, Bieth JG, Bj €o r kI ,D o l e n cI ,T u r kD ,C i m e r m a nN ,K o sJ , Colic A, Stoka V, Turk V. Regulation of the activity of lysosomalcysteine proteinases by pH-indu ced inactivation and/or endoge- nous protein inhibitors, cystatins.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biol Chem Hoppe Seyler 1995; 376(4):225-30; PMID:7626231; http://dx.doi.org/10.1515/bchm 3.1995.376.4.225 [45] Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D. Cys- teine cathepsins: from structure, function and regulation to new frontiers.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochim Biophys Acta 2012; 1824(1):68-88;PMID:22024571; http://dx.doi.org/10.1016/j.bbapap.2011.10.002 [46] Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Autophagy 2013; 9(4):581-94; PMID:23360789; http://dx.doi.org/10.4161/auto.23568 [48] Inami Y, Yamashina S, Izumi K, Ueno T, Tanida I, Ikejima K, Wata- nabe S. Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidi ﬁcation and cathepsin expres- sion.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochem Biophys Res Commun 2011; 412(4):618-25;PMID:21856284; http://dx.doi.org/10.1016/j.bbrc.2011.08.012 [49] Coffey EE, Beckel JM, Laties AM, Mitchell CH.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"J Exp Med 1996; 183(4):1331- 8; PMID:8666891; http://dx.doi.org/10.1084/jem.183.4.1331 [51] Liao G, Yao Y, Liu J, Yu Z, Cheung S, Xie A, Liang X, Bi X.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Am J Pathol 2007; 171(3):962-75; PMID:17631520; http://dx.doi.org/10.2353/ajpath.2007.070052 [52] Hannaford J, Guo H, Chen X.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Obesity (Silver Spring) 2013; 21(8):1586-95;PMID:23666609; http://dx.doi.org/10.1002/oby.20136 [53] Campisi J, d ’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells.",Non-OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Nat Rev Mol Cell Biol 2007; 8(9):729- 40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233 [54] Smogorzewska A, de Lange T. Different telomere damage signaling pathways in human and mouse cells.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"EMBO 2002; 21(16):4338-48; http://dx.doi.org/10.1093/emboj/cdf433 [55] Matsushima S, Okita N, Oku M, Nagai W, Kobayashi M, Higami Y.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Biochem Biophys Res Commun 2011; 407(3):557- 61; PMID:21419099; http://dx.doi.org/10.1016/j.bbrc.2011.03.061 [56] Okita N, Ishikawa N, Mizunoe Y, Oku M, Nagai W, Suzuki Y, Mat- sushima S, Mikami K, Okado H, Sasaki T, et al.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"Inhibitory effect of p53 on mitochondrial content and function during adipogenesis.Biochem Biophys Res Commun 2014; 446(1):91-7; PMID:24565844;http://dx.doi.org/10.1016/j.bbrc.2014.02.059 [57] Barrett AJ, Kirschke H. CTSB, cathepsin H, and CTSL.",OADS,/arxiv_data1/oa_pdf/58/a1/kaup-13-04-1274850.PMC5388215.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/36/ott-10-1947.PMC5388217.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1947–1954OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1947Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12304 2 Clinical significance of serum cathepsin B and  cystatin c levels and their ratio in the prognosis  of patients with esophageal cancer Yan Yan1,* Kun Zhou2,* liping Wang1 Feng Wang1 Xinfeng Chen3 Qingxia Fan1 1Department of Oncology,   2Department of Thoracic Surgery,   3Department of Biotherapy Center,   The First Affiliated  Hospital of  Zhengzhou University, Zhengzhou,   People’s Republic of China *These authors contributed equally  to this workObjective:  The main purpose of this study was to analyze the serum cathepsin B (CTSB) and  cystatin C (CysC) levels in patients with esophageal carcinoma and their correlation with the  clinical indices and prognosis.",Non-OADS,/arxiv_data1/oa_pdf/5d/36/ott-10-1947.PMC5388217.pdf
"Therefore, it is urgent to find new  reliable markers.correspondence: Qingxia Fan;   liping Wang Department of Oncology,  The First Affiliated Hospital of  Zhengzhou University, no 1 Jianshe  east road, Zhengzhou 450052,  People’s Republic of China Tel +86 371 6629 5532;   +86 371 6629 5552 email nnty1608@163.co m;   wlp@zzu.edu.c nJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Y an et al Running head recto: Serum cathepsin B and cystatin C are prognostic for esophageal cancer DOI: http://dx.doi.org/10.2147/OTT.S123042",Non-OADS,/arxiv_data1/oa_pdf/5d/36/ott-10-1947.PMC5388217.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5d/36/ott-10-1947.PMC5388217.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/36/ott-10-1947.PMC5388217.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"4, 686 –702 http://dx.doi.org/10.1080/15548627.2017.1280207",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Trends Mol Med 2014; 20:105-15; PMID:24380646; http://dx.doi.org/10.1016/j.molmed.2013.11.006 [2] de Serres F, Blanco I.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Chest 2002; 122:1818-29; PMID:12426287; http://dx.doi.org/10.1378/chest.122.5.1818 [4] Brantly M, Nukiwa T, Crystal RG.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Hepatology2005; 42:514-21; PMID:16044402; http://dx.doi.org/10.1002/hep.20815 [6] Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin de ﬁciency.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"N Engl J Med 1986; 314:736-9; PMID:3485248; http://dx.doi.org/10.1056/NEJM198603203141202 [7] Lomas DA, Evans DL, Finch JT, Carrell RW.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Nature 1992; 357:605- 7; PMID:1608473; http://dx.doi.org/10.1038/357605a0 [8] Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, Maur- ice N, Mukherjee A, Goldbach C, Watkins S, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Science 2010; 329:229-32; PMID:20522742; http://dx.doi.org/10.1126/science.1190354 [9] Chu AS, Perlmutter DH, Wang Y.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
Pediatr Res 2014; 75:133-9; PMID:24226634; http://dx.doi.org/10.1038/pr.2013.190 [11] Perlmutter DH.,OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Annu Rev Med 2011; 62:333-45; PMID:20707674; http://dx.doi.org/10.1146/annurev-med- 042409-151920 [12] Qu D, Teckman JH, Omura S, Perlmutter DH.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Biol Chem 1996; 271:22791-5;PMID:8798455;http://dx.doi.org/10.1074/ jbc.271.18.10577 [13] Werner ED, Brodsky JL, McCracken AA.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Biol Chem 2001; 276:44865-72; PMID:11577074; http://dx.doi.org/10.1074/jbc.M103703200 [15] Kamimoto T, Shoji S, Hidvegi T, Mizushima N, Umebayashi K, Perl- mutter DH, Yoshimori T. Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Biol Chem 2006; 281:4467-76; PMID:16365039; http://dx.doi.org/10.1074/jbc.M509409200 [16] Christianson JC, Shaler TA, Tyler RE, Kopito RR.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Nat Cell Biol 2008; 10:272-82; PMID:18264092;http://dx.doi.org/10.1038/ncb1689 [17] Kostova Z, Tsai YC, Weissman AM.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Semin Cell Dev Biol 2007; 18:770-9; PMID:17950636; http://dx.doi.org/10.1016/j.semcdb.2007.09.002 [18] Zhong Y, Wang Y, Yang H, Ballar P, Lee JG, Ye Y, Monteiro MJ, Fang S. Importin beta interacts with the endoplasmic reticulum-asso- ciated degradation machinery and promotes ubiquitination and deg-radation of mutant alpha1-antitrypsin.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Biol Chem 2011; 286:33921- 30; PMID:21832065; http://dx.doi.org/10.1074/jbc.M111.272906 [19] Lemus L, Goder V. Regulation of Endoplasmic Reticulum-Associated Protein Degradation (ERAD) by Ubiquitin.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Cells 2014; 3:824-47;PMID:25100021; http://dx.doi.org/10.3390/cells3030824 [20] Stein A, Ruggiano A, Carvalho P, Rapoport TA.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Cell 2014; 158:1375-88; PMID:25215493; http://dx.doi.org/10.1016/j.cell.2014.07.050 [21] Yamasaki S, Yagishita N, Sasaki T, Nakazawa M, Kato Y, Yamadera T, Bae E, Toriyama S, Ikeda R, Zhang L, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"EMBO Rep 2008; 9:480-5; PMID:18369366; http://dx.doi.org/10.1038/embor.2008.37 [23] Tsuchiya Y, Morita T, Kim M, Iemura S, Natsume T, Yamamoto M, Kobayashi A. Dual regulation of the transcriptional activity of Nrf1by beta-TrCP- and Hrd1-dependent degradation mechanisms.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"MolCell Biol 2011; 31:4500-12; PMID:21911472; http://dx.doi.org/ 10.1128/MCB.05663-11 [24] Yang H, Qiu Q, Gao B, Kong S, Lin Z, Fang D. Hrd1-mediated BLIMP-1 ubiquitination promotes d endritic cell MHCII expression for CD4 T cell priming during in ﬂammation.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Exp Med 2014; 211:2467- 79; PMID:25366967; http://dx.doi.org/10.1084/jem.20140283 [25] Yang H, Zhong X, Ballar P, Luo S, Shen Y, Rubinsztein DC, Mon- teiro MJ, Fang S. Ubiquitin ligase Hrd1 enhances the degradationand suppresses the toxicity of polyglutamine-expanded huntingtin.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Exp Cell Res 2007; 313:538-50; PMID:17141218; http://dx.doi.org/ 10.1016/j.yexcr.2006.10.031 [26] Shen YX, Sun AM, Fang S, Feng LJ, Li Q, Hou HL, Liu C, Wang HP, Shen JL, Luo J, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Curr Mol Med 2012; 12:138-52; PMID:22280354;http://dx.doi.org/10.2174/156652412798889009 [27] Amano T, Yamasaki S, Yagishita N, Tsuchimochi K, Shin H, Kawa- hara K, Aratani S, Fujita H, Zhang L, Ikeda R, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy.Genes Dev 2003; 17:2436-49; PMID:12975321; http://dx.doi.org/10.1101/gad.1096603 [28] Zhong Y, Shen H, Wang Y, Yang Y, Yang P, Fang S. Identi ﬁcation of ERAD components essential for dislocation of the null Hong Kongvariant of alpha-1-antitrypsin (NHK).",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
Biochem Biophys Res Com- mun 2015; 458:424-8; PMID:25660456; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Mol Cell Biochem 2011; 346:137-45; PMID:20886262; http://dx.doi.org/10.1007/s11010-010-0600-9 [30] Teckman JH, Perlmutter DH.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Trends Biochem Sci 2014; 39:61-71; PMID:24369758; http://dx.doi.org/10.1016/j.tibs.2013.12.001 [32] Fujita N, Yoshimori T. Ubiquitination-mediated autophagy against invading bacteria.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Curr Opin Cell Biol 2011; 23:492-7; PMID:21450448; http://dx.doi.org/10.1016/j.ceb.2011.03.003 [33] Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Genes Cells 2010; 15:923-33; PMID:20670274; http://dx.doi.org/10.1111/j.1365-2443.2010.01433.x [35] Ding WX, Yin XM.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Nat Cell Biol 2010; 12:836-41;PMID:20811356; http://dx.doi.org/10.1038/ncb0910-836 [37] Khaminets A, Behl C, Dikic I. Ubiquitin-Dependent And Indepen- dent Signals In Selective Autophagy.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Trends in cell biology 2016;26:6-16; PMID:26437584; http://dx.doi.org/10.1016/j.tcb.2015.08.010 [38] Teckman JH, Gilmore R, Perlmutter DH.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"HumMol Genet 2006; 15:433-42; PMID:16368705; http://dx.doi.org/ 10.1093/hmg/ddi458 [40] Chiramel AI, Dougherty JD, Nair V, Robertson SJ, Best SM.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"The Jour- nal of biological chemistry 2015; 290:28175-88; PMID:26463207;http://dx.doi.org/10.1074/jbc.M115.656660 [42] Claessen JH, Mueller B, Spooner E, Pivorunas VL, Ploegh HL.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
The Journal of biological chemistry 2010;285:20732-9; PMID:20435896; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Mol Cell 2009; 34:259-69; PMID:19450525;http://dx.doi.org/10.1016/j.molcel.2009.04.026 [47] Weissman AM, Shabek N, Ciechanover A.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
Nat Rev Mol Cell Biol 2011; 12:605-20; PMID:21860393; http://dx.doi.org/10.1038/nrm3173 [48] Finley D. Recognition and processi ng of ubiquitin-protein conjugates by the proteasome.,OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Annu Rev Biochem 2009; 78:477-513;PMID:19489727; http://dx.doi.org/10.1146/annurev.biochem.78.081507.101607 [49] Deshaies RJ, Joazeiro CA.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Annu Rev Biochem 2009; 78:399-434; PMID:19489725; http://dx.doi.org/10.1146/annurev.biochem.78.101807.093809 [50] Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP, Ho MW, Troncoso J, Gygi SP, Lee MK, et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Hum Mol Genet 2008; 17:431-9; PMID:17981811; http://dx.doi.org/10.1093/ hmg/ddm320 [51] Riley BE, Kaiser SE, Shaler TA, Ng AC, Hara T, Hipp MS, Lage K, Xavier RJ, Ryu KY, Taguchi K, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Cell Biol 2010; 191:537-52;PMID:21041446; http://dx.doi.org/10.1083/jcb.201005012 [52] Liu Z, Chen P, Gao H, Gu Y, Yang J, Peng H, Xu X, Wang H, Yang M, Liu X, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
Cancer Cell 2014; 26:106-20; PMID:25026213; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Biol Chem 2008; 283:5427-40; PMID:18083707; http://dx.doi.org/10.1074/jbc.M704973200 [54] Wooten MW, Geetha T, Babu JR, Seibenhener ML, Peng J, Cox N, Diaz-Meco MT, Moscat J.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J BiolChem 2008; 283:6783-9; PMID:18174161; http://dx.doi.org/10.1074/ jbc.M709496200 [55] Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Aro- zena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-GhisoJA, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Autophagy 2012; 8:445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496 [56] Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"FEBS Lett 2010; 584:1379-85; PMID:20083108; http://dx.doi.org/10.1016/j.febslet.2010.01.018 [58] Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
Science 2011; 333:228-33; PMID:21617041; http://dx.doi.org/10.1126/science.1205405 [59] Cecconi F. c-Cbl targets active Src for autophagy.,Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Nat Cell Biol 2012; 14:48-9; ; http://dx.doi.org/10.1038/ncb2413 [60] Zhu Y, Zhang M, Kelly AR, Cheng A.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Autophagy 2009; 5:732-3; PMID:19398892; http://dx.doi.org/10.4161/auto.5.5.8566 [62] Salminen A, Kaarniranta K, Haapasalo A, Hiltunen M, Soininen H, Alafuzoff I.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Prog Neurobiol 2011; 96:87-95; PMID:22138392; http://dx.doi.org/10.1016/j.pneurobio.2011.11.005 [63] He X, Li Y, Li C, Liu LJ, Zhang XD, Liu Y, Shu HB.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"J Mol Cell Biol 2013; 5:39-47; PMID:22611252; http://dx.doi.org/10.1093/jmcb/mjs024 [64] Li Y, He X, Wang S, Shu HB, Liu Y. USP2a positively regulates TCR- induced NF-kappaB activation by bridging MALT1-TRAF6.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Protein Cell 2013; 4:62-70; PMID:23264041; http://dx.doi.org/10.1007/ s13238-012-2120-8 [65] Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. LC3, a mammalian homo- logue of yeast Apg8p, is localized in autophagosome membranes after processing.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"EMBO J 2000; 19:5720-8; PMID:11060023; http://dx.doi.org/10.1093/emboj/19.21.5720 [66] Zhang YB, Gong JL, Xing TY, Zheng SP, Ding W. Autophagy protein p62/SQSTM1 is involved in HAMLET-induced cell death by modu-lating apotosis in U87MG cells.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Cell Death Dis 2013; 4:e550;PMID:23519119; http://dx.doi.org/10.1038/cddis.2013.77 [67] Murrow L, Malhotra R, Debnath J. ATG12-ATG3 interacts with Alix to promote basal autophagic ﬂux and late endosome function.",Non-OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
"Nat Cell Biol 2015; 17:300-10; PMID:25686249; http://dx.doi.org/10.1038/ncb3112 [68] Chen L, Feng L, Wang X, Du J, Chen Y, Yang W, Zhou C, Cheng L, Shen Y, Fang S, et al.",OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
Sci Rep 2015; 5:8133; PMID:25640174; http://dx.doi.org/10.1038/srep08133702 L. FENG ET AL.,OADS,/arxiv_data1/oa_pdf/8e/97/kaup-13-04-1280207.PMC5388218.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2017:8 85–95Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 85 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S100026Treatment strategies for the female athlete triad  in the adolescent athlete: current perspectives Jill Thein-Nissenbaum1 erin Hammer2 1Department of Family Medicine,   University of wisconsin-Madison,   Madison, wi, USA; 2Department of  Orthopedics and Rehabilitation,   University of wisconsin-Madison,   Madison, wi, USAAbstract: Since the passage of Title IX in 1972, female sports participation has dramatically  increased.",Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
"Keywords: energy availability, menstrual dysfunction, bone mineral density, treatment Introduction and history Title IX of the educational amendments requires that any federally funded programs  or institutions (such as high schools and universities) provide equal opportunity Correspondence: Jill Thein-Nissenbaum Physical Therapy Program, Department of Family Medicine, University of wisconsin-Madison, 1300 University Avenue, Room 5195 MSC, Madison, wi 53706, USATel +1 608 263 6354Fax +1 608 262 7809email thein@pt.wisc.eduJournal name: Open Access Journal of Sports Medicine Article Designation: RevIewY ear: 2017volume: 8 Running head verso: Thein-Nissenbaum and HammerRunning head recto: Treatment strategies for female athlete triad in adolescent athleteDOI: http://dx.doi.org/10.2147/OAJSM.S100026",Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
Available from: https://www.justice.gov/crt/ overview- title-ix-education-amendments-1972-20-usc-1681-et-seq.,Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
Available from: http://www.nfhs.org/ParticipationStatistics/PDF/2014-15_Participation_Sur - vey_Results.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
Available from: http://www.dsm5.org/about/Pages/Default.aspx.,OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
"Open Access Journal of Sports Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
visit http://www.dovepress.com/testimonials.php  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
Available from: http://www.iscd.org/official-positions/2013-iscd-official-positions-pediatric/.,Non-OADS,/arxiv_data1/oa_pdf/05/f8/oajsm-8-085.PMC5388220.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/81/4d/dddt-11-1095.PMC5388221.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1095–1105Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1095Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12061 8 Phenotypic evaluation and in silico aDMeT  properties of novel arylimidamides in acute  mouse models of Trypanosoma cruzi  infection cristiane França da silva1 Denise da gama Jaén  Batista1 Julianna siciliano de araújo1 edézio Ferreira cunha- Junior2 chad e stephens3 Moloy Banerjee4 abdelbasset a Farahat4,5 senol akay4 Mary K Fisher3 David W Boykin4 Maria de nazaré correia  soeiro1 1laboratory of cellular Biology,   2laboratory of Biochemistry  of Trypanosomatids, Fundação  Oswaldo cruz, rio de Janeiro,   Brazil;  3Department of chemistry  and Physics, augusta University,   augusta, 4Department of chemistry,   georgia state University, atlanta, ga,   Usa; 5Department of Pharmaceutical  Organic chemistry, Faculty of  Pharmacy, Mansoura University,   Mansoura, egyptAbstract:  Arylimidamides (AIAs), previously termed as reversed amidines, present a broad  spectrum of activity against intracellular microorganisms.",Non-OADS,/arxiv_data1/oa_pdf/81/4d/dddt-11-1095.PMC5388221.pdf
"The silent chronic morbidities and high mortalities, the prolonged  and expensive treatment courses without being effective for the late-stage disease and  the current barriers to the access to essential medicines demand urgent attention for  this neglected disease.4,5 Only two drugs are available for the treatment of CD: nifurtimox (Nf), a nitrofuran  with a fast plasmatic clearance profile (half-life of 3 h),2 and benznidazole (Bz), a nitroim - idazole, both of which show variable activity across different T. cruzi  strains.6correspondence: Maria de nazaré  correia soeiro laboratory of cellular Biology, Fundação  Oswaldo cruz, Maria de nazaré correia  soeiro, avenue Brasil 4365, Manguinhos,  rio de Janeiro, rio de Janeiro ceP, Brazil Tel +55 21 2562 1368 Fax +55 21 2562 1432 email soeiro@ioc.fiocruz.b rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: da Silva et al Running head recto: AIAs effect on T. cruzi DOI: http://dx.doi.org/10.2147/DDDT.S120618",Non-OADS,/arxiv_data1/oa_pdf/81/4d/dddt-11-1095.PMC5388221.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs340/en /.,Non-OADS,/arxiv_data1/oa_pdf/81/4d/dddt-11-1095.PMC5388221.pdf
"Available  from: http://www.dndi.org/diseases-projects/portfolio/benznidazole- paedriatric-dosage-form.htm l. Accessed November 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/81/4d/dddt-11-1095.PMC5388221.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/81/4d/dddt-11-1095.PMC5388221.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/4d/dddt-11-1095.PMC5388221.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b3/c7/ijn-12-2717.PMC5388222.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2717–2731International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2717OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12722 6 Daphnia magna  and Xenopus laevis  as in vivo  models to probe toxicity and uptake of quantum  dots functionalized with gh625 emilia galdiero1 annarita Falanga2 antonietta siciliano1 Valeria Maselli1 Marco guida1 rosa carotenuto1 Margherita T ussellino1 lucia lombardi3 giovanna Benvenuto4 stefania galdiero2 1Department of Biology, 2Department  of Pharmacy and cirP eB,   University of Naples Federico II,    3Department of experimental  Medicine, second University of  Naples, 4stazione Zoologica anton  Dohrn, Villa comunale, Napoli, ItalyAbstract:  The use of quantum dots (QDs) for nanomedicine is hampered by their potential  toxicologic effects and difficulties with delivery into the cell interior.",Non-OADS,/arxiv_data1/oa_pdf/b3/c7/ijn-12-2717.PMC5388222.pdf
"Some other  possible consequences of exposure to MNPs are production of reactive oxygen species  (ROS), genotoxicity and apoptosis, as well as mitochondrial damage and metallic ion  production.6 Size, shape and coating together with dose, route of administration and  exposure are key factors that determine the degree of toxicity.correspondence: stefania galdiero Department of Pharmacy and cirPeB,  University of Naples Federico II, Via  Mezzocannone 16, 80134 Napoli, Italy Tel +39 08 1253 4503 Fax +39 08 1253 4560 email stefania.galdiero@unina.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Galdiero et al Running head recto: Quantum dots in vivo delivery DOI: http://dx.doi.org/10.2147/IJN.S127226",Non-OADS,/arxiv_data1/oa_pdf/b3/c7/ijn-12-2717.PMC5388222.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b3/c7/ijn-12-2717.PMC5388222.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/ijn-12-2717.PMC5388222.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/a7/ijn-12-2829.PMC5388223.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2829–2843International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2829OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12827 0 ph-sensitive au–Bsa–DOX–F a nanocomposites  for combined cT imaging and targeted  drug delivery he huang1  Da-Peng Yang2 Minghuan liu2 Xiangsheng Wang1 Zhiyong Zhang1 guangdong Zhou1 Wei liu1 Yilin cao1 Wen Jie Zhang1 Xiansong Wang1 1Department of Plastic and  reconstructive surgery, shanghai  Ninth People’s hospital, shanghai  Jiao Tong University school of  Medicine, shanghai Key laboratory of  Tissue engineering, National Tissue  engineering center of china, shanghai,   2college of chemical engineering and  Materials science, Quanzhou Normal  University, Quanzhou, People’s  republic of chinaAbstract:  Albumin-based nanoparticles (NPs) as a drug delivery system have attracted much  attention owing to their nontoxicity, non-immunogenicity, great stability and ability to bind  to many therapeutic drugs.",Non-OADS,/arxiv_data1/oa_pdf/65/a7/ijn-12-2829.PMC5388223.pdf
"correspondence: Wen Jie Zhang;  Xiansong Wang Department of Plastic and reconstructive  surgery, shanghai Ninth People’s  hospital, shanghai Jiao Tong University  school of Medicine, shanghai Key  laboratory of Tissue engineering,  National Tissue engineering center of  china, 639 Zhi Zao Ju road, shanghai  200011, People’s republic of china Tel +86 21 2327 1699 Fax +86 21 5307 8128 email wenjieboshi@aliyun.co m;  vincentuis@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Huang et al Running head recto: Au–BSA–DOX–FA nanocomposite for cancer theranostic applications DOI: http://dx.doi.org/10.2147/IJN.S128270",Non-OADS,/arxiv_data1/oa_pdf/65/a7/ijn-12-2829.PMC5388223.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/65/a7/ijn-12-2829.PMC5388223.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/a7/ijn-12-2829.PMC5388223.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/39/ijn-12-2793.PMC5388224.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2793–2811International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2793OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12096 9 Methotrexate-coupled nanoparticles and magnetic   nanochemothermia for the relapse-free treatment  of T24 bladder tumors Marcus stapf Ulf T eichgräber Ingrid hilger Department of experimental  radiology, Institute of Diagnostic  and Interventional radiology, Jena  University hospital, Friedrich-schiller  University Jena, Jena, germanyAbstract:  Heat-based approaches have been considered as promising tools due to their  ability to directly eradicate tumor cells and/or increase the sensitivity of tumors to radia - tion- or chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/0c/39/ijn-12-2793.PMC5388224.pdf
"For this reason, thermal approaches are considered as promising tools for the treatment  of cancer due to the ability of eradicating tumor cells and/or increasing the sensitivity  of cancer cells to radiation- or chemotherapy.3–7 The temperature for thermal treatments  can be achieved by various strategies including water bath, infrared light, microwave correspondence: Ingrid hilger Department of experimental radiology,  Institute of Diagnostic and Interventional  radiology, Jena University hospital,  Forschungszentrum lobeda, am  Klinikum 1, D-07747 Jena, germany Tel +49 3641 9325921 email ingrid.hilger@med.uni-jena.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Stapf et al Running head recto: Methotrexate-coupled nanoparticles and magnetic nanochemothermia DOI: http://dx.doi.org/10.2147/IJN.S120969",Non-OADS,/arxiv_data1/oa_pdf/0c/39/ijn-12-2793.PMC5388224.pdf
"Available from:  http://www.cancer.org/Cancer/BladderCancer/DetailedGuide/inde x.  Accessed February 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0c/39/ijn-12-2793.PMC5388224.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0c/39/ijn-12-2793.PMC5388224.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/39/ijn-12-2793.PMC5388224.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/ca/ijn-12-2621.PMC5388225.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2621–2634International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2621OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12892 1 Delivery of curcumin by directed self-assembled  micelles enhances therapeutic treatment of  non-small-cell lung cancer Wen-Ting Zhu1,2,* sheng-Yao liu3,* lei Wu1,2 hua-li Xu4 Jun Wang1,2 guo-Xin Ni3,5 Qing-Bing Zeng1,2 1Biomaterial research center, school  of Pharmaceutical sciences, southern  Medical University, guangzhou, china;   2guangdong Provincial Key laboratory  of New Drug screening, school of  Pharmaceutical sciences, southern  Medical University, guangzhou, china;   3Department of Orthopeadics and  Traumatology, Nanfang hospital,   southern Medical University,   guangzhou, china; 4Department of  anesthesiology, Zhujiang hospital,   southern Medical University,   guangzhou, china; 5Department  of rehabilitation Medicine, First  affiliated hospital, Fujian Medical  University, Fuzhou, china *These authors contributed equally  to this workBackground:  It has been widely reported that curcumin (CUR) exhibits anticancer activity  and triggers the apoptosis of human A549 non-small-cell lung cancer (NSCLC) cells.",Non-OADS,/arxiv_data1/oa_pdf/17/ca/ijn-12-2621.PMC5388225.pdf
"Curcumin (CUR), a natural polyphenolic compound isolated from the rhizome  of Curcuma longa , has the potential to inhibit cell survival, proliferation, invasion,  migration and angiogenesis.4–6 A variety of signaling pathways, including Cyclin D1, correspondence: Qing-Bing Zeng Biomaterial research center, school  of Pharmaceutical sciences, southern  Medical University, 1023 southern shatai  street, guangzhou, gD 510515, china Tel/fax +86 20 6278 9462 email zengqb@smu.edu.c n  guo-Xin Ni Department of Orthopaedics and  Traumatology, Nanfang hospital,  southern Medical University, 1838  guangzhou avenue (N), guangzhou,  gD 510515, china Tel/fax +86 20 6164 1744 email guoxinni15tg@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhu et al Running head recto: Delivery of CUR by directed self-assembled micelles DOI: http://dx.doi.org/10.2147/IJN.S128921",Non-OADS,/arxiv_data1/oa_pdf/17/ca/ijn-12-2621.PMC5388225.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/17/ca/ijn-12-2621.PMC5388225.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/ca/ijn-12-2621.PMC5388225.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/6b/copd-12-1085.PMC5388229.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1085–1091International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1085OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13177 8 Magnitude of exercise capacity and quality of  life improvement following repeat pulmonary  rehabilitation in patients with COPD Jacqueline s sandoz1,2 Mary M roberts1,3,4 Jin-gun Cho1,3–5 John r Wheatley1,3–5 1respiratory ambulatory Care  service, Western sydney local  health District, nsW, australia;   2Canadian alternatives in non-invasive  Ventilation (C anVent) Program,   Ottawa hospital rehabilitation  Centre, Division of respiratory  Medicine, Ottawa hospital, Ontario,   Canada; 3Department of respiratory  and sleep Medicine, Westmead  hospital, 4ludwig engel Centre for  respiratory research, Westmead  Institute for Medical research,   5sydney Medical school, University of  sydney, Westmead, nsW, australiaBackground:  Maintenance and repeated pulmonary rehabilitation programs (PRPs) for patients  with COPD have attempted to prolong PRP benefits beyond 12–24 months.",Non-OADS,/arxiv_data1/oa_pdf/7f/6b/copd-12-1085.PMC5388229.pdf
"Overall, there are clear benefits to patients with COPD  repeating pulmonary rehabilitation as clinically required, which is not affected by the time  interval between programs.Correspondence: Jin-gun Cho Department of respiratory and  sleep Medicine, Westmead hospital,  PO Box 533, Wentworthville,  nsW 2145, australia email jin.cho@sydney.edu.a u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sandoz et al Running head recto: Effects of repeating pulmonary rehabilitation in COPD DOI: http://dx.doi.org/10.2147/COPD.S131778",Non-OADS,/arxiv_data1/oa_pdf/7f/6b/copd-12-1085.PMC5388229.pdf
Available from: http://lungfoundation.com.,Non-OADS,/arxiv_data1/oa_pdf/7f/6b/copd-12-1085.PMC5388229.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7f/6b/copd-12-1085.PMC5388229.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/6b/copd-12-1085.PMC5388229.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0e/6b/dddt-11-1081.PMC5388234.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1081–1093Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1081Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13193 6 Formulation, release characteristics, and  bioavailability study of gastroretentive  floating matrix tablet and floating raft  system of Mebeverine hcl Mohamed a el nabarawi1 Mahmoud h T eaima1 rehab a abd el-Monem2 nagla a el nabarawy3 Dalia a gaber4 1Department of Pharmaceutics  and industrial Pharmacy, Faculty of  Pharmacy, cairo University, cairo,   egypt; 2Department of Pharmaceutics  and industrial Pharmacy, Faculty of  Pharmacy, Misr University for science  and T echnology, 6th of October,   egypt; 3national egyptian center  of environment and Toxicological  research ( nec Ter), Faculty of  Medicine, cairo University, cairo,   egypt; 4Department of Quality  control, holding company for  Biological Products and Vaccines,   cairo, egyptAbstract:  To prolong the residence time of dosage forms within the gastrointestinal tract until  all drug is released at the desired rate is one of the real challenges for oral controlled-release  drug delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/0e/6b/dddt-11-1081.PMC5388234.pdf
"Gastroretentive drug delivery system (GRDDS) is one  such example where attributes like gastric retention time coupled with the drug release  for extended time have significantly improved patient compliance.3,4correspondence: Dalia a gaber Department of Quality control, holding  company for Biological Products and  Vaccines, cairo 11562, egypt Tel +20 100 142 4439 email dr_daliaahmed@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: El Nabarawi et al Running head recto: Bioavailability study of floating systems DOI: http://dx.doi.org/10.2147/DDDT.S131936",Non-OADS,/arxiv_data1/oa_pdf/0e/6b/dddt-11-1081.PMC5388234.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0e/6b/dddt-11-1081.PMC5388234.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/6b/dddt-11-1081.PMC5388234.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bb/17/ijn-12-2759.PMC5388236.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2759–2767International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2759OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13178 6 Doxorubicin-loaded cell-derived nanovesicles:  an alternative targeted approach for anti-tumor  therapy Wei Jiang goh1,2 choon Keong lee2 shui Zou2 esther cY Woon2 Bertrand czarny2,3 giorgia Pastorin1,2,4 1NUs graduate school for Integrative  sciences and engineering, centre for  life sciences (cels), 2Department  of Pharmacy, National University  of singapore, 3school of Materials  science and engineering (M se) &  lee Kong chian school of Medicine,   Nanyang T echnological University,   4NUsNNI-Nano core, National  University of singapore, T -lab,   singapore, singaporeAbstract:  Cell-derived nanovesicles (CDNs) are an emerging class of biological drug delivery  systems (DDS) that retain the characteristics of the cells they were derived from, without the  need for further surface functionalization.",Non-OADS,/arxiv_data1/oa_pdf/bb/17/ijn-12-2759.PMC5388236.pdf
"CDNs were inspired from  endogenously produced exosomes, which were found to be suited for drug delivery  purposes, being nanovesicles naturally involved in intercellular communication.7  In addition, exosomes already shuttle endogenous biological cargo, such as mRNAs, correspondence: giorgia Pastorin Department of Pharmacy, National  University of singapore, science Drive 2,   s15#05-PI-03, singapore 117543,  singapore Tel +65 6516 1876 email phapg@nus.edu.s g Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Goh et al Running head recto: Doxorubicin-loaded cell-derived nanovesicles DOI: http://dx.doi.org/10.2147/IJN.S131786",Non-OADS,/arxiv_data1/oa_pdf/bb/17/ijn-12-2759.PMC5388236.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bb/17/ijn-12-2759.PMC5388236.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/17/ijn-12-2759.PMC5388236.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/5a/ott-10-2003.PMC5388238.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2003–2007OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2003Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12749 8 altered status of programmed death-ligand 1 after  recurrence in resected lung adenocarcinoma  patients Jun chen hui li ronglin Pang Jia huang Department of chemoradiotherapy,   Yinzhou hospital affiliated to ningbo  University school of Medicine,   ningbo, People’s republic of chinaPurpose:  Programmed death-ligand 1 (PD-L1) is found to be overexpressed in non-small cell  lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/e5/5a/ott-10-2003.PMC5388238.pdf
"The present study was intended to detect the PD-L1 expression status in resection  and recurrent samples and validate its clinical value in lung adenocarcinoma.correspondence: Jun chen Department of chemoradiotherapy,  Yinzhou Hospital Affiliated to Ningbo  University school of Medicine, east  Baizhang road, ningbo 315100,  People’s republic of china Tel +86 574 8701 6888 Fax +86 574 8701 6888 email chenjunningbo@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Chen et al Running head recto: PD-L1 expression in lung adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S127498",Non-OADS,/arxiv_data1/oa_pdf/e5/5a/ott-10-2003.PMC5388238.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/5a/ott-10-2003.PMC5388238.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/5a/ott-10-2003.PMC5388238.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e3/10/ijn-12-2635.PMC5388239.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2635–2644International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2635OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12274 6 redox-sensitive Pluronic F127-tocopherol  micelles: synthesis, characterization, and  cytotoxicity evaluation Yuling liu1,2,* sai Fu1,* longfei lin1 Yuhong cao3 Xi Xie3 hua Yu2 Meiwan chen2 hui li1 1Institute of chinese Materia  Medica, china academy of chinese  Medical sciences, Beijing, 2state Key  laboratory of Quality research  in chinese Medicine, Institute of  chinese Medical sciences, University  of Macau, Macau, People’s republic  of china; 3Department of Materials  science and engineering, stanford  University, stanford, ca, Usa *These authors contributed equally  to the workAbstract:  Pluronic F127 (F127), an amphiphilic triblock copolymer, has been shown to have  significant potential for drug delivery, as it is able to incorporate hydrophobic drugs and self- assemble into nanosize micelles.",Non-OADS,/arxiv_data1/oa_pdf/e3/10/ijn-12-2635.PMC5388239.pdf
"Furthermore, nanomi - celles also facilitate high tumor accumulation on the basis of enhanced permeability  and retention effect.1,2 To prove this concept, several polymeric micelles have been  developed as drug carriers for cancer chemotherapy.3–5 Pluronic F127 (F127, BASF SE,  Ludwigshafen, Germany) is one kind of poly(ethylene oxide) (PEO)-poly(propylene  oxide) (PPO)-poly(ethylene oxide) (PEO) triblock copolymers, which is accepted  as an excipient by the U.S. and British Pharmacopoeia and is widely used in clinical  applications.6 The amphiphilic chemical structure, including a hydrophobic PPO  segment and a hydrophilic PEO segment, allows it to incorporate hydrophobic drugs  and self-assemble into micelles with a hydrophilic shell and a hydrophobic core in  aqueous medium.7,8 Carlson et al9 developed the curcumin and resveratrol co-loaded correspondence: hui li Institute of chinese Materia Medica,  china academy of chinese Medical  sciences, 16 Nanxiao street,  Dongzhimen, Dongcheng District, Beijing  100700, People’s republic of china email lihuiyiren@163.co m  Meiwan chen state Key laboratory of Quality  research in chinese Medicine, Institute  of chinese Medical sciences, University  of Macau, avenue Padre Tomas Pereira sJ,  Taipa, Macau 999078, People’s  republic of china email mwchen@umac.m o Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Liu et al Running head recto: Redox-sensitive Pluronic F127-tocopherol micelles DOI: http://dx.doi.org/10.2147/IJN.S122746",Non-OADS,/arxiv_data1/oa_pdf/e3/10/ijn-12-2635.PMC5388239.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e3/10/ijn-12-2635.PMC5388239.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/10/ijn-12-2635.PMC5388239.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7c/78/vhrm-13-127.PMC5388240.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7c/78/vhrm-13-127.PMC5388240.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management 2017:13 127–137Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  127 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S119490High adherence to therapy and low cardiac  mortality and morbidity in patients after acute  coronary syndrome systematically managed by  office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study Franz Goss1 Johannes Brachmann2 Christian W Hamm3 Winfried Haerer4 Nicolaus Reifart5 Benny Levenson6 1Herzzentrum Alter Hof, München,   Germany; 2Klinikum Coburg GmbH,   II.",Non-OADS,/arxiv_data1/oa_pdf/7c/78/vhrm-13-127.PMC5388240.pdf
"Between 2005 and 2009, Correspondence: Franz Goss Herzzentrum Alter Hof, Lehrpraxis der Ludwig-Maximilian-Universität, Dienerstraße 12, D-80331 München, GermanyEmail franz.goss@web.deJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 13Running head verso: Goss et alRunning head recto: High adherence to therapy and low cardiac mortality and morbidityDOI: http://dx.doi.org/10.2147/VHRM.S119490",Non-OADS,/arxiv_data1/oa_pdf/7c/78/vhrm-13-127.PMC5388240.pdf
"Vascular Health and Risk Management 2017:13submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/7c/78/vhrm-13-127.PMC5388240.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 137 High adherence to therapy and low cardiac mortality and morbidity  16.,Non-OADS,/arxiv_data1/oa_pdf/7c/78/vhrm-13-127.PMC5388240.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/21/copd-12-1061.PMC5388245.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1061–1070International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1061OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13106 1 Pulmonary rehabilitation for COPD improves  exercise time rather than exercise tolerance:  effects and mechanisms Keisuke Miki1 ryoji Maekura1 seigo Kitada1 Mari Miki1 Kenji Y oshimura1 hiroshi Yamamoto2 T oshiko Kawabe2 hiroyuki Kagawa1 Y ohei Oshitani1 akitoshi satomi1 Kohei nishida1 nobuhiko sawa1 Kimiko Inoue2 1Department of respiratory Medicine,   2Department of rehabilitation  Medicine, national hospital  Organization, Toneyama national  hospital, T oyonaka, JapanBackground:  COPD patients undergoing pulmonary rehabilitation (PR) show various  responses.",Non-OADS,/arxiv_data1/oa_pdf/3c/21/copd-12-1061.PMC5388245.pdf
"Keywords:  cardiopulmonary exercise testing, oxygen requirement, ventilatory equivalents,  body weight, carbon dioxide output Introduction Exercise intolerance with dyspnea is a major complaint of patients with advanced  COPD.1–4 It has been clearly demonstrated that pulmonary rehabilitation (PR), as an  essential non-pharmacologic treatment option for COPD, increases exercise tolerance  and reduces dyspnea.1–4 However, the responses to PR vary significantly and may be  unique.1–5 It has been reported that some COPD patients receive little or no benefit at  all from PR, although the definition of non-responders to PR needs to be considered.1–5  In addition, it has been reported that, regardless of whether exercise tolerance was Correspondence: Keisuke Miki Department of respiratory Medicine,  national hospital Organization,  Toneyama national hospital, 5-1-1,  Toyonaka, Osaka 560-8552, Japan Tel +81 6 6853 2001 Fax +81 6 6853 3127 email mikisuke@toneyama.go.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Miki et al Running head recto: Mechanisms and predictors of benefits from pulmonary rehabilitation in COPD DOI: http://dx.doi.org/10.2147/COPD.S131061",Non-OADS,/arxiv_data1/oa_pdf/3c/21/copd-12-1061.PMC5388245.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3c/21/copd-12-1061.PMC5388245.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/21/copd-12-1061.PMC5388245.pdf
Available form: http://goldcopd.org/gold-2017-global-strategy- diagnosis-management-prevention-copd /.,Non-OADS,/arxiv_data1/oa_pdf/3c/21/copd-12-1061.PMC5388245.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/11/ijn-12-2781.PMC5388247.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2781–2792International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2781OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13013 6 Quantum dots modulate intracellular ca2+ level  in lung epithelial cells huijuan Yin1 Jacopo M Fontana1 Johan solandt1,2 Johnny Israelsson Jussi1 hao Xu1 hjalmar Brismar1 Ying Fu1 1section of cellular Biophysics,   Department of applied Physics,   royal Institute of T echnology (KTh),   science for life laboratory, solna,   2astraZeneca  r&D, Mölndal, swedenAbstract:  While adverse effects of nanoparticles on lung health have previously been  proposed, few studies have addressed the direct effects of nanoparticle exposure on the airway  epithelium.",Non-OADS,/arxiv_data1/oa_pdf/69/11/ijn-12-2781.PMC5388247.pdf
"The Calu-3 human lung adenocarcinoma cell  line is commonly used to study the airway epithelial barrier because 1) it expresses  the cystic fibrosis transmembrane conductance regulator (CFTR) and several acinar  cell markers, 2) it forms polarized monolayers with tight junctions, 3) it has robust  cAMP-stimulated anion transport, 4) it responds to secretagogues that regulate the  glands in vivo,  and 5) it secretes mucus.8 Calu-3 cells were recently shown to display  a transient transepithelial electrical resistance (TEER) decrease in direct response to correspondence: Ying Fu section of cellular Biophysics,  Department of applied Physics, royal  Institute of Technology (KTh), science  for life laboratory, se-171 21 solna,  sweden Tel +46 73765 0507 email fu@kth.s e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Yin et al Running head recto: Quantum dots modulate intracellular Ca2+ level DOI: http://dx.doi.org/10.2147/IJN.S130136",Non-OADS,/arxiv_data1/oa_pdf/69/11/ijn-12-2781.PMC5388247.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/69/11/ijn-12-2781.PMC5388247.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/11/ijn-12-2781.PMC5388247.pdf
Geneva: World health Organization; 2013  Available from: http://www.who.int/whr/en/.,Non-OADS,/arxiv_data1/oa_pdf/69/11/ijn-12-2781.PMC5388247.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/94/29/ott-10-1977.PMC5388249.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1977–1982OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1977Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12432 1 serum galectin-1 in patients with multiple  myeloma: associations with survival, angiogenesis,  and biomarkers of macrophage activation Morten nørgaard  andersen1–3,* Maja ludvigsen1,3,* niels abildgaard4 irma Petruskevicius3 rikke hjortebjerg5 Mette Bjerre5 Bent honoré1 holger J Møller2 niels F andersen3 1Department of Biomedicine,   Faculty of health, aarhus University,   2Department of clinical Biochemistry,   3Department of hematology,   aarhus University hospital, aarhus,   4Department of hematology, Odense  University hospital, Odense, 5Medical  research laboratory, Department of  clinical Medicine, Faculty of health,   aarhus University, aarhus, Denmark *These authors contributed equally  to this workAbstract:  Galectin-1 (Gal-1) is known to regulate cell signaling within the immune system  and may be a target for new anticancer immune therapy.",Non-OADS,/arxiv_data1/oa_pdf/94/29/ott-10-1977.PMC5388249.pdf
"Keywords:  galectin-1, multiple myeloma, macrophage, soluble CD163, soluble mannose  receptor, angiogenesis Introduction Galectins comprise a 15-member family of lectins (carbohydrate-binding proteins), of  which some are widely distributed in various tissues and others are more confined.1,2  Galectins exert diverse functions by binding to carbohydrate moieties on, for example,  extracellular proteins, but they also function intracellularly where they are involved  in cell signaling processes.1 Furthermore, galectins have been linked with the regu - lation of hematopoiesis and modulation of the immune system in both acute and  chronic inflammation.1,3 Galectin-1 (Gal-1) is involved in regulating homeostasis and differentiation of  both T and B cells, can skew an immune reaction in a TH2-like (anti-inflammatory)  direction, and may sway monocyte/macrophage polarization toward an alternatively  activated (M2-like) phenotype.4,5 Importantly, studies have indicated that inhibition correspondence: Morten nørgaard  andersen Department of Biomedicine, aarhus  University, Wilhelm Meyers allé 4,  aarhus c 8000, Denmark email morten@immunology.au.d k Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Andersen et al Running head recto: Serum Gal-1 in multiple myeloma DOI: http://dx.doi.org/10.2147/OTT.S124321",Non-OADS,/arxiv_data1/oa_pdf/94/29/ott-10-1977.PMC5388249.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/94/29/ott-10-1977.PMC5388249.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/29/ott-10-1977.PMC5388249.pdf
"Published with license by Taylor & FrancisThis is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"4, 739 –753 http://dx.doi.org/10.1080/15548627.2017.1280220",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
Curr Top Microbiol Immunol 2009; 33533-70; PMID:19802559; http://dx.doi.org/10.1007/978-3-642-00302-8_2 [2] Klionsky DJ.,OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Cell Cycle 2010; 9(7):1295-307; PMID:20305376; http://dx.doi.org/10.4161/cc.9.7.11109 [4] Marino G, Lopez-Otin C. Autophagy: molecular mechanisms, physi- ological functions and relevance in human pathology.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Cell Mol LifeSci 2004; 61(12):1439-54; PMID:15197469; http://dx.doi.org/ 10.1007/s00018-004-4012-4 [5] Levine B, Mizushima N, Virgin HW.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Nature 2011; 469(7330):323-35; PMID:21248839; http://dx.doi.org/10.1038/nature09782 [6] Mizushima N, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
Nat Cell Biol 2007; 9(10):1102-9; PMID:17909521; http://dx.doi.org/10.1038/ncb1007-1102 [8] Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems.,OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Nat Rev Mol Cell Biol 2001; 2(3):211-6; PMID:11265251; http://dx.doi.org/10.1038/35056522 [9] Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Mol Biol Cell 2009; 20(7):1981-91;PMID:19211835; http://dx.doi.org/10.1091/mbc.E08-12-1248 [10] He C, Levine B.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
Curr Opin Cell Biol 2010; 22(2):140-9; PMID:20097051; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
Nature 1998; 395(6700):395-8; PMID:9759731; http://dx.doi.org/10.1038/26506 [12] Tanida I. Autophagy basics.,Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Microbiol Immunol 2011; 55(1):1-11; PMID:21175768; http://dx.doi.org/10.1111/j.1348-0421.2010.00271.x [13] Trocoli A, Djavaheri-Mergny M. The complex interplay between autophagy and NF-kappaB signaling pathways in cancer cells.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Nat Cell Biol 2009; 11(4):385-96; PMID:19270696; http://dx.doi.org/10.1038/ncb1846 [15] Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, Chait BT, Heintz N, Yue Z.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Nat Cell Biol 2009; 11(4):468-76; PMID:19270693; http://dx.doi.org/10.1038/ncb1854 [16] Itakura E, Kishi C, Inoue K, Mizushima N. Beclin 1 forms two dis- tinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Mol Biol Cell 2008; 19(12):5360-72;PMID:18843052; http://dx.doi.org/10.1091/mbc.E08-01-0080 [17] Yuk JM, Yoshimori T, Jo EK.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Acta Pharmacol Sin 2005; 26(12):1421-34; PMID:16297339; http://dx.doi.org/10.1111/j.1745-7254.2005.00235.x [19] Tiwari M, Sharma LK, Vanegas D, Callaway DA, Bai Y, Lechleiter JD, Herman B.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Autophagy 2014; 10(6):1054-70; PMID:24879153; http://dx.doi.org/10.4161/auto.28528 [20] Li L, Wang L, Xiao R, Zhu G, Li Y, Liu C, Yang R, Tang Z, Li J, Huang W, et al.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Biosci Rep 2012; 32(2):171-86; PMID:21729006; http://dx.doi.org/10.1042/BSR20110069 [21] Talloczy Z, Virgin HWt, Levine B. PKR-dependent autophagic deg- radation of herpes simplex virus type 1.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Autophagy 2006; 2(1):24-9; PMID:16874088; http://dx.doi.org/10.4161/auto.2176 [22] Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, Zhang W, Burns D, Leib DA, Levine B. HSV-1 ICP34.5 confers neuroviru- lence by targeting the Beclin 1 autophagy protein.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Cell host &microbe 2007; 1(1):23-35; http://dx.doi.org/10.1016/j.chom.2006.12.001 [23] Shelly S, Lukinova N, Bambina S, Berman A, Cherry S. Autophagy is an essential component of Drosophila immunity against vesicularstomatitis virus.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Immunity 2009; 30(4):588-98; PMID:19362021;http://dx.doi.org/10.1016/j.immuni.2009.02.009 [24] Hu B, Zhang Y, Jia L, Wu H, Fan C, Sun Y, Ye C, Liao M, Zhou J.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Auto-phagy 2015; 11(3):503-15; PMID:25714412; http://dx.doi.org/ 10.1080/15548627.2015.1017184 [25] Su WC, Chao TC, Huang YL, Weng SC, Jeng KS, Lai MM.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Virol 2011; 85(20):10561-71; PMID:21835792; http://dx.doi.org/10.1128/JVI.00173-11 [26] Van Grol J, Subauste C, Andrade RM, Fujinaga K, Nelson J, Subauste CS.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"PloS One 2010; 5(7):e11733; http://dx.doi.org/10.1371/journal.pone.0011733 [27] Surviladze Z, Sterk RT, DeHaro SA, Ozbun MA.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Virol 2013; 87(5):2508-17; PMID:23255786; http://dx.doi.org/10.1128/JVI.02319-12 [28] Lahaye X, Vidy A, Pomier C, Obiang L, Harper F, Gaudin Y, Blondel D. Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription andreplication.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Biol Chem 2007; 282(33):24131-45; PMID:17580304; http://dx.doi.org/10.1074/jbc.M702824200 [30] von Hoven G, Kloft N, Neukirch C, Ebinger S, Bobkiewicz W, Weis S, Boller K, Janda KD, Husmann M. Modulation of translation and induction of autophagy by bacterial exoproducts.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Med MicrobiolImmun 2012; 201(4):409-18; http://dx.doi.org/10.1007/s00430-012-0271-0 [31] Lamark T, Kirkin V, Dikic I, Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Cell Cycle2009; 8(13):1986-90; PMID:19502794; http://dx.doi.org/10.4161/cc.8.13.8892 [32] Matsushita M, Suzuki NN, Obara K, Fujioka Y, Ohsumi Y, Inagaki F. Structure of Atg5.Atg16, a complex essential for autophagy.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J BiolChem 2007; 282(9):6763-72; PMID:17192262; http://dx.doi.org/10.1074/jbc.M609876200 [33] Jounai N, Takeshita F, Kobiyama K, Sawano A, Miyawaki A, Xin KQ, Ishii KJ, Kawai T, Akira S, Suzuki K, et al.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Proc Natl Acad Sci USA 2007; 104(35):14050-5; PMID:17709747; http://dx.doi.org/ 10.1073/pnas.0704014104 [34] Kim JH, Park JM, Kim EK, Lee JO, Lee SK, Jung JH, You GY, Park SH, Suh PG, Kim HS.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Cell Physiol 2010; 223(3):771-8; PMID:20205235; http://dx.doi.org/10.1002/jcp.22093 [35] Sajan MP, Bandyopadhyay G, Miura A, Standaert ML, Nimal S, Longnus SL, Van Obberghen E, Hainault I, Foufelle F, Kahn R, et al.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Biol Chem 2009; 284 (32):21412-24; PMID:19520853; http://dx.doi.org/10.1074/jbc.M109.026013 [37] Tang G, Yue Z, Talloczy Z, Hagemann T, Cho W, Messing A, Sulzer DL, Goldman JE.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Hum Mol Genet 2008; 17(11):1540-55; PMID:18276609; http://dx.doi.org/10.1093/hmg/ddn042 [38] Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Nat Rev Immunol 2007; 7(10):767-77;PMID:17767194; http://dx.doi.org/10.1038/nri2161 [39] Espert L, Codogno P, Biard-Piechaczyk M. Involvement of auto- phagy in viral infections: antiviral function and subversion byviruses.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Mol Med (Berl) 2007; 85(8):811-23; PMID:17340132;http://dx.doi.org/10.1007/s00109-007-0173-6 [40] Jung CH, Ro SH, Cao J, Otto NM, Kim DH.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"FEBS Lett 2010; 584(7):1287-95; PMID:20083114; http://dx.doi.org/10.1016/j.febslet.2010.01.017 [41] Liu C, Chapman NM, Karmaus PW, Zeng H, Chi H. mTOR and metabolic regulation of conventional and regulatory T cells.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Leuko-cyte Biol 2015; PMID:25714803; http://dx.doi.org/10.1189/jlb.2RI0814-408R [42] Huang H, Kang R, Wang J, Luo G, Yang W, Zhao Z.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Autophagy 2013; 9(2):175-95; PMID:23169238; http://dx.doi.org/10.4161/auto.22791 [43] Sun Y, Li C, Shu Y, Ju X, Zou Z, Wang H, Rao S, Guo F, Liu H, Nan W, et al.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Sci Signal 2012; 5(212):ra16; PMID:22355189; http://dx.doi.org/10.1126/scisignal.2001931 [44] Peng J, Zhu S, Hu L, Ye P, Wang Y, Tian Q, Mei M, Chen H, Guo X. Wild-type rabies virus induces autophagy in human and mouse neu- roblastoma cell lines.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Autophagy 2016; 1-17; PMID:26799652; http://dx.doi.org/10.1080/15548627.2016.1196315 [45] Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Dis- tinct classes of phosphatidylinositol 3 0-kinases are involved in signal- ing pathways that control macroautophagy in HT-29 cells.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J BiolChem 2000; 275(2):992-8; PMID:10625637; http://dx.doi.org/ 10.1074/jbc.275.2.992 [46] Eskelinen EL, Prescott AR, Cooper J, Brachmann SM, Wang L, Tang X, Backer JM, Lucocq JM.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Traf ﬁc 2002; 3(12):878-93; PMID:12453151; http://dx.doi.org/ 10.1034/j.1600-0854.2002.31204.x [47] Zeng X, Overmeyer JH, Maltese WA.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Cell Sci 2006;119(Pt 2):259-70; PMID:16390869; http://dx.doi.org/10.1242/ jcs.02735 [48] Row PE, Reaves BJ, Domin J, Luzio JP, Davidson HW.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Biochem J 2001; 353(Pt 3):655-61; PMID:11171063; http://dx.doi.org/10.1042/bj3530655 [49] Siddhanta U, McIlroy J, Shah A, Zhang Y, Backer JM.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Cell Biol 1998; 143(6):1647-59; PMID:9852157; http://dx.doi.org/10.1083/jcb.143.6.1647 [50] Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy.Mol Cell 2008; 30(6):678-88; PMID:18570871; http://dx.doi.org/10.1016/j.molcel.2008.06.001 [51] He C, Zhu H, Li H, Zou MH, Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and pro-tects against cardiomyocyte apoptosis in diabetes.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Diabetes 2013; 62(4):1270-81; PMID:23223177; http://dx.doi.org/10.2337/db12-0533 [52] Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteinsinhibit Beclin 1-dependent autophagy.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Cell 2005; 122(6):927-39; PMID:16179260; http://dx.doi.org/10.1016/j.cell.2005.07.002 [53] Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Autophagy 2008; 4(5):600-6;PMID:18497563; http://dx.doi.org/10.4161/auto.6260 [54] Di Bartolomeo S, Corazzari M, Nazio F, Oliverio S, Lisi G, Antonioli M, Pagliarini V, Matteoni S, Fuoco C, Giunta L, et al.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Cell Biol 2010; 191(1):155-68; PMID:20921139; http://dx.doi.org/10.1083/jcb.201002100 [55] Itakura E, Mizushima N. Characterization of autophagosome forma- tion site by a hierarchical analysis of mammalian Atg proteins.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Auto- phagy 2010; 6(6):764-76; PMID:20639694; http://dx.doi.org/10.4161/ auto.6.6.12709 [56] Koyama-Honda I, Itakura E, Fujiwara TK, Mizushima N. Temporal analysis of recruitment of mammalian ATG proteins to the autopha- gosome formation site.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Autophagy 2013; 9(10):1491-9; PMID:23884233; http://dx.doi.org/10.4161/auto.25529 [57] Zhang J, Ruan X, Zan J, Zheng X, Yan Y, Liao M, Zhou J. Ef ﬁcient generation of monoclonal antibodies against major structural pro- teins of rabies virus with suckling mouse brain antigen.",Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"Monoclon Antib Immunodiagn Immunother 2014; 33(2):94-100;PMID:24746150; http://dx.doi.org/10.1089/mab.2013.0087 [58] Zhang J, Wu X, Zan J, Wu Y, Ye C, Ruan X, Zhou J.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"J Virol 2013; 87(13):7608-21; PMID:23637400; http://dx.doi.org/10.1128/JVI.03186-12 [59] Zhang X, Zhou J, Wu Y, Zheng X, Ma G, Wang Z, Jin Y, He J, Yan Y.",OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
J Proteome Res 2009; 8(11):5111-9; PMID:19708719;http://dx.doi.org/10.1021/pr900488qAUTOPHAGY 753,Non-OADS,/arxiv_data1/oa_pdf/38/6f/kaup-13-04-1280220.PMC5388250.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/e7/opth-11-599.PMC5388251.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 599–604Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  599Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13137 0 Is high myopia a risk factor for visual field  progression or disk hemorrhage in primary  open-angle glaucoma?",Non-OADS,/arxiv_data1/oa_pdf/67/e7/opth-11-599.PMC5388251.pdf
"Progressive tilting of the optic disk with a nasal  shift of the temporal optic disk margin and simultaneous development/enlargement of Correspondence: Koji nitta Department of Ophthalmology, Fukui-ken  saiseikai hospital, 7-1 Wadanaka-machi  Funabashi, Fukui 918-8503, Japan Tel +81 776 23 1111 Fax +81 776 28 7754 email nitta.koji7001@fukui.saiseikai.or.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Nitta et al Running head recto: Clinical features of high myopic POAG DOI: http://dx.doi.org/10.2147/OPTH.S131370",Non-OADS,/arxiv_data1/oa_pdf/67/e7/opth-11-599.PMC5388251.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/67/e7/opth-11-599.PMC5388251.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/e7/opth-11-599.PMC5388251.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4e/b7/copd-12-1101.PMC5388252.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1101–1112International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1101OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13041 6 Peripheral leukocyte micrornas as novel  biomarkers for COPD ruiying Wang* Jianying Xu* hu liu* Zhiping Zhao* Department of respiratory, shanxi  Dayi hospital affiliated to shanxi  Medical University, Taiyuan, shanxi,   People’s republic of China *These authors contributed equally  to this workAbstract:  COPD is a multifactorial disease caused by environmental determinants as well  as genetic risk factors.",Non-OADS,/arxiv_data1/oa_pdf/4e/b7/copd-12-1101.PMC5388252.pdf
"Mainly  for mild to moderate disease processes, 60%–85% of patients are estimated to remain  undiagnosed.4,5 Due to the progressive nature of the disease, forced expiratory volume  in 1 second (FEV1) typically declines over time.6 Clinical manifestations of COPD  are highly variable, and comorbidities are significantly increased in patients, severely  affecting survival quality and life.7 To date, the majority of treatments do not prevent the  decline of lung function.8 Therefore, we assume to screen the biomarkers and treatment Correspondence: Jianying Xu Department of respiratory, shanxi Dayi  Hospital Affiliated to Shanxi Medical  University, Taiyuan, shanxi, People’s  republic of China Tel +86 139 0343 6432 email xujyty@126.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wang et al Running head recto: Peripheral leukocyte mRNA as biomarkers for COPD DOI: http://dx.doi.org/10.2147/COPD.S130416",Non-OADS,/arxiv_data1/oa_pdf/4e/b7/copd-12-1101.PMC5388252.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4e/b7/copd-12-1101.PMC5388252.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/b7/copd-12-1101.PMC5388252.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/60/ndt-13-1013.PMC5388253.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1013–1021Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1013OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12844 2 recombinant human brain-derived neurotrophic  factor prevents neuronal apoptosis in a novel  in vitro model of subarachnoid hemorrhage Mingchang li1 Yuefei Wang1 Wei Wang1 changlin Zou1 Xin Wang2 Qianxue chen1 1Department of Neurosurgery,   renmin hospital of Wuhan University,   Wuhan, People’s republic of china;   2Department of Neurosurgery,   Brigham and Women’s hospital,   harvard Medical school, Boston,   Ma, UsaAbstract:  Subarachnoid hemorrhage (SAH) is a hemorrhagic stroke with high mortality and  morbidity.",Non-OADS,/arxiv_data1/oa_pdf/18/60/ndt-13-1013.PMC5388253.pdf
"Recombinant human brain-derived neurotrophic factor (rhBDNF) is a neurotrophin  that binds to the high-affinity tropomyosin-related receptor kinase B (TrkB) receptor  to regulate neurodevelopmental processes, including neuronal survival, neuronal  differentiation, and synaptic plasticity.9–11 Huang et al12 showed that upregulation of correspondence: Mingchang li;  Qianxue chen Department of Neurosurgery, renmin  hospital of Wuhan University, 238 Jiefang  rd, Wuchang District, Wuhan 430060,  People’s republic of china Tel +86 27 8804 1911 ext 82237 email whulmc@126.co m;   chenqx666@sohu.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Li et al Running head recto: Human BDNF prevents neuronal apoptosis in SAH DOI: http://dx.doi.org/10.2147/NDT.S128442",OADS,/arxiv_data1/oa_pdf/18/60/ndt-13-1013.PMC5388253.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/18/60/ndt-13-1013.PMC5388253.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/60/ndt-13-1013.PMC5388253.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/35/e1/ijn-12-2845.PMC5388254.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2845–2855International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2845OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13397 1 linseed hydrogel-mediated green synthesis  of silver nanoparticles for antimicrobial and  wound-dressing applications Muhammad Tahir haseeb1,2 Muhammad ajaz hussain3 Khawar abbas3 Bahaa gM Y oussif4,5 sajid Bashir1 soon hong Yuk2 syed Nasir abbas Bukhari5 1Faculty of Pharmacy, University of  sargodha, sargodha, Pakistan; 2college  of Pharmacy, Korea University, sejong,   republic of Korea; 3Department of  chemistry, University of sargodha,   sargodha, Pakistan; 4Department of  Pharmaceutical Organic chemistry,   Faculty of Pharmacy, assiut University,   assiut, egypt; 5Department of  Pharmaceutical chemistry, college  of Pharmacy, aljouf University, aljouf,   sakaka, saudi arabiaAbstract:  Polysaccharides are being extensively employed for the synthesis of silver  nanoparticles (Ag NPs) having diverse morphology and applications.",Non-OADS,/arxiv_data1/oa_pdf/35/e1/ijn-12-2845.PMC5388254.pdf
"The more commonly used methods include chemical  and photochemical reduction,17,18 electrochemical method,19 and laser ablation.20,21 Use of chemical reduction method for synthesis of Ag NPs involves environmen - tally hostile reducing agents,22,23 toxic solvents,24 and nonbiodegradable/synthetic correspondence: Muhammad  ajaz hussain Department of chemistry, University  of sargodha, sargodha 40100, Pakistan Tel +92 346 861 4959 Fax +92 48 322 2121 email majaz172@yahoo.co m  Bahaa gM Youssif Department of Pharmaceutical Organic  chemistry, Faculty of Pharmacy, assiut  University, assiut 71526, egypt Tel +20 100 423 7882 email bgyoussif@ju.edu.s a Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Haseeb et al Running head recto: Linseed hydrogel-mediated green synthesis of silver nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S133971",Non-OADS,/arxiv_data1/oa_pdf/35/e1/ijn-12-2845.PMC5388254.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/35/e1/ijn-12-2845.PMC5388254.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/e1/ijn-12-2845.PMC5388254.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/58/copd-12-1057.PMC5388255.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1057–1060International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1057Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S13010 7 Automated versus manual oxygen titration in  COPD exacerbation: machine or hands, this is the  question Gulsah Karaoren1 Senay Goksu tomruk1 Antonio M esquinas2 1Department of Anesthesiology and  reanimation, Istanbul Umraniye  research Hospital, Istanbul, turkey;   2Intensive Care Unit, Hospital Morales  Meseguer, Murcia, SpainDear editor We have read the article titled “Automated oxygen titration and weaning with FreeO2  in patients with acute exacerbation of COPD: a pilot randomized trial” by Lellouche  et al with great interest; however, there are some key aspects to take into account for  proper practical implications.1 First, regarding ethical aspects, there seem to be some confusing points about  disclosure and researchers.",Non-OADS,/arxiv_data1/oa_pdf/44/58/copd-12-1057.PMC5388255.pdf
"It was reported that the principal investigators were not involved in the care and  disposition of study patients and that emergency room clinicians and nurses performed  works related to the study; however, it was impossible that clinicians and nurses Correspondence: Gulsah Karaoren Department of Anesthesiology and  reanimation, Istanbul Umraniye research  Hospital, Istanbul, turkey tel +90 505 357 3121 email drgyilmaz@yahoo.co m Journal name: International Journal of COPD Article Designation: Letter Y ear: 2017 Volume: 12 Running head verso: Karaoren et al Running head recto: Automated versus manual oxygen titration in COPD exacerbation DOI: http://dx.doi.org/10.2147/COPD.S130107",Non-OADS,/arxiv_data1/oa_pdf/44/58/copd-12-1057.PMC5388255.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/44/58/copd-12-1057.PMC5388255.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/58/copd-12-1057.PMC5388255.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/0a/dddt-11-1115.PMC5388256.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1115–1126Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1115Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13209 2 Efficacy of the dual PI3K and mTOR inhibitor NVP- BEZ235 in combination with imatinib mesylate  against chronic myelogenous leukemia cell lines Pengliang Xin chuntuan li Yan Zheng Qunyi Peng Huifang Xiao Yuanling huang Xiongpeng Zhu Department of haematology, First  hospital of Quanzhou affiliated to  Fujian Medical University, licheng,   Quanzhou, Fujian Province, ChinaBackground:  Phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/ mTOR) pathway is a therapy target of cancer.",Non-OADS,/arxiv_data1/oa_pdf/2e/0a/dddt-11-1115.PMC5388256.pdf
"Although allogeneic hematopoietic stem cell transplantation (Allo-SCT) can affect a  radical cure on CML, it suffers from the potential disadvantage of difficulty in finding a Correspondence: Xiongpeng Zhu Department of haematology, First  Hospital of Quanzhou Affiliated to Fujian  Medical University, 248 east street,  Licheng District, Quanzhou 362000,  Fujian Province, China Tel +86 138 0599 8581 Fax +86 595 2227 7301 email xiongpengzhu@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Xin et al Running head recto: Efficacy of NVP-BEZ235 in combination with imatinib against CML cell lines DOI: http://dx.doi.org/10.2147/DDDT.S132092",Non-OADS,/arxiv_data1/oa_pdf/2e/0a/dddt-11-1115.PMC5388256.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2e/0a/dddt-11-1115.PMC5388256.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/0a/dddt-11-1115.PMC5388256.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/56/ijn-12-2703.PMC5388257.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2703–2716International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2703OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13160 2 antimicrobial photodynamic activity and  cytocompatibility of au25(capt)18 clusters  photoexcited by blue leD light irradiation saori Miyata1 hirofumi Miyaji1 hideya Kawasaki2 Masaki Yamamoto2 erika Nishida1 hiroko Takita3 Tsukasa akasaka4 Natsumi Ushijima3 T oshihiko Iwanaga5 Tsutomu sugaya1 1Department of Periodontology and  endodontology, hokkaido University  graduate school of Dental Medicine,   Kita-ku, sapporo, 2Department of  chemistry and Materials engineering,   Faculty of chemistry, Materials and  Bioengineering, Kansai University,   suita-shi, Osaka, 3support section for  education and research, hokkaido  University graduate school of Dental  Medicine, 4Department of Biomedical,   Dental Materials and engineering,   graduate school of Dental Medicine,   hokkaido University, 5Department  of anatomy, laboratory of histology  and cytology, hokkaido University  graduate school of Medicine, Kita-ku,   sapporo, JapanAbstract:  Antimicrobial photodynamic therapy (aPDT) has beneficial effects in dental  treatment.",Non-OADS,/arxiv_data1/oa_pdf/5a/56/ijn-12-2703.PMC5388257.pdf
"This therapy is based on an oxygen-dependent photochemical reaction that  occurs upon light-mediated activation of a photosensitizing compound, leading to  the generation of cytotoxic reactive oxygen species (ROS), including singlet oxygen  (1O2) and superoxide.1–3 ROS consistently exhibit antimicrobial and anticancer  effects through severe damage to DNA and the cytoplasmic membrane.3–5 It has been  reported that aPDT rarely creates drug-resistant bacteria, which is an adverse effect of  antibiotic therapy.6 Since ROS exhibit a broad spectrum of antimicrobial activity, aPDT correspondence: hirofumi Miyaji Department of Periodontology and  endodontology, hokkaido University  graduate school of Dental Medicine, N13  W7, Kita-ku, sapporo 060-8586, Japan Tel +81 11 706 4266 Fax +81 11 706 4334 email miyaji@den.hokudai.ac.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Miyata et al Running head recto: Au25(Capt)18 cluster-mediated photodynamic effects DOI: http://dx.doi.org/10.2147/IJN.S131602",Non-OADS,/arxiv_data1/oa_pdf/5a/56/ijn-12-2703.PMC5388257.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5a/56/ijn-12-2703.PMC5388257.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/56/ijn-12-2703.PMC5388257.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/18/opth-11-631.PMC5388258.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 631–638Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  631CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13138 4 Comparison of 0.2% and 0.18% hyaluronate eye  drops in patients with moderate to severe dry  eye with keratitis or keratoconjunctivitis Dorothea Groß1  Marc Childs2  Jean-Marie piaton3  1Ursapharm arzneimittel GmbH,   Saarbrücken, Germany; 2laboratoires  Delbert, paris, 3Ophthalmic practice,   Domont, FrancePurpose:  Comparison of efficacy and safety of 0.2% and 0.18% hyaluronic acid (HA) eye  drops three times a day (tid) in patients with moderate to severe dry eye disease, related to  keratitis or keratoconjunctivitis.",Non-OADS,/arxiv_data1/oa_pdf/28/18/opth-11-631.PMC5388258.pdf
"The goal  of topical therapy in the form of lubricating eye drops is to control the activity and Correspondence: Dorothea Groß Ursapharm arzneimittel GmbH,  industriestrasse 35, D-66129  Saarbrücken, Germany Tel +49 680 592 92132 Fax +49 680 592 9287 email dorothea.gross@ursapharm.d e Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2017 Volume: 11 Running head verso: Groß et al Running head recto: 0.2% and 0.18% hyaluronate eye drops in dry eye treatment DOI: http://dx.doi.org/10.2147/OPTH.S131384",Non-OADS,/arxiv_data1/oa_pdf/28/18/opth-11-631.PMC5388258.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/28/18/opth-11-631.PMC5388258.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/18/opth-11-631.PMC5388258.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/ijn-12-2749.PMC5388259.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2749–2758International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2749RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S13130 4 Recent developments in the nanostructured  materials functionalized with ruthenium  complexes for targeted drug delivery to tumors Prakash Thangavel1 Buddolla viswanath1 Sanghyo Kim1,2 1Department of Bionanotechnology,   Gachon University, Bokjeong- Dong, Sujeong-Gu, Seongnam-Si,   Gyeonggi-Do, 2Graduate Gachon  Medical Research Institute,   Gil Medical Center, Incheon,   Republic of KoreaAbstract:  In recent years, the field of metal-based drugs has been dominated by other existing  precious metal drugs, and many researchers have focused their attention on the synthesis of  various ruthenium (Ru) complexes due to their potential medical and pharmaceutical applications.",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/ijn-12-2749.PMC5388259.pdf
"Therefore, Ru complexes are considered more efficient, less toxic, and target-specific  noncovalent DNA-binding anticancer drugs.4 Another property of Ru compounds that  makes them ideal candidates for medicinal applications is their ability to mimic iron  binding to certain biomolecules such as serum transferrin and albumin, which are  utilized by mammals to solubilize and transport iron, thus reducing cellular toxicity.4,5 Correspondence: Sanghyo Kim Department of Bionanotechnology,  Gachon University, Bokjeong-Dong,  Sujeong-Gu, Seongnam-Si, Gyeonggi-Do,  Incheon, Republic of Korea Tel +82 31 750 8554 email samkim@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Thangavel et al Running head recto: Nanostructured materials functionalized with Ru complexes  DOI: http://dx.doi.org/10.2147/IJN.S131304",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/ijn-12-2749.PMC5388259.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/ijn-12-2749.PMC5388259.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/4f/ijn-12-2749.PMC5388259.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/b9/tcrm-13-447.PMC5388260.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 447–454Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  447Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8891 1 Use of direct oral anticoagulants for the  prevention and treatment of thromboembolic  disease in patients with reduced renal function:  a short review of the clinical evidence Kristine C willett Amanda M Morrill Department of Pharmacy Practice,   School of Pharmacy, MCPHS  University, Manchester, NH, USABackground:  The use of direct oral anticoagulants (DOACs) is restricted by the limitations  of clinical trials guiding therapy for patients with renal impairment, as many of these trials  excluded patients with severe renal impairment.",Non-OADS,/arxiv_data1/oa_pdf/29/b9/tcrm-13-447.PMC5388260.pdf
"These agents are all US Food and Drug Administration (FDA) –   approved for long-term anticoagulation management in patients with nonvalvular atrial Correspondence: Kristine C willett Department of Pharmacy Practice, School  of Pharmacy, MCPHS University, 1260  elm Street, Manchester, NH 03101, USA Tel +1 603 314 1778 email kristine.willett@mcphs.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Willett and Morrill Running head recto: DOACs for patients with renal disease DOI: http://dx.doi.org/10.2147/TCRM.S88911",Non-OADS,/arxiv_data1/oa_pdf/29/b9/tcrm-13-447.PMC5388260.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/29/b9/tcrm-13-447.PMC5388260.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/b9/tcrm-13-447.PMC5388260.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/da/a3/ott-10-1969.PMC5388261.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1969–1975OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1969Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13600 6 HSD17B12  gene rs11037575 c .T polymorphism  confers neuroblastoma susceptibility in a  southern chinese population Zhuorong Zhang,1,2  Yan Zou,2 Jinhong Zhu,3  ruizhong Zhang,2 Tianyou  Yang,2 Fenghua Wang,2  huimin Xia,1,2 Jing he,2  Zhichun Feng1,4–6 1southern Medical University,   guangzhou, guangdong, 2Department  of Pediatric surgery, guangzhou  institute of Pediatrics, guangzhou  Women and children’s Medical  center, guangzhou Medical  University, guangzhou, guangdong,   3Molecular epidemiology laboratory,   Department of laboratory Medicine,   harbin Medical University cancer  hospital, harbin, heilongjiang,   4Division of neonatology, affiliated  BaYi children’s hospital, clinical  Medical college in P la army general  hospital, southern Medical University,   5national engineering laboratory for  Birth Defects Prevention and control  of Key T echnology, 6Beijing Key  laboratory of Pediatric Organ Failure,   Beijing, People’s republic of chinaAbstract:  A previous genome-wide association study (GWAS) identified four genetic  polymorphisms (rs1027702 near DUSP12 , rs10055201 in IL31RA , rs2619046 in DDX4 , and  rs11037575 in HSD17B12  gene) that were associated with neuroblastoma susceptibility,  especially for low-risk subjects.",Non-OADS,/arxiv_data1/oa_pdf/da/a3/ott-10-1969.PMC5388261.pdf
"It is the most frequent peripheral nervous system tumor of infancy and  childhood,1,2 which constitutes of approximately 7%–10% of all childhood cancers.3  Neuroblastoma is the third leading cause of cancer-related death in children.3 Despite  of remarkable advances in the treatments of many childhood cancers, neuroblastoma  remains a serious clinical problem, causing 15% of childhood cancer mortality.4 The  median age at diagnosis of this disease is around 17 months.5 Neuroblastoma may  occur throughout the sympathetic nervous system, mostly within the abdomen and  adrenal medulla.6 The incidence rate of neuroblastoma is about 1 in 7000 live newborns  worldwide.7 It is also one of the most commonly diagnosed solid tumors in the Chinese  infants, with an incidence rate of ~7.7 per million.8 The majority of neuroblastomas are  sporadic, and only about 1% of patients have a family history of this type of disease.9  Thus far, the etiology of neuroblastoma remains largely unidentified, especially for correspondence: Zhichun Feng Division of Neonatology, Affiliated BaYi  children’s hospital, clinical Medical  college in Pla army general hospital,  southern Medical University, no 5  nanmen cang hutong, Dongcheng  District, Beijing 100700, People’s  republic of china Tel +86 10 6672 1786 Fax +86 10 6406 3099 email bzfengzc@yahoo.co m  Jing he Department of Pediatric surgery,  guangzhou institute of Pediatrics,  guangzhou Women and children’s  Medical center, guangzhou Medical  University, 9 Jinsui road, guangzhou  510623, guangdong, People’s republic  of china Tel/fax +86 20 3807 6560 email hejing198374@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhang et al Running head recto: HSD17B12  polymorphism and neuroblastoma risk DOI: http://dx.doi.org/10.2147/OTT.S136006",Non-OADS,/arxiv_data1/oa_pdf/da/a3/ott-10-1969.PMC5388261.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/da/a3/ott-10-1969.PMC5388261.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/a3/ott-10-1969.PMC5388261.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ott-10-2009.PMC5388262.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2009–2016OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2009Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12380 3 Role of postmastectomy radiotherapy in early- stage (T1–2N0–1M0) triple-negative breast  cancer: a systematic review Fengxia Chen1 Feifei Pu2 1Department of Medical Oncology,   General Hospital of The Yangtze  River Shipping, 2Department of  Orthopedics, Union Hospital, Tongji  Medical College, Huazhong University  of Science and T echnology, wuhan,   Hubei, People’s Republic of ChinaAbstract:  Triple-negative breast cancer (TNBC), which represents 15%–20% of all breast  cancers, is defined by the absence of estrogen receptor (ER) and progesterone receptor (PR) and  overexpression of human epidermal growth factor receptor 2 (HER2).",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ott-10-2009.PMC5388262.pdf
"For patients with early-stage TNBC, surgery can merely remove detectable  macroscopic tumor, but some microscopic tumor foci might still remain in the  locoregional tissue (ie, chest wall or regional lymph nodes) that could, if untreated, lead  to recurrence and breast cancer mortality.8 Owing to the paucity of therapeutic targets,  women with TNBC do not benefit from endocrine therapy or targeted agents, and system - atic chemotherapy continues to be the mainstay in TNBC patients.9 Particularly for the Correspondence: Feifei Pu Department of Orthopedics, Union  Hospital, Tongji Medical College,  Huazhong University of Science and  Technology, 1277 Jiefang Avenue,  wuhan, Hubei 430022, People’s  Republic of China email pufeifeiemail@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Chen and Pu Running head recto: Review of adjuvant radiotherapy in early-stage TNBC DOI: http://dx.doi.org/10.2147/OTT.S123803",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ott-10-2009.PMC5388262.pdf
"Available from:  https://www.nccn.org/patients/guidelines/stage_i_ii_breast/index.htm l.  Accessed July 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ott-10-2009.PMC5388262.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ott-10-2009.PMC5388262.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/fc/ott-10-2009.PMC5388262.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/94/ott-10-2017.PMC5388263.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2017–2023OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2017Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13144 3 reg3a promotes the proliferation, migration,  and invasion of gastric cancer cells Zhou-Feng chen Zhi-Ming huang hai-Bo Xue Xiu-Qing lin ren-Ping chen Meng-Jun chen rui-Fang Jin Department of gastroenterology  and hepatology, The First affiliated  hospital of Wenzhou Medical  University, Wenzhou, People’s  republic of chinaAbstract:  The mechanism underlying the metastasis of gastric cancer (GC) cells remains  elusive.",Non-OADS,/arxiv_data1/oa_pdf/5e/94/ott-10-2017.PMC5388263.pdf
"We further demonstrated correspondence: rui-Fang Jin Department of gastroenterology and  Hepatology, The First Affiliated Hospital  of Wenzhou Medical University, shangcai  Village, Wenzhou, 325000, People’s  republic of china Tel +86 577 5557 8166 email jruf871113@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Chen et al Running head recto: REG3A promotes gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S131443",Non-OADS,/arxiv_data1/oa_pdf/5e/94/ott-10-2017.PMC5388263.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/94/ott-10-2017.PMC5388263.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/94/ott-10-2017.PMC5388263.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/24/83/ijn-12-2657.PMC5388264.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2657–2672International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2657OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13292 9 sl2B aptamer and folic acid dual-targeting DNa  nanostructures for synergic biological effect with  chemotherapy to combat colorectal cancer Pengchao sun* Nan Zhang* Yafang Tang Yanan Yang Xiao chu Y ongxing Zhao Department of Pharmaceutics,   school of Pharmaceutical sciences,   Zhengzhou University, Zhengzhou,   heNan, People’s republic of china *These authors contributed equally  to the workAbstract:  DNA nanostructures prepared by self-assembly possess good stability, high  biocompatibility, and low immunogenicity as drug delivery vehicles.",Non-OADS,/arxiv_data1/oa_pdf/24/83/ijn-12-2657.PMC5388264.pdf
"PEGylation and structure modification of aptamers have been reported to increase their  stability and bioactivity.6–8 At present, several aptamers have been used in clinical  studies for diseases, including mNOX-E36-3 ′PEG aptamer for glomerulosclerosis,9  AS1411 aptamer for acute myeloid leukemia,10 and ARC 1779 for von Willebrand correspondence: Yongxing Zhao Department of Pharmaceutics, school  of Pharmaceutical sciences, Zhengzhou  University, room a315, No 100 KeXue  ave, Zhengzhou, heNan 45001, People’s  republic of china Tel +86 371 6778 1901 Fax +86 371 6773 9546 email zhaoyx@zzu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sun et al Running head recto: SL2B aptamer and folic acid dual-targeting DNA nanostructures DOI: http://dx.doi.org/10.2147/IJN.S132929",Non-OADS,/arxiv_data1/oa_pdf/24/83/ijn-12-2657.PMC5388264.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/24/83/ijn-12-2657.PMC5388264.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/83/ijn-12-2657.PMC5388264.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/48/opth-11-619.PMC5388265.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 619Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  619COrrigendumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S13667 0 Prolongation of injection interval after switching therapy from  ranibizumab to aflibercept in Japanese patients with macular edema  secondary to branch retinal vein occlusion [Corrigendum] Tagami M, Sai R, Fukuda M, Azumi A. Clin Ophthalmol .",Non-OADS,/arxiv_data1/oa_pdf/6f/48/opth-11-619.PMC5388265.pdf
"Page 405, Comparison of injection intervals section, line 6,  “We also com pared the intervals between the last and the  second-to the-last intravitreal injection of ranibizumab and Journal name: Clinical Ophthalmology Article Designation: Corrigendum Y ear: 2017 Volume: 11 Running head verso: Tagami et al Running head recto: Prolongation of injection interval after switching therapy DOI: http://dx.doi.org/10.2147/OPTH.S136670 the first and the second intravitreal injection of aflibercept”  should have read “We also compared the interval between  the last injection of ranibizumab and the first injection of  aflibercept with the interval between the first and the second  injection of aflibercept”.",Non-OADS,/arxiv_data1/oa_pdf/6f/48/opth-11-619.PMC5388265.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6f/48/opth-11-619.PMC5388265.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s,Non-OADS,/arxiv_data1/oa_pdf/6f/48/opth-11-619.PMC5388265.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/bc/ijn-12-2769.PMC5388266.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 2769–2779International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2769OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S13079 9 effects of arginine–glycine–aspartic acid peptide- conjugated quantum dots-induced photodynamic  therapy on pancreatic carcinoma in vivo Ming-Ming li* Jia cao* Jia-chun Yang Yu-Jie shen Xiao-lei cai Yuan-Wen chen chun-Ying Qu Yi Zhang Feng shen lei-Ming Xu Department of gastroenterology,   Xinhua hospital, school of Medicine,   shanghai Jiaotong University, shanghai,   People’s republic of china *These authors contributed equally to  this workAbstract:  Quantum dots (QDs) conjugated with integrin antagonist arginine–glycine–aspartic  acid (RGD) peptides (QDs-RGD) are novel nanomaterials with a unique optical property:   a high molar extinction coefficient.",Non-OADS,/arxiv_data1/oa_pdf/a0/bc/ijn-12-2769.PMC5388266.pdf
"PDT is a minimally invasive treatment that damages target  cells by imparting toxicity through generation of reactive oxygen species (ROS).10–17 correspondence: lei-Ming Xu Department of gastroenterology, Xinhua  hospital, school of Medicine, shanghai  Jiaotong University, 1665 Kongjiang  road, Yangpu District, shanghai 200092,  People’s republic of china Tel/fax +86 21 2507 8999 email leiming.xu@aliyun.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: Effects of QDs-RGD-induced PDT on pancreatic cancer in vivo DOI: http://dx.doi.org/10.2147/IJN.S130799",Non-OADS,/arxiv_data1/oa_pdf/a0/bc/ijn-12-2769.PMC5388266.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a0/bc/ijn-12-2769.PMC5388266.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/bc/ijn-12-2769.PMC5388266.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 679–687Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  679 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S123966Prevalence of chronic pain with neuropathic  characteristics: a randomized telephone survey  among medical center patients in Kuwait Nadia Zghoul1  Edgar L Ross2  Robert R Edwards2  Adel Ahmed1,3  Robert N Jamison2 1Clinical Research Department,   Dasman Diabetes Institute,   Kuwait City, Kuwait; 2Department  of Anesthesiology, Pain Management  Center, Brigham and Women’s Hospital, Harvard Medical School,  Chestnut Hill, MA, USA;  3Faculty  of Medicine, Kuwait University,   Safat,  KuwaitBackground: Chronic pain with neuropathic characteristics is considered to be an interna- tional health problem.",Non-OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
"3Correspondence: Robert N Jamison Department of Anesthesiology, Pain Management Center, Brigham and Women’s Hospital, Harvard Medical School, 850 Boylston Street, Suite 320, Chestnut Hill, MA 02467, USA Tel +1 617 732 9046 Fax +1 617 732 9050   Email rjamison@partners.orgJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Zghoul et alRunning head recto: Prevalence of neuropathic pain in KuwaitDOI: http://dx.doi.org/10.2147/JPR.S123966",Non-OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
All calls were recorded with permission of the subjects using a CISCO phone call recording program (CallREC) and software by Zoom Inter - national (http://www.zoomint.com).,OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
Available from: http://www.ispor.org/news/articles/July09/HCE.asp.,Non-OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 687 Prevalence of neuropathic pain in Kuwait 14.,Non-OADS,/arxiv_data1/oa_pdf/6f/5c/jpr-10-679.PMC5388267.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fe/1f/opth-11-621.PMC5388268.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 621–629Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  621Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12351 3 T esting the clinical value of multifocal  electroretinography and microperimetry and the  effects of intravitreal therapy with ranibizumab  on macular function in the course of wet  age-related macular degeneration: a 1-year  prospective study Mihaela reinsberg1 ralf-Dieter hilgers2 inger lüdeke1 Khaled nassar1 swaantje grisanti1 salvatore grisanti1 Julia lüke1,* Matthias lüke1,* 1University eye hospital, University  of lübeck, lübeck, 2Department of  Medical statistics, rWTh aachen  University, aachen, germany *These authors contributed equally  to this workPurpose:  To investigate the clinical value of multifocal electroretinography (mfERG) and  microperimetry and the effects of intravitreal therapy with ranibizumab (Lucentis®) on macular  function in the course of neovascular age-related macular degeneration (nAMD).",Non-OADS,/arxiv_data1/oa_pdf/fe/1f/opth-11-621.PMC5388268.pdf
"AMD is classified  into one of two general subgroups: the nonexudative form of the disease and the Correspondence: Matthias lüke University eye hospital, University of  lübeck, 160 ratzeburger allee, lübeck  23538, germany Tel +49 451 500 2211 Fax +49 451 500 2945 email matthias.lueke@uksh.d e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Reinsberg et al Running head recto: mfERG and microperimetry in nAMD DOI: http://dx.doi.org/10.2147/OPTH.S123513",Non-OADS,/arxiv_data1/oa_pdf/fe/1f/opth-11-621.PMC5388268.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fe/1f/opth-11-621.PMC5388268.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/1f/opth-11-621.PMC5388268.pdf
Available  from: http://www2.sas.com/proceedings/sugi29/198-29.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fe/1f/opth-11-621.PMC5388268.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 707–718Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  707OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12255 6 Medication adherence and persistence in type 2  diabetes mellitus: perspectives of patients,  physicians and pharmacists on the spanish health  care system elena labrador Barba1 Marta rodríguez de Miguel1 Antonio hernández- Mijares2,3 Francisco Javier Alonso- Moreno4 Maria luisa Orera Peña1 susana Aceituno5 María José Faus Dader6 1Department of Medicine,   Mylan, Madrid, 2Department of  endocrinology and nutrition, Doctor  Peset University hospital, Valencia,   3Department of Medicine, University  of Valencia, Valencia, 4Department  for Primary health care, centro de  salud sillería, T oledo, 5Outcomes’10,   castellon, 6Department of  Biochemistry and Molecular Biology,   Faculty of Pharmacy, University of  granada, granada, spainObjective:  A good relationship between diabetes patients and their health care team is crucial  to ensure patients’ medication adherence and self-management.",Non-OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
"Keywords:  type 2 diabetes mellitus, adherence, persistence, factors, strategies Introduction Diabetes is a highly common metabolic disease whose prevalence worldwide has  increased in recent decades.1 In 2013, its prevalence was estimated at 8.3%, affecting  382 million people;2 notably, a further increase to 592 million is expected by 2035.3  The estimated prevalence of type 2 diabetes mellitus (T2DM) in Spain is 13.8%, with  approximately 6% of the population being undiagnosed.4 Other chronic conditions are correspondence: elena labrador Barba established Pharmaceuticals Division,  Department of Medicine, Mylan, Avenida  de Burgos, 91, 28050 Madrid, spain Tel +34 91 337 3350 email elena.labrador@mylan.co m Journal name: Patient Preference and Adherence  Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Labrador Barba et al Running head recto: Patients and healthcare workers’ perspective in medication adherence DOI: http://dx.doi.org/10.2147/PPA.S122556",Non-OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
"Available from: http://www.idf.org/diabetesatla s. Accessed July 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
"Available from: http://www.who.int/chp/knowledge/ publications/adherence_full_report.pd f. Accessed July 1, 2016.",OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
Available from: http://www.ine.,Non-OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
"Available from: http://www.msps.es/novedades/docs/ OfYneceEspMedicos_ESP_2010_2025_03.pd f. Accessed July 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/9f/00/ppa-11-707.PMC5388272.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/tcrm-13-439.PMC5388273.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 439–446Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  439Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/TCRM.S12932 7 Genetic factors in pathogenesis of diabetes  mellitus after kidney transplantation Maciej Tarnowski1 Sylwia Słuczanowska- Głabowska1 Andrzej Pawlik1 Małgorzata Mazurek- Mochol2 Elżbieta Dembowska2 1Department of Physiology,   2Department of Periodontology,   Pomeranian Medical University,   Szczecin, PolandAbstract:  Posttransplant diabetes mellitus (PTDM) is one of the major metabolic complications  after transplantation of solid organs including the kidney.",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/tcrm-13-439.PMC5388273.pdf
"Correspondence: Maciej Tarnowski Department of Physiology, Pomeranian  Medical University, Powstańców  Wielkopolskich 72, 70-111  Szczecin, Poland Tel +48 91 466 1611 Fax +48 91 466 1612 email maciejt@pum.edu.p l Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Tarnowski et al Running head recto: Gene polymorphism and PTDM DOI: http://dx.doi.org/10.2147/TCRM.S129327",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/tcrm-13-439.PMC5388273.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/tcrm-13-439.PMC5388273.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/1b/tcrm-13-439.PMC5388273.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/aa/ndt-13-1033.PMC5388275.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1033–1042Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1033OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S13151 7 an innovative nonpharmacological intervention  combined with intravenous patient-controlled  analgesia increased patient global improvement  in pain and satisfaction after major surgery chia-chun chuang1 chien-ching lee1,2 li-Kai Wang1 Bor-shyh lin2 Wen-Ju Wu1 chung-han ho3 Jen-Yin chen1,4 1Department of anesthesiology,   chi Mei Medical center, 2Department  of imaging and Biomedical  Photonics, National chiao Tung  University, 3Department of Medical  research, chi Mei Medical center,   4Department of the senior citizen  service Management, chia Nan  University of Pharmacy and science,   Tainan, Taiwan, republic of chinaPurpose:  This study aimed to evaluate whether a nonpharmacological approach through  implementation of a communication improvement program (named CICARE for Connect,  Introduce, Communicate, Ask, Respond and Exit) into standard operating procedure (SOP)  in acute pain service (APS) improved satisfaction in patients receiving intravenous patient- controlled analgesia (IV -PCA).",Non-OADS,/arxiv_data1/oa_pdf/ce/aa/ndt-13-1033.PMC5388275.pdf
"Poor management of postoperative acute  pain may lead to severe complications such as pneumonia, deep vein thrombosis and correspondence: Jen-Yin chen Department of anesthesiology,  chi Mei Medical center,  No 901, Zhonghua road, Yongkang,  Tainan 710, Taiwan, republic of china Tel +886 6 281 2811 53322 Fax +886 6 283 2639 email chenjenyin@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chuang et al Running head recto: Nonpharmacological interventions and acute pain DOI: http://dx.doi.org/10.2147/NDT.S131517",Non-OADS,/arxiv_data1/oa_pdf/ce/aa/ndt-13-1033.PMC5388275.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ce/aa/ndt-13-1033.PMC5388275.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/aa/ndt-13-1033.PMC5388275.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5e/d4/srep06447.PMC5388276.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/7b/ndt-13-1023.PMC5388277.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1023–1032Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1023Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12151 7 Quetiapine monotherapy versus placebo in the  treatment of children and adolescents with bipolar  depression: a systematic review and meta-analysis Benchalak Maneeton1 Suwannee Putthisri2 Narong Maneeton1 Pakapan woottiluk3 Sirijit Suttajit1 Chawanun Charnsil1 Manit Srisurapanont1 1Department of Psychiatry, Faculty  of Medicine, Chiang Mai University,   Chiang Mai, 2Department of  Psychiatry, Faculty of Medicine,   Ramathibodi Hospital, Mahidol  University, Bangkok, 3Psychiatric  Nursing Division, Faculty of Nursing,   Chiang Mai University, Chiang  Mai, ThailandBackground:  Some studies have indicated the efficacy of quetiapine in the treatment of bipolar  depression in adult patients.",Non-OADS,/arxiv_data1/oa_pdf/74/7b/ndt-13-1023.PMC5388277.pdf
"Patients with bipolar I or II disorders often experience depressive symptoms,  including time to clinical remission longer than either hypomanic or manic episodes.1–3  Depressive episodes in bipolar disorders are associated with significant impairment of  various occupational, academic, and social functioning, negative effects on the quality Correspondence: Narong Maneeton Department of Psychiatry, Faculty of  Medicine, Chiang Mai University, 110  intawaroros Road, Sriphum, Amphur  Muang, Chiang Mai 50200, Thailand Tel +66 53 935 422 Fax +66 53 935 426 email narong.m@cmu.ac.t h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Maneeton et al Running head recto: Quetiapine monotherapy vs placebo in the treatment of bipolar depression DOI: http://dx.doi.org/10.2147/NDT.S121517",Non-OADS,/arxiv_data1/oa_pdf/74/7b/ndt-13-1023.PMC5388277.pdf
Available from http://training.cochrane.org/handbook.,Non-OADS,/arxiv_data1/oa_pdf/74/7b/ndt-13-1023.PMC5388277.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/74/7b/ndt-13-1023.PMC5388277.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7b/ndt-13-1023.PMC5388277.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/amep-8-265.PMC5388278.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4d/5c/amep-8-265.PMC5388278.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 265–267Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 265 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S133702 Practically prepared?",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/amep-8-265.PMC5388278.pdf
"As such, the fact remains  Correspondence: Naeem Dowlut   Biomedical Engineering and Clinical  Materials, Barts and The London School of Medicine, 4 Newark Street, London E1 2AT, UK Email m.dowlut@smd12.qmul.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2017V olume: 8Running head verso: DowlutRunning head recto: Pre-intern student views following an education packageDOI: http://dx.doi.org/10.2147/AMEP .S133702",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/amep-8-265.PMC5388278.pdf
Available from: http://www.gmc-uk.org/Clinical_placements_for_medical_students___guid-ance_under_review_0815.pdf_56437824.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/amep-8-265.PMC5388278.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/amep-8-265.PMC5388278.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 267 Pre-intern student views following an education package Authors’ reply Susan McKenzie   Craig Mellis Central Clinical School, Sydney Medical School, The University of  Sydney, Camperdown, NSW, Australia Correspondence: Susan McKenzie   Central Clinical School, Sydney Medical School, The University of  Sydney, Building 63, Level 4, Royal Prince Alfred Hospital,Missenden Road, Camperdown, NSW 2050, Australia   Tel +61 2 9515 6548   Email susan.mckenzie@sydney.edu.au Dear editor Thank you for providing the opportunity to respond to the  letter by Mr Dowlut.",Non-OADS,/arxiv_data1/oa_pdf/4d/5c/amep-8-265.PMC5388278.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/66/f3/lra-10-031.PMC5388280.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/66/f3/lra-10-031.PMC5388280.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2017:10 31–39Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  31 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S111554Ambulatory thyroidectomy: an anesthesiologist’s  perspective Benjamin Murray1 Sankalap Tandon2 Ged Dempsey1 1Department of Anaesthesia and  Critical Care, 2Department of  Otolaryngology, Head & Neck  Surgery, Aintree University Hospital NHS Foundation Trust, Liverpool, UKAbstract: Thyroidectomy has been performed on an inpatient basis because of concerns regard- ing postoperative complications.",Non-OADS,/arxiv_data1/oa_pdf/66/f3/lra-10-031.PMC5388280.pdf
"2 The com- plications that have resulted in thyroidectomy remaining predominantly an inpatient procedure have largely been surgical; the risk of airway compromise because of cervical hematoma and bilateral RLN injury and symptomatic hypocalcemia due to Correspondence: Ged Dempsey Department of Anaesthesia and Critical Care, Aintree University Hospital, Lower Lane, Liverpool L9 7AL, UKTel +44 151 529 5153Email ged.dempsey@aintree.nhs.ukJournal name: Local and Regional Anesthesia Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Murray et alRunning head recto: Ambulatory thyroidectomyDOI: http://dx.doi.org/10.2147/LRA.S111554",Non-OADS,/arxiv_data1/oa_pdf/66/f3/lra-10-031.PMC5388280.pdf
"Local and Regional Anesthesia 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/66/f3/lra-10-031.PMC5388280.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 39 Ambulatory thyroidectomy,Non-OADS,/arxiv_data1/oa_pdf/66/f3/lra-10-031.PMC5388280.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/79/copd-12-1093.PMC5388281.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1093–1099International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1093OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13314 8 Burden of asthma, dyspnea, and chronic cough  in south asia ghose Bishwajit1,2 shangfeng Tang1 sanni Yaya3 Zhanchun Feng1 1school of Medicine and health  Management, Tongji Medical  College, huazhong University of  science and T echnology, Wuhan,   hubei, People’s republic of China;   2Institute of nutrition and Food  science, University of Dhaka, Dhaka,   Bangladesh; 3school of International  Development and global studies,   University of Ottawa, Ottawa,   On, CanadaBackground:  Asthma, dyspnea, and chronic cough are well-established risk factors of COPD  and often associated with exacerbation of the disease, which is a leading cause of morbidity  and mortality in South Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/3c/79/copd-12-1093.PMC5388281.pdf
"Keywords:  asthma, chest pain, respiratory diseases, chronic cough, dyspnea, older population,  South Asia Introduction Chronic respiratory diseases represent a group of diseases characterized by abnormal  condition of the respiratory system such as inflammation of the airways, airflow obstruc - tion, chest pain, dyspnea, hemoptysis, and sputum production.1 Globally, respiratory  diseases remain the largest single contributor to the overall burden of disease measured  in terms of disability-adjusted life-years (DALYs) loss, and the overall burden has  been increasing at an alarming rate, especially COPD.2 According to a comprehen - sive report “Respiratory Disease in the World: Realities of Today – Opportunities for  Tomorrow” published by The Forum of International Respiratory Societies (FIRS), the  five largest contributors to the global burden of respiratory diseases include asthma,  COPD, acute respiratory infections, tuberculosis (TB), and lung cancer.2,3 At any point, Correspondence: Zhanchun Feng school of Medicine and health  Management, Tongji Medical College,  13 hangkong lu, hankou 430030,  Wuhan, hubei Province, People’s  republic of China Tel +86 27 8369 2731 email zcfeng@hust.edu.c n Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Bishwajit et al Running head recto: Burden of asthma, dyspnea, and chronic cough DOI: http://dx.doi.org/10.2147/COPD.S133148",Non-OADS,/arxiv_data1/oa_pdf/3c/79/copd-12-1093.PMC5388281.pdf
The questionnaires are available at: http://www.who.int/ healthinfo/survey/instruments/en /.,OADS,/arxiv_data1/oa_pdf/3c/79/copd-12-1093.PMC5388281.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3c/79/copd-12-1093.PMC5388281.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/79/copd-12-1093.PMC5388281.pdf
Available  from: http://www.who.int/respiratory/asthma/GINA_WR_2006_ copyright%5B1%5D.pd f.  5.,Non-OADS,/arxiv_data1/oa_pdf/3c/79/copd-12-1093.PMC5388281.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/11/opth-11-639.PMC5388284.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 639–640Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  639Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S13568 5 Immediate sequential bilateral intravitreal  injections: an Indian perspective Koushik tripathy Department of Vitreoretina and Uvea,   ICAre eye Hospital and Postgraduate  Institute, Sector-26, Noida,   Uttar Pradesh, IndiaDear editor Recently, Ruão et al1 have shown in a study spanning 6 years that only 1 of 6560  (0.015%) eyes undergoing unilateral intravitreal anti-vascular endothelial growth  factor (anti-VEGF) injection developed culture-proven endophthalmitis.",Non-OADS,/arxiv_data1/oa_pdf/89/11/opth-11-639.PMC5388284.pdf
"The rate of infectious endophthalmitis  after intravitreal anti-VEGF injections has been noted to reach up to 0.078%.1 Thus, Correspondence: Koushik tripathy Department of Vitreoretina and Uvea,  ICAre eye Hospital and Postgraduate  Institute, e3A, Sector-26, Noida 201301,  Uttar Pradesh, India tel +91 120 255 5969 email drkoushiktripathy@i carehospital.or g Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2017 Volume: 11 Running head verso: Tripathy Running head recto: ISBIVT injections DOI: http://dx.doi.org/10.2147/OPTH.S135685",Non-OADS,/arxiv_data1/oa_pdf/89/11/opth-11-639.PMC5388284.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/89/11/opth-11-639.PMC5388284.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/11/opth-11-639.PMC5388284.pdf
"Available from: http://aios.org/avguide - lines.pd f. Accessed March 20, 2017.",Non-OADS,/arxiv_data1/oa_pdf/89/11/opth-11-639.PMC5388284.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e0/32/amep-8-257.PMC5388285.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e0/32/amep-8-257.PMC5388285.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 257–263Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 257 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S128963 Development of performance and error metrics  for ultrasound-guided axillary brachial plexus  block Osman M Ahmed1 Brian D O’Donnell1,2 Anthony G Gallagher2 George D Shorten1,2 1Department of Anaesthesia and  Intensive Care, University College  Cork and Cork University Hospital,   2The ASSERT Center, University  College Cork, Cork, IrelandPurpose: Change in the landscape of medical education coupled with a paradigm shift toward  outcome-based training mandates the trainee to demonstrate specific predefined performance  benchmarks in order to progress through training.",Non-OADS,/arxiv_data1/oa_pdf/e0/32/amep-8-257.PMC5388285.pdf
"2  Competence-based procedural skills training has been endorsed and prioritized by Correspondence: Osman M Ahmed Department of Anaesthesia and Intensive Care, Cork University Hospital, Cork, IrelandTel +353 2 1492 2135Fax +353 2 1454 6434Email dr19osman@icloud.comJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Ahmed et alRunning head recto: Development of performance metricsDOI: http://dx.doi.org/10.2147/AMEP .S128963",Non-OADS,/arxiv_data1/oa_pdf/e0/32/amep-8-257.PMC5388285.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/e0/32/amep-8-257.PMC5388285.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 263 Development of performance metrics 14.,Non-OADS,/arxiv_data1/oa_pdf/e0/32/amep-8-257.PMC5388285.pdf
Available at: http://www.rcoa.ac.uk/document-store/cct-anaesthetics-iv-compe-tency-based-higher-and-advanced-level-2007.,Non-OADS,/arxiv_data1/oa_pdf/e0/32/amep-8-257.PMC5388285.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/18/evx055.PMC5388287.pdf
Phylogenies were visualized with FigTree (v.1.4.2 http://tree.bio.ed.ac.uk/software/ﬁgtree /).,OADS,/arxiv_data1/oa_pdf/5e/18/evx055.PMC5388287.pdf
EPPO Reporting Service 3:4. http://archives.eppo.int/EPPOReporting/2011/ Rse-1103.pdf .,OADS,/arxiv_data1/oa_pdf/5e/18/evx055.PMC5388287.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/1a/evx036.PMC5388290.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/3c/evx058.PMC5388293.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/   4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/ae/jiw632.PMC5388299.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/ 4.0/), which permits non-commercial reproduction and distribution of the work, in  any medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/fb/jiw590.PMC5388302.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c7/ad/jpr-10-787.PMC5388303.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c7/ad/jpr-10-787.PMC5388303.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 787–795Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  787 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S131156Subanesthetic ketamine for pain management  in hospitalized children, adolescents, and young  adults: a single-center cohort study Kathy A Sheehy1,*  Caroline Lippold1,*  Amy L Rice1  Raissa Nobrega1  Julia C Finkel1  Zenaide MN Quezado1,2 1Division of Anesthesiology, Pain, and  Perioperative Medicine, The Sheikh  Zayed Institute for Pediatric Surgical Innovation, Children’s Research Institute, Children’s National Health System, George Washington University School of Medicine and Health Sciences,  2Center for  Neuroscience Research, Children’s Research Institute, Children’s National Health System, Washington,  DC, USA *These authors contributed equally to  this workBackground: Subanesthetic doses of ketamine, an N-methyl- d-aspartate receptor antagonist  used as an adjuvant to opioid for the treatment of pain in adults with acute and chronic pain,  have been shown, in some instances, to improve pain intensity and to decrease opioid intake.",Non-OADS,/arxiv_data1/oa_pdf/c7/ad/jpr-10-787.PMC5388303.pdf
"3 Conversely, Correspondence: Zenaide MN Quezado   Department of Perioperative Medicine  National Institutes of Health Clinical Center National Institutes of Health 10 Center Drive Building 10, Room 6-5561 Bethesda, MD 20892, USA   Email zquezado@nih.govJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Sheehy et alRunning head recto: Ketamine for pain managementDOI: http://dx.doi.org/10.2147/JPR.S131156",Non-OADS,/arxiv_data1/oa_pdf/c7/ad/jpr-10-787.PMC5388303.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/c7/ad/jpr-10-787.PMC5388303.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 795 Ketamine for pain management 14.,Non-OADS,/arxiv_data1/oa_pdf/c7/ad/jpr-10-787.PMC5388303.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/0e/iew118.PMC5388308.pdf
URL http://www.R-project.org [accessed March 2016].,Non-OADS,/arxiv_data1/oa_pdf/3e/0e/iew118.PMC5388308.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/60/iew123.PMC5388311.pdf
Available on- line at: https://archive.epa.gov/pesticides/reregistration/web/html/aldicarb_fs.html.,OADS,/arxiv_data1/oa_pdf/1f/60/iew123.PMC5388311.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/00/iew107.PMC5388312.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/ea/iew124.PMC5388316.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/2b/iew117.PMC5388317.pdf
"https://www.beiresources.org/ Carroll, S. P., and J. Loye.",Non-OADS,/arxiv_data1/oa_pdf/b6/2b/iew117.PMC5388317.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Insect Science ( 2017 ) 17(1): 28; 1–27 doi: 10.1093/jisesa/iew121 Forum",Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
A num-ber of new air cargo airlines were formed in Colombia to take advan-tage of the opening market to Europe and the United States (http://www.airlinehistory.co.uk/Americas/Colombia/Airlines.asp).,Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
"Names of all chalcids have been validatedwith the London Natural History Museum’s, UniversalChalcidoidea Database http://www.nhm.ac.uk/our-science/data/chalcidoids/.Many adult parasitoids exhibit host-feeding behavior to en- hance protein levels during ova formation and maturation ( Jervis a n dK i d d1 9 8 6 ).",Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
http://www.iadb.org/res/laresnetwork/projects/pr284ﬁnaldraft.,Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
http://www.agnet.org/htmlarea_ﬁle/activities/20110826121346/ paper-340485333.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
"https://www.aphis.usda.gov/Journal of Insect Science , 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
http://www.catalogueoﬂife.org/annual-checklist/2016/search/all/key/Liriomyza/fossil/0/match/1 (accessed 16 June 2016).,OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
"http://glifos.concyt.gob.gt/digital/fodecyt/fodecyt %201997.05.pdf MacVean, C., and R. Pe ´rez.",Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
"http://www.nonnativespecies.org//factsheet/factsheet.cfm?speciesId ¼2037 Milla, K., and S. Reitz.",OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
Available at: http://www.omafra.gov.on.ca/english/crops/facts/14-037.htm (accessed 22 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
"http://uvg.edu.gt/publicaciones/revista/volumenes/revista7.pdf Pereira, D. I. P., J. C. Souza, L. V. C. Santa-Cec /C19ılia, P. R. Reis, and M. A. Souza.",Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
"http://research.cip.cgiar.org/conﬂuence/display/ilcym/ Downloads Sporleder, M., H. E. Tonnang, P. Carhuapoma, J. C. Gonzales, H. Juarez, and J. Kroschel.",OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
"http://siteresources.worldbank.org/ EXTAIRTRANSPORT/Resources/515180-1262792532589/6683177- 1268747346047/air_cargo_ch5.pdf Yabar, E. 1988 .",Non-OADS,/arxiv_data1/oa_pdf/4f/65/iew121.PMC5388319.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8c/b1/imcrj-10-123.PMC5388342.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8c/b1/imcrj-10-123.PMC5388342.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 123–125International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 123 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S129087Pulmonary alveolar hemorrhage following  thrombolytic therapy Santhosh Narayanan1  NK Thulaseedharan1  Gomathy Subramaniam2  Geetha Panarkandy1  Narayanan Arathi1 1Department of Medicine,   2Department of Radiodiagnosis,   Government Medical College,   Kozhikode, Kerala, IndiaAbstract:  We report a case of a 58-year-old male without any comorbidities who was throm- bolysed with streptokinase for acute anterior wall myocardial infarction and developed mas- sive hemoptysis with dyspnea and imaging features showing bilateral alveolar infiltrates.",Non-OADS,/arxiv_data1/oa_pdf/8c/b1/imcrj-10-123.PMC5388342.pdf
"On follow-up after 1 month,  Correspondence: Santhosh Narayanan   Department of Medicine, Government  Medical College, Medical College PO, Kozhikode, Kerala 673008, India   Email drsanthosh4@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Narayanan et alRunning head recto: Pulmonary alveolar hemorrhageDOI: http://dx.doi.org/10.2147/IMCRJ.S129087",Non-OADS,/arxiv_data1/oa_pdf/8c/b1/imcrj-10-123.PMC5388342.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/8c/b1/imcrj-10-123.PMC5388342.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 125 Pulmonary alveolar hemorrhage abuse.,Non-OADS,/arxiv_data1/oa_pdf/8c/b1/imcrj-10-123.PMC5388342.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f0/a0/ndt-13-1007.PMC5388343.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1007–1012Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1007OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13493 0 relationship between hypnosis and personality  trait in participants with high or low hypnotic  susceptibility Yingchun Zhang1,2,* Yunke Wang1,* chanchan shen1,2 Yingying Ye1 si shen1 Bingren Zhang1,2 Jiawei Wang1,2 Wei chen2 Wei Wang1,2 1Department of clinical Psychology  and Psychiatry, school of Public  health, 2Department of Mental health,   sir run run shaw hospital, Zhejiang  University college of Medicine,   hangzhou, People’s republic of china *These authors contributed equally  to this workBackground:  The relationship between normal personality and hypnotic susceptibility is  important for understanding mental processing and mental disorders, but it is less consistent  in normal people or in patients with a psychiatric disorder.",Non-OADS,/arxiv_data1/oa_pdf/f0/a0/ndt-13-1007.PMC5388343.pdf
"correspondence: Wei Wang Department of clinical Psychology and  Psychiatry, school of Public health,  Zhejiang University college of Medicine,  Yuhangtang road 866, hangzhou, Zhejiang  310058, People’s republic of c hina Tel +86 571 8820 8188 email drwangwei@zju.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Zhang et al Running head recto: Personality and hypnosis DOI: http://dx.doi.org/10.2147/NDT.S134930",Non-OADS,/arxiv_data1/oa_pdf/f0/a0/ndt-13-1007.PMC5388343.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f0/a0/ndt-13-1007.PMC5388343.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/a0/ndt-13-1007.PMC5388343.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/36/5a/jpr-10-797.PMC5388344.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/36/5a/jpr-10-797.PMC5388344.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 797–809Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  797 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128597Systemic alterations in plasma proteins from  women with chronic widespread pain compared  to healthy controls: a proteomic study Karin Wåhlén   Patrik Olausson   Anders Carlsson   Nazdar Ghafouri   Björn Gerdle   Bijar Ghafouri Pain and Rehabilitation Centre,   Department of Medical and Health Sciences, Linköping University,  Linköping, SwedenAbstract:  Chronic widespread pain (CWP) is a complex pain condition that is difficult to treat.",Non-OADS,/arxiv_data1/oa_pdf/36/5a/jpr-10-797.PMC5388344.pdf
"1,8–11 There is evidence that CWP/FMS is more prominent among  women with increased age, obesity, depression and low physical activity.4,12 Central alterations in the pain matrix in the brain and central hyperexcitability are  known to be part of the underlying mechanism in CWP/FMS.13–15 There are several  studies suggesting that peripheral factors and alterations could have a prominent role and therefore contribute to the maintenance of pain and increased pain sensitivity in Correspondence: Karin Wåhlén   Pain and Rehabilitation Centre,  Department of Medical and Health Sciences, PAINOMICS ® Laboratory,  Linköping University, SE-581 85 Linköping, Sweden Tel +46 10 103 4155   Email karin.wahlen@liu.seJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Wåhlén et alRunning head recto: Plasma proteomics in women with CWPDOI: http://dx.doi.org/10.2147/JPR.S128597",Non-OADS,/arxiv_data1/oa_pdf/36/5a/jpr-10-797.PMC5388344.pdf
"As a quality control, we used plasma references from Vitamin D External Quality Control Scheme (DEQAS; http://www.deqas.org).",Non-OADS,/arxiv_data1/oa_pdf/36/5a/jpr-10-797.PMC5388344.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/36/5a/jpr-10-797.PMC5388344.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 809 Plasma proteomics in women with CWP,Non-OADS,/arxiv_data1/oa_pdf/36/5a/jpr-10-797.PMC5388344.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6b/41/jaa-10-109.PMC5388345.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6b/41/jaa-10-109.PMC5388345.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 109–110Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 109 COMMENTARY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S129580Egg introduction: differential allergic responses Amrita Dosanjh Medical Center, Rady Childrens  Hospital, San Diego, CA, USAAbstract:  The use of egg protein preparations in clinical trials to reduce the incidence of egg  allergy among infants includes a number of preparations of egg.",Non-OADS,/arxiv_data1/oa_pdf/6b/41/jaa-10-109.PMC5388345.pdf
"Among the 383 infants not sensitized at 4–6 Correspondence: Amrita Dosanjh Medical Center, Rady Childrens Hospital, San Diego, CA, USATel +1 858 442 6146Email pulmd1@gmail.comJournal name: Journal of Asthma and Allergy Article Designation: COMMENTAR YY ear: 2017V olume: 10Running head verso: DosanjhRunning head recto: Egg introduction: differential allergic responsesDOI: http://dx.doi.org/10.2147/JAA.S129580",Non-OADS,/arxiv_data1/oa_pdf/6b/41/jaa-10-109.PMC5388345.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/6b/41/jaa-10-109.PMC5388345.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/87/5c/jpr-10-811.PMC5388346.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/87/5c/jpr-10-811.PMC5388346.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 811–823Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  811 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S129295Prevalence, characteristics, and burden of failed  back surgery syndrome: the influence of various  residual symptoms on patient satisfaction and  quality of life as assessed by a nationwide Internet survey in Japan Shinsuke Inoue1,2 Mitsuhiro Kamiya2 Makoto Nishihara1 Y oung-Chang P Arai1,3 Tatsunori Ikemoto1,3 Takahiro Ushida1,3 1Multidisciplinary Pain Center,   2Department of Orthopaedic Surgery,   3Institute of Physical Fitness, Sports  Medicine and Rehabilitation, Aichi  Medical University, Aichi, JapanAbstract: We conducted a cross-sectional, Internet-based survey with a nationally representative  sample of Japanese adults to assess the prevalence and characteristics of failed back surgery syn- drome (FBSS).",Non-OADS,/arxiv_data1/oa_pdf/87/5c/jpr-10-811.PMC5388346.pdf
"Indeed, symptoms aside from pain tend  Correspondence: Shinsuke Inoue Multidisciplinary Pain Center, Aichi Medical University, 1-1 Yazako Karimata, Nagakute, Aichi 480-1195, JapanTel +81 561 62 5004Fax +81 561 62 5004Email misty-ssk@umin.netJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Inoue et alRunning head recto: Characteristics of failed back surgery syndromeDOI: http://dx.doi.org/10.2147/JPR.S129295",Non-OADS,/arxiv_data1/oa_pdf/87/5c/jpr-10-811.PMC5388346.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/87/5c/jpr-10-811.PMC5388346.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 823 Characteristics of failed back surgery syndrome,Non-OADS,/arxiv_data1/oa_pdf/87/5c/jpr-10-811.PMC5388346.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1b/48/imcrj-10-117.PMC5388347.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1b/48/imcrj-10-117.PMC5388347.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 117–121International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 117 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S130210First case of imported chikungunya infection in  Croatia, 2016 Boris Luksic,1,2 Nenad  Pandak,2,3 Edita Drazic- Maras,1 Svjetlana Karabuva,1  Mislav Radic,2,4 Andrea  Babic-Erceg,5 Ljubo Barbic,6  Vladimir Stevanovic,6  Tatjana Vilibic-Cavlek5,7,8 1Clinical Department of Infectious  Diseases, University Hospital Centre  Split, Split, Croatia; 2School of  Medicine, University of Split, Split,  Croatia;  3Department of Infectious  Diseases, General Hospital “Dr Josip Bencevic”, Slavonski Brod, Croatia;   4Department of Rheumatology and  Clinical Immunology, University Hospital Centre Split, Split, Croatia ;   5Croatian National Institute of Public  Health, Zagreb, Croatia; 6Department  of Microbiology and Infectious Diseases with Clinic, Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia;  7Reference  Centre for Diagnosis and Surveillance of Viral Zoonoses of the Ministry of Health of the Republic of Croatia,  Zagreb, Croatia;  8School of Medicine,   University of Zagreb, Zagreb, CroatiaAbstract: In recent years, several European countries reported cases of imported chikungunya  infection.",Non-OADS,/arxiv_data1/oa_pdf/1b/48/imcrj-10-117.PMC5388347.pdf
"11 We report the first detection of an  imported, clinically manifested case of chikungunya fever in Croatia.Correspondence: Nenad Pandak Department of Infectious Diseases, General Hospital “Dr Josip Bencevic”, Andrije Stampara 42, 35000 Slavonski Brod, CroatiaEmail npandak@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Luksic et alRunning head recto: Chikungunya infection in CroatiaDOI: http://dx.doi.org/10.2147/IMCRJ.S130210",Non-OADS,/arxiv_data1/oa_pdf/1b/48/imcrj-10-117.PMC5388347.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/1b/48/imcrj-10-117.PMC5388347.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 121 Chikungunya infection in Croatia  18.,Non-OADS,/arxiv_data1/oa_pdf/1b/48/imcrj-10-117.PMC5388347.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 133–144Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 133 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S125885First, do no harm: institutional betrayal and trust  in health care organizations Carly Parnitzke Smith Department of Psychology, University  of Oregon, Eugene, OR, USAPurpose: Patients’ trust in health care is increasingly recognized as important to quality care,  yet questions remain about what types of health care experiences erode trust.",Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
"7  Very little research has focused on the types of health care experiences that are likely Correspondence: Carly Parnitzke Smith Penn State University College of Medicine, Department of Humanities, 500 University Drive, Hershey, PA, 17033, USATel +1 717 531 8778   Fax +1 717 531 3894   Email csmith34@pennstatehealth.psu.eduJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: SmithRunning head recto: Institutional betrayal in health careDOI: http://dx.doi.org/10.2147/JMDH.S125885",Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
Retrieved from: http://www.nap.edu/books/0309068371/html/.,Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK2673/.,Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
Available from: https://www.americanbar.org/content/dam/aba/images/medical_liability/CRS_SI.pdf.,OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
Retrieved from: http://papers.ssrn.com/abstract= 1744225.,Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
Creative Commons license  and disclaimer available from: http://creativecommons.org/licenses/by/4.0/legalcode.1,Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 144 Smith References 1.,Non-OADS,/arxiv_data1/oa_pdf/09/95/jmdh-10-133.PMC5388348.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/70/dd/jmdh-10-157.PMC5388350.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/70/dd/jmdh-10-157.PMC5388350.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 157–166Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 157 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S124298Unlocking the “black box” of practice  improvement strategies to implement surgical  safety checklists: a process evaluation  Brigid M Gillespie1–3 Kyra Hamilton4 Dianne Ball5 Joanne Lavin6 Therese Gardiner6 T eresa K Withers7 Andrea P Marshall1–3 1School of Nursing & Midwifery,   Griffith University, Gold Coast,   2Gold Coast University Hospital  and Health Service, Southport,   3Nursing & Midwifery Education  & Research Unit (NMERU), National  Centre of Research Excellence in  Nursing, Menzies Health Institute of Queensland, Griffith University, Gold Coast,  4School of Applied Psychology,   Griffith University, Mt Gravatt,   5Communio Pty Ltd, Sydney, 6Nursing  & Midwifery Education & Research Unit,  7Surgical and Procedural  Services, Gold Coast University Hospital and Health Service,  Southport, AustraliaBackground: Compliance with surgical safety checklists (SSCs) has been associated with  improvements in clinical processes such as antibiotic use, correct site marking, and overall  safety processes.",Non-OADS,/arxiv_data1/oa_pdf/70/dd/jmdh-10-157.PMC5388350.pdf
"Following  development, the WHO SSC was tested in eight diverse settings, including  developing Correspondence: Brigid M Gillespie  National Centre of Research Excellence in Nursing, Menzies Health Institute Queensland, School of Nursing and Midwifery, Griffith University, Room 2.04, G01, Griffith University, Southport, QLD 4222, AustraliaTel +61 7 5552 9718 (Griffith)Email b.gillespie@griffith.edu.auJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Gillespie et alRunning head recto: Process evaluation of surgical safety checklist implementationDOI: http://dx.doi.org/10.2147/JMDH.S124298",Non-OADS,/arxiv_data1/oa_pdf/70/dd/jmdh-10-157.PMC5388350.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/70/dd/jmdh-10-157.PMC5388350.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 166 Gillespie et al 37.,Non-OADS,/arxiv_data1/oa_pdf/70/dd/jmdh-10-157.PMC5388350.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/d3/main.PMC5388355.pdf
Contents lists available at ScienceDirect American Journal of Ophthalmology Case Reports journal homepage: http://www.ajocasereports.com/ http://dx.doi.org/10.1016/j.ajoc.2017.01.001 2451-9936/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/d3/main.PMC5388355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).American Journal of Ophthalmology Case Reports 6 (2017) 15 e17,Non-OADS,/arxiv_data1/oa_pdf/86/d3/main.PMC5388355.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 145–155Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 145 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S113483Managing the patient with osteogenesis  imperfecta: a multidisciplinary approach Caroline Marr1,*  Alison Seasman1,*  Nick Bishop2 1Metabolic Bone Disease T eam,   2Academic Unit of Child Health,   Department of Human Metabolism,   University of Sheffield, Sheffield Children’s NHS Foundation Trust,  Sheffield, UK *These authors contributed equally to  this workAbstract:  Osteogenesis imperfecta (OI) is a heterogeneous heritable connective tissue disor - der characterized by low bone density.",Non-OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
"It aims to demonstrate how a specialist and an MDT are  Correspondence: Caroline Marr Metabolic Bone Disease Team, Sheffield Children’s NHS Foundation Trust, Western Bank, Sheffield, South   Yorkshire S10 2TH, UK   Tel +44 114 226 7890   Fax +44 114 226 7832   Email Caroline.Marr@sch.nhs.ukJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Marr et alRunning head recto: Managing the patient with OIDOI: http://dx.doi.org/10.2147/JMDH.S113483 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
Or use: http://youtu.be/r_FtTo7sIFU,Non-OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
Available from: http://apps.who.int/iris/bitstream/10665/43960/1/9789241547482_eng.pdf.,OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 155 Managing the patient with OI 64.,Non-OADS,/arxiv_data1/oa_pdf/91/f1/jmdh-10-145.PMC5388361.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/0e/fww038.PMC5388365.pdf
"See: https://www.varta.org.au/sites/default/ﬁles/VARTA%20Annual%20Report%202015.pdf, accessed 1 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/f5/0e/fww038.PMC5388365.pdf
"9 See, eg, the stories of Narelle Grech <http://www.smh.com.au/comment/their-right-to-know-20130413- 2hset.html >accessed 1 September 2016 and Lauren Burns <http://www.abc.net.au/austory/specials/ searchingforcelevenpartone/ >accessed 1 September 2016, both of whom appeared before Victoria’s Inquiry into Access , ibid.",Non-OADS,/arxiv_data1/oa_pdf/f5/0e/fww038.PMC5388365.pdf
<https://www.varta.org.au/sites/default/ﬁles/VARTA%20Annual%20Report%202015.,Non-OADS,/arxiv_data1/oa_pdf/f5/0e/fww038.PMC5388365.pdf
<http://docs2.health.vic.,Non-OADS,/arxiv_data1/oa_pdf/f5/0e/fww038.PMC5388365.pdf
30 Donor Sibling Registry: <https://www.donorsiblingregistry.com/ >accessed 1 September 2016.576 • MEDICAL LAW REVIEW,Non-OADS,/arxiv_data1/oa_pdf/f5/0e/fww038.PMC5388365.pdf
"Jasmine had lobbied both the 50 See, eg, the story of Sarah Dingle whose donor number was cut out of her records by a nurse at the Royal North Shore Hospital in Sydney: S Dingle, ‘Misconception’ Sydney Morning Herald (16 August 2014) <http://www.smh.com.au/lifestyle/life/misconception-20140810-3dha9.html >accessed 1 September 2016.Donor Identity Disclosure • 589",Non-OADS,/arxiv_data1/oa_pdf/f5/0e/fww038.PMC5388365.pdf
"OcAlphaMed Press 1083-7159/2016/$20.00/0 http://dx.doi.org/10.1634/theoncologist.2016-0409 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/b0/bd/onco12106.PMC5388388.pdf
"Available DSMC plans include those by the National Institute of Dental andCraniofacial Research (https://www.nidcr.nih.gov/Research/ ToolsforResearchers/Toolkit/ DSMBGuidelines.htm), and the University of Oregon, the University of Wisconsin, and theDana-Farber Cancer Institute, among others (https://cancer- centers.cancer.gov/).",Non-OADS,/arxiv_data1/oa_pdf/b0/bd/onco12106.PMC5388388.pdf
J Clin Oncol 2016 [Epub ahead of print] See http://www.TheOncologist.com for supplemental material available online.374 Academic Cancer Center Phase I Programs Oc2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/onco12106.PMC5388388.pdf
"To more fully understand how the 32 differentially expressed genes affect autophagy, we further performed a gene network analysis by using the STRING online database( http://string-db.org/ ).Wefoundthatthe20down- regulatedgenespredominantlyfunctioninthepositivereg- ulation of NF- /H9260B activity and biosynthetic processes (Fig- ure5A, red balls), indicating that loss of H2Bub1 likely re- sults in the inhibition of NF- /H9260B activity and biosynthetic processes.NF- /H9260Bhasbeenrecognizedasanegativeregula- tor of autophagy in multiple conditions ( 53,54), and lower biosyntheticactivityisaknowncharacteristicofautophagy (55).",OADS,/arxiv_data1/oa_pdf/6e/df/gkw1025.PMC5388390.pdf
( A)Twentydown-regulatedand( B)12up-regulatedgenesfrom Figure4DweresubjectedtoSTRINGnetworkanalysis( http://string-db.org/ ).,OADS,/arxiv_data1/oa_pdf/6e/df/gkw1025.PMC5388390.pdf
"The results have beencollated into a comprehensive online repository of miRNA expression and features such as modiﬁca- tions and RNA editing events, which is availableat:http://wwwdev.ebi.ac.uk/enright-dev/miratlas .W e believe these ﬁndings will further contribute to our understanding of miRNA function in animals andbeneﬁt the miRNA community in general.",OADS,/arxiv_data1/oa_pdf/c7/05/gkw1031.PMC5388392.pdf
"Southern hybridization TheextractedgenomicDNAsweredigestedwithEcoRIto detect telomeres, telo-5k, telo-9k, telo-15k, telo-33k, con- trol region (genomic location 2232548–2233109 chromo- some II, http://www.ncbi.nlm.nih.gov/nuccore/CU329671.",OADS,/arxiv_data1/oa_pdf/5f/63/gkw1176.PMC5388396.pdf
"1), andhis1(genomic location 4314109–4314600 chromo- someI,http://www.ncbi.nlm.nih.gov/nuccore/CU329670.1 ) fragments.",Non-OADS,/arxiv_data1/oa_pdf/5f/63/gkw1176.PMC5388396.pdf
The sequence files are archived in Pom- base ( http://ebi.edu.au/ftp/databases/pombase/pombe/ Archived directories/Cosmid sequences/ ).,OADS,/arxiv_data1/oa_pdf/5f/63/gkw1176.PMC5388396.pdf
"In addition, in chromatin immunoprecipitates with an anti-Mcm10 polyclonal antibody, amplification of the lozengegene upstream region containing binding sites for various insulator associated factors such as MDG4, Su(Hw), CTCF, CP190 and BEAF32 (ModEncode: http://gbrowse.modencode.org/fgb2/gbrowse/fly/?start = 9180673;end =9182335;ref =X;label =Genes;label = White INSULATORS WIG;width =750#) was 25-fold higher than with control rabbit IgG (Figure 10B).",Non-OADS,/arxiv_data1/oa_pdf/7a/7b/gkw1174.PMC5388399.pdf
Gene sets of transcriptional modules for hematopoiesis weredownloadedfromtheStemSitewebsiteattheGeorge Daley lab ( http://daleystem.hms.harvard.edu/ )(53).,OADS,/arxiv_data1/oa_pdf/72/26/gkw1214.PMC5388401.pdf
Scripts are available open source (MITlicense) on GitHub at https://github.com/VoigtLab/MIT- BroadFoundry/tree/master/dialout-designs/ .,OADS,/arxiv_data1/oa_pdf/40/37/gkw1226.PMC5388403.pdf
The script is available on GitHub at https://github.com/VoigtLab/MIT- BroadFoundry/tree/master/dialout-designs/ .,Non-OADS,/arxiv_data1/oa_pdf/40/37/gkw1226.PMC5388403.pdf
The code for the design tools described in this work is available on GitHub ( https://github.com/VoigtLab/ MIT-BroadFoundry/tree/master/dialout-designs/ and https://github.com/CIDARLAB/poolDesigner/ ).,OADS,/arxiv_data1/oa_pdf/40/37/gkw1226.PMC5388403.pdf
"For all the Uniprot AARS enzymes that were used for training, the resulting phylogenetic trees together with thecorresponding motifs and motif architectures are availableinhtmlformatinthewebsite( http://bioinf.bio.uth.gr/aars ).",OADS,/arxiv_data1/oa_pdf/e0/e1/gkw1182.PMC5388404.pdf
Those data have been converted from TAIR6 to TAIR10 coordinates by a perl script provided bythe1001genomesproject( http://1001genomes.org/data/ software/translate tair8/)andmanuallyvalidated.tasiRNA producing loci were given by tasiRNAdb ( 71).,OADS,/arxiv_data1/oa_pdf/2d/61/gkw1264.PMC5388410.pdf
"The figures of the structures are performed with UCSF Chimera(51),ePMV( 52)andBlender( http://www.blender.org ).",OADS,/arxiv_data1/oa_pdf/22/b4/gkw1233.PMC5388414.pdf
"Nucleotide sequence analysis The alignment of sixty-six unique 3 /primeUTR sequences of FMDV field isolates deposited in GenBank, representative ofallserotypes,wasperformedusingCLUSTALXsoftwarewithdefaultparameters( http://www.clustal.org ).Sequence logos(http://weblogo.berkeley.edu )weregeneratedfromthe multiple-sequence alignment of the RNA sequences.",OADS,/arxiv_data1/oa_pdf/5f/d3/gkw795.PMC5388415.pdf
Coreandplasmidpathwaysinfluencedby SmYbeY.ChangesinmRNAabundanceinexponential(log)andstationary(stat)culturesarevisualized in heatmaps generated with the MeV tool ( http://www.tm4.org/mev.html ).,OADS,/arxiv_data1/oa_pdf/be/73/gkw1234.PMC5388416.pdf
The AbcR2- prbAantisense interaction as predicted by IntaRNA ( http://rna.informatik.uni-freiburg.de/ IntaRNA/Input.jsp ) is shown on top.,OADS,/arxiv_data1/oa_pdf/be/73/gkw1234.PMC5388416.pdf
"shRNAs design, cloning and transfection Custom shRNAs were constructed using the TRC hairpin design tool ( http://www.broadinstitute.org/rnai/public/seq/ search),anddesignedtotargetthe3 /prime-UTRoftheFbltran- script (NM 007991).",OADS,/arxiv_data1/oa_pdf/4b/c0/gkw810.PMC5388417.pdf
"Prediction of guide snoRNAs ToidentifyputativesnoRNAstargetingthediscoveredsites, a sequence of 20 nucleotides centered on the discoveredsite was extracted, and passed to the Snoscan software (14)(http://lowelab.ucsc.edu/snoscan/ ),withdefaultparam- eters.",OADS,/arxiv_data1/oa_pdf/4b/c0/gkw810.PMC5388417.pdf
"For mouse rRNA 2/prime-OMe sites analysis, 18S and 28S rRNA sequences from human and mouse were aligned using the EMBOSS Needle tool ( http://www.ebi.ac.uk/ Tools/psa/emboss needle/nucleotide.html ), and known hu- man sites wereliftedover from human tomouse.",OADS,/arxiv_data1/oa_pdf/4b/c0/gkw810.PMC5388417.pdf
The secondary structure of the human 18S rRNA has been obtained fromCRWwebsite( 34)(http://www.rna.icmb.utexas.edu/ ).,OADS,/arxiv_data1/oa_pdf/4b/c0/gkw810.PMC5388417.pdf
Bedtools is a publically available toolset for genomics analysis and can be found at http://bedtools.readthedocs.,OADS,/arxiv_data1/oa_pdf/a7/40/gkw883.PMC5388423.pdf
"An online implementation of this ap- proach, IMHOTEP (‘Integrating Molecular Heuristics and Other Tools for Effect Prediction’), is provided at http://www.uni-kiel.de/medinfo/cgi-bin/predictor/ .INTRODUCTION Unravelling thegenetic basis ofinheriteddiseases has been amajorfocusofhumangeneticsresearchfordecades.Over thelast10years,thedevelopmentoffast,accurateandinex-pensive DNA sequencing technologies has brought within reachthecomprehensivecharacterizationofallgeneticvari- antscarriedbyagivenindividual,manyofthemrareorevenprivate.",OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
An online implementa-tion of our integration approach is provided under the acronym IMHOTEP (‘Integrating Molecular Heuristics and Other Tools for Effect Prediction’) at http://www.uni- kiel.de/medinfo/cgi-bin/predictor/ .,OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
"Heis associated with the Greek god of medicine, Asclepios (https://www.britannica.com/biography/Imhotep )(26).",Non-OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
"MATERIALS AND METHODS Mutationdata TwosetsofnsSNVswithputativelyknownfunctionalcon- sequenceswereusedtoconstructandevaluateacomposite predictionscore.Thefirstsetofdatawasretrievedbymeansof the UCSC Genome Browser ( http://genome.ucsc.edu/ cgi-bin/hgTables , table: snp135Common) and filtered ac- cording to the following criteria: (i) minor allele frequency(MAF) >10%, (ii) missense variant, (iii) validated by at leasttwomethods(e.g.presenceinbothHapMapand1000 Genomesproject),(iv)nomorethantwoallelesreportedsofar and (v) absent from HGMD.",OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
We deliberatelychose not to label these variants ‘neutral’ because ‘neutral’ hasanestablishedmeaninginpopulationgenetics( 27).The corresponding amino acid substitutions were derived from dbSNP(http://www.ncbi.nlm.nih.gov/SNP/ )andtheunder- lying amino acid sequences were downloaded from UCSC.Allinformationwascombinedusinganin-housePerlscript.,Non-OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
"PolyPhen-2 ( http://genetics.bwh.harvard.edu/pph2/ ), SIFT ( http://sift.bii.a-star.edu.sg ), MutationTaster2 (http://www.mutationtaster.org/ ), Mutation Asses- sor (http://mutationassessor.org/r3/ )a n dF A T H M M (http://fathmm.biocompute.org.uk/inherited.html )w e r e accessed by way of batch queries.",OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
"Owing to the largenumber of queries necessary, the output of MutPred (http://mutpred.mutdb.org/ ) had to be generated locally by staff from the School of Informatics and Com-puting, Indiana University.",OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
"The output of SNPs&GO (http://snps-and-go.biocomp.unibo.it/snps-and-go/ )w a s obtainedusingaPerlscript.Allresultfilesweremergedand processed with R (R v.3.2.2, https://www.R-project.org .)",OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
"All relevant model parameters of the logistic regression analysis and the final decision tree can be found in Figure 1andSupplementaryTableS12.Furthermore,awebserver hasbeenset-upwhichautomaticallyscoresvariantsaccord- ing to our best integration models ( http://www.uni-kiel.de/ medinfo/cgi-bin/predictor/ ).Theinputforthiswebserveris thepredictionscoresoftheindividualpredictiontools(e.g.",OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
An online imple- mentation of the integration approach developed in this study (IMHOTEP) is provided at http://www.uni-kiel.de/,Non-OADS,/arxiv_data1/oa_pdf/7e/4c/gkw886.PMC5388428.pdf
"The BLASTx searches were used for generating ROCker profiles for NosZ, NirKand RpoB protein references (profiles available through http://enve-omics.ce.gatech.edu/rocker ).",OADS,/arxiv_data1/oa_pdf/1d/a7/gkw900.PMC5388429.pdf
All gen-erated data sets are available through http://enve-omics.ce.,OADS,/arxiv_data1/oa_pdf/1d/a7/gkw900.PMC5388429.pdf
An in housescript (‘JPlace.to iToL.rb’ available throughhttp://enve-omics.gatech.edu ) was used to prepare the visualization of the generated jplace file ( 25)i ni T O L (26).,OADS,/arxiv_data1/oa_pdf/1d/a7/gkw900.PMC5388429.pdf
"Availability and dependencies of ROCker The ROCker package, documentation and pre-computed profiles are available through http://enve-omics.ce.gatech.",OADS,/arxiv_data1/oa_pdf/1d/a7/gkw900.PMC5388429.pdf
edu/rocker .ROCkerisdistributedbothasapackagedRuby gem (https://rubygems.org/gems/bio-rocker ) and source code (https://github.com/lmrodriguezr/rocker ) under the terms of the Artistic License 2.0.,Non-OADS,/arxiv_data1/oa_pdf/1d/a7/gkw900.PMC5388429.pdf
"In addition, ROCker models can be built online through http://enve-omics.ce.gatech.edu/rocker-build/ .",Non-OADS,/arxiv_data1/oa_pdf/1d/a7/gkw900.PMC5388429.pdf
lividus transcriptome databases ( http://octopus.obs- vlfr.fr)usingthehomologous human (NCBI)and Strongy- locentrotuspurpuratus (http://Echinobase.org ;(40)) protein sequences.,OADS,/arxiv_data1/oa_pdf/6a/2f/gkw907.PMC5388431.pdf
ACKNOWLEDGEMENTS We thank T. Lepage and P. Dru for granting access to the P. lividus transcriptome at http://octopus.obs-vlfr.fr/ .W e thank the SMO and M3 services of the Station Biologique forcollectionand maintenance of seaurchins.,Non-OADS,/arxiv_data1/oa_pdf/6a/2f/gkw907.PMC5388431.pdf
"Databases URLs The NT2-D1 ChIP-seq datasets for H3K27me3 (wgEn- codeEH000908), H3K4me3 (wgEncodeEH000909), H3K36me3 (wgEncodeEH000915) and input (wgEn-codeEH000654) were obtained and visualized from the UCSC genome browser ( http://http://genome.ucsc.edu ).",OADS,/arxiv_data1/oa_pdf/c8/b8/gkw966.PMC5388432.pdf
The ‘my5C-heatmap’ bioinfor- matics tool can be found at http://3dg.umassmed.edu/ my5Cheatmap/heatmap.php .,OADS,/arxiv_data1/oa_pdf/c8/b8/gkw966.PMC5388432.pdf
"Mol Cell Biochem 2016; 416:47-62; http://dx.doi.org/10.1007/s11010-016-2695-0;Logan SM, Tessier SN, Tye J, Storey KB.",OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
Mol Cell Biochem 2016; 414:115-27;http://dx.doi.org/10.1007/s11010-016-2665-6 Humans live within a surprisingly narrow window of body temperature (T b)w i t hc o r eT btypically regulated at 36.5–37.5/C14C.,Non-OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"1, 15 –17 http://dx.doi.org/10.1080/23328940.2016.1211071",Non-OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"Apoptosis 20 10; 15:386-99; PMID:20127173; http://dx.doi.org/ 10.1007/s10495-010-0467-y [2] Logan SM, Luu BE, Storey KB.",Non-OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"Mol Cell Biochem 2016; 416:47-62; PMID:27032768; http://dx.doi.org/10.1007/s11010-016-2695-0 [3] Logan SM, Tessier SN, Tye J, Storey KB.",OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"Mol Cell Biochem 2016; 414:115-27; PMID:2 6885984; http://dx.doi.org/10.1007/s11010-016-2665-6 [4] Biggar KK, Storey KB.",Non-OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"J Exp Biol 2015; 218:1281-9; PMID:25954040; http://dx.doi.org/10.1242/jeb.104828 [5] McMullen DC, Hallenbeck JM.",OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"J Comp Physiol B Biochem Syst Environ Physiol 2010; 180:927-934; http://dx.doi.org/10.1007/s00360-010-0468-8 Samantha M. Logan and Kenneth B. Storey Institute of Biochemistry &Department of Biology, Carleton University 1125 Colonel By Drive, Ottawa, Ontario K1S 5B6, Canada KenStorey@cunet.carleton.ca; kenneth_storey@carleton.caTEMPERATURE 17",Non-OADS,/arxiv_data1/oa_pdf/9b/4d/ktmp-04-01-1211071.PMC5388434.pdf
"Nature 2016; 534:267-71; http://dx.doi.org/10.1038/nature18296 First discovered in 1947, the Zika virus is an arbovirus of the Flaviviridae family, that has not been reported to cause human disease until 2007 when the ﬁrst outbreak took place in the Yap State, Micronesia.",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/ktmp-04-01-1208319.PMC5388436.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/ktmp-04-01-1208319.PMC5388436.pdf
"1, 13 –14 http://dx.doi.org/10.1080/23328940.2016.1208319",Non-OADS,/arxiv_data1/oa_pdf/ac/a7/ktmp-04-01-1208319.PMC5388436.pdf
"Cell Stem Cell 2016; 19:120 –6; http://dx.doi.org/10.1016.j.stem.2016.04.017 [2] Cugola FR, Fernandes IR, Russo FB, Freitas BC, Dias JL, Guimar ~aes KP, Benazzato C, Almeida N, Pignatari GC, Romero S, et al.",OADS,/arxiv_data1/oa_pdf/ac/a7/ktmp-04-01-1208319.PMC5388436.pdf
"Cell 2016; 165:1081-91; PMID:27180225; http://dx.doi.org/10.1016/j.cell.2016.05.008 [4] Higa LM, Trindade P, Delvecchio R, Tanuri A, Rehen SK.",OADS,/arxiv_data1/oa_pdf/ac/a7/ktmp-04-01-1208319.PMC5388436.pdf
"Cell 2016; 165:1238-54; PMID:27118425; http://dx.doi.org/10.1016/j.cell.2016.04.032 Jean Pierre Schatzmann Peron Neuroimmune Interactions Laboratory Department of Immunology, University of S ~ao Paulo, S ~ao Paulo 05508-000, Brazil jeanpierre@usp.br Patr/C19ıcia Cristina Baleeiro Beltr ~ao Braga Stem Cell Laboratory Department of Surgery, University of S ~ao Paulo - S ~ao Paulo, S ~ao Paulo, Brazil Figure 1.",OADS,/arxiv_data1/oa_pdf/ac/a7/ktmp-04-01-1208319.PMC5388436.pdf
Available at: http://www.medical-outcomes.com.,Non-OADS,/arxiv_data1/oa_pdf/43/f7/ACER-41-836.PMC5388456.pdf
"2009[cited 2016 Jan. 3]; Available from: URL: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf 2) Lee IM, Shiroma EJ, Lobelo FPuska P, Blair SN, Katzmarzyk PT.",Non-OADS,/arxiv_data1/oa_pdf/86/24/1348-9585-59-24.PMC5388609.pdf
"[cited 2016 Jan. 3]; Available from: URL: http://www.who.int/chp/steps/GPAQ/en/ 25) Hallal PC, Andersen LB, Bull FC, et al.",OADS,/arxiv_data1/oa_pdf/86/24/1348-9585-59-24.PMC5388609.pdf
[cited 2016 Jan. 3]; Available from:URL: http://www.who.int/chp/steps/resources/GPAQ_Analysis_Guide.pdf 28) Oka K. Stages of change for exercise behavior and self- efficacy for exercise among middle-aged adults.,OADS,/arxiv_data1/oa_pdf/86/24/1348-9585-59-24.PMC5388609.pdf
"[cited 2016 Jan. 3]; Available from: URL: http://www.st atmodel.com/ugexcerpts.shtml 31) Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC.",Non-OADS,/arxiv_data1/oa_pdf/86/24/1348-9585-59-24.PMC5388609.pdf
"Seoul, 2016[cited2016 May 30]; Available from: URL: http://www.moel.go.kr/english/download_eng.jsp?type=&file=(49)_INDUSTRIAL_ACCIDENT_COMPENSATION_INSURANCE_ACT_2015(13323)v1.pdf 20) Seok H, Yoon JH, Lee W, et al.",Non-OADS,/arxiv_data1/oa_pdf/b3/d4/1348-9585-59-38.PMC5388611.pdf
"Seoul, 2016[cited 2016 May 30]; Available from:URL: http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2771 24) Seok H, Yoon JH, Lee W, et al.",OADS,/arxiv_data1/oa_pdf/b3/d4/1348-9585-59-38.PMC5388611.pdf
Interventions Participants in the intervention group were provided access to an information website for stress and depressionnamed The University of Tokyo website for Stress Man-agement and Education on Depression; UTSMed (http://mental.m.u-tokyo.ac.jp/utsmed/) 28 ).,Non-OADS,/arxiv_data1/oa_pdf/cf/d2/1348-9585-59-46.PMC5388612.pdf
1991 Availablefrom: URL: https://www.osha.gov/ pls/oshaweb/owadisp.show _document?p_table=STANDARDS&p_id=9735.,OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
1998Available from: URL: http://www.cdc.gov/niosh/docs/98-126/.,OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
Available from: URL: https://osha.europa.eu/en/legislation/directives/82.,Non-OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
2005Available from: URL: http://www.legislation.gov.uk/uksi/2005/ 1643/regulation/4/made.,Non-OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
[Online].2006Available from: URL: http://www.shawpat.or.th/index.php?option=com_phocadownloa d&view=category&id=12%3A ministerial-regulation&Itemid=157.,Non-OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
2010Available from: URL: http://www.shawpat.or.th/inde x.php?option=com_phocadownloa d&view=category&id=6%3A-m---m-s&Itemid=77&limitstart=20.,Non-OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
[Online].Available from: URL: http://www.shawpat.or.th/index.php?option=com_phocadownload&view=category&id=6%3A-m---m-s&Itemid=77&limitstart=30.,Non-OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
Available from: URL: https://onlinecourses.science.psu.edu/stat501/node/344.,OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
Available from: URL: http://i-medipro.com.www.readyplanet.net/_m/article/content/content.php?aid=70931.,OADS,/arxiv_data1/oa_pdf/75/c5/1348-9585-59-55.PMC5388613.pdf
Available from: http://www.cos-mag.com/health-page/health-page-sto ries/4125-moving-the-needle.html.,Non-OADS,/arxiv_data1/oa_pdf/dd/9c/1348-9585-59-63.PMC5388614.pdf
"29];Available from: URL: http://www.ccohs.ca/oshanswers/diseases/needlestick_injuries.html 4) Appelbaum NP, Dow A, Mazmanian PE, Jundt DK, Appel- baum EN.",Non-OADS,/arxiv_data1/oa_pdf/dd/9c/1348-9585-59-63.PMC5388614.pdf
Verfügbar unter: Available from: URL: http://www.ergonomieself.org/documen ts/36eme-Montreal-2001/ PD F-ENG/V4-058-R219-DA- SILVEIRA.pdf [14.7.20.2010].,Non-OADS,/arxiv_data1/oa_pdf/57/04/1348-9585-59-81.PMC5388617.pdf
All tests followed the testing and qual- ity assurance practices outlined by the European Committee on Antimicrobial Susceptibility Test-ing (Eucast) (http://www.eucast.org).,Non-OADS,/arxiv_data1/oa_pdf/d8/ac/CIEMD-1-102.PMC5388794.pdf
The deduced amino acid sequences were aligned with those retrieved from the Gen-Bank database by using the CLUSTAL W (http://www.ebi.ac.uk/tools/ clustalw2).,OADS,/arxiv_data1/oa_pdf/d8/ac/CIEMD-1-102.PMC5388794.pdf
"https://clinicaltrials.gov , 2010 , NCT01109498.",Non-OADS,/arxiv_data1/oa_pdf/56/94/CPB-16-684.PMC5388796.pdf
"[20] Investigation of t he safety and feasibility of AAV1 /SERCA2a  gene transfer in patients with chronic heart failure and a left  ventricular assist device (SERCA -LVAD), http://clinicaltrials.gov  (Accessed October 24, 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/56/94/CPB-16-684.PMC5388796.pdf
Guidance for Industry: INDs -approaches to complying  with CGMP during Phase 1. http://www.fda.gov/ cber/   guidelines.htm.,Non-OADS,/arxiv_data1/oa_pdf/56/94/CPB-16-684.PMC5388796.pdf
"http://www.bio - rad.com/webroot/web/pdf/psd/literature/Bulletin_2156.pdf  (Accessed October 24, 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/56/94/CPB-16-684.PMC5388796.pdf
"http://www.gelifesci ences.com/gehcls_images/GELS/Related%20C ontent/Files/1349939730181/litdoc29022223_20130925000229.pdf  (Accessed June 25, 2012 ).",OADS,/arxiv_data1/oa_pdf/56/94/CPB-16-684.PMC5388796.pdf
"Investigating the comme rcial  database of the Leibniz -Institut DSMZ -Deutsche Sammlung   von Mikroorganismen und Zellkulturen GmbH, 51 different  AML cell lines are available (http://www.dsmz.de/ catalogues/  catalogue -human -and-animal -cell-lines.html, a ccessed 26.02.",OADS,/arxiv_data1/oa_pdf/cd/88/CPB-17-52.PMC5388801.pdf
§The mutation data was obtained from the Sanger Institute Catalogue of Somatic Mutations in Cancer (COSMIC) web site (http://www.sanger .ac.uk/cosmic ) [35].,OADS,/arxiv_data1/oa_pdf/cd/88/CPB-17-52.PMC5388801.pdf
"REFERENCES   [1] SEER Cancer Statistics Review, 1975 -2011. http://seer.cancer.gov/csr/  1975_2011/ (accessed April 16, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/cd/88/CPB-17-52.PMC5388801.pdf
"In @ERSpublications PAVMs pose unique management challenges; publication patterns indicate their importanceremains poorly recognised http://ow.ly/7iIT304WYl2 Cite this article as: Shovlin CL, Gossage JR.",Non-OADS,/arxiv_data1/oa_pdf/5e/dd/00104-2016.PMC5388822.pdf
ERJ Open Res 2017; 3: 00104-2016 [https://doi.org/10.1183/ 23120541.00104-2016].,Non-OADS,/arxiv_data1/oa_pdf/5e/dd/00104-2016.PMC5388822.pdf
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. https://doi.org/10.1183/23120541.00104-2016 ERJ Open Res 2017; 3: 00104-2016 ORIGINAL RESEARCH LETTER,Non-OADS,/arxiv_data1/oa_pdf/5e/dd/00104-2016.PMC5388822.pdf
https://doi.org/10.1183/23120541.00104-2016 2ORIGINAL RESEARCH LETTER | C.L.,Non-OADS,/arxiv_data1/oa_pdf/5e/dd/00104-2016.PMC5388822.pdf
https://doi.org/10.1183/23120541.00104-2016 3ORIGINAL RESEARCH LETTER | C.L.,Non-OADS,/arxiv_data1/oa_pdf/5e/dd/00104-2016.PMC5388822.pdf
"23 38106 Braunschweig Germany E-Mail: reinhold.haux@plri.deMethods Inf Med 2017; 56(Open): e39 – e48 https://doi.org/10.3414/ME16-01-0124 received: October 21, 2016 accepted: February 18, 2017 published: March 8, 2017 OPEN ACCESS © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )",Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
"9.Strategic Information Management in  Hospitals:                Strategic, tactical and operational in - formation management, organizational  structures for information management,  License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017",Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
© Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) University of Amsterdam: LectureUniversity of Heidelberg: LectureUMIT: LectureUniversity of Braunschweig: Lecture Student groups exerciseStudent groups exerciseStudent groups exerciseStudent groups exercise 3 days: Joint Three Days of the Frank - van Swieten Lectures Joint completion of exercises within international student groups Oral presentation by international student groupsBlock 2 Block 3University of Leipzig: Lecture Student groups exerciseFigure 1   Organization of the  Frank – van Swieten  Lectures.,Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
"c8 Students train their English capabilities,  learn about different countries’ styles of  HIS and experience different cultural  backgrounds.2.2 Universities and Educational  Programs Involved The participating students come (with  some variations over the last 16 years, for  details see ▶ Table 1) from the Medical In- formatics bachelor program of the Uni - versity of Amsterdam, from the Medical  Informatics master program of the Univer- sity of Heidelberg / University of Applied  Sciences Heilbronn, from the Medical In- formatics master program of the University  for Health Sciences, Medical Informatics  and Technology (UMIT) in Hall in Tirol,  from the Computer Science (in Econom - ics) master program of the University of  Braunschweig, and from the Computer  Science master program of the University  License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017Table 1 Year, participating universities, and location of the Joint Three Days of the Frank – van Swieten Lectures.",Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
Johann Peter Frank was an impor- tant protagonist in social medicine; be- tween 1779 and 1819 he published 6 vol- umes of a System of Complete Medical  © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )Table 2 Year and analysed sub-information systems of the Frank – van Swieten Lectures.,Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
"Here many responses of both (1) and (3)  again positively highlighted the opportun- License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017Table 3 Participating students, returned evaluation questionnaires and results to the question “C1.",Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
© Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
"License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017* Some of them – B.H., W .O.H., N.H., G.H.B., C.M.,  B.O., J.S., N.S., A.S. and M.v.d.H.",Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
: On Teaching International Courses © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )has been assistant lecturer at UMIT from  2003 to 2006.,Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
Available from:  http://www.who.int/goe/en/.,OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
Available from: http://vbn.aau.dk/ files/16597939/The_ Career_Paths.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
": On Teaching International Courses License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 201738.Laxer C, Daniels M, Cajander A, Wollowski M.  Evolution of an International Collaborative Stu- dent Project.",Non-OADS,/arxiv_data1/oa_pdf/54/70/ME-56-Open-16010124.PMC5388878.pdf
"Box 1627 FI-70211 Kuopio Finland E-mail: virpi.jylha@hotus.fiMethods Inf Med 2017; 56(Open): e30 – e38 https://doi.org/10.3414/ME16-01-0075 received: June 17, 2016 accepted: January 25, 2017 published: March 8, 2017 Funding Part of this research received funding from the   European Union’s Seventh Framework Program  (FP7/2007–2013) under grant agreement n° 223468.",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
"Consequently, the causes of errors are  not just the responsibility of the individual  nurse or physician but also of the hospital Original Articles OPEN ACCESS © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )The Impact of Information Culture  on Patient Safety Outcomes Development of a Structural Equation Model Virpi Jylhä1; Santtu Mikkonen2; Kaija Saranto1; David W. Bates3,4 1Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland;   2Department of Applied Physics, University of Eastern Finland, Kuopio, Finland;   3Division of General Medicine and Primary Care and Department of Medicine, Brigham and Women‘s Hospital,   Harvard Medical School, Boston, MA, USA;   4Partners HealthCare Information Systems, Division of Clinical and Quality Analysis, Wellesley, MA, USA",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017Figure 1 Hypothesized model modified from Reason’s model for the stages of development of organ- izational accidents [13].,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )Table 1   Survey items and de- scriptive statistics of  the constructs and  variables used in the  hypothesized model.Variable (n = 909) Information availability (5 items) Electronic patient data are available when needed.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017Table 2 Demographics of the respondents and descriptive statistics of the study variables.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )Figure 2   The final model with  the standardized  path coefficients.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017Table 3 Standardized direct and indirect total effects of the organizational factors (columns) on information management incidents and patient safety out- comes (rows).,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
Available from:  http://bok.ahima.org/PdfView?oid=300306.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
Available from: http://www.ecri.org/ Resources/HIT/CP_Toolkit/CopyPaste_Litera- ture_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
Available from:  http://eprints.soton.ac.uk/346019/1/High-Quality- Care-Metrics-for-Nursing----Nov-2012.pdf.V.,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
: The Impact of Information Culture on Patient Safety © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/fd/8c/ME-56-Open-16010075.PMC5388883.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/66/main.PMC5388907.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/66/main.PMC5388907.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.014Urology Case Reports 13 (2017) 1 e2,Non-OADS,/arxiv_data1/oa_pdf/0d/66/main.PMC5388907.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/16/main.PMC5388908.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/16/main.PMC5388908.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.018Urology Case Reports 13 (2017) 3 e5,Non-OADS,/arxiv_data1/oa_pdf/0f/16/main.PMC5388908.pdf
Studying SNP rs2596542C/T association with HCC and LC susceptibility revealed that statistical http://dx.doi.org/10.1016/j.jare.2017.03.004 2090-1232/ /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.,OADS,/arxiv_data1/oa_pdf/79/9f/main.PMC5388909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Peer review under responsibility of Cairo University.,Non-OADS,/arxiv_data1/oa_pdf/79/9f/main.PMC5388909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/9f/main.PMC5388909.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/9e/main.PMC5388910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/9e/main.PMC5388910.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.015Urology Case Reports 13 (2017) 6 e9,Non-OADS,/arxiv_data1/oa_pdf/9e/9e/main.PMC5388910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/ba/main.PMC5388911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/ba/main.PMC5388911.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.020Urology Case Reports 13 (2017) 10 e12,Non-OADS,/arxiv_data1/oa_pdf/da/ba/main.PMC5388911.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
http://dx.doi.org/10.1016/j.ymgmr.2017.03.006 2214-4269/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
"At present, according to the Human Gene Mutation Database (HGMD; http://www.hgmd.cf.ac.uk/ac/index.php ) 259 mutations caus- ing MSUD have been reported.",Non-OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
Puri ﬁed PCR products covering the entire coding region of each of the threegenes identi ﬁed on Ensembl ( http://www.ensembl.org/index.html ).,OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
"Mutation prediction, protein conservation, and modelling of mutationsin BCKDHA, BCKDHB and DBT Novel mutations were analyzed in silico using MutationTaster [10] and Polyphen2 to predict pathogenicity ( http://www.mutationtaster.",OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
"org/,http://genetics.bwh.harvard.edu/pph2/ ).",Non-OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
"Protein conservation was performed using the protein sequence alignment program, ClustalOmega ( http://www.ebi.ac.uk/Tools/msa/clustalo/ ) using sequences obtained from NCBI BLAST ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ).",OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
Intronic variants were analyzed using the BDGP: Splice Site Prediction by Neural Network program ( http://www.fruit ﬂy.org/seq_tools/splice.,OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
"html ) and by the NetGene2 ( http://www.cbs.dtu.dk/services/ NetGene2/ ) server, both of which are services producing neural net- work predictions of splice sites in various organisms.",OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
"Single Amino Acid Polymorphism data anal- ysis pipeline (SAAPdap; [13]), which contains fourteen structural analy- ses and one sequence-based analysis [14,15] were used to investigate the local structural effects of the novel missense mutations using Pro- tein Data Bank (PDB) structures ( http://www.rcsb.org/pdb/home/ home.do ).",OADS,/arxiv_data1/oa_pdf/2b/de/main.PMC5388912.pdf
This is an ope n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EzogabineRetigabine Anti-seizure drug Side effectSkin discolorationReversibility 1.,Non-OADS,/arxiv_data1/oa_pdf/58/d3/main.PMC5388913.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2017.01.001 2213-3232/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/58/d3/main.PMC5388913.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/d3/main.PMC5388913.pdf
"The most common ROS in human biology result for the reduction of oxygen http://dx.doi.org/10.1016/j.redox.2017.03.011 Received 23 January 2017; Received in revised form 12 February 2017; Accepted 9 March 2017⁎Correspondence to: Health Research Institute La Fe, Division of Neonatology, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell 106, 46026 Valencia, Spain.",Non-OADS,/arxiv_data1/oa_pdf/11/ed/main.PMC5388914.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/11/ed/main.PMC5388914.pdf
The latter binds substrate proteins and E2s http://dx.doi.org/10.1016/j.redox.2017.04.007 Received 15 December 2016; Received in revised form 1 April 2017; Accepted 3 April 2017⁎Corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/6d/main.PMC5388915.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1a/6d/main.PMC5388915.pdf
"Using this approach, it has been demonstrated that bioenergetic measures of http://dx.doi.org/10.1016/j.redox.2017.04.005 Received 17 January 2017; Received in revised form 28 March 2017; Accepted 1 April 2017⁎Correspondence to: University of Alabama at Birmingham, Center for AIDS Research, 845 19th Street South, BBRB 203, Birmingham, AL 35294, United States E-mail addresses: mandyrd@uab.edu (A.L.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"44 (2007) 726 –734, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"[2] D. Muyanja, C. Muzoora, A. Muyingo, W. Muyindike, M.J. Siedner, High prevalence of metabolic syndrome and cardiovascular disease risk among people with HIV on stable ART in Southwestern Uganda, AIDS Patient Care STDS 30 (2016) 4 –10, http://dx.doi.org/10.1089/apc.2015.0213 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"50 (2009) 499 –505, http://dx.doi.org/10.1097/QAI.0b013e31819c291b .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"65 (2014) 160 –166, http://dx.doi.org/10.1097/QAI.0000000000000009 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"21 (2003) 1377 –1382, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"Sterling, The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antire- troviral therapy, AIDS 30 (2016) 83 –91,http://dx.doi.org/10.1097/QAD.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"31 (2015) 898 –904, http://dx.doi.org/10.1089/AID.2015.0062 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"18 (2013) 65–75,http://dx.doi.org/10.3851/IMP2450 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"17 (2012)1281 –1289, http://dx.doi.org/10.3851/IMP2348 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"201 (2010) 1788 –1795, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"210 (2014) 1248 –1259, http://dx.doi.org/10.1093/infdis/jiu254 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"69 (2015) 154 –160, http://dx.doi.org/ 10.1097/QAI.0000000000000566 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"Benjamin, Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: theFramingham O ﬀspring Study, Diabetes Care 30 (2007) 2529 –2535, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"[16] G. Garrabou, S. Lopez, C. Moren, E. Martinez, J. Fontdevila, F. Cardellach, et al., Mitochondrial damage in adipose tissue of untreated HIV-infected patients, AIDS 25 (2011) 165 –170, http://dx.doi.org/10.1097/QAD.0b013e3283423219 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"12 (2005) 1417 –1428, http://dx.doi.org/10.1038/sj.cdd.4401668 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"207 (2013) 604 –611, http://dx.doi.org/10.1093/infdis/jis720 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"39 (2004) 710 –716, http://dx.doi.org/10.1086/423176 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"205 (2012) 1778 –1787, http://dx.doi.org/10.1093/ infdis/jis101 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"93 (2015) 177 –186, http://dx.doi.org/10.1007/s00109-014-1233-3 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"27 (2016) 2467 –2473, http://dx.doi.org/10.1681/ASN.2015060661 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"2 (2015) 40, http://dx.doi.org/10.1186/s40608-015-0070-4 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"95 (2010) 2948 –2956, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"Dis.9 (2013) 936 –941, http://dx.doi.org/10.1016/j.soard.2013.03.009 .",OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"127 (2014) 367 –373, http://dx.doi.org/10.1042/CS20140101 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
http://dx.doi.org/10.3791/ 51301 .,Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"95 (2015) 132 –141, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"[31] N. Cardenes, C. Corey, L. Geary, S. Jain, S. Zharikov, S. Barge, et al., Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation, Blood 123 (2014) 2864 –2872, http://dx.doi.org/10.1182/blood-2013-09-529420 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"10 (2016) 65 –77,http://dx.doi.org/10.1016/j.redox.2016.09.009 .",OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"70 (2015) 1394 –1399, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
http://dx.doi.org/10.1038/labinvest.2013.53 .,OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"8 (2016) 43–50,http://dx.doi.org/10.1016/j.redox.2015.12.008 .",OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"Rep. (2015) 35, http://dx.doi.org/10.1042/BSR20150161 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"O'Donnell, et al., Patterns of abdominal fat distribution: the Framingham Heart Study, Diabetes Care32 (2009) 481 –485, http://dx.doi.org/10.2337/dc08-1359 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"13 (2010) 197 –203, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"Dis.16 (2006) 513 –523, http://dx.doi.org/10.1016/j.numecd.2005.10.010 .",OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"36 (2012) 286 –294, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"31 (2010) 737 –746, http://dx.doi.org/10.1093/eurheartj/ehp487 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"Lewis, R. Kronmal, S. Heyms ﬁeld, et al., Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy, AIDS 24 (2010) 1717 –1726, http://dx.doi.org/10.1097/QAD.0b013e32833ac7a2 .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"42 (2006) 562 –571, http://dx.doi.org/10.1097/01.qai.0000229996.75116.da .",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"393 (2012) 1485 –1512, http://dx.doi.org/10.1515/hsz- 2012-0198 .A.L.",Non-OADS,/arxiv_data1/oa_pdf/24/92/main.PMC5388916.pdf
"Additionally, melatonin inhibits cAMP response element-binding protein (CREB) phosphoryla- http://dx.doi.org/10.1016/j.redox.2017.04.006 Received 19 March 2017; Received in revised form 27 March 2017; Accepted 1 April 2017⁎Correspondence to: Department of Physiology, Istanbul Medipol University, Regenerative and Restorative Medical Research Center, Ekinciler cad.",Non-OADS,/arxiv_data1/oa_pdf/d3/7c/main.PMC5388917.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d3/7c/main.PMC5388917.pdf
"23 38106 Braunschweig Germany E-mail: reinhold.haux@plri.deMethods Inf Med 2017;56(Open): e1– e10 https://doi.org/10.3414/ME16-01-0125 received: November 5, 2016 accepted: November 17, 2016 published: January 25, 2017 OPEN ACCESS © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )",Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
"At the factory, I was shown many pictures  License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017",Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
"Furthermore, I  would like to see more co-creating re- © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )",Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
© Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
John Mantas:  The adoption of the IMIA  educational recommendations [16] is a  License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
New  discoveries and disruptions often happen  © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
Available from: https://www.amia.,Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
Avail- able from: http://www.panarchy.org/vonberta lanffy/systems.1968.html.,Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
Available from: https://en.wikipedia.org/ wiki/Shannon%E2%80%93Weaver_model.,OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
Clinician preferences for verbal communi- © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/a6/43/ME-56-Open-16010125.PMC5388922.pdf
"Correspondence to: Fernan Gonzalez Bernaldo de Quiros, MD, MSc, FACMI Hospital Italiano de Buenos Aires Juan D. Perón 4190 (C1199ABB) Buenos Aires Argentina E-mail: fernan.quiros@hospitalitaliano.org.arMethods Inf Med 2017; 56(Open): e13 – e19 https://doi.org/10.3414/ME16-05-0001 received: February 2, 2016 accepted: May 30, 2016 published: February 1, 2017 * Written and extended version of a keynote   lecture the first author gave at Medinfo 2015  in Sao Paulo, Brazil.1.",Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
OPEN ACCESS © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
"For exam - ple, a recent study in the United States  showed that most of the variation in life ex- License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017",Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
The authors of this re- search noted in the conclusions that it will  © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
"These concrete  resources reflect “things” that people con- struct with and because of the information  in the context of their capacities and re- strictions; what they do with and from  their strengths and weaknesses, e.g., as - License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017",Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
"This proposal faces several limitations,  including the fact that, although at present  the human sciences are based on epistemo- © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )",Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
The Relation Be- License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
Avail- able from: http://www.oecd.org/dataoecd/44/41/  43891980.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
© Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/2d/93/ME-56-Open-16050001.PMC5388923.pdf
"© Schattauer 2017 Methods Inf Med Open/2017e11 For Discussion – Editorial Health Information Systems   Supporting Health and Resiliency  Through Improved Decision-making David Ring1; William M. Tierney2 1Department of Surgery & Perioperative Care, Dell Medical School, University of Texas at Austin, Austin, TX, USA;   2Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, TX, USA Correspondence to: William M. Tierney, MD Professor and Chair, Department of Population Health Dell Medical School, University of Texas at Austin 1912 Speedway, Suite 562 Austin, Texas 78712 USA E-mail: tierney@utexas.eduMethods Inf Med 2017; 56(Open): e11– e12 https://doi.org/10.3414/ME16-25-0001 published: February 1, 2017 OPEN ACCESS © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )We wish all illness was like strep throat: im- mediate, accurate diagnosis and rapid cure.",Non-OADS,/arxiv_data1/oa_pdf/2a/5c/ME-56-Open-16250001.PMC5388924.pdf
Methods Inf Med Open/2017 © Schattauer 2017e12 Editorial License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017and using EHRs in which both patients  and providers can actively participate.,Non-OADS,/arxiv_data1/oa_pdf/2a/5c/ME-56-Open-16250001.PMC5388924.pdf
"Correspondence to: See list of authors’ addresses at the end of the articleMethods Inf Med 2017; 56(Open): e20 – e29 https://doi.org/10.3414/ME16-15-0001 published: February 1, 2017 With these comments on the paper “Repre- sentation of People’s Decisions in Health  Information Systems: A Complementary  Approach for Understanding Health Care  Systems and Population Health” written by  Fernan Gonzalez Bernaldo de Quiros, Ad- riana Ruth Dawidowski, and Silvana Figar  [1], the journal seeks to stimulate a broad  discussion on the future role of health in- formation systems.",Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
•Person-centered approach  is “a non- directive approach to being with an- other; that believes in the other’s poten- tial and ability to make the right choices  OPEN ACCESS © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
It can  License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
"physicians, nurses) to collect  © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )",Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
"puts forth a challenge to health informatics  researchers and professionals to model, de- License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017",Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
There are plenty of reasons why  including patient preferences in the medi- © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
From each individual we  form millions in the world and while we Figure 1 Impact on a person’s decision People ChallengesBasic Life  Environment Reasoning ThinkingKnowledge UnderstoodInternal  Directed External DirectedBehavioral License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
"For instance, by knowing  that the arteries’ cross-sections were  © Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 )",Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
"For  example, requirements engineering meth- License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017",Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from: http://www.merriam- webster.com/dictionary/decision.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from: http://www.learners dictionary.com/definition/engagement.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from:  http://www.bapca.org.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from: http://www.merriam- webster.com/dictionary/conceptualize.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available  from: http://www.fda.gov/scienceresearch/special topics/personalizedmedicine/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from: http://www.un.org/sustain abledevelopment/sustainable-development-goals/.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from: http://apps.who.int/iris/bitstream/  10665/250047/1/9789241511308-eng.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from:  http://www.ahrq.gov/professionals/quality-pa tient-safety/talkingquality/create/sixdo- mains.html#_ftn1.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from: http://www.brainyquote.com/ quotes/quotes/s/stephencol578488.html.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
Available from: http://policylab.chop.edu/ project/social-determinants-healthcare-workload- acknowledging-social-risk-factors-health-care.,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
© Schattauer 2017 License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ),Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
16–18 04107 Leipzig Germany E-mail: alfred.winter@imise.uni-leipzig.de License terms: CC-BY-NC-ND ( https://creativecommons.org/licenses/by -nc-nd/4.0 ) © Schattauer 2017,Non-OADS,/arxiv_data1/oa_pdf/29/3a/ME-56-Open-16150001.PMC5388925.pdf
"sg Received 3 November 2016 Revised 12 March 2017Accepted 14 March 2017 ▸http://dx.doi.org/10.1136/ heartasia-2016-010867 To cite: Tan JWC, Lam CSP, Kasim SS, et al.Heart Asia 2017; 9:81–87.",Non-OADS,/arxiv_data1/oa_pdf/0b/b8/heartasia-2016-010818.PMC5388929.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Moran AE, Forouzanfar MH, Roth GA, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/b8/heartasia-2016-010818.PMC5388929.pdf
"2010. http://www.nice.org.uk/guidance/cg9424 Rof ﬁM, Patrono C, Collet J-P, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/b8/heartasia-2016-010818.PMC5388929.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/27/main.PMC5388930.pdf
http://dx.doi.org/10.1016/j.idcr.2017.03.013 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/27/main.PMC5388930.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  50–53 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/5b/27/main.PMC5388930.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.03.0172211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/46/main.PMC5388931.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/46/main.PMC5388931.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/cc/46/main.PMC5388931.pdf
The patients http://dx.doi.org/10.1016/j.ymgmr.2017.01.017 Received 28 December 2016; Received in revised form 18 January 2017; Accepted 18 January 2017☆The authors do not have con ﬂict of interests concerning this work.,Non-OADS,/arxiv_data1/oa_pdf/df/5e/main.PMC5388932.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/df/5e/main.PMC5388932.pdf
http://dx.doi.org/10.1007/8904_ 2015_469 .,Non-OADS,/arxiv_data1/oa_pdf/df/5e/main.PMC5388932.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/e4/main.PMC5388933.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.03.038 2049-0801/ ©2017 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/34/e4/main.PMC5388933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 17 (2017) 54 e60,Non-OADS,/arxiv_data1/oa_pdf/34/e4/main.PMC5388933.pdf
"2015 (2015), http://dx.doi.org/10.1093/ mmcts/mmv034 pii: mmv034.",Non-OADS,/arxiv_data1/oa_pdf/34/e4/main.PMC5388933.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.02.008,Non-OADS,/arxiv_data1/oa_pdf/ea/82/main.PMC5388934.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,9 6 –97 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ea/82/main.PMC5388934.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.02.009,Non-OADS,/arxiv_data1/oa_pdf/7f/64/main.PMC5388935.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,9 8–100 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/7f/64/main.PMC5388935.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,9 8–100 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/7f/64/main.PMC5388935.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.03.020 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/j.amepre.2016.,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1162/rest_a_00217 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/ 10.1007/s12160-012-9403-4 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/j.evolhumbehav.2009.07.005 .,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Available from: http://www.cdc.gov/growthcharts/html_charts/bmiagerev.htm [Accessed 10th September].,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Available from: http://www.cdc.gov/nchs/data/hestat/obesity_ child_09_10/obesity_child_09_10.htm [Accessed 19th September].,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
"Normal Weight, Overweight, and Obesity Among Adults Aged 20 and over, by Selected Characteristics: United States, Selected Years 1988 – 1994 Through 2011 –2014 Available from: http://www.cdc.gov/nchs/data/hus/ 2015/058.pdf [Accessed 25th June].",Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Available from: http://www.cdc.gov/nchs/fastats/ obesity-overweight.htm [Accessed 21st June].,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1007/bf00846145 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
"2012, 290589. http://dx.doi.org/10.1155/2012/290589 .",Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1037/0278-6133.13.5.373 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/j.jpeds.2013.01.009 .,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1542/peds.2014- 0063 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/j.cct.,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Pediatrics115 (1):22 –27.http://dx.doi.org/10.1542/peds.2004-0220 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1542/peds.2008-1284 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1162/003355300554917 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1186/s13104-014-0959-x .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
BMC Public Health 16:618. http://dx.doi.org/10.1186/ s12889-016-3244-1 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1177/ 0899764006295993 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
"http://dx.doi.org/10.1016/j.ypmed.2011.12.024 .Jeffery, R.W., Gerber, W.M., Rosenthal, B.S., Li ndquist, R.A., 1983.",OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1037//0022-006x.51.2.242 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1037/0893-3200.20.2.175 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00002 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/j.acap.,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1093/aepp/ppu014 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
75:75 –85.http://dx.doi.org/10.1016/j.ypmed.2015.,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
3. http://dx.doi.org/10.1002/14651858.CD009728.pub2 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
1 (1):e5 –e6.http://dx.doi.org/10.1016/ S2213-8587(13)70016-0 .,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/j.amepre.2013.06.017 .,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1111/opo.12112 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1002/ 14651858.CD001872.pub2 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Facts 2 (1):17 –24.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/j.jand.2014.03.011 .,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1001/jamapediatrics.2015.3778 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1080/17437199.2015.1030685 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Available from: http://quickfacts.census.gov/qfd/states/06/06067.html [Accessed 10th February].,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1001/jama.2008.804 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1016/S0140-6736(11)60814-3 .,OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
http://dx.doi.org/10.1001/archpedi.158.4.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Trials 14:95. http://dx.doi.org/10.1186/1745- 6215-14-95 .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
Available from: http://college.wfu.edu/economics/ wp-content/uploads/hashemi_working_paper.pdf [Accessed 2nd April].293 B.-K. Yoo et al.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/main.PMC5388936.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/96/main.PMC5388938.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/96/main.PMC5388938.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Figure 5 |Heat treatment composed of exposure to 25 6C for 10 days of fire salamanders naturally infected with Batrachochytrium salamandrivorans .After ascertaining presence of B. salamandrivorans in all animals they were subjected to an ambient temperature of 25 uC for 10 days.",Non-OADS,/arxiv_data1/oa_pdf/ad/98/srep08037.PMC5389025.pdf
"Among the 20 molecules listed by the National Cancer Institute forthe treatment of mCRC (http://www.cancer.gov/cancertopics/treatment/colon-and-rectal), cetuximab is one ofthe most successful monoclonal antibodies (http://www.croh-online.com/article/S1040-8428(13)00102-9/fulltext) 3,4.",Non-OADS,/arxiv_data1/oa_pdf/14/8e/srep08013.PMC5389028.pdf
As of November 2014; 1881 primary miRNA transcripts in the human genome has been annotated in the miRBase database (http://www.mirbase.org).,OADS,/arxiv_data1/oa_pdf/14/8e/srep08013.PMC5389028.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/8e/srep08013.PMC5389028.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/ea/srep08036.PMC5389030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8036 | DOI: 10.1038/srep08036 11",Non-OADS,/arxiv_data1/oa_pdf/c2/ea/srep08036.PMC5389030.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/54/srep08074.PMC5389051.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8074 | DOI: 10.1038/srep08074 8",Non-OADS,/arxiv_data1/oa_pdf/ce/54/srep08074.PMC5389051.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/48/main.PMC5389100.pdf
The  patient  was  subjected  to  a  skin-nipple-sparing  mastectomy with  the  insertion  of  a  breast  expander  also  after  having  gone through  the  technique  of  sentinel  lymph  node  and  extemporane- http://dx.doi.org/10.1016/j.ijscr.2017.03.016 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/16/48/main.PMC5389100.pdf
http://dx.doi.org/10.1016/j.mmcr.2017.04.001 Received 30 January 2017; Received in revised form 30 March 2017; Accepted 5 April 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/1e/17/main.PMC5389101.pdf
This is an open access article under the CC  BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/17/main.PMC5389101.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5389103.pdf
"At  27 years  of  age,  following  the  sudden  onset  of  hematemesis,  an  upper gastrointestinal  endoscopy  revealed  esophageal  varices  that  were positive for  the  red  color  (RC)  sign  without  any  evidence  of  active http://dx.doi.org/10.1016/j.ijscr.2017.03.036 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5389103.pdf
"GeneReviews®, University of Washington, Seattle,  2008,  Updated 24 Apr 2014  https://www.ncbi.nlm.nih.gov/books/NBK2701/ .",Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5389103.pdf
"(2016),  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2e/07/main.PMC5389103.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/da/main.PMC5389106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/da/main.PMC5389106.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.021Urology Case Reports 13 (2017) 16 e18,Non-OADS,/arxiv_data1/oa_pdf/a2/da/main.PMC5389106.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/57/main.PMC5389107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/57/main.PMC5389107.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.014Urology Case Reports 13 (2017) 13 e15,Non-OADS,/arxiv_data1/oa_pdf/47/57/main.PMC5389107.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/7e/main.PMC5389108.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.03.024 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/7e/main.PMC5389108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 84 e85,Non-OADS,/arxiv_data1/oa_pdf/33/7e/main.PMC5389108.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5389110.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.004 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5389110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 82 e83,Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5389110.pdf
"26 (7) (2008 Mar 1) 1171 e1174, http://dx.doi.org/10.1200/JCO.2007.14.8106 .",Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5389110.pdf
"Marine Regions (2014)at ,http://www.marineregions.org/ ., date of access: 30/10/2014.",Non-OADS,/arxiv_data1/oa_pdf/72/01/srep08481.PMC5389130.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/01/srep08481.PMC5389130.pdf
"Images for both19F and1H nuclei were acquired using the bSSFP sequence and post-processing of data using ImageJ (National Institutes of Health, USA, http://imagej.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
"The four acquisitions were combined by the sum of squares method using ImageJ (National Institutes of Health, USA, http://imagej.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
"European Journal of Pharmaceutical Sciences 27, 27–36, doi:http://dx.doi.org/10.1016/j.ejps.",Non-OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
"Biomaterials 22, 2857–2865, doi:http://dx.doi.org/10.1016/S0142-9612(01)00030-8 (2001).",OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
"Biochimica et Biophysica Acta (BBA) - Biomembranes 1062 , 142–148, doi:http://dx.doi.org/10.1016/0005- 2736(91)90385-L (1991).",OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
"FEBS Lett 284, 263–266, doi:http://dx.doi.org/10.1016/0014-5793(91)80699- 4 (1991).",OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
"Biochimica et Biophysica Acta (BBA) - Biomembranes 944, 144–154, doi:http://dx.doi.org/10.1016/0005- 2736(88)90427-0 (1988).",OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8427 | DOI: 10.1038/srep08427 10",Non-OADS,/arxiv_data1/oa_pdf/48/b0/srep08427.PMC5389132.pdf
http://www.google.org/flutrends/us/data.txt (Date of access: 12/09/2013).,OADS,/arxiv_data1/oa_pdf/44/83/srep08154.PMC5389136.pdf
http://www.afro.who.,Non-OADS,/arxiv_data1/oa_pdf/44/83/srep08154.PMC5389136.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs110/en/.,Non-OADS,/arxiv_data1/oa_pdf/08/87/IJSTD-38-100.PMC5389208.pdf
Available from: http://www.who.int/mediacentre/ factsheets/antibiotic‑resistance/en/.,Non-OADS,/arxiv_data1/oa_pdf/08/87/IJSTD-38-100.PMC5389208.pdf
Available from: http://www.who.int/mediacentre/ factsheets/antibiotic‑resistance/en/.,Non-OADS,/arxiv_data1/oa_pdf/a5/5e/IJSTD-38-101.PMC5389209.pdf
Available from:  http://www.mospi.nic.in/mospi_new/upload/elderly_in_india.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/dc/IJSTD-38-15.PMC5389211.pdf
Gorman M. Development and the Rights of Older People; 1999  Available from: http://www.popline.org/node/529164.,Non-OADS,/arxiv_data1/oa_pdf/d2/dc/IJSTD-38-15.PMC5389211.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d2/dc/IJSTD-38-15.PMC5389211.pdf
Available  from: http://www.files.unaids.org/en/media/unaids/contentassets/ documents/epidemiology/2013/gr2013/UNAIDS_Global_ Report_2013_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8b/2b/IJSTD-38-47.PMC5389215.pdf
Available from: https://www.aids.gov/ hiv‑aids‑basics/just‑diagnosed‑with‑hiv‑aids/hiv‑in‑your ‑body/stages‑ of‑hiv/.,Non-OADS,/arxiv_data1/oa_pdf/8b/2b/IJSTD-38-47.PMC5389215.pdf
Available from: http://www.who.int/hiv/pub/imai/om_appendix.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8b/2b/IJSTD-38-47.PMC5389215.pdf
Available from: http://www.scielo.br/scielo.,Non-OADS,/arxiv_data1/oa_pdf/8b/2b/IJSTD-38-47.PMC5389215.pdf
Available from: http://naco.gov.in/ documents/annual‑reports.,OADS,/arxiv_data1/oa_pdf/d4/3e/IJSTD-38-54.PMC5389216.pdf
Available from: http://naco.gov.in/ documents/annual‑reports.,OADS,/arxiv_data1/oa_pdf/d4/3e/IJSTD-38-54.PMC5389216.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/45/47/SJA-11-137.PMC5389230.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/45/47/SJA-11-137.PMC5389230.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/53/c9/SJA-11-144.PMC5389231.pdf
Available from: http://www.clevelandclinicmeded.,Non-OADS,/arxiv_data1/oa_pdf/dc/ff/SJA-11-222.PMC5389244.pdf
"Here, we seek to elucidate the relationship between Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> Received 17 March 2016 | Accepted 7 April 2017 | Published 10 April 2017© 2017 Molecular Vision 210Complement C5a receptor knockout has diminished light-induced  microglia/macrophage retinal migration Delu Song,1 Michael E. Sulewski Jr,1 Chenguang Wang,1,2 Jiantao Song,1,3 Rupak Bhuyan,1 Jacob Sterling,1  Esther Clark,1 Wen-Chao Song,4 Joshua L. Dunaief1 (The third and fourth authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  211complement anaphylatoxins and microglia in the light damage  model using C3aR and C5aR KO mice.,Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  212RESULTS Upregulation of complement genes after light damage:   Several genes in the complement pathway were upregulated  in the neural retina by light damage.,Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
"Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  213negative controls for C3aR and C5aR labeling, respectively.",Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
"Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  214DISCUSSION In this study, we compared the microglia/macrophage  response in the retina following light damage in WT mice  versus mice lacking one of two complement anaphylatoxin  receptors, C3aR or C5aR.",Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
"Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  215neural retina, the mRNA levels of Cfb, Cfd, C3, and C5 in  the retina were significantly increased following light damage  suggesting that more C5a would be generated.",Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  216anaphylatoxins were found to contribute to CNV and macro - phage recruitment in choroid tissue [ 15].,Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  217REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
Molecular Vision  2017; 23:210-218 <http://www.molvis.org/molvis/v 23/210> © 2017 Molecular Vision  21824.,Non-OADS,/arxiv_data1/oa_pdf/41/cc/mv-v23-210.PMC5389337.pdf
"Both Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> Received 18 October 2016 | Accepted 31 March 2017 | Published 3 April 2017© 2017 Molecular Vision 198Cone dystrophy or macular dystrophy associated with novel  autosomal dominant GUCA1A  mutations Gaël Manes,1,2 Sonia Mamouni,3 Emilie Hérald,2 Anne-Claire Richard,2 Audrey Sénéchal,1 Karim Aouad,4  Béatrice Bocquet,2,3 Isabelle Meunier,1,2,3 Christian P. Hamel1,2,3 1Institut National de la Santé et de la Recherche Médicale, U1051, Institute for Neurosciences of Montpellier, Montpellier,  France; 2University of Montpellier, Montpellier, France; 3CHRU, Genetics of Sensory Diseases, Montpellier, France; 4Aravis  Medical Center, Ophthalmology Department, Argonay, France Purpose:  Sixteen different mutations in the guanylate cyclase activator 1A gene ( GUCA1A ), have been previously identi - fied to cause autosomal dominant cone dystrophy (adCOD), cone–rod dystrophy (adCORD), macular dystrophy (adMD),  and in an isolated patient, retinitis pigmentosa (RP).",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
"Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  199guanylate cyclases are expressed in rods and cones, but GC1  is predominantly expressed in cones [ 15-18].",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  200Table  1.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  201 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  202(MTP434 and MTP1560) were performed.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  203delayed.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  204cosegregation analysis was possible to validate the mutation  [30].,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  205 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  206 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
"Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  2071), namely p.Leu84Phe [ 36], p.Glu89Lys [ 27], Tyr99Cys  [37], p.Asp100Gly [ 38], p.Ile107Thr [ 36], and p.Leu176Phe  [39].",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  2087.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
Molecular Vision  2017; 23:198-209 <http://www.molvis.org/molvis/v 23/198> © 2017 Molecular Vision  209inherited cone disorders.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/mv-v23-198.PMC5389339.pdf
This is an Open Access artic le distributed under the terms  of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/licenses/by-nc/3.0) DOI 10.1080/17453674.2017.1297918Abstract —  The combination of modern interventional and pre- ventive medicine has led to an epidemic of ageing.,Non-OADS,/arxiv_data1/oa_pdf/88/5d/iort-87-1.PMC5389427.pdf
"Retrieved January 25, 2016, from http://www.who.int/healthinfo/ survey/ageingdefnolder/en/.",OADS,/arxiv_data1/oa_pdf/88/5d/iort-87-1.PMC5389427.pdf
